<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/sitemap_generator/default/sitemap.xsl"?>
<!--Generated by the Simple XML Sitemap Drupal module: https://drupal.org/project/simple_sitemap.-->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
 <url>
  <loc>https://www.novartis.com/</loc>
  <lastmod>2022-08-25T07:25:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/andreas-von-planta</loc>
  <lastmod>2022-07-05T11:31:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/william-winters</loc>
  <lastmod>2022-07-05T11:41:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/ton-buechner</loc>
  <lastmod>2022-07-05T10:30:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/harry-kirsch</loc>
  <lastmod>2022-04-04T07:06:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/james-bradner</loc>
  <lastmod>2022-09-12T14:00:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/simon-moroney</loc>
  <lastmod>2022-07-05T10:25:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/patrice-bula</loc>
  <lastmod>2022-07-19T15:43:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/nancy-andrews</loc>
  <lastmod>2022-07-05T10:27:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/joerg-reinhardt</loc>
  <lastmod>2022-07-05T10:22:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/frans-van-houten</loc>
  <lastmod>2022-07-05T11:30:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/karen-hale</loc>
  <lastmod>2022-05-17T10:22:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/klaus-moosmayer</loc>
  <lastmod>2022-04-04T07:05:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/lutz-hegemann</loc>
  <lastmod>2022-08-16T15:50:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/marie-france-tschudin</loc>
  <lastmod>2022-04-04T07:20:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/elizabeth-doherty</loc>
  <lastmod>2022-07-05T10:37:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/michael-willi</loc>
  <lastmod>2022-04-04T07:02:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/charlotte-pamer-wieser</loc>
  <lastmod>2022-07-05T11:43:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/charles-sawyers</loc>
  <lastmod>2022-09-29T17:06:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/richard-saynor</loc>
  <lastmod>2022-04-04T07:05:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/bridgette-heller</loc>
  <lastmod>2022-07-05T10:58:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/vasant-narasimhan</loc>
  <lastmod>2022-05-23T21:27:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/steffen-lang</loc>
  <lastmod>2022-04-04T09:12:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-and-european-union-eu/novartis-eu-public-affairs-team/arnaud-maheas</loc>
  <lastmod>2021-09-22T11:29:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-and-european-union-eu/novartis-eu-public-affairs-team/elke-grooten</loc>
  <lastmod>2021-09-22T11:31:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-and-european-union-eu/novartis-eu-public-affairs-team/julie-chauvet</loc>
  <lastmod>2021-09-22T11:33:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-and-european-union-eu/novartis-eu-public-affairs-team/julie-de-smet</loc>
  <lastmod>2021-09-22T11:34:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-and-european-union-eu/novartis-eu-public-affairs-team/vincent-vanwijnsberghe</loc>
  <lastmod>2021-09-22T12:30:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-and-european-union-eu/novartis-eu-public-affairs-team/sarah-moundir</loc>
  <lastmod>2022-05-18T15:15:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/structure-of-life</loc>
  <lastmod>2021-10-19T10:24:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/wonderwall</loc>
  <lastmod>2021-10-19T10:26:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/guangwu-untitled</loc>
  <lastmod>2021-10-19T10:27:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/towards-twilight</loc>
  <lastmod>2021-10-19T10:28:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/stele-of-guernica</loc>
  <lastmod>2021-10-19T10:30:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/tyger-tyger</loc>
  <lastmod>2021-10-19T10:34:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/shell-light-green</loc>
  <lastmod>2021-10-19T10:36:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/curve-and-straight-line</loc>
  <lastmod>2021-10-19T10:38:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/bee-opera</loc>
  <lastmod>2021-10-19T10:39:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/chemiebild-die-neue-zeit</loc>
  <lastmod>2021-10-19T10:40:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/walkway</loc>
  <lastmod>2021-10-19T10:45:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/seven-stones</loc>
  <lastmod>2021-10-19T10:55:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/table</loc>
  <lastmod>2021-10-19T10:56:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/dirk-s-pod</loc>
  <lastmod>2021-10-19T10:42:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/el-anatsui_tismenskiblo</loc>
  <lastmod>2021-10-19T10:52:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/partnering-leadership-team/nigel-sheail</loc>
  <lastmod>2021-09-23T18:52:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/partnering-leadership-team/philip-gotwals</loc>
  <lastmod>2021-09-23T18:55:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/partnering-leadership-team/neil-johnston</loc>
  <lastmod>2021-09-23T18:58:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/partnering-leadership-team/susanne-kreutz</loc>
  <lastmod>2021-09-23T19:00:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/partnering-leadership-team/ulrich-uili-osswald</loc>
  <lastmod>2021-09-23T19:03:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/partnering-leadership-team/jean-marc-sequier</loc>
  <lastmod>2021-09-23T19:05:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/partnering-leadership-team/anne-witt</loc>
  <lastmod>2021-09-23T19:07:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/partnering-leadership-team/knut-sturmhoefel</loc>
  <lastmod>2021-09-23T19:11:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/partnering-leadership-team/markus-kalousek</loc>
  <lastmod>2022-01-07T12:55:46+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/rob-kowalski</loc>
  <lastmod>2022-04-04T07:05:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/strategy/data-and-digital/artificial-intelligence/shahram-ebadollahi</loc>
  <lastmod>2021-10-07T12:16:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/cloud-modules</loc>
  <lastmod>2021-11-12T09:02:22+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/various-compositions</loc>
  <lastmod>2021-11-12T09:02:28+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/the-end-of-2012</loc>
  <lastmod>2021-11-12T09:02:36+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/cluster-3</loc>
  <lastmod>2021-11-12T09:02:40+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection/lin-untitled</loc>
  <lastmod>2021-11-12T09:02:46+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/partnering-leadership-team/osama-nabulsi</loc>
  <lastmod>2022-01-07T12:04:52+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/who-we-are/christoph-buerki</loc>
  <lastmod>2022-07-25T14:47:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/who-we-are/anton-gerdenitsch</loc>
  <lastmod>2022-07-25T14:46:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/who-we-are/harald-oberegger</loc>
  <lastmod>2022-08-11T08:29:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/who-we-are/sheik-abdul-hafidz</loc>
  <lastmod>2022-08-11T09:03:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/who-we-are/isabel-feuerstein</loc>
  <lastmod>2022-08-11T08:27:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/who-we-are/markus-stemp</loc>
  <lastmod>2022-08-11T09:03:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/who-we-are/franziska-zangerl</loc>
  <lastmod>2022-08-11T09:05:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/who-we-are/rathish-ravindrakumar</loc>
  <lastmod>2022-08-11T08:16:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/daniel-hochstrasser</loc>
  <lastmod>2022-07-05T11:02:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/ana-de-pro-gonzalo</loc>
  <lastmod>2022-06-29T10:54:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/victor-bulto</loc>
  <lastmod>2022-05-02T11:40:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/who-we-are/emily-dubis</loc>
  <lastmod>2022-07-25T14:47:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/who-we-are/amit-kumar-rai</loc>
  <lastmod>2022-07-25T14:46:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/kees-roks</loc>
  <lastmod>2022-05-17T19:23:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/shreeram-aradhye</loc>
  <lastmod>2022-08-04T11:25:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/aharon-ronny-gal-phd</loc>
  <lastmod>2022-09-12T14:02:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/who-we-are/carrie-bracco</loc>
  <lastmod>2022-08-11T15:39:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/who-we-are/lauren-perdue</loc>
  <lastmod>2022-08-11T15:38:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/who-we-are/jana-wuenschmann</loc>
  <lastmod>2022-08-11T15:38:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/manufacturing-facility-stein-ch</loc>
  <lastmod>2021-10-11T09:11:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-campus-walkway</loc>
  <lastmod>2021-08-16T07:48:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-production-and-manufacturing-b-roll-video</loc>
  <lastmod>2021-08-16T07:51:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/karen-l-hale</loc>
  <lastmod>2022-04-04T07:08:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-pavillon-rendering-7</loc>
  <lastmod>2021-08-16T09:12:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/what-non-alcoholic-steatohepatitis-nash</loc>
  <lastmod>2021-08-16T07:56:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/access-fact-sheet</loc>
  <lastmod>2021-08-16T09:06:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/healthy-family-fact-sheet</loc>
  <lastmod>2021-08-16T09:09:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/thalassemia-backgrounder</loc>
  <lastmod>2021-08-16T07:59:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/sickle-cell-disease-backgrounder</loc>
  <lastmod>2021-08-16T08:02:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/chronic-iron-overload-backgrounder</loc>
  <lastmod>2021-08-16T08:04:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/myelodysplastic-syndromes-mds-backgrounder</loc>
  <lastmod>2021-08-16T08:06:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/anaplastic-lymphoma-kinase-positive-non-small-cell-lung-cancer-interactive-media-guide</loc>
  <lastmod>2021-08-16T08:09:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/neuroendocrine-tumors-expert-media-guide</loc>
  <lastmod>2021-08-16T08:11:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/leprosy</loc>
  <lastmod>2021-08-16T08:13:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/reimagining-management-sickle-cell-disease-africa</loc>
  <lastmod>2021-08-16T08:14:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/malaria</loc>
  <lastmod>2022-03-15T09:27:38+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/chagas-disease</loc>
  <lastmod>2021-08-16T08:18:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-access-fact-sheet</loc>
  <lastmod>2021-08-03T20:09:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/chronic-myeloid-leukemia-today-and-tomorrow-visual-fact-sheet</loc>
  <lastmod>2021-08-10T19:47:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/renal-cell-carcinoma-rcc-fact-sheet</loc>
  <lastmod>2021-08-10T19:48:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/early-versus-advanced-breast-cancer-list</loc>
  <lastmod>2021-08-10T19:49:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/frontal-view-gehry-building</loc>
  <lastmod>2021-08-16T09:15:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/gehry-building-from-distance</loc>
  <lastmod>2021-08-16T09:17:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/center-campus-from-aerial-view</loc>
  <lastmod>2021-08-16T09:18:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tables-and-chairs-next-green-space</loc>
  <lastmod>2021-08-16T09:19:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/steffen-lang-phd</loc>
  <lastmod>2022-04-04T07:07:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-logo</loc>
  <lastmod>2021-10-19T15:46:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/frans-van-houten</loc>
  <lastmod>2021-08-16T10:14:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/charlotte-pamer-wieser-phd</loc>
  <lastmod>2021-08-16T10:16:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/michael-willi</loc>
  <lastmod>2022-04-04T07:06:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/william-t-winters</loc>
  <lastmod>2021-08-16T10:25:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/charles-l-sawyers-md</loc>
  <lastmod>2021-08-16T10:26:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/andreas-von-planta-phd</loc>
  <lastmod>2021-08-16T10:28:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/elizabeth-liz-doherty</loc>
  <lastmod>2021-08-16T10:31:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/ton-buechner</loc>
  <lastmod>2021-08-16T10:33:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/nancy-c-andrews-md-phd</loc>
  <lastmod>2021-08-16T10:35:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/joerg-reinhardt-phd</loc>
  <lastmod>2021-08-16T10:38:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/vasant-vas-narasimhan-md</loc>
  <lastmod>2022-04-04T07:02:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/trees-casting-shadows-along-fabrikstrasse</loc>
  <lastmod>2021-08-13T07:10:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/james-jay-bradner-md</loc>
  <lastmod>2022-04-04T07:02:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/harry-kirsch</loc>
  <lastmod>2022-04-04T07:07:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/aerial-view-basel-campus-novartis-hq</loc>
  <lastmod>2021-08-16T10:48:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/antimalarial-pills</loc>
  <lastmod>2021-08-16T10:49:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/antimalarial-raw-material</loc>
  <lastmod>2021-08-16T10:51:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/artemisinin-combination-therapy-act</loc>
  <lastmod>2021-08-16T10:54:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/artemisinin-extraction</loc>
  <lastmod>2021-08-16T10:58:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/farmer-harvesting-artemisia-annua</loc>
  <lastmod>2021-08-16T11:01:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/hedge-and-trees-along-fabrikstrasse</loc>
  <lastmod>2021-08-16T11:02:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/malaria-diagnostic-test</loc>
  <lastmod>2021-08-16T11:06:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/malaria-prevention</loc>
  <lastmod>2021-08-16T11:10:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/malaria-researchers-nairobi-kenya</loc>
  <lastmod>2021-08-16T11:13:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/marie-france-tschudin</loc>
  <lastmod>2022-04-04T07:06:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/mode-action-cgrp-receptor-blocker</loc>
  <lastmod>2021-08-16T11:28:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-pavillon-rendering-8</loc>
  <lastmod>2021-08-16T11:31:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-pavillon-rendering-9</loc>
  <lastmod>2021-08-16T11:32:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/patients-frozen-t-cells</loc>
  <lastmod>2021-08-16T11:39:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/richard-saynor</loc>
  <lastmod>2022-04-04T07:06:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/sms-life</loc>
  <lastmod>2021-08-16T13:19:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/sms-life-training-session</loc>
  <lastmod>2021-08-16T13:22:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/t-cell-arrival-novartis-manufacturing-facility</loc>
  <lastmod>2021-08-16T13:23:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-fabrikstrasse-novartis-hq</loc>
  <lastmod>2021-08-16T13:24:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/worldwide-distribution-center-novartis-antimalarial-basel-switzerland</loc>
  <lastmod>2021-08-16T13:30:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/young-malaria-patient</loc>
  <lastmod>2021-08-16T13:32:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/covid-19-novartis-response</loc>
  <lastmod>2021-08-16T13:34:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/cancer-2030-growing-global-crisis</loc>
  <lastmod>2021-08-16T13:35:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/sickle-cell-world-assessment-survey-sway-results</loc>
  <lastmod>2021-08-16T13:35:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/new-era-medicine</loc>
  <lastmod>2021-08-16T13:37:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/cell-and-gene-key-focus-areas</loc>
  <lastmod>2021-08-16T13:40:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/introduction-cell-and-gene-therapy</loc>
  <lastmod>2021-08-16T13:42:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-financial-results-q3-2018-infographic</loc>
  <lastmod>2021-08-16T13:44:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/side-image-gehry-building</loc>
  <lastmod>2021-08-16T09:21:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/klaus-moosmayer-phd</loc>
  <lastmod>2022-04-04T07:07:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-financial-results-q2-2018-infographic</loc>
  <lastmod>2021-08-12T06:34:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/impact-migraine</loc>
  <lastmod>2021-08-12T06:51:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-financial-results-q1-2018-infographic</loc>
  <lastmod>2021-08-12T07:26:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/spinal-muscular-atrophy-sma-infographic</loc>
  <lastmod>2021-08-13T13:21:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/inflammation-and-cardiovascular-risk</loc>
  <lastmod>2021-08-12T07:45:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/measuring-inflammation-and-role-hscrp</loc>
  <lastmod>2021-08-16T07:42:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/chimeric-antigen-receptor-t-cell-car-t-therapy</loc>
  <lastmod>2021-08-16T13:45:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/chronic-iron-overload-infographic</loc>
  <lastmod>2021-08-12T07:55:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/chronic-myleoid-leukemia-meet-milestones-matter-one-pager</loc>
  <lastmod>2021-08-12T07:57:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/facts-about-melanoma-infographic</loc>
  <lastmod>2021-08-12T08:03:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/chronic-iron-overload-complications-infographic</loc>
  <lastmod>2021-08-12T08:04:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/anaplastic-lymphoma-kinase-non-small-cell-lung-cancer-disease-state-infographic</loc>
  <lastmod>2021-08-12T08:09:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/about-noncommunicable-diseases-infographic</loc>
  <lastmod>2021-08-12T08:15:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/access-ncd-treatment-infographic</loc>
  <lastmod>2021-08-12T08:16:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/understanding-chronic-myeloid-leukemia-infographic</loc>
  <lastmod>2021-08-12T08:19:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/gastrointestinal-neuroendocrine-tumors-infographic</loc>
  <lastmod>2021-08-12T08:27:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/pancreatic-neuroendocrine-tumors-infographic</loc>
  <lastmod>2021-08-12T08:36:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/lung-neuroendocrine-tumors-infographic</loc>
  <lastmod>2021-08-12T08:44:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tuberous-sclerosis-complex-patient-journey-infographic</loc>
  <lastmod>2021-08-12T08:52:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/advanced-soft-tissue-sarcoma-infographic</loc>
  <lastmod>2021-08-12T08:52:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tuberous-sclerosis-complex-common-threads-infographic</loc>
  <lastmod>2021-08-12T09:04:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/renal-cell-carcinoma-infographic</loc>
  <lastmod>2021-08-12T09:06:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/embarking-young-adulthood-tsc-monitoring-manifestations-over-time</loc>
  <lastmod>2021-08-12T09:06:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/psychological-social-impact-advanced-breast-cancer</loc>
  <lastmod>2021-08-12T09:12:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-society-us-report-2020</loc>
  <lastmod>2021-08-12T09:14:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-society-esg-report-2020</loc>
  <lastmod>2021-08-12T09:28:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-annual-report-2020</loc>
  <lastmod>2021-08-12T09:30:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-annual-report-2019</loc>
  <lastmod>2021-08-16T08:35:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-society-us-report-2019</loc>
  <lastmod>2021-08-12T09:53:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/malaria-futures-central-africa</loc>
  <lastmod>2021-08-12T09:58:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-society-esg-report-2019</loc>
  <lastmod>2021-08-12T10:03:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/malaria-futures-asia</loc>
  <lastmod>2021-08-12T10:23:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-social-business-report-2018</loc>
  <lastmod>2021-08-12T10:29:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-society-us-report-2018</loc>
  <lastmod>2021-08-12T10:35:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-society-report-2018</loc>
  <lastmod>2022-02-01T18:02:31+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/malaria-futures-africa</loc>
  <lastmod>2021-08-12T10:46:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-annual-report-2018</loc>
  <lastmod>2021-08-12T10:50:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-annual-report-2017</loc>
  <lastmod>2021-08-12T10:50:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/healthy-family-10-year-report</loc>
  <lastmod>2021-08-12T10:54:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-access-two-year-report</loc>
  <lastmod>2021-08-12T10:59:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/corporate-responsibility-report-2017</loc>
  <lastmod>2021-08-12T10:59:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-access-one-year-report</loc>
  <lastmod>2021-08-12T11:08:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/building-trust-society-our-priorities</loc>
  <lastmod>2021-08-16T09:02:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/strengthening-our-global-health-corporate-responsibility-function</loc>
  <lastmod>2021-08-13T08:18:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/spinal-muscular-atrophy-sma-factsheet</loc>
  <lastmod>2021-08-13T08:51:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/heart-failure-hospitalization-why-moment-matters</loc>
  <lastmod>2021-08-13T08:46:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/about-migraine</loc>
  <lastmod>2021-08-13T08:55:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/diffuse-large-b-cell-lymphoma-dlbcl</loc>
  <lastmod>2021-08-13T09:01:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/acute-lymphoblastic-leukemia-all</loc>
  <lastmod>2021-08-13T09:46:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/acute-lymphoblastic-leukemia-fact-sheet</loc>
  <lastmod>2021-08-13T09:51:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/advancing-global-health</loc>
  <lastmod>2021-08-13T10:03:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/chronic-myeloid-leukemia-background-fact-sheet</loc>
  <lastmod>2021-08-12T11:55:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/science-behind-car-t-cell-therapy</loc>
  <lastmod>2021-08-13T13:16:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/manufacturing-car-t-cell-therapies-novartis-approach</loc>
  <lastmod>2021-08-12T13:13:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-pavillon-rendering-4</loc>
  <lastmod>2021-08-13T10:22:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-pavillon-rendering-6</loc>
  <lastmod>2021-10-05T06:50:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-pavillon-rendering-5</loc>
  <lastmod>2021-08-12T14:23:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-pavillon-rendering-3</loc>
  <lastmod>2021-08-13T10:26:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-pavillon-rendering-1</loc>
  <lastmod>2021-08-13T10:34:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-pavillon-rendering-2</loc>
  <lastmod>2021-08-13T10:31:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/lutz-hegemann-md-phd</loc>
  <lastmod>2022-06-20T11:31:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/bridgette-heller</loc>
  <lastmod>2021-08-12T14:40:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/simon-moroney-dphil</loc>
  <lastmod>2021-08-12T14:48:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/bad-sackingen-novartis-stein-switzerland</loc>
  <lastmod>2021-08-12T14:54:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/operator-culture-medium-bag</loc>
  <lastmod>2021-08-12T14:58:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-site-stein-switzerland</loc>
  <lastmod>2021-08-12T15:02:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/marc-boutin</loc>
  <lastmod>2021-10-05T14:35:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/operators-clean-room</loc>
  <lastmod>2021-08-13T06:19:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/operator-labels-culture-plates</loc>
  <lastmod>2021-08-13T06:23:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/operator-prepares-connecting-hose</loc>
  <lastmod>2021-08-13T06:25:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/patrice-bula</loc>
  <lastmod>2022-03-03T10:25:30+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/people-park</loc>
  <lastmod>2021-08-13T06:31:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/break-park</loc>
  <lastmod>2021-08-13T06:33:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/operator-performs-process-operation-biosafety-cabinet</loc>
  <lastmod>2021-08-13T06:36:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/grocery-shop-staircase</loc>
  <lastmod>2021-08-13T06:40:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/staircase-visitor-center</loc>
  <lastmod>2021-08-13T06:57:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/avenue-trees-along-fabrikstrasse</loc>
  <lastmod>2021-08-13T07:03:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tower-surrounding-buildings</loc>
  <lastmod>2021-08-13T07:09:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/courtyard-koi-pond-and-trees</loc>
  <lastmod>2021-08-13T07:10:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/sitting-koi-pond</loc>
  <lastmod>2021-08-13T07:16:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-visitor-center-trees</loc>
  <lastmod>2021-08-13T07:16:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-staircase-gehry-building</loc>
  <lastmod>2021-08-13T07:25:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/first-results-from-global-net-survey-part-1-time-diagnosis</loc>
  <lastmod>2021-08-13T07:51:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tackling-chronic-disease-novartis-access</loc>
  <lastmod>2021-10-12T11:24:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/results-from-first-global-net-survey-part-2-net-patient-experience</loc>
  <lastmod>2021-08-13T08:32:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/what-polycythemia-vera</loc>
  <lastmod>2021-08-13T07:56:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/how-polycythemia-vera-diagnosed</loc>
  <lastmod>2021-08-13T07:59:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/what-are-symptoms-and-complications-polycythemia-vera</loc>
  <lastmod>2021-08-13T08:11:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tsc-common-threads-future-outlook-tsc</loc>
  <lastmod>2021-08-13T08:18:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tsc-common-threads-grandia-family-story</loc>
  <lastmod>2021-08-13T08:33:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tsc-talk-did-you-know</loc>
  <lastmod>2021-08-13T08:33:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tsc-common-threads-tsc-affects-each-person-differently</loc>
  <lastmod>2021-08-13T08:40:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tsc-common-threads-moss-family</loc>
  <lastmod>2021-08-13T08:44:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tsc-common-threads-life-tsc</loc>
  <lastmod>2021-08-13T08:46:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/acute-myeloid-leukemia-unique-needs-patients-and-caregivers</loc>
  <lastmod>2021-08-13T08:52:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/alk-non-small-cell-lung-cancer-patient-video-anne-marie</loc>
  <lastmod>2021-08-13T08:57:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/alk-non-small-cell-lung-cancer-patient-video-miriam-joel</loc>
  <lastmod>2021-08-13T09:06:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-access-how-well-expand-access-healthcare</loc>
  <lastmod>2021-08-13T09:12:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/experts-gather-explore-response-chronic-illness-poor-countries</loc>
  <lastmod>2021-08-13T09:12:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-and-international-red-cross-partner-provide-medicines-syrian-refugees</loc>
  <lastmod>2021-08-13T09:18:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/museum-ms</loc>
  <lastmod>2021-08-13T09:21:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/what-do-you-know-about-noncommunicable-diseases</loc>
  <lastmod>2021-08-13T09:27:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/about-erenumab-amg-334</loc>
  <lastmod>2021-09-09T10:48:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/erenumab-amg-334-key-clinical-trials-numbers</loc>
  <lastmod>2021-09-09T10:48:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/how-does-acz885-work</loc>
  <lastmod>2021-09-09T10:48:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/juliet-clinical-trial</loc>
  <lastmod>2021-09-09T10:48:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/kymriahtmtisagenlecleucel-children-and-young-adults-b-cell-all-refractory-or-relapsed-least-twice</loc>
  <lastmod>2021-09-09T10:47:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/rth258-brolucizumab-clinical-trials</loc>
  <lastmod>2021-09-09T10:47:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/kymriahtm-tisagenlecleucel-suspension-intravenous-infusion</loc>
  <lastmod>2021-10-12T11:01:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/interleukin-17-il-17a-inflammatory-joint-disease</loc>
  <lastmod>2021-09-09T10:47:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/interleukin-17-il-17a-psoriasis</loc>
  <lastmod>2021-09-09T10:46:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/rob-kowalski</loc>
  <lastmod>2022-04-04T07:07:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/managing-tsc-transition-adult-care</loc>
  <lastmod>2021-10-06T09:33:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/square-3-novartis-campus</loc>
  <lastmod>2021-11-05T23:27:32+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/physic-garden-3-novartis-campus</loc>
  <lastmod>2021-11-05T23:28:00+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/nibr-basel</loc>
  <lastmod>2021-11-05T23:28:38+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/nibr-cambridge-united-states</loc>
  <lastmod>2021-11-05T23:28:53+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-animated-logo</loc>
  <lastmod>2021-11-05T23:29:09+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/forum-3-novartis-campus</loc>
  <lastmod>2021-11-05T23:29:48+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/fabrikstrasse-6-visitor-center-novartis-campus</loc>
  <lastmod>2021-11-05T23:31:58+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/fabrikstrasse-28-novartis-campus</loc>
  <lastmod>2021-11-25T15:20:24+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/fabrikstrasse-18-novartis-campus</loc>
  <lastmod>2021-11-25T15:20:24+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/fabrikstrasse-16-novartis-campus</loc>
  <lastmod>2021-11-25T15:20:24+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/fabrikstrasse-15-novartis-campus</loc>
  <lastmod>2021-11-25T15:20:24+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/fabrikstrasse-14-novartis-campus</loc>
  <lastmod>2021-11-25T15:20:27+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/fabrikstrasse-12-novartis-campus</loc>
  <lastmod>2021-11-25T15:20:27+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/fabrikstrasse-10-novartis-campus</loc>
  <lastmod>2021-11-25T15:20:27+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/fabrikstrasse-4-novartis-campus</loc>
  <lastmod>2021-11-25T15:20:27+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-forum-1-and-fabrikstrasse-novartis-campus-basel</loc>
  <lastmod>2021-12-07T14:30:18+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-fabrikstrasse-15-novartis-campus-basel</loc>
  <lastmod>2021-12-07T10:11:08+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/outside-meeting-space-novartis-campus-basel</loc>
  <lastmod>2021-12-08T09:48:37+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-asklepios-8-along-rhine-riverbank-novartis-campus-basel</loc>
  <lastmod>2021-12-07T14:29:09+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-towards-asklepios-8-and-dreirosenbruckebasel-novartis-campus-basel</loc>
  <lastmod>2021-12-07T14:37:40+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-banting-1-and-novartis-campus-basel</loc>
  <lastmod>2021-12-13T10:14:35+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-banting-1</loc>
  <lastmod>2021-12-13T10:14:45+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-novartis-campus-and-banting-1-basel</loc>
  <lastmod>2021-12-13T10:14:23+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-banting-1-and-fabrikstrasse-novartis-campus-basel</loc>
  <lastmod>2022-01-26T15:09:13+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-banting-1-and-fabrikstrasse-6-passing-cyclist-novartis-campus-basel</loc>
  <lastmod>2022-01-26T15:18:29+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-banting-1-and-fabrikstrasse-6-novartis-campus-basel</loc>
  <lastmod>2022-01-26T15:18:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-annual-report-2021</loc>
  <lastmod>2022-02-01T23:17:40+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/ana-de-pro-gonzalo</loc>
  <lastmod>2022-03-04T14:59:28+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/daniel-hochstrasser</loc>
  <lastmod>2022-03-04T15:00:01+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-novartis-campus-forum-1-banting-1-and-fabrikstrasse</loc>
  <lastmod>2022-04-05T15:44:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-pavillon-banting-1-background</loc>
  <lastmod>2022-04-05T15:45:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-pavillon-novartis-campus-and-banting-1-background</loc>
  <lastmod>2022-04-05T15:45:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-from-novartis-campus-towards-novartis-pavillon-and-basel-alongside-rhine-river</loc>
  <lastmod>2022-04-05T15:46:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-from-novartis-campus-towards-novartis-pavillon-and-basel</loc>
  <lastmod>2022-04-05T15:48:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-pavillon-located-park-south-novartis-campus</loc>
  <lastmod>2022-04-05T15:51:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/illumination-zero-energy-media-facade-novartis-pavillon-artwork-semiconductor-0</loc>
  <lastmod>2022-04-05T15:50:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/illumination-zero-energy-media-facade-novartis-pavillon-artwork-semiconductor</loc>
  <lastmod>2022-04-05T15:52:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/illumination-zero-energy-media-facade-novartis-pavillon-0</loc>
  <lastmod>2022-04-05T15:52:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/illumination-zero-energy-media-facade-novartis-pavillon</loc>
  <lastmod>2022-04-05T15:53:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/organic-solar-cell-led-core-which-builds-illuminating-skin-novartis-pavillon</loc>
  <lastmod>2022-04-05T15:54:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/schoolhub-ground-floor-novartis-pavillon</loc>
  <lastmod>2022-04-05T15:54:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/interior-view-ground-floor-novartis-pavillon</loc>
  <lastmod>2022-04-05T15:55:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/welcome-wall-and-staircase-exhibition-wonders-medicine-novartis-pavillon</loc>
  <lastmod>2022-04-05T15:56:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/welcome-wall-novartis-pavillon</loc>
  <lastmod>2022-04-05T15:56:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/content-area-fragility-life-wonders-medicine-exhibition-novartis-pavillon</loc>
  <lastmod>2022-04-05T15:57:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/victor-bulto</loc>
  <lastmod>2022-04-04T07:08:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/kees-roks</loc>
  <lastmod>2022-05-02T11:41:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/shreeram-aradhye-md</loc>
  <lastmod>2022-08-04T10:29:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/crizanlizumab-clinical-setting-from-international-managed-access-program-map</loc>
  <lastmod>2022-06-17T12:20:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/aharon-ronny-gal-phd</loc>
  <lastmod>2022-09-12T14:17:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/about-gene-therapy</loc>
  <lastmod>2022-08-12T09:29:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/gene-therapy-manufacturing-north-carolina</loc>
  <lastmod>2022-08-12T09:34:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/about-novartis-gene-therapies</loc>
  <lastmod>2022-10-03T10:34:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-gene-therapies-manufacturing-process</loc>
  <lastmod>2022-10-03T10:31:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/screen-unseen-newborn-screening-sma</loc>
  <lastmod>2022-08-12T09:22:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-aav-platform</loc>
  <lastmod>2022-10-03T10:28:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/spinal-muscular-atrophy</loc>
  <lastmod>2022-08-12T09:33:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/scientist-laboratory-banting-1-office-space-background</loc>
  <lastmod>2022-09-05T16:45:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/scientists-fermentation-hub-banting-1</loc>
  <lastmod>2022-09-05T16:45:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/fermentation-hub-banting-1-where-natural-products-and-biomolecules-can-be-produced</loc>
  <lastmod>2022-09-05T16:45:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/scientists-one-state-art-laboratories-banting-1</loc>
  <lastmod>2022-09-05T16:45:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/scientists-laboratory-banting-1-where-global-discovery-chemistry-group-based</loc>
  <lastmod>2022-09-05T16:45:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/pandemic-has-been-reset-pharmas-reputation</loc>
  <lastmod>2021-09-10T11:48:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/moving-towards-next-normal</loc>
  <lastmod>2021-09-21T06:27:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/enabling-stable-supply-medicines-during-covid-19</loc>
  <lastmod>2021-09-21T06:31:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/overcoming-manufacturing-challenges</loc>
  <lastmod>2021-09-21T06:32:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/proactive-scenario-planning-and-supply-risk-management</loc>
  <lastmod>2021-09-21T06:34:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/supply-chain-organization-during-covid-19-pandemic</loc>
  <lastmod>2021-09-21T06:41:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/coronavirus-giving-health-and-pharma-companies-chance-woo-tech-talent</loc>
  <lastmod>2021-09-21T06:45:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/pharmas-pandemic-response-could-help-attract-tech-talent</loc>
  <lastmod>2021-09-21T06:46:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/new-era-healthcare-innovation</loc>
  <lastmod>2021-09-21T07:06:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/developing-drugs-during-pandemic</loc>
  <lastmod>2021-09-21T07:18:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/breaking-through-glass-ceiling-spring-women-artificial-intelligence</loc>
  <lastmod>2021-09-21T07:22:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/curious-advantage-curiosity-ceo-and-chief-people-and-organization-officer-perspective</loc>
  <lastmod>2021-09-21T08:04:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-pharmaceuticals-head-chief-marie-france-tschudin-rethinking-drug-launch-formula</loc>
  <lastmod>2021-09-21T08:06:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-ceo-vasant-narasimhan-building-trust-society</loc>
  <lastmod>2021-09-21T08:13:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/how-be-boss-unbossed-company</loc>
  <lastmod>2021-09-21T08:19:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/medicines-and-transformative-effect</loc>
  <lastmod>2021-09-21T08:21:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/its-time-pivot-towards-transformational-innovation</loc>
  <lastmod>2021-09-21T08:24:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-flipping-pyramid-explains-steven-baert</loc>
  <lastmod>2021-09-21T08:35:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/fortunes-most-admired-pharmaceutical-companies-2019</loc>
  <lastmod>2021-09-21T08:38:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/science-and-business-innovative-medicines</loc>
  <lastmod>2021-09-21T08:40:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/how-long-till-final-world-malaria-day</loc>
  <lastmod>2021-09-21T08:49:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-and-government-cameroon-sign-agreement-fight-chronic-diseases</loc>
  <lastmod>2021-09-21T08:51:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/changing-world</loc>
  <lastmod>2021-09-21T08:53:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/increasing-access-ncd-treatments-uganda</loc>
  <lastmod>2021-09-21T08:54:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-and-government-pakistan-sign-memorandum-understanding</loc>
  <lastmod>2021-09-21T08:56:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-perspective-key-fighting-chronic-disease-south-east-asia-young-people</loc>
  <lastmod>2021-09-21T09:20:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-perspective-how-smart-partnerships-can-help-us-fight-chronic-disease-africa</loc>
  <lastmod>2021-09-21T09:22:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/what-really-driving-malaria-control-personal-accountability-and-passion-community-health-workers</loc>
  <lastmod>2021-09-21T09:29:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/juncture-malaria-eradication</loc>
  <lastmod>2021-09-21T09:37:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/world-malaria-report-2016-keeping-momentum</loc>
  <lastmod>2021-09-21T09:39:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-perspectives-pharma-partners-african-countries-chronic-diseases</loc>
  <lastmod>2021-09-21T09:56:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/confronting-next-global-health-challenge</loc>
  <lastmod>2021-09-21T11:30:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/new-strategies-improving-access-lower-income-countries</loc>
  <lastmod>2021-09-21T11:32:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/tackling-chronic-disease-novartis-access</loc>
  <lastmod>2021-09-21T11:33:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/price-drugs-should-reflect-value-they-deliver</loc>
  <lastmod>2021-09-21T11:44:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-perspectives-making-medicines-affordable-worlds-poorest-people</loc>
  <lastmod>2021-09-21T11:53:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/reigniting-passion-science</loc>
  <lastmod>2021-09-21T12:11:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-perspectives-how-new-business-models-can-help-fight-chronic-diseases</loc>
  <lastmod>2021-09-21T12:27:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-perspectives-kenyas-new-health-care-battle</loc>
  <lastmod>2021-09-21T12:34:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/perfecting-access-through-embedded-sustainability-pooling-resources-and-consolidating-expertise</loc>
  <lastmod>2021-09-21T12:41:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/expanding-access-healthcare-what-will-it-really-take</loc>
  <lastmod>2021-09-21T13:21:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/malarias-deadly-comeback</loc>
  <lastmod>2021-09-21T13:23:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-perspectives-expanding-access-healthcare-what-will-it-really-take</loc>
  <lastmod>2021-09-21T13:27:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-hosts-second-stakeholder-dialogue</loc>
  <lastmod>2021-09-21T13:29:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-perspectives-fighting-africas-future-epidemics</loc>
  <lastmod>2021-09-21T13:33:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/beautiful-medicine-rediscover-power-natures-exquisite-complexity</loc>
  <lastmod>2021-09-21T13:34:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/crispr-genome-editing-fuels-cancer-drug-discovery</loc>
  <lastmod>2021-09-21T13:36:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-perspectives-tailoring-tactics-tackle-chronic-disease-low-income-countries</loc>
  <lastmod>2021-09-29T12:08:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/joe-jimenez-how-improve-healthcare</loc>
  <lastmod>2021-09-21T13:44:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-one-year-report</loc>
  <lastmod>2021-09-29T10:40:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-ceo-outlines-how-improve-pandemic-preparedness-warns-another-one-bound-happen</loc>
  <lastmod>2021-10-04T16:58:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/terms-use</loc>
  <lastmod>2021-09-29T14:31:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy</loc>
  <lastmod>2022-05-04T13:35:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/home</loc>
  <lastmod>2022-08-25T07:25:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/page-not-found</loc>
  <lastmod>2022-09-15T15:05:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers</loc>
  <lastmod>2022-09-08T07:17:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/news-archive</loc>
  <lastmod>2022-06-23T08:12:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/event-calendar</loc>
  <lastmod>2022-09-29T10:12:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data</loc>
  <lastmod>2022-09-21T09:02:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/shareholder-information</loc>
  <lastmod>2022-01-31T14:56:04+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors</loc>
  <lastmod>2022-03-03T14:52:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee</loc>
  <lastmod>2022-09-12T14:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/contacts</loc>
  <lastmod>2021-10-07T19:54:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/about-clinical-trials</loc>
  <lastmod>2022-01-11T11:57:49+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/glossary-clinical-trial-terms</loc>
  <lastmod>2021-10-04T11:09:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/medical-congresses-and-events</loc>
  <lastmod>2022-09-10T09:05:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/research-disease-areas</loc>
  <lastmod>2021-10-08T10:37:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs</loc>
  <lastmod>2022-09-01T16:01:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/early-talent/us-nibr-internship-programs</loc>
  <lastmod>2022-09-16T09:18:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/awards-and-recognition</loc>
  <lastmod>2022-07-14T13:21:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/company-overview/corporate-governance</loc>
  <lastmod>2022-05-16T13:17:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-teams/careers-digital</loc>
  <lastmod>2022-03-28T14:34:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-teams/careers-research</loc>
  <lastmod>2022-06-22T15:09:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-teams/careers-information-technology-it</loc>
  <lastmod>2021-10-19T19:35:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-teams/careers-procurement</loc>
  <lastmod>2021-10-19T19:37:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-teams/careers-health-safety-environment</loc>
  <lastmod>2021-10-19T19:34:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-teams/careers-people-organization</loc>
  <lastmod>2021-10-19T19:37:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-teams/careers-medical-development</loc>
  <lastmod>2021-11-09T16:08:00+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-teams/careers-communications-and-engagement</loc>
  <lastmod>2022-08-25T13:33:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-teams/careers-commercial</loc>
  <lastmod>2022-08-30T13:52:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-teams/careers-consulting</loc>
  <lastmod>2021-10-19T19:32:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-teams/careers-strategy</loc>
  <lastmod>2021-10-19T19:39:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-teams/careers-manufacturing-supply</loc>
  <lastmod>2022-04-26T10:25:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/novartis-alumni</loc>
  <lastmod>2021-10-11T09:36:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/novartis-alumni/alumni-life</loc>
  <lastmod>2022-05-17T12:28:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/novartis-alumni/alumni-stories</loc>
  <lastmod>2022-06-27T14:18:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/personal-growth</loc>
  <lastmod>2022-08-23T13:18:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/well-being</loc>
  <lastmod>2021-10-11T08:29:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/international-careers</loc>
  <lastmod>2021-10-07T16:33:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/how-we-work</loc>
  <lastmod>2022-07-25T14:28:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/share-data-analysis/share-overview</loc>
  <lastmod>2021-09-03T15:38:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/share-data-analysis/share-ownership</loc>
  <lastmod>2022-01-27T16:27:08+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/share-data-analysis/return-investment-calculator</loc>
  <lastmod>2022-08-24T15:24:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/share-data-analysis/dividend-information</loc>
  <lastmod>2022-04-05T11:42:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/shareholder-information/american-depository-receipts-adr/adr-voting-center</loc>
  <lastmod>2022-02-07T19:46:31+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/shareholder-information/share-buy-back</loc>
  <lastmod>2021-11-08T09:29:56+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/annual-results</loc>
  <lastmod>2022-02-08T13:52:24+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results</loc>
  <lastmod>2022-07-25T17:09:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/share-data-analysis/share-monitor</loc>
  <lastmod>2021-09-02T14:20:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2019-q3-transcript</loc>
  <lastmod>2021-09-22T11:59:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2019-q4-and-full-year-results-transcript</loc>
  <lastmod>2021-09-22T11:35:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/sec-filings</loc>
  <lastmod>2021-10-11T16:08:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/product-sales</loc>
  <lastmod>2022-02-01T17:27:49+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2020-q1-transcript</loc>
  <lastmod>2021-09-22T11:26:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2020-q2-transcript</loc>
  <lastmod>2021-09-22T11:02:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/expected-currency-impact</loc>
  <lastmod>2022-09-21T09:05:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/shareholder-information/american-depository-receipts-adr</loc>
  <lastmod>2022-01-28T13:41:38+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2020-q3-transcript</loc>
  <lastmod>2021-11-02T17:32:21+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2020-q4-and-full-year-results-transcript</loc>
  <lastmod>2021-09-22T17:03:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2021-q2-transcript</loc>
  <lastmod>2021-09-22T17:04:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2021-q1-transcript</loc>
  <lastmod>2021-09-22T17:03:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/strategy</loc>
  <lastmod>2022-09-22T08:44:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-and-european-union-eu/eucancerplan</loc>
  <lastmod>2021-09-30T10:53:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-and-european-union-eu/novartis-eu-public-affairs-team</loc>
  <lastmod>2022-05-18T15:16:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/25-years-novartis-more-250-years-innovation</loc>
  <lastmod>2021-10-19T11:08:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/investigator-initiated-trials-studies</loc>
  <lastmod>2022-08-10T16:37:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/environmental-sustainability/waste</loc>
  <lastmod>2022-02-01T10:38:56+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/novartis-external-funding</loc>
  <lastmod>2022-02-21T16:06:46+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/research-development-approach</loc>
  <lastmod>2021-09-22T09:02:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/healthcare-professional-resources-country</loc>
  <lastmod>2022-09-08T09:08:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/patients-and-caregivers/novartis-commitment-patients-and-caregivers</loc>
  <lastmod>2022-04-08T13:54:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/environmental-sustainability/climate</loc>
  <lastmod>2022-05-17T08:14:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/environmental-sustainability/climate/case-study-breezhaler-carbon-footprint</loc>
  <lastmod>2022-05-13T08:50:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/environmental-sustainability/water</loc>
  <lastmod>2022-06-13T11:20:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond/car-t-healthcare-professionals/science-car-t-cell-therapy</loc>
  <lastmod>2021-10-07T18:50:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/no-filter-when-kidney-stops-working</loc>
  <lastmod>2021-09-13T13:42:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/community-approach-health-equity</loc>
  <lastmod>2021-09-13T13:47:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond/car-t-healthcare-professionals/process-car-t-cell-therapy</loc>
  <lastmod>2021-10-07T18:50:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/malaria</loc>
  <lastmod>2022-08-10T16:23:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/sickle-cell-disease</loc>
  <lastmod>2022-08-17T10:51:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/stay-up-to-date/subscribed</loc>
  <lastmod>2021-11-03T15:55:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/stay-date/subscription-cancelled</loc>
  <lastmod>2021-09-15T13:46:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/coronavirus/patients-caregivers</loc>
  <lastmod>2021-09-15T14:03:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/chagas-disease</loc>
  <lastmod>2022-04-14T12:45:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/novartis-annual-reporting-suite</loc>
  <lastmod>2022-08-10T16:36:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/leprosy</loc>
  <lastmod>2022-01-27T18:28:50+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/translational-medicine-research-novartis</loc>
  <lastmod>2022-07-13T18:03:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/reporting/transparency-and-disclosure</loc>
  <lastmod>2022-08-19T10:00:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/reporting/transparency-and-disclosure/patient-organization-funding</loc>
  <lastmod>2022-06-28T12:14:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/reporting/transparency-and-disclosure/payments-healthcare-professionals</loc>
  <lastmod>2022-07-07T11:23:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/reporting/transparency-and-disclosure/living-wage</loc>
  <lastmod>2022-02-01T14:36:40+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/strategy/people-and-culture/we-are-inspiring-our-people</loc>
  <lastmod>2022-04-25T11:04:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/strategy/people-and-culture/we-are-instilling-curiosity</loc>
  <lastmod>2021-11-24T15:45:55+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/strategy/people-and-culture/we-create-unbossed-environment</loc>
  <lastmod>2022-05-03T07:35:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/reporting/transparency-and-disclosure/public-policy-advocacy</loc>
  <lastmod>2022-02-01T18:09:33+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/reporting/transparency-and-disclosure/safe-workplace</loc>
  <lastmod>2021-09-28T11:08:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/reporting/transparency-and-disclosure/animal-research</loc>
  <lastmod>2022-05-18T21:26:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/coronavirus/our-response-covid-19</loc>
  <lastmod>2022-09-08T08:05:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/coronavirus/patients-and-caregivers-covid-19-information</loc>
  <lastmod>2021-10-08T16:13:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/novartis-quantitative-sciences-academic-industry-symposium-2021</loc>
  <lastmod>2021-10-12T07:57:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/novartis-institutes-biomedical-research/nibr-global-scholars-program</loc>
  <lastmod>2022-04-07T22:57:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/coronavirus/healthcare-professionals-covid-19-information</loc>
  <lastmod>2021-10-11T09:01:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/coronavirus/covid-19-country-resources</loc>
  <lastmod>2021-10-08T18:59:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/coronavirus/perspectives-covid-19</loc>
  <lastmod>2021-10-19T11:20:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/diversity-inclusion/equity</loc>
  <lastmod>2022-09-08T07:13:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/coronavirus/can-covid-clinical-trial</loc>
  <lastmod>2021-10-07T16:42:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/diversity-inclusion/diversity-inclusion-governance-and-community</loc>
  <lastmod>2021-09-30T10:45:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/diversity-inclusion/equity/our-equal-pay-international-coalition-epic-commitments</loc>
  <lastmod>2021-09-30T10:46:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/diversity-inclusion/equity/lgbtqi-equity</loc>
  <lastmod>2022-06-30T17:12:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/diversity-inclusion/inclusivity</loc>
  <lastmod>2022-09-08T07:14:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/diversity-inclusion/parental-leave</loc>
  <lastmod>2022-05-03T07:37:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/novartis-access-principles</loc>
  <lastmod>2021-10-19T11:25:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/novartis-access-principles/research-development</loc>
  <lastmod>2022-05-24T13:48:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/novartis-access-principles/affordability</loc>
  <lastmod>2022-02-01T19:43:28+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/novartis-access-principles/strengthening-healthcare-systems</loc>
  <lastmod>2022-02-01T16:50:51+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/environmental-social-and-governance</loc>
  <lastmod>2021-09-21T14:04:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/patents-and-licensing</loc>
  <lastmod>2022-02-01T10:21:19+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/donations</loc>
  <lastmod>2022-09-13T14:32:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/strategy/data-and-digital/artificial-intelligence/novartis-ai-life-residency-program</loc>
  <lastmod>2022-05-17T14:04:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/digital-solutions</loc>
  <lastmod>2022-03-21T16:29:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/generics-and-biosimilars</loc>
  <lastmod>2022-03-23T14:32:49+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/privacy-policy</loc>
  <lastmod>2022-05-04T13:45:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/innovative-medicines</loc>
  <lastmod>2022-01-06T17:25:18+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/novartis-binding-corporate-rules-bcr</loc>
  <lastmod>2022-05-04T13:36:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/shareholder-information/frequently-asked-questions</loc>
  <lastmod>2022-07-20T18:41:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/general-privacy-notice-external-stakeholders</loc>
  <lastmod>2022-05-04T13:46:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/managed-access-programs</loc>
  <lastmod>2022-02-09T16:25:45+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/shareholder-information/general-meetings</loc>
  <lastmod>2022-06-28T13:37:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/novartis-directory</loc>
  <lastmod>2022-07-28T17:41:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/our-approach-partnering</loc>
  <lastmod>2022-03-21T17:56:53+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/partnering-leadership-team</loc>
  <lastmod>2022-01-07T12:51:51+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/creating-sustainable-business-models</loc>
  <lastmod>2022-01-27T19:11:14+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/creating-sustainable-business-models/novartis-access</loc>
  <lastmod>2022-02-01T09:59:28+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/creating-sustainable-business-models/healthy-family-programs</loc>
  <lastmod>2022-01-28T08:39:48+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/guidelines/novartis-facebook-community-guidelines</loc>
  <lastmod>2021-09-24T09:05:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/guidelines/novartis-instagram-community-guidelines</loc>
  <lastmod>2021-09-24T09:11:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/guidelines/novartis-linkedin-community-guidelines</loc>
  <lastmod>2021-09-24T09:13:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/guidelines/novartis-twitter-community-guidelines</loc>
  <lastmod>2021-09-24T09:15:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/guidelines/novartis-youtube-community-guidelines</loc>
  <lastmod>2021-09-24T09:17:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/fixed-income-securities</loc>
  <lastmod>2022-09-21T23:08:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/clinical-trials-faqs</loc>
  <lastmod>2021-10-11T12:46:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/patients-and-caregivers</loc>
  <lastmod>2022-01-11T12:01:01+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/innovative-medicines/novartis-pharmaceuticals/novartis-gene-therapies/what-cell-and-gene-therapy</loc>
  <lastmod>2021-10-06T10:55:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/innovative-medicines/novartis-pharmaceuticals/novartis-gene-therapies/cell-and-gene-therapy-explained-vox-creative</loc>
  <lastmod>2021-10-06T10:53:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond/car-t-healthcare-professionals</loc>
  <lastmod>2021-10-07T18:50:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/transparency</loc>
  <lastmod>2021-12-14T09:59:19+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/ethics-clinical-trials</loc>
  <lastmod>2022-02-11T09:12:17+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/diversity-inclusion/society</loc>
  <lastmod>2022-09-08T07:14:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/fixed-income-securities/disclaimer</loc>
  <lastmod>2021-09-28T10:59:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/novartis-oncology-access</loc>
  <lastmod>2021-10-12T16:05:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/fixed-income-securities/sustainability-linked-bond-documents</loc>
  <lastmod>2021-09-28T10:54:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/novartis-annual-reporting-suite/reporting-archive</loc>
  <lastmod>2022-02-16T13:50:21+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/reporting/targets</loc>
  <lastmod>2022-08-19T10:09:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/reporting/materiality-assessment</loc>
  <lastmod>2022-07-14T14:22:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/research-locations/novartis-institute-tropical-diseases</loc>
  <lastmod>2021-10-11T10:55:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/novartis-institutes-biomedical-research/collaborations</loc>
  <lastmod>2021-10-07T14:31:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/coronavirus/nibr-science-therapeutics-symposium</loc>
  <lastmod>2021-10-08T16:43:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/reporting/positions</loc>
  <lastmod>2022-09-06T11:18:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/reporting/codes-policies-and-guidelines</loc>
  <lastmod>2022-09-30T08:58:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/contacts/media-contacts</loc>
  <lastmod>2022-09-01T08:20:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/contacts/investor-contacts</loc>
  <lastmod>2022-06-09T11:30:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/research-locations</loc>
  <lastmod>2021-10-11T10:59:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/community-exploration-learning-lab-cell</loc>
  <lastmod>2021-10-08T19:33:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about-novartis</loc>
  <lastmod>2021-09-29T18:00:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/andreas-bender-phd</loc>
  <lastmod>2022-09-05T10:27:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/sereina-riniker-phd</loc>
  <lastmod>2022-09-05T10:29:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/boxun-lu-phd</loc>
  <lastmod>2022-09-05T10:28:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/novartis-innovation-postdoctoral-fellowship</loc>
  <lastmod>2022-09-05T10:57:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/novartis-discovery-postdoctoral-fellowship</loc>
  <lastmod>2022-09-05T10:58:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes</loc>
  <lastmod>2021-09-30T15:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors</loc>
  <lastmod>2022-03-01T23:58:11+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/novartis-esg-update-april-29-2020</loc>
  <lastmod>2021-10-05T11:18:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/event-calendar/novartis-enters-agreement-acquire-medicines-company</loc>
  <lastmod>2021-10-01T16:15:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/ethical-behavior/code-ethics</loc>
  <lastmod>2021-10-12T15:54:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/ethical-behavior/speakup</loc>
  <lastmod>2022-01-28T14:12:40+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors</loc>
  <lastmod>2021-10-29T21:36:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/computational-sciences-postdoc-mentors</loc>
  <lastmod>2022-04-07T14:52:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/immunology-postdoc-mentors</loc>
  <lastmod>2022-03-01T23:53:15+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/musculoskeletal-postdoc-mentors</loc>
  <lastmod>2021-10-28T14:45:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/neurobiology-postdoc-mentors</loc>
  <lastmod>2021-10-01T20:41:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors</loc>
  <lastmod>2022-03-02T01:21:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/regenerative-medicine-postdoc-mentors</loc>
  <lastmod>2022-03-01T23:45:28+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/structural-biology-postdoc-mentors</loc>
  <lastmod>2021-10-20T03:35:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/ana-maria-avalos-chadbourne-phd</loc>
  <lastmod>2021-10-01T13:49:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/ethical-behavior</loc>
  <lastmod>2022-01-28T14:27:49+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/alyson-freeman-phd</loc>
  <lastmod>2021-10-01T11:37:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/compliance</loc>
  <lastmod>2021-10-11T08:51:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/compliance/anti-bribery-and-anti-corruption</loc>
  <lastmod>2022-01-26T17:01:27+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/compliance/professional-practices</loc>
  <lastmod>2021-10-12T15:59:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/risk-management</loc>
  <lastmod>2022-01-31T11:32:21+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/risk-management/third-party-risk-management/scope-and-governance</loc>
  <lastmod>2022-02-01T17:47:35+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/risk-management/third-party-risk-management/our-ethical-and-sustainability-standards-third-parties</loc>
  <lastmod>2022-02-01T17:40:28+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/bing-wang-phd</loc>
  <lastmod>2021-10-20T02:14:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/immunology-postdoc-mentors/catherine-regnier-phd</loc>
  <lastmod>2021-10-11T10:51:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/immunology-postdoc-mentors/daniela-cipolletta-phd</loc>
  <lastmod>2021-10-11T10:53:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/immunology-postdoc-mentors/elisabetta-traggiai-phd</loc>
  <lastmod>2021-10-11T10:55:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/immunology-postdoc-mentors/frederic-bornancin-phd</loc>
  <lastmod>2021-10-11T10:57:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/immunology-postdoc-mentors/haihui-lu-phd</loc>
  <lastmod>2021-10-11T11:10:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/immunology-postdoc-mentors/james-rush-phd</loc>
  <lastmod>2021-10-11T11:12:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/immunology-postdoc-mentors/jose-carballido-phd</loc>
  <lastmod>2021-10-01T03:56:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/immunology-postdoc-mentors/juan-zhang-phd</loc>
  <lastmod>2021-10-20T04:07:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/carlotta-costa-phd</loc>
  <lastmod>2021-10-01T08:34:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/catherine-sabatos-peyton-phd</loc>
  <lastmod>2021-10-01T13:53:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/claudio-thoma-phd</loc>
  <lastmod>2021-10-01T11:55:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/david-kodack-phd</loc>
  <lastmod>2021-10-01T12:13:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/eusebio-manchado-phd</loc>
  <lastmod>2021-10-01T13:29:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/e-robert-mcdonald-iii-phd</loc>
  <lastmod>2021-10-01T12:18:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/giorgio-g-galli-phd</loc>
  <lastmod>2021-10-01T13:36:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/huaixiang-hao-phd</loc>
  <lastmod>2021-10-01T13:46:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/katie-campbell-phd</loc>
  <lastmod>2021-10-01T13:51:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/matthew-j-meyer-phd</loc>
  <lastmod>2021-10-01T14:10:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/tobias-schmelzle-phd</loc>
  <lastmod>2021-10-01T14:38:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/javad-golji-phd</loc>
  <lastmod>2021-10-01T13:59:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/xiaomo-jiang-phd</loc>
  <lastmod>2021-10-01T14:48:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/marta-cortes-cros-phd</loc>
  <lastmod>2021-10-01T14:04:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/rebecca-leary-phd</loc>
  <lastmod>2021-10-01T14:31:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/tony-dalessio-phd</loc>
  <lastmod>2021-10-01T14:44:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/zainab-jagani-phd</loc>
  <lastmod>2021-10-01T14:53:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/immunology-postdoc-mentors/martin-alexander-schneider-phd</loc>
  <lastmod>2021-10-11T11:14:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/immunology-postdoc-mentors/max-warncke-phd</loc>
  <lastmod>2021-10-01T17:25:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/immunology-postdoc-mentors/miriam-bibel-phd</loc>
  <lastmod>2021-10-01T17:30:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/immunology-postdoc-mentors/thomas-calzascia-phd</loc>
  <lastmod>2021-10-11T11:19:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/immunology-postdoc-mentors/tobias-junt-phd</loc>
  <lastmod>2021-10-11T11:21:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/immunology-postdoc-mentors/viviana-cremasco-phd</loc>
  <lastmod>2021-10-11T11:23:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/neurobiology-postdoc-mentors/gopi-shanker-phd</loc>
  <lastmod>2021-10-11T12:21:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/neurobiology-postdoc-mentors/ivan-galimberti-phd</loc>
  <lastmod>2021-10-11T12:22:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/neurobiology-postdoc-mentors/rajeev-sivasankaran-phd</loc>
  <lastmod>2021-10-11T12:24:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/neurobiology-postdoc-mentors/robert-j-ihry-phd</loc>
  <lastmod>2021-10-11T12:26:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/neurobiology-postdoc-mentors/taeho-kim-phd</loc>
  <lastmod>2021-10-11T12:32:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/strategy/people-and-culture/engagement-and-volunteering</loc>
  <lastmod>2022-01-14T13:12:11+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/innovative-medicines/novartis-pharmaceuticals/novartis-gene-therapies/about-novartis-gene-therapies</loc>
  <lastmod>2022-08-03T09:25:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/innovative-medicines/novartis-pharmaceuticals/novartis-gene-therapies/gene-therapy-manufacturing</loc>
  <lastmod>2022-05-23T09:19:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/innovative-medicines/novartis-pharmaceuticals/novartis-gene-therapies/resources-rare-disorders-patient-community</loc>
  <lastmod>2022-08-03T09:20:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/human-rights</loc>
  <lastmod>2022-06-29T15:59:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/learning-and-engagement</loc>
  <lastmod>2022-01-28T14:37:45+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/heart-failure</loc>
  <lastmod>2021-10-11T11:04:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/acute-myeloid-leukemia-aml</loc>
  <lastmod>2021-10-11T13:00:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/alk-positive-non-small-cell-lung-cancer-nsclc</loc>
  <lastmod>2021-10-05T14:21:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/chronic-myeloid-leukemia</loc>
  <lastmod>2022-02-08T17:21:23+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/multiple-myeloma</loc>
  <lastmod>2022-07-15T14:43:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/advanced-melanoma</loc>
  <lastmod>2021-10-05T15:16:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/research-disease-areas/immuno-oncology-research-novartis</loc>
  <lastmod>2022-07-12T07:19:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/value-based-pricing</loc>
  <lastmod>2022-06-30T11:50:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/reporting/esg-rating-performance</loc>
  <lastmod>2022-08-04T15:37:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/risk-management/third-party-risk-management</loc>
  <lastmod>2022-02-01T17:52:33+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/research-disease-areas/oncology-research-novartis</loc>
  <lastmod>2021-10-19T12:26:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/research-disease-areas/cardiovascular-and-metabolic-disease-research-novartis</loc>
  <lastmod>2021-10-19T11:06:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/research-disease-areas/autoimmunity-transplantation-and-inflammatory-disease-research-novartis</loc>
  <lastmod>2021-10-19T11:04:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/risk-management/enterprise-risk-management</loc>
  <lastmod>2021-10-05T15:44:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/research-disease-areas/ophthalmology-research-novartis</loc>
  <lastmod>2021-10-19T12:21:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/quality/audit-program</loc>
  <lastmod>2022-02-01T12:30:16+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/quality/novartis-quality-management-system-qms</loc>
  <lastmod>2021-10-05T16:25:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/quality/product-and-patient-safety-training</loc>
  <lastmod>2022-02-01T12:25:39+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/quality/regulatory-inspections</loc>
  <lastmod>2022-02-01T12:34:51+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/quality/product-recalls</loc>
  <lastmod>2022-02-01T14:26:17+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/quality/third-party-suppliers</loc>
  <lastmod>2022-02-01T12:23:19+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/managed-access-programs/novartis-gene-therapies-managed-access-program</loc>
  <lastmod>2022-02-14T23:28:05+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/novartis-institutes-biomedical-research/collaborations/academic-partnerships-and-external-innovation</loc>
  <lastmod>2021-10-11T11:03:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/innovative-medicines/novartis-pharmaceuticals/novartis-gene-therapies/novartis-gene-therapies-request-funding</loc>
  <lastmod>2022-02-14T11:13:49+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-teams/ethics-risk-compliance-erc</loc>
  <lastmod>2021-10-19T19:41:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/research-disease-areas/neuroscience-research-novartis</loc>
  <lastmod>2021-10-19T12:29:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/research-disease-areas/musculoskeletal-disease-research-novartis</loc>
  <lastmod>2021-10-19T12:32:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/strategy/data-and-digital/empowering-new-wave-data-scientists</loc>
  <lastmod>2021-10-06T11:11:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/strategy/data-and-digital/power-data-driven-mindset</loc>
  <lastmod>2021-10-12T08:13:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/spinal-muscular-atrophy-sma</loc>
  <lastmod>2022-08-03T09:21:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/strategy/data-and-digital/journey-amy-argy-and-vera</loc>
  <lastmod>2021-10-12T08:15:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/respiratory-disease-research-novartis</loc>
  <lastmod>2021-10-19T11:58:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/medical-congresses-and-events/abstract-summaries-eular</loc>
  <lastmod>2022-03-10T14:21:41+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/recognition</loc>
  <lastmod>2021-10-11T12:41:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-program-leadership</loc>
  <lastmod>2022-09-05T10:32:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-program-leadership/jeff-porter-phd</loc>
  <lastmod>2022-09-05T10:47:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-program-leadership/karin-briner-phd</loc>
  <lastmod>2022-09-05T10:48:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-program-leadership/tewis-bouwmeester-phd</loc>
  <lastmod>2021-10-06T19:42:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-program-leadership/sandra-jacob-phd</loc>
  <lastmod>2021-10-06T19:45:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-program-leadership/feng-cong-phd</loc>
  <lastmod>2021-10-06T19:58:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-program-leadership/darrin-stuart-phd</loc>
  <lastmod>2021-10-06T22:36:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond/car-t-cell-therapy-pioneering-cancer-therapy</loc>
  <lastmod>2022-03-11T09:21:14+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond/car-t-healthcare-professionals/treatment-landscape-haematologic-malignancies</loc>
  <lastmod>2021-10-11T10:46:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/strategy/data-and-digital/artificial-intelligence/our-commitment-ethical-and-responsible-use-ai</loc>
  <lastmod>2022-02-04T13:12:23+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/medical-congresses-and-events/abstract-summaries-acr</loc>
  <lastmod>2021-10-07T07:54:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/innovative-medicines/novartis-pharmaceuticals/novartis-gene-therapies/newborn-screening-spinal-muscular-atrophy-sma</loc>
  <lastmod>2022-08-03T09:19:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/strategy/data-and-digital/artificial-intelligence/ai-innovation-lab</loc>
  <lastmod>2021-10-07T09:13:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/strategy/data-and-digital/artificial-intelligence/ai-novartis</loc>
  <lastmod>2021-10-07T12:12:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/novartis-institutes-biomedical-research/collaborations/nibr-business-development-licensing</loc>
  <lastmod>2021-10-07T14:30:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/research-disease-areas/dax-exploratory-disease-research-novartis</loc>
  <lastmod>2021-10-19T12:39:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/event-calendar/jp-morgan-healthcare-conference-presentation-transcript</loc>
  <lastmod>2021-10-11T10:38:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond/car-t-healthcare-professionals/pioneers-car-t-cell-and-gene-therapy</loc>
  <lastmod>2021-10-11T10:51:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/open-source-science</loc>
  <lastmod>2021-10-08T16:37:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/alexei-karpov-phd</loc>
  <lastmod>2021-10-29T01:51:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/andreas-marzinzik-phd</loc>
  <lastmod>2021-10-29T01:54:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/andreas-lingel-phd</loc>
  <lastmod>2021-10-20T02:12:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/cara-brocklehurst-phd</loc>
  <lastmod>2021-10-29T01:55:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/charles-wartchow-phd</loc>
  <lastmod>2021-10-29T01:58:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/elina-siirola-phd</loc>
  <lastmod>2021-10-29T02:10:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/eric-martin-phd</loc>
  <lastmod>2021-10-28T23:19:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/folkert-reck-phd</loc>
  <lastmod>2021-10-29T02:13:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/frederic-berst-phd</loc>
  <lastmod>2021-10-29T02:15:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/finton-sirockin-phd</loc>
  <lastmod>2021-10-28T23:22:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/jay-larrow-phd</loc>
  <lastmod>2021-10-29T21:09:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/jeff-mckenna-dphil</loc>
  <lastmod>2021-10-29T21:10:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/nikolaus-stiefl-phd</loc>
  <lastmod>2021-10-29T21:13:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/kian-tan-phd</loc>
  <lastmod>2021-10-29T21:12:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/patrick-chene-phd</loc>
  <lastmod>2021-10-20T02:31:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/patrick-j-rudewicz-phd</loc>
  <lastmod>2021-10-29T21:15:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/peter-meier-phd</loc>
  <lastmod>2021-10-29T21:17:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/piro-siuti-phd</loc>
  <lastmod>2021-10-29T21:18:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/richard-robinson-phd</loc>
  <lastmod>2021-10-29T21:23:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/razvan-nutiu-phd</loc>
  <lastmod>2021-10-20T04:16:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/robert-grotzfeld-phd</loc>
  <lastmod>2021-10-29T21:24:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/tejas-pathak-phd</loc>
  <lastmod>2021-10-29T21:26:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/steve-canham-phd</loc>
  <lastmod>2021-10-29T21:25:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/computational-sciences-postdoc-mentors/antoine-de-weck-phd</loc>
  <lastmod>2021-10-28T23:11:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/computational-sciences-postdoc-mentors/ansgar-schuffenhauer-phd</loc>
  <lastmod>2021-10-28T23:07:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/computational-sciences-postdoc-mentors/audrey-kauffmann-phd</loc>
  <lastmod>2021-10-28T23:15:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/computational-sciences-postdoc-mentors/florian-nigsch-phd</loc>
  <lastmod>2021-10-28T23:25:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/computational-sciences-postdoc-mentors/hanneke-jansen-phd</loc>
  <lastmod>2021-10-28T23:48:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/computational-sciences-postdoc-mentors/jelena-curcic-phd</loc>
  <lastmod>2021-10-28T23:59:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/computational-sciences-postdoc-mentors/nicole-renaud-phd</loc>
  <lastmod>2021-10-20T04:08:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/computational-sciences-postdoc-mentors/robert-pearlstein-phd</loc>
  <lastmod>2021-10-20T04:20:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/computational-sciences-postdoc-mentors/trixie-wagner-phd</loc>
  <lastmod>2021-10-29T00:25:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/computational-sciences-postdoc-mentors/viktor-hornak-phd</loc>
  <lastmod>2021-10-29T00:29:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/musculoskeletal-postdoc-mentors/brian-clarke-phd</loc>
  <lastmod>2021-10-28T14:40:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/musculoskeletal-postdoc-mentors/mara-fornaro-phd</loc>
  <lastmod>2021-10-28T14:42:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/musculoskeletal-postdoc-mentors/mark-nash-dphil</loc>
  <lastmod>2021-10-28T14:43:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/musculoskeletal-postdoc-mentors/olivier-leupin-phd</loc>
  <lastmod>2021-10-28T14:43:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/musculoskeletal-postdoc-mentors/estelle-trifilieff-phd</loc>
  <lastmod>2021-10-28T14:41:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/musculoskeletal-postdoc-mentors/sophie-brachat-phd</loc>
  <lastmod>2021-10-28T14:44:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/musculoskeletal-postdoc-mentors/valerie-salazar-phd</loc>
  <lastmod>2021-10-28T14:44:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/beat-nyfeler-phd</loc>
  <lastmod>2021-10-20T03:45:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/david-rowlands-phd</loc>
  <lastmod>2021-10-20T03:46:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/ann-marie-faust-phd</loc>
  <lastmod>2021-10-20T03:43:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/dominic-hoepfner-phd</loc>
  <lastmod>2021-10-20T03:51:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/ellie-growcott-phd</loc>
  <lastmod>2021-10-20T03:52:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/feng-cong-phd</loc>
  <lastmod>2021-10-20T03:56:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/frederic-bassilana-phd</loc>
  <lastmod>2021-10-20T03:59:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/giorgia-jurisic-snijder-phd</loc>
  <lastmod>2021-10-20T04:01:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/john-koschwanez-phd</loc>
  <lastmod>2021-10-20T04:04:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/jeremy-jenkins-phd</loc>
  <lastmod>2021-10-20T04:03:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/philipp-hoppe-phd</loc>
  <lastmod>2021-10-20T04:10:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/qian-huang-phd</loc>
  <lastmod>2021-10-20T04:14:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/robert-esterberg-phd</loc>
  <lastmod>2021-10-20T04:18:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/yan-feng-phd</loc>
  <lastmod>2021-10-20T04:21:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/yi-yang-phd</loc>
  <lastmod>2021-10-20T04:23:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/regenerative-medicine-postdoc-mentors/heinz-ruffner-phd</loc>
  <lastmod>2021-10-20T01:24:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/regenerative-medicine-postdoc-mentors/felix-lohmann-phd</loc>
  <lastmod>2021-10-20T01:26:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/structural-biology-postdoc-mentors/jean-michel-rondeau-phd</loc>
  <lastmod>2021-10-20T02:20:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/regenerative-medicine-postdoc-mentors/jan-tchorz-phd</loc>
  <lastmod>2021-10-20T01:19:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/structural-biology-postdoc-mentors/martin-renatus-phd</loc>
  <lastmod>2021-10-20T02:23:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/structural-biology-postdoc-mentors/veli-pekka-jaakola-phd</loc>
  <lastmod>2021-10-20T02:34:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/structural-biology-postdoc-mentors/nicolas-thoma-phd</loc>
  <lastmod>2021-10-20T02:27:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/structural-biology-postdoc-mentors/wilhelm-weihofen-phd</loc>
  <lastmod>2021-10-20T02:37:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/structural-biology-postdoc-mentors/wolfgang-jahnke-phd</loc>
  <lastmod>2021-10-20T02:42:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-teams/careers-legal</loc>
  <lastmod>2022-03-29T15:22:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/early-talent</loc>
  <lastmod>2022-09-01T09:20:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/sub-saharan-africa</loc>
  <lastmod>2021-11-22T10:38:13+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/test-cache-strategy-1</loc>
  <lastmod>2021-10-18T14:29:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/regenerative-medicine-postdoc-mentors/tewis-bouwmeester-phd</loc>
  <lastmod>2021-10-20T01:14:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/notice-all-applicants-us-job-openings</loc>
  <lastmod>2021-10-25T15:40:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/open-source</loc>
  <lastmod>2022-01-20T09:56:33+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2021-q3-transcript</loc>
  <lastmod>2022-02-01T22:49:15+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/prostate-cancer</loc>
  <lastmod>2021-12-17T14:10:08+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/reporting/transparency-and-disclosure/public-policy-advocacy/novartis-responsible-lobbying-disclosures</loc>
  <lastmod>2022-05-24T17:36:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/technology-platforms/cell-therapy/charging-towards-next-generation-car-t</loc>
  <lastmod>2021-11-26T14:50:41+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/multiplesclerosis</loc>
  <lastmod>2021-12-16T11:26:56+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/multiplesclerosis/types-ms-and-ms-progression</loc>
  <lastmod>2021-12-16T08:30:07+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/multiplesclerosis/ms-tools</loc>
  <lastmod>2021-12-16T08:30:43+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/multiplesclerosis/ms-treatment-options</loc>
  <lastmod>2021-12-16T08:33:26+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/migraine</loc>
  <lastmod>2021-12-16T08:24:30+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/migraine/types-migraine</loc>
  <lastmod>2021-12-16T10:58:41+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/migraine/migraine-treatment-options</loc>
  <lastmod>2021-12-16T08:18:35+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/migraine/migraine-tools</loc>
  <lastmod>2021-12-16T08:19:24+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2021-q4-and-full-year-results-transcript</loc>
  <lastmod>2022-02-08T11:40:24+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/joanne-wong-phd</loc>
  <lastmod>2022-02-23T17:06:45+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/immunology-postdoc-mentors/anette-karle-phd</loc>
  <lastmod>2022-03-01T23:51:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/anke-bill-phd</loc>
  <lastmod>2022-03-01T23:54:41+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/yi-bao-phd</loc>
  <lastmod>2022-03-01T23:48:21+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/regenerative-medicine-postdoc-mentors/katie-mccauley-phd</loc>
  <lastmod>2022-03-01T23:43:52+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/kidney-disease</loc>
  <lastmod>2022-03-25T08:51:54+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/patients-and-caregivers/diseases/kidney-disease/complement-mediated-kidney-diseases-and-their-impact</loc>
  <lastmod>2022-03-09T07:17:19+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/novartis-medical-information</loc>
  <lastmod>2022-05-23T15:43:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/dry-eye-disease</loc>
  <lastmod>2022-03-28T14:59:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/computational-sciences-postdoc-mentors/alejandro-reyes-phd</loc>
  <lastmod>2022-04-07T14:51:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/privacy-notice-pharmacovigilance</loc>
  <lastmod>2022-05-04T13:46:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/global-health/avoidable-blindness</loc>
  <lastmod>2022-05-05T10:33:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2022-q1-transcript</loc>
  <lastmod>2022-05-02T18:05:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/general-privacy-notice-business-partners</loc>
  <lastmod>2022-05-04T13:46:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/general-privacy-notice-third-parties</loc>
  <lastmod>2022-05-04T13:46:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/elevated-lipoproteina</loc>
  <lastmod>2022-05-24T11:49:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/global-health/anti-microbial-resistance-amr</loc>
  <lastmod>2022-05-18T14:29:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index/access-medicines</loc>
  <lastmod>2022-09-06T11:19:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index/governance</loc>
  <lastmod>2022-09-06T11:19:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index/environmental-sustainability</loc>
  <lastmod>2022-07-06T15:45:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index/ethical-business-practices</loc>
  <lastmod>2022-07-06T15:45:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index/human-capital</loc>
  <lastmod>2022-07-06T15:47:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index/innovation</loc>
  <lastmod>2022-09-26T09:52:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index/quality</loc>
  <lastmod>2022-07-06T15:46:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index/supply-chain-sourcing</loc>
  <lastmod>2022-07-20T16:57:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/scc-c2p</loc>
  <lastmod>2022-05-24T12:08:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/scc-c2c</loc>
  <lastmod>2022-05-24T12:08:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index/other</loc>
  <lastmod>2022-07-20T16:46:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index</loc>
  <lastmod>2022-07-20T16:48:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/research-collaborations</loc>
  <lastmod>2022-07-11T14:17:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2022-q2-transcript</loc>
  <lastmod>2022-07-25T17:01:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/sourcing-and-procurement</loc>
  <lastmod>2022-09-14T22:02:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/supplier-onboarding</loc>
  <lastmod>2022-09-21T17:37:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/invoicing-novartis</loc>
  <lastmod>2022-09-21T17:43:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/simple-invoice-checking</loc>
  <lastmod>2022-09-16T15:02:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/documentation</loc>
  <lastmod>2022-09-21T17:38:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/tr/sourcing-and-procurement</loc>
  <lastmod>2022-09-14T22:14:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/tr/supplier-onboarding</loc>
  <lastmod>2022-09-14T21:37:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/tr/invoicing-novartis</loc>
  <lastmod>2022-09-16T15:08:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/fr/sourcing-and-procurement</loc>
  <lastmod>2022-09-14T21:45:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/fr/supplier-onboarding</loc>
  <lastmod>2022-09-14T21:46:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/lung-cancer</loc>
  <lastmod>2022-08-25T17:06:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/es/sourcing-and-procurement</loc>
  <lastmod>2022-09-14T22:08:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/es/supplier-onboarding</loc>
  <lastmod>2022-09-14T22:09:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/es/invoicing-novartis</loc>
  <lastmod>2022-09-16T15:10:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/fr/simple-invoice-checking</loc>
  <lastmod>2022-09-14T21:47:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/es/simple-invoice-checking</loc>
  <lastmod>2022-09-14T22:11:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/tr/simple-invoice-checking</loc>
  <lastmod>2022-09-14T22:20:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/lung-cancer/sound-up</loc>
  <lastmod>2022-08-25T17:05:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/fr/invoicing-novartis</loc>
  <lastmod>2022-09-16T15:07:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/sandoz-spinoff</loc>
  <lastmod>2022-08-25T14:00:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/cancer</loc>
  <lastmod>2022-09-29T18:59:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/general-privacy-notice-clinical-trial-site-personnel</loc>
  <lastmod>2022-09-01T09:51:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/medical-congresses-and-events/abstract-summaries-eadv</loc>
  <lastmod>2022-09-10T08:35:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/event-calendar/meet-novartis-management</loc>
  <lastmod>2022-09-28T17:21:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342046br/director-ethics-risk-compliance-integrated-marketing</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/331461br/global-new-products-director-dfm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344227br/oncology-specialist-representative-mindanao</loc>
  <lastmod>2022-09-15T12:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344323br/fra-analyst-representative-offices-mfd</loc>
  <lastmod>2022-09-19T18:01:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345277br/director-operations-biopharma-dfm</loc>
  <lastmod>2022-09-15T12:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345581br/associate-manager-data-steward</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346129br/bpa-specialist</loc>
  <lastmod>2022-09-28T14:01:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347577br/quality-specialist-medical-devices-fmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347905br/apprenti-chef-de-produit-neurologie-hf</loc>
  <lastmod>2022-09-15T16:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348934br/global-program-clinical-head-hematology-car-t-80-100</loc>
  <lastmod>2022-09-19T14:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347633br/quality-metrics-governance-lead</loc>
  <lastmod>2022-09-27T10:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349378br/associate-global-program-regulatory-manager-agprm-gprm-lcm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349153br/executive-director-media-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349501br/director-predictive-analytics-solutions-x4</loc>
  <lastmod>2022-09-19T08:01:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349506br/2x-director-data-science</loc>
  <lastmod>2022-09-19T08:01:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349352br/associate-director-trade-gpo-account-strategy-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349996br/payroll-manager</loc>
  <lastmod>2022-09-19T18:01:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348963br/manager-business-analyst-marketing-automation-business-analytics</loc>
  <lastmod>2022-09-24T00:01:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350519br/diagnostic-account-specialist-rlt-pacific-remote</loc>
  <lastmod>2022-09-21T02:01:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349259br/supply-chain-master-data-manager-80</loc>
  <lastmod>2022-09-16T14:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350888br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350907br/director-rlt-planning-execution</loc>
  <lastmod>2022-09-24T00:01:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351027br/senior-principal-user-researcher-ux</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351057br/associate-director-marketing-data-solutions</loc>
  <lastmod>2022-09-30T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351199br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-19T06:00:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351813br/solution-delivery-functional-design-associate-director</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351006br/senior-scientist-neurodegeneration</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351211br/r2r-senior-specialist-gl-reporting</loc>
  <lastmod>2022-10-03T06:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351249br/tactical-planner</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351308br/senior-scientist-compound-management</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351654br/maschinenbediener-der-verpackung-dwm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351665br/r2r-senior-specialist-gl-reporting</loc>
  <lastmod>2022-10-03T06:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351769br/associate-director-marketing-strategy</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351800br/arc-expert-demarrage-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351972br/qc-associate-scientist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352055br/commercial-analyst</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352079br/qa-operations-expert-mfd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352090br/specjalista-ast</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352093br/senior-medical-lead-oncology</loc>
  <lastmod>2022-09-15T12:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352156br/expert-drug-supply-process-expert</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352160br/associate-expert-drug-supply</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352210br/h2r-services-expert</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352213br/seniorexpert-qa-compliance</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352415br/healthcare-network-partner</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352419br/neuro-portfolio-lead-nsw-south-act</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352420br/neuro-portfolio-lead-vic-west</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352421br/neuro-portfolio-lead-vic-east-and-tas</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352423br/director-national-accounts-rlt-account-management-central-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352446br/shift-lead-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352465br/research-scientist-protein-mass-spectrometry</loc>
  <lastmod>2022-09-19T12:01:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352565br/marketing-head-rx-and-biosimilars</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352701br/local-gcppv-auditor</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352715br/quality-assurance-manager-eso</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352723br/technicien-analytique-validation-transfert-cdd-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352725br/ausbildung-zum-pharmakantenin-ab-august-2023-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352727br/qa-operations-lead</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352729br/qa-compliance-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352732br/tecnico-de-produccion</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352733br/legal-trainee-novartis-operations</loc>
  <lastmod>2022-09-28T12:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352806br/clinical-development-manager-respiratory</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/335705br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342640br/qa-operations-specialist-2nd-shift</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342858br/gprmsrgprm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342965br/process-team-lead-fmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343532br/qa-operations-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344530br/regional-financial-reporting-accounting-manager-apma</loc>
  <lastmod>2022-10-03T06:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344697br/quality-system-compliance-and-operations-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345883br/analytical-project-lead-associate-director</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347389br/demand-and-supply-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347662br/quality-integration-project-lead-bdl-fmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347708br/strategic-account-manager-south-east-england</loc>
  <lastmod>2022-09-22T12:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347710br/strategic-account-manager-north-east-england</loc>
  <lastmod>2022-09-22T12:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347824br/strategic-account-manager-north-west-england</loc>
  <lastmod>2022-09-22T12:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347847br/associate-director-project-management-cell-and-gene-therapy-aav</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347979br/daquyiyuanzhunrujingli</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348869br/clinical-development-director-medical-director-neuroscience</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349014br/qc-associate-scientist-bioanalytics</loc>
  <lastmod>2022-09-29T18:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349018br/senior-specialist-ims-technical-services</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349308br/dir-us-market-access-therapeutic-area-strategy-immunologyms-2-roles</loc>
  <lastmod>2022-09-15T16:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349316br/dir-us-market-access-therapeutic-area-strategy-oncology-2-roles</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349567br/senior-data-scientist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349929br/senior-qc-specialist-chemops-80-100</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349968br/senior-scientist-characterization-mass-spectrometry-bsms</loc>
  <lastmod>2022-09-27T04:00:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350065br/senior-expert-science-technology-analytical-project-leader-fmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350186br/product-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350543br/financial-reporting-accounting-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350667br/tprm-specialist</loc>
  <lastmod>2022-09-19T08:01:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350820br/senior-scientist-analytics-and-formulations</loc>
  <lastmod>2022-09-17T02:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352737br/key-account-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352744br/primary-care-sales-specialist-crm-arlington-heights-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352745br/oncology-data-science-intern</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352746br/institutional-sales-specialist-crm-middletown-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352760br/apprenti-reglementaire-affaires-cliniques-fh</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352755br/postgraduate-pu-galenic</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352761br/qc-lab-technician</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352765br/expert-drug-product-modelling</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352768br/director-media-relations-dfm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352770br/senior-principal-scientist-imaging</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352771br/neuroscience-sales-specialist-ms-new-york-ny-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352773br/research-scientist-characterization-mass-spectrometry</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352774br/expert-scientist-science-technology-upstream</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352775br/pharma-operator-assistant-2nd-shift</loc>
  <lastmod>2022-09-29T16:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352780br/data-scientist-early-analytics-drug-development</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352791br/national-sales-manager-breast</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343623br/associate-expert-preclinical-manufacturing-drug-supply</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348357br/qa-compliance-expert-fmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348782br/manager-learning-culture-communications</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349116br/paralegal-ip</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349558br/analyst</loc>
  <lastmod>2022-09-29T14:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349872br/sr-product-technology-manager-patient-specialty-services-remote</loc>
  <lastmod>2022-09-23T22:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350096br/cloud-platform-engineering-and-security</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350320br/quality-assurance-manager-eso</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351051br/senior-ip-counsel</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351775br/group-lead-clinical-project-management</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351982br/director-comops-strategy-sandoz-germany-dfm</loc>
  <lastmod>2022-09-21T00:01:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351983br/director-country-operations-strategy-sandoz-germany-dfm</loc>
  <lastmod>2022-09-21T00:01:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352128br/chef-de-projets-bon-usage-et-charte-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352158br/drug-product-functional-lead-senior-expert-science-technology</loc>
  <lastmod>2022-09-15T12:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352667br/sr-financial-analyst-marketing-bpa</loc>
  <lastmod>2022-09-29T20:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352395br/production-floorpackaging-line-leader-1st-shift</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352428br/demand-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352597br/gaojiyiyaodaibiaozishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352603br/associate-key-account-manager-retail</loc>
  <lastmod>2022-10-03T10:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352606br/associate-key-account-manager-government</loc>
  <lastmod>2022-10-03T10:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352607br/qa-specialist-qa-operations</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352610br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352613br/procesoperator</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352616br/proces-operator</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352622br/associate-manager-master-data-operations</loc>
  <lastmod>2022-09-20T08:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352649br/principal-biostatistician</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352654br/planning-and-logistics-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352658br/associate-expert-science-technology-analytical-process-development</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352662br/qc-ast-chemistry-expert</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352666br/sr-microbiology-analyst</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352670br/associate-director-biostatistics</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352671br/qc-lab-technician</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352674br/x2-associate-director-pss-process-design-improvement</loc>
  <lastmod>2022-09-23T20:01:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352676br/institutional-sales-specialist-crm-puerto-rico-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352677br/primary-care-sales-specialist-crm-allentown-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352679br/primary-care-sales-specialist-crm-east-bay-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352680br/primary-care-sales-specialist-crm-buffalo-n-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352683br/sales-specialist-rheumatology-spokane-wa-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352684br/sr-scientist-immuno-oncology-hematology-flow-cytometry-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352685br/lab-operations-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352686br/medical-representative-baguiola-union</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352689br/medical-representative-mindanao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352691br/sr-qa-officer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352694br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342997br/medicinal-chemistry-research-scientist-bs-or-ms</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344212br/ophthalmology-physician-scientist-nibr</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345502br/technical-operator-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345523br/synthetic-chemistry-research-scientist-bs-or-ms</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346122br/applied-computational-biologist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346477br/analytical-chemist-and-nmr-spectroscopist-separations-group</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346568br/synthetic-organic-chemist-recent-bs-or-ms-graduate</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346576br/principal-bioinformatics-software-engineer-clinical-pipeline</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346624br/associate-regulatory-strategy-cmc-group</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347018br/expert-process-usp-hf</loc>
  <lastmod>2022-09-15T14:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347342br/global-clinical-supply-analyst</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347413br/associate-director-production</loc>
  <lastmod>2022-10-01T02:01:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347997br/biomarker-therapeutic-area-leadbiomarker-strategy</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348936br/field-reimbursement-manager-fort-myers</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349124br/senior-manager-marketing-respiratory</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349494br/bsms-research-scientist-oncology-drug-discovery-biotherapeutics</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349849br/senior-scientist-oncology-drug-discovery</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350308br/disease-area-lead-malignant-hem-philadelphia-pa-remote</loc>
  <lastmod>2022-09-30T22:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350316br/disease-area-lead-melanoma-new-york-ny-remote</loc>
  <lastmod>2022-09-30T22:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350317br/disease-area-lead-melanoma-philadelphia-pa-remote</loc>
  <lastmod>2022-09-30T22:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350334br/disease-area-lead-benign-hem-seattle-wa-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350337br/disease-area-lead-melanoma-seattle-wa-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350349br/disease-area-lead-malignant-hem-washington-dc-remote</loc>
  <lastmod>2022-10-02T02:00:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350350br/associate-director-dermatology-clinical-sales-grand-rapids-mi-remote</loc>
  <lastmod>2022-09-30T08:01:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350360br/disease-area-lead-melanoma-charlotte-nc-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350364br/disease-area-lead-lung-miami-fl-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350367br/disease-area-lead-melanoma-washington-dc-remote</loc>
  <lastmod>2022-10-02T02:00:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350593br/senior-scientist-innovative-lentiviral-vector-design-bsms</loc>
  <lastmod>2022-09-21T04:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350761br/field-reimbursement-manager-omaha-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350784br/reimbursement-specialist-1-schedule-1-8am-5pm-multiple-positions</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350790br/care-navigator-2-schedule-1-8am-5pm-multiple-positions</loc>
  <lastmod>2022-09-27T00:01:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350792br/care-navigator-2-schedule-2-11am-8pm-multiple-positions</loc>
  <lastmod>2022-09-27T00:01:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350914br/analytics-and-separations-research-scientist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351008br/head-cancer-therapeutics-nibr-san-diego</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351036br/senior-data-visualisation-engineer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351042br/packaging-mechanic-all-shifts</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351043br/principal-scientist-oncology-drug-discovery-vivo-pharmacology</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351198br/business-integration-manager-regulatory-operations</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351229br/product-manager-otc</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351290br/district-manager-specialty-gma</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351347br/production-technician-iii-2nd-shift-compressionencapsulation</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351401br/mlodszy-inzynier-utrzymania-ruchu</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351472br/director-clinical-pbpk-ms-pk-sciences-us-nj-or-ma-or-basel</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351440br/director-product-strategy-counsel-im-us-3-roles</loc>
  <lastmod>2022-09-29T20:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351495br/clinical-supply-project-lead</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351539br/vivo-senior-scientist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351540br/head-production-support</loc>
  <lastmod>2022-10-01T02:01:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351597br/senior-scientist-iii-oncology-translational-research</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351620br/translational-research-proteomic-mass-spectrometry-expertise</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351683br/nmr-spectroscopist-analytics-separations-group</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351708br/nibr-strategic-feasibility-manager-strategic-feasibility-expert</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351725br/fpa-lead</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351776br/senior-scientist-discovery-biology-flow-cytometry-expertise</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351798br/financial-analyst</loc>
  <lastmod>2022-09-27T14:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352046br/equipment-operator-solids-novartis-stein</loc>
  <lastmod>2022-09-15T10:00:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352052br/biomarker-scientific-monitor-study-coordinator-sr-scientist-ii</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352522br/auszubildende-fur-den-ausbildungsberuf-industriekaufmann-frau-dmw</loc>
  <lastmod>2022-09-16T14:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352521br/duales-studium-bwl-gesundheitsmanagement-dwm-bachelor-arts</loc>
  <lastmod>2022-09-16T14:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352277br/senior-expert-data-science</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352321br/senior-sales-executives</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352429br/delegue-hospitalier-immunologie-secteur-lyon-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352442br/manager-digital-finance</loc>
  <lastmod>2022-09-29T10:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352460br/medical-sales-representative</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352479br/key-account-representative-craiova</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352494br/vivo-research-scientist-musculoskeletal-disease-bsms</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352497br/planning-and-logistics-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352532br/ast-expert</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352517br/principal-biostatistician</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352520br/team-lead-ims-technical-services</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352524br/executive-ra-gdd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352534br/qa-validation-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352540br/operative-executive-production-encapsulation</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352556br/specialist-quality-operations</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352557br/specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352558br/srproduct-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352559br/ausbildung-zum-chemielaborantenin-ab-august-2023-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352560br/specialist-quality-operations</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352561br/ausbildung-zum-mechatronikerin-ab-august-2023-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352563br/channel-operation-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352567br/associate-director-marketing-generics</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352572br/associate-director-program-launch-and-change-excellence-2-positions</loc>
  <lastmod>2022-09-15T16:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352577br/cardiovascular-sales-specialist-crm-cleveland-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352587br/principal-scientist-antibody-discovery</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352588br/senior-principal-biostatistician</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352596br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343255br/gmp-and-data-integrity-officer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351829br/equipment-specialist-weegdienst</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352514br/shengchancaozuoyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352515br/shengchancaozuoyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/326395br/scientist-immuno-oncology-flow-cytometry</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/338803br/planning-and-logistics-lead</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/339265br/bpa-manager-mfd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345357br/technical-development-director-analytical-development</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345653br/regulatory-coordinator-sr-regulatory-coordinator-lcm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346830br/invoice-cash-collection-specialist-dutch</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350094br/scheduler-maintenance</loc>
  <lastmod>2022-09-30T22:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350105br/executive-director-product-strategy-lead-pnh</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350454br/analyst</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350455br/analyst</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351095br/strategic-business-analyst-master-data-management</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351399br/assoc-dir-data-analytics-review-80-100</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351448br/executive-director-incentive-compensation</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351770br/sr-prin-sciassoc-dirdirector-pcs-portfolio-anat-pathologist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351979br/packaging-specialist</loc>
  <lastmod>2022-09-24T00:01:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352283br/vitro-scientist-neuroscience-rare-diseases</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352501br/sr-financial-analyst-marketing-bpa</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352432br/equipment-operator-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352450br/equipment-operator-i</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352453br/qc-analyst-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352478br/analyst-managed-care</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352480br/primary-care-sales-specialist-crm-scranton-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352498br/shipping-and-receiving-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352500br/packaging-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/331860br/market-access-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/336353br/analist-controlul-calitatii-hplc</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/337492br/associate-directordirector-pk-sciences</loc>
  <lastmod>2022-09-16T18:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/337543br/principal-scientist-pk-sciences</loc>
  <lastmod>2022-09-16T20:01:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/340259br/talent-acquisition-partner-contractor-multiple-openings</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/340532br/technical-steward</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345276br/sr-principal-scientist-associate-director-translational-ms</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348966br/associate-director-product-tag-management</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349042br/director-integrated-experience-planning</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349584br/principal-scientist-translational-modeling-simulation</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349697br/senior-expert-sr-scientist-downstream-process-development</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350250br/biologics-admedmpk-project-rep-principal-scientist-oncology</loc>
  <lastmod>2022-09-16T18:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350202br/principal-scientist-translational-modeling-simulation</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350203br/sr-principal-scientist-associate-director-translational-ms</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350786br/director-pss-program-strategy-management-rlt</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350788br/executive-director-pss-rlt</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351235br/starszy-specjalista-ast</loc>
  <lastmod>2022-09-15T12:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351463br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351492br/qc-specialist-ii</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351727br/ast-analyst-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352087br/ast-analyst-befristet-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352265br/site-engineering-head</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352323br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352326br/starszy-specjalista-ast</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352338br/technical-qa-engineer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352339br/manager-ethics-risk-compliance-division-hatotaimu</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352340br/product-manager-neurosciences</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352342br/maneshiyaeshitsukusu-risuku-konfuraiansutongkuobu-hatotaimu</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352343br/japan-program-head</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352351br/principle-business-analyst</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352372br/expert-el-fmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352379br/senior-payroll-accounting-specialist-dfm-aaa-germany-gmbh</loc>
  <lastmod>2022-09-23T12:01:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352388br/principal-scientist-cardiovascular-safety-pharmacologist</loc>
  <lastmod>2022-09-16T20:01:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352394br/associate-director-labeling-team-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352407br/trainee-lawyer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352409br/cardiovascular-sales-specialist-crm-houston-se-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352412br/associate-clinical-development-medical-director</loc>
  <lastmod>2022-09-21T04:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352414br/senior-administrative-assistant-office-president</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352422br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342053br/director-ethics-risk-compliance-patient-services-advisor</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342052br/executive-dir-ethics-risk-compliance-customer-engagement</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347849br/director-erc-customer-engagement-advisor-remote-multiple-positions</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349229br/institutional-sales-specialist-crm-shreveport-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349319br/director-us-market-access-mature-brands-ta-x-2-2</loc>
  <lastmod>2022-09-15T12:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350042br/exec-director-marketing-strategist-oncology-breast-cancer</loc>
  <lastmod>2022-09-27T20:01:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350181br/product-marketing-strategy-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351550br/maintenance-and-calibration-engineer</loc>
  <lastmod>2022-09-27T02:01:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351958br/tehnik-vzdrzevanja-tehnicnih-storitev-ii-mzd</loc>
  <lastmod>2022-09-27T14:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352212br/medical-representative-specialty-hcm-sandoz</loc>
  <lastmod>2022-09-15T12:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352215br/shift-manager-downstream</loc>
  <lastmod>2022-09-15T12:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352231br/gaojidequjingli</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352233br/commercial-excellence-analyst-and-crm-lead</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352234br/defensive-cyber-security-researcher</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352235br/commercial-excellence-business-partner</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352239br/patient-engagement-advocacy-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352253br/primary-care-sales-specialist-crm-greensboro-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352261br/director-federal-policy-wash-dc-or-princeton-nj-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352285br/senior-expert-science-technology-analytical-platform-development</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352292br/primary-care-sales-specialist-crm-daytona-beach-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352310br/director-us-external-engagement</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/340250br/qa-operations-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346969br/delegue-medical-hospitalier-picardie-hf</loc>
  <lastmod>2022-09-16T18:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347529br/responsable-sectoriel-riv-tne-cancer-prostate-oncologie-idf-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348059br/responsable-sectoriel-riv-tne-cancer-prostate-oncologie-idf-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348061br/responsable-sectoriel-riv-tne-cancer-prostate-onco-normandie-hf</loc>
  <lastmod>2022-09-29T18:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348062br/responsable-sectoriel-rivtnecancer-prostateoncohauts-de-france-hf</loc>
  <lastmod>2022-09-20T14:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348981br/maschinenfuhrer-mwd</loc>
  <lastmod>2022-09-15T10:00:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349300br/dir-us-market-access-therapeutic-area-strategy-cardiovascular</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349324br/associate-director-us-market-access-ta-strategy-cardiovascular</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349485br/quality-control-analyst-2nd-shift</loc>
  <lastmod>2022-10-01T02:01:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349926br/director-process-mapping-improvement</loc>
  <lastmod>2022-09-23T16:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350640br/elektroniker-mwd-betriebstechnikautomatisierungstechnik</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351284br/senior-analytical-expert-science-technology-fmd</loc>
  <lastmod>2022-09-15T12:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351529br/public-affairs-lead</loc>
  <lastmod>2022-09-15T12:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351698br/customer-operational-excellence-specialist-sandoz</loc>
  <lastmod>2022-09-30T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351741br/technical-competence-center-manger-b2b</loc>
  <lastmod>2022-09-15T12:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352074br/manager-senior-manager-value-and-access</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352075br/associate-dir-serv-ops-manufacturingmes-werum-pas-x-systems</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352081br/principal-clinical-data-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352082br/senior-clinical-data-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352083br/principal-clinical-data-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352085br/cra-bj</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352089br/principal-clinical-data-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352092br/postgraduate-cell-gene-therapy-talent-pool</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352099br/head-global-regulatory-ims-business-process-excellence-dfm</loc>
  <lastmod>2022-09-15T12:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352106br/clinical-scientific-expert-i</loc>
  <lastmod>2022-09-15T10:00:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352110br/associate-director-threat-hunting-response</loc>
  <lastmod>2022-09-15T10:00:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352117br/principal-clinical-data-manager</loc>
  <lastmod>2022-09-15T10:00:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352143br/demand-manager</loc>
  <lastmod>2022-09-15T12:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352154br/senior-buyer-market-insights</loc>
  <lastmod>2022-09-27T20:01:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352184br/necropsy-histology-scientist</loc>
  <lastmod>2022-09-16T18:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352211br/h2r-services-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346845br/business-planning-and-analysis</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347294br/regulatory-affairs-officer-sandoz-copenhagen-denmark</loc>
  <lastmod>2022-09-23T12:01:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349883br/senior-regulatory-writer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350911br/head-customer-portfolio-engagement</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351396br/associate-director-security-operations-iam</loc>
  <lastmod>2022-09-26T10:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351548br/statistical-programmer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351639br/associate-literature-aggregate-report</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351992br/maintenance-technician-electrical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351994br/maintenance-technician-i-mechanical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351995br/maintenance-technician-i-mechanical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351997br/maintenance-technician-i-mechanical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351998br/maintenance-technician-i-mechanical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352000br/maintenance-technician-i-mechanical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352001br/maintenance-technician-i-mechanical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352004br/maintenance-technician-i-mechanical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352005br/specialist-quality-operations</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352007br/expert-science-technology</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352008br/tax-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352009br/data-automation-intern</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352012br/specialist-isg-independent-control-assessments</loc>
  <lastmod>2022-09-26T12:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352023br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352030br/senior-regulatory-writer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352043br/stage-procesoperator-farma</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352057br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352058br/director-risk-management</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350452br/analyst</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351986br/senior-brand-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347523br/head-business-excellence-strategy-hong-kong</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351980br/production-technician-2nd-shift</loc>
  <lastmod>2022-10-01T02:01:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/324179br/senior-expert-engineering-biotechnology-mfd-80-100</loc>
  <lastmod>2022-09-17T20:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343937br/p2p-service-delivery-innovation-lead</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348850br/qc-analyst-i</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349408br/threat-hunting-response-director</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351140br/production-technician-aseptic-cleaning</loc>
  <lastmod>2022-09-16T16:00:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351173br/key-account-mgr-dermatology-nw-london-bucks-berks-oxford</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351281br/associate-alliance-management-team</loc>
  <lastmod>2022-09-28T06:00:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351319br/specialist-network-services-performa</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351382br/omnichannel-lead-mfd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351444br/chemo-proteomic-sr-scientist-bsms</loc>
  <lastmod>2022-09-28T18:01:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351544br/manager-literature-copay-monitoring-and-reporting</loc>
  <lastmod>2022-09-30T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351589br/business-unit-head-rx-fmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351592br/media-communications-analytics-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351667br/high-performance-computing-engineer-senior</loc>
  <lastmod>2022-09-29T12:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344861br/associate-specialist-product-development-mfd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345890br/manager-data-solutions-architect-nibr</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346121br/antibody-discovery-scientist</loc>
  <lastmod>2022-09-16T18:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346763br/manager-regulatory-affairs-biosimilars</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346764br/associate-director-regulatory-strategy-and-science-ra-biopharma</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349614br/technician-iii-facility-maintenance-2nd-shift</loc>
  <lastmod>2022-09-30T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350071br/national-sales-manager-cardio-south</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350536br/associate-director-business-analyst-po-services</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350573br/assistant-ip</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350643br/head-rlt-diagnostic-strategy-execution</loc>
  <lastmod>2022-09-21T16:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350764br/ad-market-access-contracts-sandoz</loc>
  <lastmod>2022-09-16T16:00:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350840br/head-legal-sandoz-switzerland</loc>
  <lastmod>2022-09-15T10:00:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351041br/postdoc-data-science</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351046br/technicien-cq-cdd-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351152br/przedstawiciel-medyczny-cardio-zielona-gora</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351609br/delegue-hospitalier-nord-pas-de-calais-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351839br/manager-solutions-architect-analytics-and-digital-innovation</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351790br/specialist-solution-delivery-sc-esokinaxis-rapid-response</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351805br/koordynator-artwork-region-europa</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351824br/unique-phd-graduate-rotation-program-virtual-analytics-network</loc>
  <lastmod>2022-09-29T18:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351850br/associate-lab-technician</loc>
  <lastmod>2022-09-16T12:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351851br/associate-lab-supervisor</loc>
  <lastmod>2022-09-16T12:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351859br/medical-representative-ilocosabra</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351861br/oncology-specialist-representative-north-luzon</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344574br/clinical-research-medical-advisor</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345148br/vendor-master-data-administrator</loc>
  <lastmod>2022-09-22T14:01:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347677br/principal-scientist-aav-process-development-upstream</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348633br/shichangzhunrujingli</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348883br/heor-and-access-strategy-manager-policy-advocacybjsh</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348888br/heor-and-access-strategy-manager-oncology-bjsh</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348889br/heor-and-access-strategy-senior-manager-cv-bjsh</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348896br/heor-and-access-strategy-senior-manager-pricingpolicy-bjsh</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348897br/heor-and-access-strategy-manager-pipeline-bjsh</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349700br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349768br/manager-pss-program-operations-management-4-positions</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349776br/technicien-de-laboratoire-cq-5x8-cdi-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350070br/national-sales-manager-cardio-north</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351582br/scm-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351715br/buyer-gtx</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351729br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351732br/service-operator-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351740br/cra-bj</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351778br/specialist-reliability-engineer-xcc</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351779br/senior-principal-biostatistician</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/326830br/senior-process-expert-mfd</loc>
  <lastmod>2022-09-20T10:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/333015br/senior-manager-strategic-projects-dwm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345365br/national-sales-manager-oncologyhospital</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345594br/stage-business-analyst</loc>
  <lastmod>2022-09-26T12:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349190br/global-category-managers-it-digital</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349255br/manager-product-life-cycle-mgmt</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349770br/manager-patient-support-center-sops-document-management-2-positions</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349924br/director-pss-program-strategy-management-2-positions</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350375br/associate-safety-case-management</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350871br/research-scientist-protein-engineering</loc>
  <lastmod>2022-09-27T02:01:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351307br/przedstawiciel-medyczny-linia-pain-legnica-jelenia-gora</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351650br/gaojidequjingli</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351653br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351655br/head-portfolio-strategy-ops-gdd-china</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351661br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351670br/delegue-medical-hospitalier-bretagne-immuno-rhumagastr-hf</loc>
  <lastmod>2022-09-27T10:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351712br/associate-director-dermatology-clinical-sales-austin-tx-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351717br/principal-scientist-medicinal-chemistry-novartis-nibr-east-bay</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351722br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-23T14:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/341672br/produktmanager-marketing-genmed-dwm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342082br/data-privacy-manager-gdpr</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344731br/vivo-research-scientist-ophthalmology</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345508br/associate-director-dermatology-clinical-sales-los-angeles-remote</loc>
  <lastmod>2022-09-29T16:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349577br/medical-science-liaison-nephrology-wimnndsd-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350897br/rlt-customer-service-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350963br/mechanical-engineering-executive</loc>
  <lastmod>2022-09-22T12:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351022br/head-data-insights-transformation</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351079br/therapy-area-lead-immunology-fmd-commercial-ops-europe-sandoz-vi</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351129br/senior-scientist-neurodegeneration</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351226br/qc-shift-lead-wmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351277br/shift-lead-ii-schaftenau-austria</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351601br/study-monitor-nibr-preclinical-safety-nj-ma-or-basel</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351568br/validation-expert</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351576br/technolog-produktu</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351608br/engineer-process</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351610br/research-scientist-hematology-and-gene-cell-therapy</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351612br/primary-care-sales-specialist-crm-manhattan-beach-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351613br/primary-care-sales-specialist-crm-bronx-north-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351628br/research-scientist-preclinical-safety</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351636br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351637br/sr-medical-science-liaison</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351640br/manager-commercial-gmp-qa</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351559br/medical-representative-gma</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351561br/transformationprocess-excellence-lead</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344589br/responsabil-produse-expert-validare</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344657br/compliance-manager-engineering-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346972br/scientist-carlsbad-ca</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349323br/associate-director-us-market-access-portfolio-strategy-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349884br/associate-director-ppm-governance-ops</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350689br/associate-director-network-services-lan-technical-engineering</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351285br/associate-director-network-services-lan-service-management</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351482br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351483br/clinical-database-developer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351484br/senior-budget-planning-analyst</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351485br/clinical-database-developer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351486br/material-planner</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351487br/maintenance-coordinator-electrical-wmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351501br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351502br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351509br/salesforce-architect</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351512br/associate-manager-data-insights-analyticsalteryxpythonqliksense</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351514br/specialist-data-insights-analyticsalteryx-qliksense</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351515br/tender-operation-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351520br/senior-analyst-value-access-dsi</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351521br/logistics-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351523br/assoc-dir-func-dsgn-arch-commercialsap-sd-s4hana-innovations</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351525br/assoc-dir-func-dsgn-arch-commercialsap-preferably-vistex</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343415br/technical-steward-devices-mfd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348748br/qc-specialist-i-80-100</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350244br/marketing-manager-breast-cancer</loc>
  <lastmod>2022-09-27T06:00:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350388br/service-operations-expert-windows</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350981br/legal-counsel-dfm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351119br/master-thesis-diplomarbeit-controlling</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351293br/przedstawiciel-medyczny-linia-pain-tarnow</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351335br/team-assistant-engineering-50-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351370br/ra-cmc-senior-submission-coordinator</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351372br/ra-cmc-submission-coordinator</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351385br/commercial-lead-aaa</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351403br/application-system-engineer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351408br/scrum-master</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351422br/analyst-life-cycle-management</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351429br/cardiovascular-sales-specialist-crm-oklahoma-city-south-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351459br/automation-engineer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351462br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351464br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351465br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351470br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351476br/senior-scientist-data-science-digital</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351477br/project-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/334811br/director-senior-director-pharmacometrics-cambridge-ma</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345696br/senior-key-account-manager-north-londoneast-england</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351312br/senior-medical-science-liaison-solid-tumor</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351316br/specialist-networkservices-ipt</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351317br/virtual-engagement-officer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351320br/salesforce-developer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351322br/informatica-data-quality-analyst</loc>
  <lastmod>2022-09-27T10:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351338br/medical-representative-bkk-cvs-antibiotic</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351340br/erp-assoc-dir-sol-delivery-func-dsgnsap-fi-compliance-controls</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351353br/shift-lead-upstream</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351359br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351360br/chemist-1-diploma-holder</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351362br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351364br/warehouse-process-expert</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351365br/safety-signal-lead</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/338713br/qualified-person-fmd</loc>
  <lastmod>2022-09-21T12:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/341508br/senior-expert-engineering-equipment-system-validation</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347247br/hr-services-expert-slovenian</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347938br/manager-chugokushikoku-area</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348046br/specialist-ims</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348603br/shichangzhunrufujinglijinglibeijing</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350649br/r2r-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351154br/medical-advisor-cardio</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351157br/medical-advisor-pain-rxotc</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351225br/business-analyst-randomization-office</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351248br/director-strategic-bp-pricing-tendering-gtn</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351251br/director-strategic-bp-supply-chainorder-management</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351288br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351289br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351303br/primary-care-sales-specialist-crm-dallas-east-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343247br/site-validation-lead</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344894br/cmcformulation-scientist-senior-scientist-inhalation-pddfm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347592br/inzhener-po-kvalifikacii-laboratornogo-oborudovaniya</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349120br/qa-compliance-expert-associate</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349551br/senior-scientist-material-characterization-fmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350843br/head-development-regulatory-center-kundl-austria-fmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351205br/gaojiyiyaodaibiaozishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351206br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351207br/gaojiyiyaodaibiaozishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351208br/expert-science-technology-fmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351215br/dir-strat-bp-scout-ordercontract-mgmt</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351216br/director-strategic-bp-clinicalgmasafetydig</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351224br/qc-specialist-novartis-stein</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351231br/digital-business-partner</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347615br/finance-manager-r2r</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347618br/finance-manager-r2r-business-partnering</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348012br/fcc-compliance-associate</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/339781br/qa-validation-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349696br/senior-principal-scientist-protein-design</loc>
  <lastmod>2022-09-28T22:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350093br/associate-director-security-operations-iam</loc>
  <lastmod>2022-09-22T18:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350380br/qa-operations-expert-fmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351145br/solution-design-expert-erp-coesap-wms</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351164br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351178br/cell-processing-specialist-i-multiple-shifts</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351187br/principal-scientist-genome-editor-discovery-group-novartis-san-diego</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351188br/sr-scientist-protein-modeler-genome-editor-discovery-novartis-nibr</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351189br/associate-director-systems-care-crm-philadelphia-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351190br/sr-scientist-protein-engineer-genome-editor-discovery-novartis-nibr</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351193br/sr-scientist-therapeutic-effector-development-novartis-nibr</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349073br/clinical-programmer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349296br/sales-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349337br/director-account-management-pricing-access-strategy-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349385br/senior-expert-science-technology-dfm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350091br/executive-quality-control</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350585br/qa-operations-specialist-2nd-shift</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350586br/qa-operations-specialist-2nd-shift</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350587br/qa-operations-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350815br/procurement-lead</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350976br/line-technician-electrician-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351021br/tactical-planner</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351065br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351076br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351081br/product-manager-cardiology-psychiatry-sandoz-czech-republic</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351088br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351096br/strategic-business-analyst-salesforce-effectiveness</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351097br/assoc-director-business-analyst-rimmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351101br/assoc-dir-func-design-arch-scm-planningkinaxis-rapid-response</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351111br/assoc-dir-func-design-arch-scm-planningsap-apo</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351124br/procesoperator</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/336975br/senior-expert-science-technology-drug-product</loc>
  <lastmod>2022-09-27T06:00:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345157br/clinical-development-medical-director</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346126br/associate-director-project-management-biologics-san-diegoboston</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347527br/chef-de-produit-senior-net-onco-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348003br/principal-scientist-i</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349105br/safety-writer-ar</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349343br/ad-acct-management-pricing-access-strategy-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349358br/ad-soc-communications-performance-management-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349414br/director-us-market-access-strategy-and-oncology-channel-marketing</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349540br/global-procurement-manager-chemical-development</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349889br/medical-advisor-immunologyoncology</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349953br/associate-director-pss-payer-analytics</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350062br/expert-regulatory-writer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351017br/senior-qa-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351019br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351025br/senior-manager-portfolio-and-licensing</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351030br/category-buyer-it-digital</loc>
  <lastmod>2022-09-28T10:01:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351031br/clinical-data-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351032br/category-buyer-it-digital</loc>
  <lastmod>2022-09-23T12:01:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351062br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343794br/people-partner-dwm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346746br/packaging-line-mechanic-all-shifts</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347411br/manager-qa-compliance-document-control</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348867br/ad-thought-leader-liaison-remote-renal-south</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349318br/managersr-manager-ra-medical-devices-precision-medicine</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349994br/quality-manager-remote-austria-mfd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350837br/market-access-pricing-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350932br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350940br/senior-clinical-data-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350959br/country-value-access-head</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350960br/ta-director-hematology</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351013br/group-head-biostatistics-dire</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351015br/senior-principal-biostastician</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343166br/human-factors-engineering-intern-fmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343845br/sr-qc-analytical-chemist</loc>
  <lastmod>2022-10-01T02:01:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346147br/medical-representative-gma</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347814br/chemielaborant-analytiker-qc-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350852br/procurement-compliance-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350887br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350892br/senior-manager-public-affairs</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350901br/demand-planner</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350915br/primary-care-sales-specialist-crm-roanoke-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348559br/srmrpseps-professional-pharmacy</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349377br/head-business-strategy-and-special-projects-bdl</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350460br/key-account-representative-endocrinology</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350827br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347800br/industrie-apotheker-qp-stage</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347924br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347944br/hr-po-business-partner-dfm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347965br/financial-reporting-accounting-specialist-revenue-accounting</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349206br/network-engineer-network-production-engineering</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349470br/equipment-operator-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349533br/production-technician</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350539br/phd-student-im-bereich-analytische-chemie-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350614br/specialist-infra-services-disaster-recovery-dr</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350683br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350686br/group-area-marketing-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350692br/qa-specialistdeputy-qp</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350694br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350697br/gaojidequjingli</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350698br/gaojidequjingli</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350699br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350700br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350701br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350703br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350705br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350708br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350709br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350711br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350712br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350716br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350720br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350721br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350722br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350723br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350724br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350727br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350728br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350729br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350730br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350735br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350748br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350750br/data-scientist-digital-finance-hub</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350752br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350753br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350754br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350766br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350767br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350770br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350773br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350774br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350775br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350778br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350781br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350782br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350783br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350818br/gaojidequjingli</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/338508br/principal-rwe-research-analyst</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343861br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348029br/brand-manager-marketing-strategy</loc>
  <lastmod>2022-09-15T10:00:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349739br/director-incident-response</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350326br/senior-regulatory-cmc-facilitator-extsupply-large-molecules-mfd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350562br/mitarbeiter-im-arztaussendienst-dwm</loc>
  <lastmod>2022-09-29T14:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350572br/postdoctoral-scholar</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350588br/buyer-market-insights</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350603br/manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350606br/biotechnologist-3-downstream</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350607br/gaojiyiyaodaibiaozishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350627br/national-strategic-account-manager-generics</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350631br/associate-manager-ae</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350655br/manager-flow-core-flow-cytometry</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350673br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350675br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350678br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350679br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350680br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350682br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/341995br/mst-head</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343022br/senior-biostatistician</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346854br/principal-scientist-hybridoma-generation</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348558br/shichangzhunruzhaobiaojingli-xinshan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348953br/research-scientist-protein-science-bsms</loc>
  <lastmod>2022-09-26T18:01:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349204br/gestionnaire-marches-hospitaliers-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349995br/ip-data-specialist-dfm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350147br/executivesenior-director-pharmacometrics</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350446br/regional-ethics-risks-and-compliance-business-partner</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350538br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350540br/maintenance-technician-i-mechanical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350546br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350549br/maintenance-technician-i-mechanical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350563br/ausbildung-zum-industriekaufmann-mwd-ab-01092023</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350566br/duales-studium-bwl-gesundheitsmanagement-mwd-ab-01102023</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350567br/duales-studium-bwl-industrie-mwd-ab-01102023</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350597br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343715br/produktionsteamleiter-shift-lead-ii-mwd</loc>
  <lastmod>2022-09-28T10:01:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344820br/senior-clinical-programmer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349210br/service-delivery-specialist-tda</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350040br/neuroscience-sales-specialist-ms-washingtonoregon-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350266br/meister-fur-mess-und-regeltechnik-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350462br/senior-medical-advisor-breast-cancer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350486br/principal-scientist-preclinical-safety</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346646br/sales-manager-upc-north-northeast</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349582br/medical-representative-upper-north-cns-ortho-gi-allergy</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350195br/specialist-representative-bkk-government-biosimilars-team</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350442br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342329br/group-manager-qc-head-qc</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345187br/clinical-database-developer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347757br/global-medical-development-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348472br/warehouse-and-logistics-expert-fmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348715br/senior-process-expert-dsp-manager-fh</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349118br/associate-cg-planner</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349467br/junior-brand-manager-otc</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349906br/qc-specialist-ii-befristet</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350206br/r2r-sr-spec-employee-benefits-acct</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350284br/brand-manager-otc</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350405br/commercial-initiatives-lead</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350415br/senior-scientist-ii-msphd-immuno-oncology</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350416br/production-technician</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350421br/clinical-study-manager</loc>
  <lastmod>2022-09-21T04:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/333213br/equipment-operator-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/333215br/qc-analyst-ii-kundl-osterreich</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/334516br/equipment-operator-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/335218br/lab-assistant-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/336156br/qc-analyst-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/336258br/shift-lead-i-warehouse-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/336369br/maintenance-technician-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/336867br/sampling-operator-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/336920br/equipment-operator-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/337162br/equipment-operator-i</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/337429br/produktionsmitarbeiter-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/338445br/maintenance-technician-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/338446br/elektrikerelektrotechniker-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/338448br/elektrikerelektrotechniker-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/338457br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/338465br/maintenance-technician-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/338466br/mechatroniker-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/338478br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/338833br/equipment-operator-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/339254br/maintenance-technician-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/339704br/maintenance-technician-i-mechanical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/339707br/associate-scientist-im-analytical-development-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/339710br/equipment-operator-i-tagschicht-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/340749br/equipment-operator-ii-tagschicht-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/340750br/lab-technician-mst-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342936br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343034br/equipment-operator-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343352br/maintenance-technician-i-electrical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343434br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343435br/maintenance-technician-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343592br/maintenance-technician-mechanic-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343601br/quereinsteiger-produktionverpackung-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343746br/service-operator-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343749br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343750br/service-operator-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343756br/service-operator-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343804br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344126br/maintenance-technician-i-mechanical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344162br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344242br/lab-technician-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344658br/equipment-operator-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344660br/equipment-operator-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344678br/deputy-lab-supervisor-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344707br/maintenance-technician-i-electrics-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344709br/lab-technician-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344711br/maintenance-technician-i-mechanical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344714br/equipment-operator-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344887br/maintenance-technician-i-electrical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344888br/equipment-operator-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345047br/equipment-operator-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345051br/equipment-specialist-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345123br/maintenance-technician-i-electrical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345727br/sample-administrator-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345733br/sample-administrator-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345734br/maintenance-technician-i-mechanical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345735br/maintenance-technician-i-mechanical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345881br/equipment-operator-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346125br/manager-clinical-trial-flow-cytometry-car-t</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346708br/equipment-operator-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346710br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346713br/equipment-operator-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347059br/stage-digital-marketing</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347090br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347093br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347780br/equipment-operator-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347781br/equipment-specialist-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347872br/equipment-operator-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348036br/maintenance-technician-1-mechanics-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348052br/equipment-specialist-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348072br/maintenance-technician-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348149br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348150br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348572br/service-operator-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348573br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348575br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348579br/qc-analyst-ii-mwd-80</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348582br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348590br/qc-analayst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348592br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348596br/equipment-specialist-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348749br/regional-tax-manager-emea-fmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348834br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348974br/senior-scientist-principal-scientist-technology-leader</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349242br/security-supervisor</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349418br/produktionsmitarbeiter-der-neuen-amoxicillin-anlage-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349419br/produktionsmitarbeiter-ii-der-neuen-amoxicillin-anlage-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349420br/schichtfuhrer-produktion-der-neuen-amoxicillin-anlage-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349473br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349656br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349660br/qc-analyst-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349837br/maintenance-technician-i-mechanical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349838br/maintenance-technician-i-mechanical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349840br/maintenance-technician-mechanical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349841br/maintenance-technician-mechanical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349895br/maintenance-technician-i-mechanical-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350020br/team-lead-compound-sample-management</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350253br/principal-clinical-database-developer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350264br/dra-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350268br/product-safety-lead-sandoz-dfm</loc>
  <lastmod>2022-09-26T12:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350302br/specialist-security-compliance-engineering</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350372br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/337511br/manufacturing-interface-technical-steward-50-100-fmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348599br/national-commercial-manager-generics</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349298br/research-scientist-i-or-ii-cellular-immunology-lab</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349649br/przedstawiciel-medyczny-cardio-warszawa-srodmiescie</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349813br/production-supervisor</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350018br/principal-scientist-medicinal-chemistry</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350156br/onderhoudstechnieker-verpakking-2-3-ploegen</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350157br/onderhoudstechnieker-verpakking-2-3-ploegen</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350161br/medical-representative-specialty-ha-noi-sandoz</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350171br/associate-director-regulatory-affairs-biopharma-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350174br/global-program-regulatory-director-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350188br/executive-qa</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350190br/assistant-manager-qa</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350196br/clinical-bioanalysis-team-lead-pk-sciences-associate-director</loc>
  <lastmod>2022-09-16T18:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350201br/protein-biochemist-research-scientist</loc>
  <lastmod>2022-09-16T20:01:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350205br/cardiovascular-sales-specialist-crm-nashville-west-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/338441br/head-marketing-cvm-market-brands-region-europe-dfm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/339544br/pharmazeuten-im-praktikum-dwm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344629br/process-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346108br/specialist-po-preparatam-kardiologiya</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349123br/head-trial-activation</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349466br/digital-marketing-manager-otc</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349981br/specialist-tech-integration-enablement</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349985br/qc-analyst</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349986br/qc-analyst</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349997br/principal-scientist-i</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349999br/principal-scientist-ii</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350007br/specjalista-ast</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350101br/primary-care-sales-specialist-crm-bronx-south-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350112br/associate-director-business-analyst-mes</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350118br/head-business-continuity-management</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342880br/gmp-process-expert</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348198br/senior-quality-assurance-manager-mfd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349022br/molecular-and-computational-safety-scientist-safety-genetics-lab</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349979br/mst-lead</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344682br/maschinenbediener-im-bereich-pharmazeutische-produktion-mwd</loc>
  <lastmod>2022-09-29T14:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348578br/qc-analyst-ii-80-100</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349811br/scientific-operations-team-leader</loc>
  <lastmod>2022-09-20T16:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349881br/associate-tactical-planner</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349885br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349894br/process-chemist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349918br/digital-strategy-partnership-ad</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345492br/senior-process-expert</loc>
  <lastmod>2022-09-21T10:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348287br/medical-advisor-aaa</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348474br/sr-marketing-capability-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349641br/analityk-biznesowy-it</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349742br/shift-lead-ii-supervisor-abteilungsleiter-biofilling-wmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349805br/qa-operations-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349806br/qualified-person-wmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349814br/associate-director-bcm-controls-audit</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349816br/onderhoudstechnieker-farma</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349817br/onderhoudstechnieker-3-ploegen</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346946br/lab-assistant-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347366br/head-supply-chain-management-nto-lmmp-sasayama</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348620br/research-scientist-vivo-drug-discovery-pharmacology-80-100</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349432br/pharmacien-aqproduction-nuits-st-cloud-paris-hf</loc>
  <lastmod>2022-09-26T16:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349679br/senior-talent-acquisition-business-partner-german</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349723br/technieker-utilities</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349726br/onderhoudstechnieker-biotech</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349728br/onderhoudstechnieker-3-ploegen</loc>
  <lastmod>2022-09-26T20:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349729br/onderhoudstechnieker-pharma-3-ploegen</loc>
  <lastmod>2022-09-26T20:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349752br/senior-talent-acquisition-business-partner-german</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345481br/kam-digital-integrated-care-dwm-westdeutschland</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347587br/manager-operations-pmo</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348077br/senior-manager-analytics-fmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348206br/specialist-ims-it-systems-strategy-dwm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348697br/ast-lead-mfd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349585br/director-information-security-governance</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349640br/manager-value-and-access-sed</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349659br/gaojikehudaibiao-zishenkehuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349698br/senior-scientist-vitroex-vivo-ophthalmology</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349699br/scientistsenior-scientist-vitro-biology</loc>
  <lastmod>2022-09-20T22:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/340158br/key-account-manager-urologie-onkologie-dwm-westdeutschland</loc>
  <lastmod>2022-09-29T14:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342343br/senior-compliance-manager-dfm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344776br/principal-scientist-immune-tolerance-80-100</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347825br/qc-analyst-microbiology-ii</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349208br/high-performance-computing-engineer</loc>
  <lastmod>2022-09-29T12:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349528br/medical-sales-representative</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349572br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348133br/sr-digital-solution-planning-manager-im-china</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/331682br/sr-principal-scientist-structural-biophysical-chemistry-novartis</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342809br/order-management-operator</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349496br/apprenti-chef-de-produit-ophtalmologie-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349481br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349497br/apprentie-chef-de-projet-digital-parcours-de-soin</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349498br/civilarchitecturestructural-sr-executive</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344275br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346664br/principal-scientist-regenerative-medicine</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348038br/delegue-hospitalier-oncologie-bretagne-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348094br/sr-innovative-strategy-manager-new-channel-im-china</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348095br/beigene-pm-im-china</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348327br/gaojilingshouzhuanyeyaofangyiyaodaibiaozishenlingshouzhuanyeyaofangchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348371br/gaojilingshouzhuanyeyaofangyiyaodaibiaozishenlingshouzhuanyeyaofangchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348426br/gaojilingshouzhuanyeyaofangyiyaodaibiaozishenlingshouzhuanyeyaofangchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348776br/oncology-regional-managing-director-south-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348778br/oncology-regional-managing-director-west-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349309br/principal-clinical-database-developer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349335br/finance-master-data-specialist</loc>
  <lastmod>2022-09-28T00:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349370br/lingshouquanguozhongdiankehujingli</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349399br/trd-quality-project-lead</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349438br/clinical-database-developer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349440br/supply-chain-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349447br/head-global-security-us</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346481br/neuroscience-sales-specialist-ms-long-island-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348529br/director-product-strategy-lead-csu</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348533br/director-product-strategy-lead-sjogrens</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349205br/compliance-manager-regulatory-affairs-dfm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349270br/principal-clinical-database-developer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349271br/clinical-database-developer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349359br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349362br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/341165br/technicien-procede-mst-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344963br/group-manager-portfolio-product-life-cycle-mgmt</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347574br/process-expert</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347693br/medical-affairs-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349195br/medical-franchise-headhematology</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349201br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349217br/sfe-sales-training-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345193br/clinical-development-associate</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345978br/principal-scientist-imaging</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346897br/region-europe-marketing-manager-oncology-dfm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347805br/qc-analyst-microbiology-ii</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348396br/senior-scientist-ii-mass-spectrometry</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349112br/senior-expert-sciencetechnology-lab-automationdata-digital-fmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349114br/werkstudent-fra-ops-dwm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349157br/analytics-and-separations-senior-scientist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349161br/primary-care-sales-specialist-crm-panama-city-remote</loc>
  <lastmod>2022-09-30T16:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349163br/principalsenior-principal-dmpk-scientist-pk-sciences</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349171br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349173br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349174br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342190br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349071br/principal-clinical-database-developer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348820br/associate-qa-compliance</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348894br/process-expert-validation-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349006br/senior-process-expert-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/331545br/senior-scientist-immuno-oncology-cell-and-gene-therapy-group</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348454br/head-biosimilars-specialty-bu</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348818br/process-expert-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348882br/expert-science-technology-downstream-process-development</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348938br/technical-operation-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348958br/manager-managed-care-rebates-sandoz</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348969br/senior-scientist-biologics-bioanalytical-lab</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348990br/associate-director-full-stack-software-development-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348991br/associate-director-information-architect-software-dev-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348992br/senior-manager-user-experience-interface-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/332247br/vp-head-field-medical-engagement</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347486br/senior-expert-data-scientist-predictive-safety</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348666br/head-marketing-excellence</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348269br/community-account-manager-hampshire</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348623br/productie-operator-vast-contract</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348741br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348752br/associate-director-data-software-quality-assurance-engineer-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348785br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344855br/medical-science-liaison</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347665br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348535br/preclinical-safety-study-scientist</loc>
  <lastmod>2022-09-16T20:01:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348622br/productie-operator-afvulling</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348625br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348631br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348657br/principal-scientist-i-novartis-nibr-east-bay</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348551br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347179br/maintenance-and-reliability-engineer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347287br/research-scientist-pre-clinical-molecular-imaging-80-100</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348478br/ausbildung-zum-chemielaboranten-mwd-fur-2023</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348482br/ausbildung-zum-pharmakanten-mwd-fur-2023</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348487br/ausbildung-zum-mechatroniker-mwd-fur-2023</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348522br/responsable-affaires-publiques-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/340357br/manager-corporate-brand-strategy</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343307br/expert-maintenanceexploitant-clean-utilities-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343312br/expert-maintenance-exploitant-black-utilities-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347851br/associate-director-aav-technology</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348351br/kam-diagnostico</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348352br/kam-diagnostico</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348393br/cardiovascular-sales-specialist-crm-midtown-manhattan-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348397br/laborant-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348400br/duales-studium-2023-mechatronik-automation-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348401br/duales-studium-2023-technisches-management-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348404br/translational-research-expert</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348413br/senior-oeb-account-representative-gaojikehudaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343525br/chemielaborant-analytiker-qc-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347831br/qa-operations-expert</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348191br/manager-external-service-provider-management</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348197br/senior-franchise-head</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348257br/lab-operations-specialist</loc>
  <lastmod>2022-09-16T18:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348273br/virtual-sales-specialist-crm-washington-dc-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348279br/expert-science-technology-bioanalytics-scientist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343027br/opex-coordinator</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348114br/qc-chemist-2</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348124br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346467br/aseptic-process-expert</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347807br/manager-system-operations</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347908br/business-continuity-specialist-technology-transformation</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347775br/associate-pharmacovigilance</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348016br/expert-science-technology</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/317423br/rechtsreferendar-dwm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/331641br/produktionsmitarbeiter-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344977br/responsable-sectoriel-riv-tne-cancer-prostateonco-aquitaine-hf</loc>
  <lastmod>2022-09-20T14:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346985br/head-medical-excellence-clinical-ops-im-china</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347939br/senior-project-manager-pmo-process-development</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347991br/research-scientist-ii-research-collaborations</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/335673br/proces-operator-farma</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/337238br/drug-product-project-leader-associate-director-science-tech-fmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345137br/technisch-operator-filling</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346388br/hse-business-partner</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347881br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347892br/hf-apprentissage-assistant-adminitrative</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347839br/cardiovascular-sales-specialist-crm-bronx-s-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347858br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/335902br/senior-process-expert-data-management-wm</loc>
  <lastmod>2022-09-15T18:01:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346643br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347655br/key-account-representative-iasi</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347707br/senior-automation-engineer-biofuture-dist-control-system-deltav</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347714br/hr-trainee-hr-stage</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347726br/clinical-research-medical-director</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/337365br/global-gmp-senior-quality-auditor</loc>
  <lastmod>2022-09-19T14:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347672br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347611br/product-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347623br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347610br/novartis-turkey-general-application</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/332008br/betriebswerker-maschinenbediener-bereich-herstellung-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/337364br/global-gmp-senior-quality-auditor</loc>
  <lastmod>2022-09-19T14:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343849br/principal-scientist-extrahepatic-sirna-delivery-novartis-nibr-la-jolla</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344361br/sr-principal-scientist-hematology-regeneration-nibr-la-jolla</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344362br/principal-scientist-hematology-regeneration-nibr-la-jolla</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344417br/research-scientist-sr-scientist-molecular-biologist-hematology</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344418br/research-scientist-sr-scientist-hematology-and-stem-cell-biology</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345081br/principal-scientist-chemoproteomics-mass-spectrometry-nibr-la-jolla</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345220br/chemoproteomics-scientist-biochemistry-and-analytics-nibr-la-jolla</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345369br/senior-scientist-protein-production-nibr-la-jolla</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345623br/principal-scientist-regenerative-medicine-vivo-bio-nibr-la-jolla</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345800br/mitarbeiter-instandhaltung-mwd-im-bereich-konfektionierung</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345977br/research-scientist-lead-discovery-nitd-multiple-openings</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347132br/onc-medical-science-liaison-radioligand-therapy-prostate-net-remote</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347560br/gaojiyiyaodaibiaozishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347566br/priloznosti-v-talent-acquisition-nemsko-govoreci</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347595br/data-insights-manager-pharmaretail</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347607br/novartis-institute-tropical-diseases-bioinformatician</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347439br/banco-de-talentos-seja-um-talento-novartis</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347506br/medical-representative-antibiotics-can-tho-sandoz</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347513br/senior-clinical-database-developer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347514br/senior-clinical-database-developer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347517br/yangfanyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347542br/manager-state-income-tax</loc>
  <lastmod>2022-09-28T20:01:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347544br/manager-tax-operations</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347415br/director-regulatory-policy-intelligence</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347460br/expert-regulatory-writer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342910br/commercial-gmp-qa</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347381br/associate-global-labeling-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347372br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347374br/delegue-hospitalier-endocrinologie-idf-regions-voisines-hf</loc>
  <lastmod>2022-09-28T12:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347394br/quality-assurance-specialist-temporary</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346102br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347343br/executive-product-steward</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346938br/process-support-unit-lead-fmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346173br/engineering-mgr-unix</loc>
  <lastmod>2022-09-22T14:01:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346532br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-23T10:01:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346598br/expert-aq-technique-hf-cdd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347234br/proces-operator</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346473br/crisis-management-specialist-technology-transformation</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342951br/regional-anti-bribery-risk-expert-french</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344650br/coordinateur-technique</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346806br/jobs-bei-novartis-fur-ukraine-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346866br/supply-chain-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346872br/assoc-dir-global-data-governance</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346924br/associate-dra-manager</loc>
  <lastmod>2022-09-26T10:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345160br/qa-operations-specialist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346803br/productie-operator-afvulling</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342950br/team-lead-third-party-risk-management-operations-german</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342953br/third-party-risk-management-specialist-german</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345806br/sr-principal-scientist-virology-institute-tropical-diseases</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346716br/mechanical-engineering-senior-executive</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346757br/associate-clinical-label-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346635br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346639br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346671br/maintenance-technician</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346680br/apprenti-affaires-publiques-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346629br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346515br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346529br/trade-marketing-manager-otc-dwm</loc>
  <lastmod>2022-09-20T12:01:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346537br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342378br/qaqp-quality-assurance-qualified-person</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344528br/senior-manufacturing-systems-expert-dwm</loc>
  <lastmod>2022-09-16T20:01:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346101br/production-head</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346451br/gaojidequjingli</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346503br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346507br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346251br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346264br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346265br/qualification-maintenance-coordinator</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346267br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346269br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346306br/senior-expert-science-technology-mfd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346311br/gaojidequjingli</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346316br/gaojidequjingli</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346330br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346361br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345135br/technisch-operator-filling</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346152br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346191br/yangfanyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346200br/gaojidequjingli</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346206br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346221br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346234br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346237br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346238br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346239br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346240br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346242br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346243br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346134br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345731br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/338651br/senior-research-associate-digital-pathology-solutions</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344432br/sales-execution-manager-oncology-bio-bu</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345639br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346057br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346059br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/346060br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344936br/senior-scientist-flow-cytometry</loc>
  <lastmod>2022-09-27T22:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345024br/delegue-hospitalier-neurotransplant-grand-ouest</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345582br/delegue-hospitalier-endocrinologie-ouest-de-la-france</loc>
  <lastmod>2022-09-28T12:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345583br/delegue-hospitalier-endocrinologie-nord-de-la-france-hf</loc>
  <lastmod>2022-09-28T12:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345923br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345964br/cardiovascular-sales-specialist-crm-charlottesville-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345976br/apprenti-coordinateur-essais-cliniques-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345780br/apprenti-chef-de-projet-data-reporting-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345801br/research-investigator-drug-discovery-polycystic-kidney-diseases</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345826br/gaojiyiyaodaibiaozishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345830br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345898br/senior-scientist-virology-novartis-institute-tropical-diseases</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345908br/associate-clinical-development-medical-director</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344795br/expert-senior-cq-analytique-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345659br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345670br/manager-wholesalers</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345672br/shengchancaozuoyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345564br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344837br/global-biomarker-diagnostic-associate-director</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345475br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345501br/principal-clinical-data-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345335br/senior-manager-quality-assurance-precision-medicine</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345460br/medicinal-chemistry-senior-scientist-bs-or-ms</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/338871br/vivarium-operations-supervisor</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/339762br/technical-transfer-operations-lead</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345245br/gaojiyiyaodaibiaozishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345210br/web-portals-design-lead-dfm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345075br/senior-statistical-programmer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345108br/shengchancaozuoyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345161br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345041br/senior-clinical-development-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345042br/associate-external-operations-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345046br/tactical-planner</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345096br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344893br/maschinenbediener-verpackung-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344760br/sr-manager-quality-assurance</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344768br/clinical-programmer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344774br/senior-clinical-programmer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/338995br/maintenance-technician-i-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343368br/technikermechatronikermechanikerelektriker-wmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344704br/apprenti-marketing-ic-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344263br/senior-manufacturing-systems-expert-dwm</loc>
  <lastmod>2022-09-16T20:01:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344611br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344624br/qa-manager-dfm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/332383br/meister-fur-mess-und-regeltechnik-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344459br/manager-distribution-and-supply-chain</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344490br/ad-global-regulatory-affairs-remote</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344407br/associate-director-tax-planning</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342020br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344147br/associate-data-steward</loc>
  <lastmod>2022-09-22T12:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344156br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344158br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/344196br/medical-representative</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343710br/shift-lead-ii-mwd</loc>
  <lastmod>2022-09-16T16:00:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343972br/expert-science-technology</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343968br/qc-analyst</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343896br/apprenti-chargee-de-documentation-scientifique-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343911br/apprenti-analyste-strategique-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343739br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343745br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343748br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343674br/hf-apprentissage-pharmacien</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343675br/hf-apprentissage-pharmacien-bethune</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343676br/hf-apprentissage-pharmacien-troyes</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343680br/hf-apprentissage-pharmacien-saint-genis-pouilly</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343683br/hf-apprentissage-pharmacien-saint-cloud</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343690br/hf-apprenti-technicien-de-production-saint-genis-pouilly</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343692br/hf-apprenti-technicien-de-production-bethune</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343693br/hf-apprenti-technicien-de-production-saint-cloud</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343694br/hf-apprenti-technicien-de-production-marseille</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343697br/hf-apprenti-technicien-de-production-troyes</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343555br/hf-stagiaire-medical-affaires</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343564br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343348br/stagiaire-medecine-generale-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343353br/apprenti-controleur-de-gestion-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343362br/apprenti-programmeur-statistiques-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/340170br/netzwerkmanager-prostate-cancer-nord-ost-dw-berlin-dresden</loc>
  <lastmod>2022-09-29T14:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342125br/manager-bereich-sachkundige-person-mwd-gemass-amg-amwhv-und-gmp</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/340870br/eso-supply-chain-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342242br/senior-expert-science-technology-mfd-downstream-process-developm</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/340579br/senior-regulatory-writer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/341827br/python-developer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/341564br/trainee-productionquality-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/341448br/trainee-engineering-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/341426br/senior-scientist-lentivirus-and-hsc-engineering</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/340871br/supply-operations-manager-eso</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/341291br/eso-project-manager</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/341296br/stagiaire-assistante-administrative</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/341302br/stagiaire-lean-management-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/340866br/expert-science-technology</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/335081br/productie-operator-bio</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/335682br/laborant-analist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/339356br/global-transformative-solution-designer</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/339275br/associate-director-senior-corporate-counsel</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/339106br/process-engineering-senior-executive</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/338440br/mechatroniker-wmd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/329871br/lab-technicianqc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/337601br/senior-manager-eu-public-affairs</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/336296br/new-business-manager-europe-mfd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/331043br/qc-analyst-ii-mwd-tirol-schaftenau-osterreich</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/337158br/gaojiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/337018br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/336942br/directorassociate-director-pkpd-pk-sciences</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/336944br/principal-scientist-pk-sciences</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/336602br/qa-lead-eso</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/335323br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/335011br/ad-regulatory-affairs</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/329239br/medical-director-translational-medicine-expert-ns-and-ati</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/332078br/stagiaire-chef-de-produit-rhumatologie-hf</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/331040br/qc-analyst-ii-mwd-schaftenau-osterreich</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/331423br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/330195br/equipment-operator-i-mwd-schaftenau-osterreich</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/330200br/equipment-operator-i-mwd-schaftenau-osterreich</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/330416br/seniorprincipal-biostatistician</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/327680br/lab-technician-mwd-kundl-osterreich</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/329530br/equipment-specialist-mwd</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/329930br/multiomics-data-scientist</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/329631br/maintenance-technician-i-mwd-schaftenau-osterrreich</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/329648br/qc-analyst-ii-mwdkundl-osterreich</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/329533br/lab-technician-mwd-kundl-osterreich</loc>
  <lastmod>2022-09-15T08:49:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352539br/buyer-china-cluster</loc>
  <lastmod>2022-10-03T06:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/340316br/process-team-lead-fmd</loc>
  <lastmod>2022-09-15T12:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350499br/qc-specialist-ii-80-100</loc>
  <lastmod>2022-09-15T12:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351430br/specialist-life-cycle-management</loc>
  <lastmod>2022-09-15T12:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352809br/financial-analyst</loc>
  <lastmod>2022-09-26T16:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352818br/medical-representative-bkk</loc>
  <lastmod>2022-09-15T12:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352819br/manager-procurement</loc>
  <lastmod>2022-09-16T10:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352823br/senior-qa-specialist-cgt-temporary-novartis-stein</loc>
  <lastmod>2022-09-15T14:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352826br/qa-specialist-cgt-temporary-novartis-stein</loc>
  <lastmod>2022-09-15T14:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352828br/cell-processing-specialist-cgt-temporary-novartis-stein</loc>
  <lastmod>2022-09-15T14:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352831br/sr-qualification-engineer</loc>
  <lastmod>2022-09-15T14:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352827br/disease-area-specialist-hamerkaz</loc>
  <lastmod>2022-09-15T16:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352829br/disease-area-specialist-jerusalem-south</loc>
  <lastmod>2022-09-15T16:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352832br/life-cycle-manager</loc>
  <lastmod>2022-09-15T16:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352833br/responsable-grands-comptes-kam-hf</loc>
  <lastmod>2022-09-15T16:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352834br/risk-and-resilience-lead</loc>
  <lastmod>2022-09-15T16:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/340138br/biosimilar-first-line-manager</loc>
  <lastmod>2022-09-15T16:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/342888br/first-line-manager</loc>
  <lastmod>2022-09-15T16:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352843br/tactical-planner</loc>
  <lastmod>2022-09-15T18:01:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352854br/sr-microbiology-analyst</loc>
  <lastmod>2022-09-15T18:01:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352860br/pharmacien-assurance-qualite-produit</loc>
  <lastmod>2022-09-15T20:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352861br/associate-director-market-access-commercial-analytics</loc>
  <lastmod>2022-09-15T20:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352865br/principal-scientist-mass-cytometry-immuno-oncology-hematology</loc>
  <lastmod>2022-09-15T20:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352866br/cardiovascular-sales-specialist-crm-woodlands-remote</loc>
  <lastmod>2022-09-22T16:01:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352871br/ngs-research-scientist-bsms</loc>
  <lastmod>2022-09-15T22:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352874br/senior-administrative-assistant</loc>
  <lastmod>2022-09-28T22:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352897br/laboratory-operations-manager</loc>
  <lastmod>2022-09-16T02:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352322br/product-specialist</loc>
  <lastmod>2022-09-16T08:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352373br/head-market-access</loc>
  <lastmod>2022-09-16T04:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352857br/associate-director-performance-quality-improvement-2-positions</loc>
  <lastmod>2022-09-16T06:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351475br/learning-and-transformation-partner</loc>
  <lastmod>2022-09-16T08:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352245br/qc-analyst-i</loc>
  <lastmod>2022-09-16T10:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352247br/qc-analyst-ii</loc>
  <lastmod>2022-09-16T10:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352914br/crm-customer-relations-manager</loc>
  <lastmod>2022-09-16T10:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351615br/postgraduate-gcs-ops-clinical-packaging</loc>
  <lastmod>2022-09-16T12:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352924br/senior-quality-compliance-coordinator</loc>
  <lastmod>2022-09-16T12:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352938br/global-planning-business-analyst</loc>
  <lastmod>2022-09-16T12:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352941br/head-access</loc>
  <lastmod>2022-09-16T14:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352722br/head-commercial-excellence-czsk-sandoz</loc>
  <lastmod>2022-09-16T16:00:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352947br/clinical-trial-supply-manager</loc>
  <lastmod>2022-09-16T16:00:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349218br/ethics-risk-compliance-head-sandoz</loc>
  <lastmod>2022-09-28T18:01:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352959br/senior-data-engineer</loc>
  <lastmod>2022-09-16T18:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352973br/primary-care-sales-specialist-crm-tacoma-remote</loc>
  <lastmod>2022-09-16T20:01:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352366br/reimbursement-specialist-i-schedule-2-10am-7pm-multiple-positions</loc>
  <lastmod>2022-09-26T18:01:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352741br/dir-business-planning-and-strategy-patient-specialty-services</loc>
  <lastmod>2022-09-16T22:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352976br/bs-ms-senior-scientist-medicinal-chemistry-novartis-nibr-east-bay</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349877br/manager-vendor-operations-patient-specialty-services</loc>
  <lastmod>2022-09-16T22:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352374br/reimbursement-specialist-ii-schedule-1-8am-5pm-multiple-positions</loc>
  <lastmod>2022-09-16T22:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352398br/reimbursement-specialist-ii-schedule-2-10am-7pm-multiple-positions</loc>
  <lastmod>2022-09-16T22:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352403br/intake-specialist</loc>
  <lastmod>2022-09-16T22:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352776br/principal-software-engineer</loc>
  <lastmod>2022-09-17T00:01:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352778br/senior-software-engineer</loc>
  <lastmod>2022-09-17T00:01:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352977br/strategy-analytics-customer-experience-manager</loc>
  <lastmod>2022-09-17T06:01:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351656br/senior-scientist-genetic-screening</loc>
  <lastmod>2022-09-21T12:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351814br/principal-scientist-i</loc>
  <lastmod>2022-09-17T06:01:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352978br/production-lead-2nd-shift</loc>
  <lastmod>2022-09-17T22:00:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352979br/validation-specialist</loc>
  <lastmod>2022-09-18T06:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352984br/medical-representative</loc>
  <lastmod>2022-09-18T14:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352985br/medical-representative</loc>
  <lastmod>2022-09-18T16:00:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352986br/country-head-public-affairs</loc>
  <lastmod>2022-09-19T02:01:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349269br/head-drugstore-otc</loc>
  <lastmod>2022-09-19T06:00:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349515br/3x-director-resource-optimization</loc>
  <lastmod>2022-09-19T08:01:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350576br/2x-manager-customer-engagement-effectiveness</loc>
  <lastmod>2022-09-19T08:01:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352623br/team-head-mdm-igm</loc>
  <lastmod>2022-09-20T08:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352624br/business-operations-manager-gmp-officer</loc>
  <lastmod>2022-09-20T08:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352927br/gene-therapy-medical-lead</loc>
  <lastmod>2022-09-19T08:01:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352995br/laboratory-head-bioanalytics-dfm</loc>
  <lastmod>2022-09-19T08:01:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352991br/first-line-manager-mekong-sandoz</loc>
  <lastmod>2022-09-19T08:01:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352838br/manager-regulatory-affairs-fmd</loc>
  <lastmod>2022-09-23T16:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352953br/assistenz-der-geschaftsleitung-dwm</loc>
  <lastmod>2022-09-19T12:01:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353002br/bd-innovation-manager</loc>
  <lastmod>2022-09-19T12:01:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353008br/postgraduate-engineering</loc>
  <lastmod>2022-09-30T14:01:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353016br/kam-onco-biosimilars-pre-vychodne-slovensko</loc>
  <lastmod>2022-09-19T12:01:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/338621br/project-coordinator-team-lead</loc>
  <lastmod>2022-09-19T14:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351102br/ast-analyst-temp</loc>
  <lastmod>2022-09-19T14:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351845br/shift-lead-ii-steriles-novartis-stein-temporary</loc>
  <lastmod>2022-09-19T14:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353024br/specialiste-assurance-qualite-hf</loc>
  <lastmod>2022-09-19T14:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353026br/principal-clinical-data-manager</loc>
  <lastmod>2022-09-19T14:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353027br/clinical-data-manager</loc>
  <lastmod>2022-09-19T14:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353028br/senior-clinical-data-manager</loc>
  <lastmod>2022-09-19T14:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353029br/senior-clinical-data-manager</loc>
  <lastmod>2022-09-19T14:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352066br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-19T16:01:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353031br/equipment-specialist-novartis-stein-steriles-temporary</loc>
  <lastmod>2022-09-21T18:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353036br/change-engagement-specialist</loc>
  <lastmod>2022-09-21T12:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353045br/packaging-technician-iii-3rd-shift</loc>
  <lastmod>2022-09-19T16:01:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353075br/production-technician-iii-3rd-shift-compression</loc>
  <lastmod>2022-09-19T18:01:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349586br/ad-regulatory-advertising-promotion-biosimilars-remote</loc>
  <lastmod>2022-09-19T18:01:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353062br/scientist-digital-pathology-solutions</loc>
  <lastmod>2022-09-19T18:01:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353100br/manager-tax-operations</loc>
  <lastmod>2022-09-19T20:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353101br/neuroscience-sales-specialist-ms-richmond-va-remote</loc>
  <lastmod>2022-09-19T20:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353115br/oncology-medical-science-liaison-breastgyn-pacific-northwest-remote</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353117br/oncology-medical-science-liaison-breastgyn-desert-remote</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353121br/oncology-medical-science-liaison-breastgyn-upper-texas-remote</loc>
  <lastmod>2022-09-19T20:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343364br/oncology-medical-science-liaison-breastgyn-no-ca-remote</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345525br/oncology-medical-science-liaison-upper-central-remote</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349864br/associate-director-pss-enterprise-content-design-ms</loc>
  <lastmod>2022-09-19T20:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353123br/oncology-medical-science-liaison-breastgyn-lower-texas-remote</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353125br/coordinator-regulatory-compliance-temporary-12-months</loc>
  <lastmod>2022-09-19T22:01:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353127br/oncology-medical-science-liaison-breastgyn-east-gulf-coast-remote</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353139br/oncology-medical-science-liaison-breastgyn-ohio-river-remote</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353145br/oncology-medical-science-liaison-breastgyn-florida-remote</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353132br/oncology-director-priority-accounts-minneapolis-mn-remote</loc>
  <lastmod>2022-09-20T00:01:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353133br/oncology-director-priority-accounts-houston-tx-remote</loc>
  <lastmod>2022-09-20T00:01:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353136br/oncology-director-priority-accounts-charlotte-nc-remote</loc>
  <lastmod>2022-09-20T00:01:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353137br/oncology-director-priority-accounts-tampa-fl-remote</loc>
  <lastmod>2022-09-20T00:01:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353138br/oncology-director-priority-accounts-san-francisco-ca-remote</loc>
  <lastmod>2022-09-20T00:01:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353141br/oncology-director-priority-accounts-cleveland-oh-remote</loc>
  <lastmod>2022-09-21T18:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353142br/oncology-director-priority-accounts-los-angeles-n-ca-remote</loc>
  <lastmod>2022-09-20T00:01:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353143br/oncology-director-priority-accounts-dallas-tx-remote</loc>
  <lastmod>2022-09-20T00:01:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353147br/oncology-director-priority-accounts-new-york-ny-remote</loc>
  <lastmod>2022-09-21T18:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353151br/oncology-associate-director-priority-accounts-denver-co-remote</loc>
  <lastmod>2022-09-20T00:01:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353153br/oncology-director-priority-accounts-boston-ma-remote</loc>
  <lastmod>2022-09-21T18:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353154br/oncology-associate-director-priority-accounts-st-louis-mo-remote</loc>
  <lastmod>2022-09-20T00:01:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353156br/oncology-assoc-dir-priority-accounts-los-angeles-s-ca-remote</loc>
  <lastmod>2022-09-20T00:01:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353159br/oncology-associate-director-priority-accounts-memphis-tn-remote</loc>
  <lastmod>2022-09-20T00:01:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353160br/oncology-associate-director-priority-accounts-washingtonmd-remote</loc>
  <lastmod>2022-09-20T00:01:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353161br/oncology-associate-director-priority-accounts-atlanta-ga-remote</loc>
  <lastmod>2022-09-20T00:01:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353162br/oncology-associate-director-priority-accounts-chicago-il-remote</loc>
  <lastmod>2022-09-21T18:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353163br/oncology-associate-director-priority-accounts-seattle-wa-remote</loc>
  <lastmod>2022-09-20T00:01:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353164br/oncology-associate-director-priority-accounts-phoenix-az-remote</loc>
  <lastmod>2022-09-20T00:01:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353165br/oncology-associate-director-priority-accounts-new-york-ny-remote</loc>
  <lastmod>2022-09-21T18:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353166br/oncology-associate-director-priority-accounts-detroit-mi-remote</loc>
  <lastmod>2022-09-21T18:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353170br/expert-scientist-science-technology-upstream</loc>
  <lastmod>2022-09-20T00:01:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353174br/oncology-assoc-dir-priority-accounts-indianapolis-remote</loc>
  <lastmod>2022-09-21T18:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353176br/oncology-associate-director-priority-accounts-upstate-ny-remote</loc>
  <lastmod>2022-09-21T18:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353178br/oncology-assoc-dir-priority-accounts-philadelphia-pa-remote</loc>
  <lastmod>2022-09-21T18:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353179br/director-issue-advocacy</loc>
  <lastmod>2022-09-20T00:01:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352568br/director-search-evaluation</loc>
  <lastmod>2022-09-20T00:01:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353134br/marketing-intern</loc>
  <lastmod>2022-09-20T02:01:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352994br/business-planning-analyst-manager</loc>
  <lastmod>2022-09-20T04:01:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353192br/cra-bj</loc>
  <lastmod>2022-09-20T06:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353191br/xianyuzhuguanxianyuzhuren</loc>
  <lastmod>2022-09-20T06:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353193br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-20T08:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343784br/alternante-ingenieure-developpement-durable-hf</loc>
  <lastmod>2022-09-20T10:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351588br/po-services-expert-mfd</loc>
  <lastmod>2022-09-20T10:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352950br/delegue-hospitalier-oncologie-normandie-yvelines-hf</loc>
  <lastmod>2022-09-20T10:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353195br/yangfanyiyaodaibiao</loc>
  <lastmod>2022-09-20T10:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352320br/senior-sales-executive</loc>
  <lastmod>2022-09-20T12:01:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352527br/specialist-upravljanja-kakovosti-mzd</loc>
  <lastmod>2022-09-20T12:01:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353210br/senior-sales-executive</loc>
  <lastmod>2022-09-20T12:01:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353221br/medical-representative-lower-north-phitsanulok-based</loc>
  <lastmod>2022-09-20T12:01:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348268br/senior-scientist-formulation-development</loc>
  <lastmod>2022-09-20T14:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352566br/student-assistant-rxgx</loc>
  <lastmod>2022-09-20T14:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352966br/qualified-person</loc>
  <lastmod>2022-09-22T12:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353227br/internship-finance-academy</loc>
  <lastmod>2022-09-27T12:01:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353228br/associate-medical-advisor-senior-medical-advisor-neuro-science</loc>
  <lastmod>2022-09-20T14:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353229br/safety-business-partner-mfd</loc>
  <lastmod>2022-09-20T14:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353234br/production-employee</loc>
  <lastmod>2022-09-23T16:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350885br/key-account-manager</loc>
  <lastmod>2022-09-20T16:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352639br/market-access-public-affairs-manager-replacement-contract</loc>
  <lastmod>2022-09-27T10:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352903br/ad-regional-markets-south-coast-bilingual-remote-1-2</loc>
  <lastmod>2022-09-28T16:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352967br/qa-specialist</loc>
  <lastmod>2022-09-22T12:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352968br/qc-supervisor</loc>
  <lastmod>2022-09-22T12:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353289br/sales-sr-specialist-eye-care-white-plains-ny-remote</loc>
  <lastmod>2022-09-20T20:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353286br/sales-sr-sales-specialist-eye-care-portland-north-remote</loc>
  <lastmod>2022-09-20T20:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353290br/sales-sr-sales-specialist-eye-care-wichita-ks-remote</loc>
  <lastmod>2022-09-20T22:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353291br/sales-sr-sales-specialist-eye-care-fayetteville-nc-remote</loc>
  <lastmod>2022-09-20T22:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353292br/virtual-sales-specialist-eye-care-san-francisco-remote</loc>
  <lastmod>2022-09-20T22:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353294br/associate-director-technical-development-downstream</loc>
  <lastmod>2022-09-20T22:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353295br/principalsenior-principalassociate-director-pharmacometrics</loc>
  <lastmod>2022-09-20T22:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353296br/virtual-sales-specialist-eye-care-houston-remote</loc>
  <lastmod>2022-09-20T22:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353299br/virtual-sales-specialist-eye-care-denver-remote</loc>
  <lastmod>2022-09-20T22:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353304br/associate-director-pharmacometrics</loc>
  <lastmod>2022-09-21T00:01:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343850br/principal-scientist-antibody-bioconjugates-discovery-nibr-la-jolla</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353311br/principalsenior-principal-pharmacometrician</loc>
  <lastmod>2022-09-21T04:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349237br/bpa-manager</loc>
  <lastmod>2022-09-21T04:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353317br/shixiyiyaodaibiao</loc>
  <lastmod>2022-09-21T06:01:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353306br/head-vp-ms-patient-and-specialty-services-pss</loc>
  <lastmod>2022-09-21T08:01:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352695br/account-specialist-vic-east</loc>
  <lastmod>2022-09-21T10:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352794br/account-specialist-wasa</loc>
  <lastmod>2022-09-21T10:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352990br/bio-product-specialist</loc>
  <lastmod>2022-09-21T10:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353323br/senior-business-system-owner</loc>
  <lastmod>2022-09-21T10:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353329br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-21T10:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353331br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-21T10:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353332br/dra-officer</loc>
  <lastmod>2022-09-21T10:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353333br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-21T10:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353335br/senior-dra-officer</loc>
  <lastmod>2022-09-21T10:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353336br/gaojidequjingli</loc>
  <lastmod>2022-09-21T10:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353337br/sales-manager-solid-tumors</loc>
  <lastmod>2022-09-21T10:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353339br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-21T10:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/345296br/otc-product-manager</loc>
  <lastmod>2022-09-21T12:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348144br/principal-infrastruct-utilities-manager</loc>
  <lastmod>2022-09-21T12:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348359br/specialist-informatica-data-quality</loc>
  <lastmod>2022-09-21T12:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352530br/head-portfolio-international-region</loc>
  <lastmod>2022-09-26T16:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353048br/starszy-przedstawiciel-medyczny-rybnik-wojewodztwo-slaskie</loc>
  <lastmod>2022-09-21T12:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353051br/starszy-przedstawiciel-medyczny-nowy-targ-zakopane-nowy-sacz</loc>
  <lastmod>2022-09-21T12:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353341br/senior-medical-sciences-liaison</loc>
  <lastmod>2022-09-21T12:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353345br/training-learning-business-partner</loc>
  <lastmod>2022-09-21T12:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353346br/brand-manager</loc>
  <lastmod>2022-09-21T12:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353349br/technicien-de-laboratoire-lims-hf</loc>
  <lastmod>2022-09-21T12:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353350br/training-learning-business-partner</loc>
  <lastmod>2022-09-21T12:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353352br/senior-medical-sciences-liaison</loc>
  <lastmod>2022-09-21T12:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353360br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-21T14:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353361br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-21T14:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353362br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-21T14:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353363br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-21T14:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353365br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-21T14:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353366br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-21T14:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353368br/quality-manager</loc>
  <lastmod>2022-09-21T14:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353370br/scientist-genomic-biomarker-solutions</loc>
  <lastmod>2022-09-21T14:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353376br/apheresis-technical-steward-mfd</loc>
  <lastmod>2022-09-21T16:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348260br/global-director-strategy-biopharmaceuticals</loc>
  <lastmod>2022-09-21T16:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353308br/assoc-dir-us-market-access-therapeutic-area-oncology-2-roles</loc>
  <lastmod>2022-09-23T16:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353392br/associate-director-systems-care-neurology-denver-remote</loc>
  <lastmod>2022-09-21T18:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351245br/gmp-audit-planner</loc>
  <lastmod>2022-09-21T18:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353343br/customer-engagement-lead-sir</loc>
  <lastmod>2022-09-21T18:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353303br/associate-director-systems-care-crm-louisville-ky-remote</loc>
  <lastmod>2022-09-21T20:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353420br/primary-care-sales-specialist-crm-minnesota-remote</loc>
  <lastmod>2022-09-21T22:01:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353287br/cloud-engineer-container-solution</loc>
  <lastmod>2022-09-21T22:01:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353309br/sr-analyst-government-reporting</loc>
  <lastmod>2022-09-30T00:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353435br/medical-advisor</loc>
  <lastmod>2022-09-22T02:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353447br/associate-director-channel-and-pricing-strategy-remote</loc>
  <lastmod>2022-09-22T04:00:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353454br/institutional-sales-specialist-crm-kansas-city-west-remote</loc>
  <lastmod>2022-09-22T04:00:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353456br/senior-tax-analyst</loc>
  <lastmod>2022-09-22T04:00:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352668br/kae-sector-gobierno</loc>
  <lastmod>2022-09-23T02:01:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353181br/especialista-de-impuestos</loc>
  <lastmod>2022-09-22T04:00:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353465br/medical-representative-bkk-oncology</loc>
  <lastmod>2022-09-22T06:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353480br/po-manager</loc>
  <lastmod>2022-09-22T06:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352997br/regulatory-writer</loc>
  <lastmod>2022-09-22T10:01:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353494br/gaojidequjingli</loc>
  <lastmod>2022-09-22T10:01:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353496br/senior-medical-advisor-immunology</loc>
  <lastmod>2022-09-22T10:01:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353497br/regulatory-affairs-executive-ha-noi</loc>
  <lastmod>2022-09-22T10:01:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352256br/intelligence-analyst-ia</loc>
  <lastmod>2022-09-22T12:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352443br/qa-compliance-expert-gmp-auditor-fmd</loc>
  <lastmod>2022-09-27T10:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352965br/microbiology-technician</loc>
  <lastmod>2022-09-22T12:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353504br/global-lab-systems-deployment-specialist-mfd</loc>
  <lastmod>2022-09-22T12:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353510br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-22T12:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353511br/senior-medical-sciences-liaison</loc>
  <lastmod>2022-09-22T12:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353513br/medical-representative-specialty-ha-noi-sandoz</loc>
  <lastmod>2022-09-22T12:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353516br/mitarbeiter-instandhaltung-mwd-im-bereich-bulkproduktion</loc>
  <lastmod>2022-09-22T12:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353078br/security-perimeter-associate-director</loc>
  <lastmod>2022-09-26T16:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353518br/order-cash-senior-credit-management-specialist-polish</loc>
  <lastmod>2022-09-22T14:01:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353522br/manager-data-steward</loc>
  <lastmod>2022-09-22T14:01:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353528br/tehnik-v-biotehnoloski-proizvodnji-mzd</loc>
  <lastmod>2022-09-27T20:01:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352208br/group-leader-training-innovation</loc>
  <lastmod>2022-09-22T16:01:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352740br/ta-head-oncology-gene-therapies</loc>
  <lastmod>2022-09-22T16:01:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353434br/medical-lead-immunology</loc>
  <lastmod>2022-09-22T16:01:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353525br/quality-specialist-device-development</loc>
  <lastmod>2022-09-22T18:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349836br/medical-affairs-head-mta</loc>
  <lastmod>2022-09-22T20:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353561br/primary-care-sales-specialist-crm-asheville-remote</loc>
  <lastmod>2022-09-22T22:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353566br/pre-clinical-data-manager</loc>
  <lastmod>2022-09-22T22:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352754br/communications-engagement-lead-oncology</loc>
  <lastmod>2022-09-22T22:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353583br/senior-buyer-lacan-region</loc>
  <lastmod>2022-09-23T00:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353584br/senior-buyer</loc>
  <lastmod>2022-09-23T00:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353586br/director-strategic-assistant-executive-vp-us-oncology</loc>
  <lastmod>2022-09-28T18:01:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353531br/vp-head-marketing-strategy-us-oncology</loc>
  <lastmod>2022-09-23T02:01:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353316br/medical-information-manager</loc>
  <lastmod>2022-09-23T02:01:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352448br/associate-director-key-accounts-fmd</loc>
  <lastmod>2022-09-23T06:00:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352451br/director-strategic-accounts-fmd</loc>
  <lastmod>2022-09-23T06:00:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352928br/scientist-ad-mfd</loc>
  <lastmod>2022-09-23T06:00:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/348943br/clinical-scientific-expert-i</loc>
  <lastmod>2022-09-23T08:01:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353598br/group-area-marketing-manager</loc>
  <lastmod>2022-09-23T10:01:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347328br/facility-management-coordinator</loc>
  <lastmod>2022-09-23T12:01:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353519br/werkstudent-material-manager-einkauf-dwm</loc>
  <lastmod>2022-09-23T12:01:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353609br/national-director</loc>
  <lastmod>2022-09-28T10:01:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353610br/postdoc-biocatalysis</loc>
  <lastmod>2022-09-23T12:01:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353612br/sr-ecompliance-specialist</loc>
  <lastmod>2022-09-23T12:01:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353620br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-23T12:01:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353626br/process-team-lead</loc>
  <lastmod>2022-09-23T14:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353630br/production-technician</loc>
  <lastmod>2022-09-23T14:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353634br/production-line-supervisor</loc>
  <lastmod>2022-09-23T14:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353652br/reporting-specialist</loc>
  <lastmod>2022-09-23T16:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353656br/lead-antitrust-counsel-us</loc>
  <lastmod>2022-09-23T16:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353503br/research-scientist-protein-physicalchemical-characterization80-100</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353683br/synbiogene-therapy-expert-principal-scientist</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352830br/technology-department-manager</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352964br/microquality-control-technician</loc>
  <lastmod>2022-09-23T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353589br/associate-director-launch-project-management</loc>
  <lastmod>2022-09-23T20:01:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351452br/associate-director-hcp-marketing-oncology</loc>
  <lastmod>2022-09-23T20:01:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353696br/associate-director-technical-product-management-remote</loc>
  <lastmod>2022-09-23T22:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353702br/primary-care-sales-specialist-crm-royal-oak-remote</loc>
  <lastmod>2022-09-23T22:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353704br/cardiovascular-sales-specialist-crm-columbus-oh-remote</loc>
  <lastmod>2022-09-23T22:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353705br/cardiovascular-account-specialist-cva-central-penn-remote</loc>
  <lastmod>2022-09-23T22:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353706br/manager-automation-calibration-engineering</loc>
  <lastmod>2022-09-28T22:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353707br/sr-global-program-regulatory-manager-hematology</loc>
  <lastmod>2022-09-24T00:01:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353710br/asset-life-cycle-engineer</loc>
  <lastmod>2022-09-25T08:00:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353711br/retirement-benefits-expert</loc>
  <lastmod>2022-09-25T10:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353713br/retirement-benefits-expert</loc>
  <lastmod>2022-09-25T10:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353714br/sr-payroll-specialist</loc>
  <lastmod>2022-09-25T10:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351751br/associate-director-portfolio-data-science-and-advanced-analytics</loc>
  <lastmod>2022-09-26T06:01:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352447br/principal-senior-principal-pharmacometrician-80-100</loc>
  <lastmod>2022-09-26T06:01:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352817br/ethics-risk-compliance-manager</loc>
  <lastmod>2022-09-26T06:01:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353715br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-26T06:01:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353719br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-26T06:01:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353721br/sr-erc-manager-coe</loc>
  <lastmod>2022-09-26T06:01:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352064br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-26T08:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353720br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-26T08:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353725br/financial-analyst</loc>
  <lastmod>2022-09-26T08:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353726br/manager</loc>
  <lastmod>2022-09-26T08:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353727br/financial-analyst</loc>
  <lastmod>2022-09-26T08:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353728br/project-engineer</loc>
  <lastmod>2022-09-26T08:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353730br/financial-analyst</loc>
  <lastmod>2022-09-26T08:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353731br/automation-engineer</loc>
  <lastmod>2022-09-26T08:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353729br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-26T10:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353733br/project-engineer</loc>
  <lastmod>2022-09-26T10:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353739br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-26T10:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353740br/inzhener-tekhnolog-po-processu</loc>
  <lastmod>2022-09-27T18:01:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353743br/brand-manager-breast-cancer</loc>
  <lastmod>2022-09-26T10:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353757br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-26T12:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353636br/production-engineering-head</loc>
  <lastmod>2022-09-26T14:01:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353764br/deployment-data-migration-expert-commercial</loc>
  <lastmod>2022-09-26T14:01:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352109br/process-expert-mwd</loc>
  <lastmod>2022-09-26T16:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353607br/edo-relationship-lead</loc>
  <lastmod>2022-09-26T16:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353608br/edo-relationship-lead</loc>
  <lastmod>2022-09-26T16:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353768br/rukovoditel-smeny-proizvodstva</loc>
  <lastmod>2022-09-26T16:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353778br/estagiario-em-engenharia-de-manutencao</loc>
  <lastmod>2022-09-26T16:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353201br/global-medical-manager-immunology-dfm</loc>
  <lastmod>2022-09-26T18:01:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353219br/lab-technician-qc-analyst</loc>
  <lastmod>2022-09-26T18:01:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353279br/sc-projects-master-data-cordinator</loc>
  <lastmod>2022-09-26T18:01:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353359br/direktor-po-kachestvu</loc>
  <lastmod>2022-09-26T18:01:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353574br/cardiovascular-sales-specialist-crm-florence-remote</loc>
  <lastmod>2022-09-26T18:01:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353780br/warehouse-logistics-compliance-manager-mwd</loc>
  <lastmod>2022-09-26T18:01:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353781br/head-quality-assurance-operations</loc>
  <lastmod>2022-09-26T18:01:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353786br/quality-assurance-lead</loc>
  <lastmod>2022-09-26T20:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353789br/sr-manager-integrated-marketing</loc>
  <lastmod>2022-09-26T20:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353791br/primary-care-sales-specialist-crm-oklahoma-city-north-remote</loc>
  <lastmod>2022-09-26T20:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353794br/principal-scientist-cell-gene-therapy</loc>
  <lastmod>2022-09-26T22:01:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353795br/propagandista-prod-farm-jr-neocare-atb-sta-maria-rs-sandoz</loc>
  <lastmod>2022-09-26T22:01:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353796br/vp-business-leader-biosimilars-specialty-products</loc>
  <lastmod>2022-09-26T22:01:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353798br/quality-control-chemist-i</loc>
  <lastmod>2022-09-26T22:01:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353800br/quality-control-chemist-i</loc>
  <lastmod>2022-09-26T22:01:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353802br/neuroscience-sales-specialist-ms-albany-remote</loc>
  <lastmod>2022-09-26T22:01:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353568br/senior-specialist-lab-operations</loc>
  <lastmod>2022-09-26T22:01:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353804br/quality-control-chemist-iii</loc>
  <lastmod>2022-09-27T00:01:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353808br/onc-medical-science-liaison-radioligand-therapy-prostate-net-remote</loc>
  <lastmod>2022-09-27T00:01:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353809br/director-patient-services-counsel</loc>
  <lastmod>2022-09-27T18:01:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/350833br/process-engineering-expert</loc>
  <lastmod>2022-09-27T04:00:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352525br/senior-scientist-i-cell-line-screening-and-development</loc>
  <lastmod>2022-09-28T06:00:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349631br/biosimilar-product-specialist-cairo-upper-egypt</loc>
  <lastmod>2022-09-27T06:00:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352263br/executive-assistant-admin-lead</loc>
  <lastmod>2022-10-03T10:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353326br/executive-assistant-asia-aspiring-cluster</loc>
  <lastmod>2022-10-03T10:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353816br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-27T08:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353817br/medical-representative-mindanao-ipod</loc>
  <lastmod>2022-09-27T08:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353818br/medical-representative-bacolod</loc>
  <lastmod>2022-09-27T08:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353821br/medical-lead</loc>
  <lastmod>2022-09-27T08:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353822br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-27T08:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353830br/clinical-data-manager</loc>
  <lastmod>2022-09-27T12:01:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353842br/gaojiyiyaodaibiaozishenchanpinzhuguan</loc>
  <lastmod>2022-09-27T12:01:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347297br/bpa-student-assistant</loc>
  <lastmod>2022-09-27T14:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353827br/product-steward</loc>
  <lastmod>2022-09-27T14:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353845br/hvac-executive</loc>
  <lastmod>2022-09-27T14:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353847br/production-operative-executive-onco-osd-packing</loc>
  <lastmod>2022-09-27T14:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353852br/clinical-data-manager</loc>
  <lastmod>2022-09-27T14:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353853br/clinical-data-manager</loc>
  <lastmod>2022-09-27T14:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353854br/clinical-scientific-expert-i</loc>
  <lastmod>2022-09-27T14:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352065br/senior-legal-counsel-gcc-imi</loc>
  <lastmod>2022-09-29T12:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352151br/assistente-adm-jr-po-sandoz-vaga-exclusiva-profissional-pcd-sp</loc>
  <lastmod>2022-09-27T16:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353340br/clinical-research-associate</loc>
  <lastmod>2022-09-27T16:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353839br/business-administrative-assistant</loc>
  <lastmod>2022-09-27T16:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353855br/qc-senior-analysts</loc>
  <lastmod>2022-09-27T16:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353858br/quality-manager</loc>
  <lastmod>2022-09-27T16:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353866br/sales-manager-hybrid-private-channel</loc>
  <lastmod>2022-09-27T16:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353869br/senior-manager-science-and-technology-analytical-characterization</loc>
  <lastmod>2022-09-27T16:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349862br/team-lead-case-management</loc>
  <lastmod>2022-09-27T18:01:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353874br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-27T18:01:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353877br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-27T18:01:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353880br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-27T18:01:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353881br/xianyuzhuren-xianyuzhuguan</loc>
  <lastmod>2022-09-27T18:01:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353893br/vendor-master-data-steward</loc>
  <lastmod>2022-09-27T22:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353895br/virtual-patient-solutions-associate</loc>
  <lastmod>2022-09-27T22:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353449br/director-associate-engagement-im-us-oncology</loc>
  <lastmod>2022-09-27T22:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353451br/director-associate-engagement-us-people-culture</loc>
  <lastmod>2022-09-27T22:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353897br/project-manager</loc>
  <lastmod>2022-09-28T00:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353898br/propagandista-prod-farmaceuticos-pl-neocare-snc-natal-rn-sandoz</loc>
  <lastmod>2022-09-28T00:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353899br/consultor-tecnico-jrpl-crm-farma-espirito-santo</loc>
  <lastmod>2022-09-28T00:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353570br/primary-care-sales-specialist-crm-charleston-remote</loc>
  <lastmod>2022-09-28T00:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353438br/customer-experience-lead</loc>
  <lastmod>2022-09-28T02:01:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353904br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-28T06:00:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353910br/global-clinical-trial-associate</loc>
  <lastmod>2022-09-28T06:00:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353911br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-28T06:00:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352549br/principal-scientist-i-biotherapeutic-engineering-and-gene-therapy</loc>
  <lastmod>2022-09-28T06:00:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353908br/so-manager</loc>
  <lastmod>2022-09-28T06:00:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353912br/specialist-scm-map</loc>
  <lastmod>2022-09-28T08:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353919br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-28T10:01:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353924br/senior-talent-acquisition-business-partner-location-tyrol-or-remote</loc>
  <lastmod>2022-09-28T10:01:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353931br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-28T10:01:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352038br/product-specialist-lombardia-sandoz</loc>
  <lastmod>2022-09-28T12:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353922br/equipment-operator-i-mwd</loc>
  <lastmod>2022-09-28T12:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353941br/yangfanyiyaodaibiao</loc>
  <lastmod>2022-09-28T12:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353945br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-28T12:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353947br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-28T12:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353948br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-28T12:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353951br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-28T12:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353890br/exec-dir-therapeutic-area-strategy-ch-usa</loc>
  <lastmod>2022-09-28T14:01:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353891br/director-therapeutic-area-strategy-ch-usa</loc>
  <lastmod>2022-09-28T14:01:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353959br/quality-compliance-leader</loc>
  <lastmod>2022-09-28T14:01:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353741br/lehrling-fur-den-lehrberuf-mechatronik-fertigungstechnik-mwd</loc>
  <lastmod>2022-09-28T16:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353748br/lehrling-fur-den-lehrberuf-mechatronik-automatisierungstechnik-mwd</loc>
  <lastmod>2022-09-28T16:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353751br/lehrling-fur-den-lehrberuf-elektrotechnik-mwd</loc>
  <lastmod>2022-09-28T16:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353755br/lehrling-fur-den-lehrberuf-pharmatechnologie-mwd</loc>
  <lastmod>2022-09-28T16:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353759br/lehrling-fur-den-lehrberuf-chemieverfahrenstechnik-mwd</loc>
  <lastmod>2022-09-28T16:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353760br/lehrling-fur-den-lehrberuf-labortechnik-chemie-mwd</loc>
  <lastmod>2022-09-28T16:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353766br/head-kams-pharmacy-chains</loc>
  <lastmod>2022-10-03T14:02:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353834br/maintenance-technician-i-automatiker-automation-technican</loc>
  <lastmod>2022-09-28T16:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353977br/external-supply-organization-procurement-business-partner-canada-usa</loc>
  <lastmod>2022-09-28T16:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353993br/director-business-planning-strategy-oncology-customer-engagement</loc>
  <lastmod>2022-09-28T18:01:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/347902br/senior-scientist</loc>
  <lastmod>2022-09-28T18:01:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351301br/warehouse-specialist</loc>
  <lastmod>2022-09-28T18:01:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353788br/bpa-manager-cts</loc>
  <lastmod>2022-09-28T18:01:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353879br/regulatory-affairs-manager-fmd-temporary-contract</loc>
  <lastmod>2022-09-28T18:01:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353883br/qa-operations-associate</loc>
  <lastmod>2022-09-28T18:01:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354000br/trial-monitoring-associate-director-cra-manager-remote</loc>
  <lastmod>2022-09-28T20:01:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354002br/associate-scientist-flow-cytometry</loc>
  <lastmod>2022-09-28T20:01:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354006br/primary-care-sales-specialist-crm-lexington-e-remote</loc>
  <lastmod>2022-09-28T20:01:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354008br/primary-care-sales-specialist-crm-st-louis-west-remote</loc>
  <lastmod>2022-09-28T22:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352028br/research-scientist-pre-clinical-pharmacologyin-vivo-imaging</loc>
  <lastmod>2022-09-29T20:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352047br/medical-science-liaison-northern-england-and-scotland</loc>
  <lastmod>2022-09-28T22:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353886br/principal-data-scientist-global-medical-affairs</loc>
  <lastmod>2022-09-28T22:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354013br/qa-compliance-specialist-documentation-control</loc>
  <lastmod>2022-09-29T00:01:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354017br/medical-information-manager</loc>
  <lastmod>2022-09-29T04:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351849br/clinical-research-medical-advisor</loc>
  <lastmod>2022-09-29T04:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354024br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-29T06:00:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/349842br/executive-director-senior-legal-counsel</loc>
  <lastmod>2022-09-29T06:00:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352992br/medical-representative</loc>
  <lastmod>2022-09-29T06:00:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352993br/medical-representative</loc>
  <lastmod>2022-09-29T06:00:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353595br/product-specialist-breast-cancer</loc>
  <lastmod>2022-09-29T06:00:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354026br/manager-tokyokanagawa-area</loc>
  <lastmod>2022-09-29T08:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354027br/gaojiyiyaodaibiaozishenchanpinzhuguan</loc>
  <lastmod>2022-09-29T08:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354029br/sourcing-manager-rd</loc>
  <lastmod>2022-09-29T10:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354038br/associate-mi-manager</loc>
  <lastmod>2022-09-29T10:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354039br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-29T10:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354040br/brand-manager</loc>
  <lastmod>2022-09-29T10:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354041br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-29T10:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353034br/key-account-immunology-bucharest</loc>
  <lastmod>2022-10-03T14:02:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353035br/key-account-immunology-cluj</loc>
  <lastmod>2022-10-03T14:02:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353038br/key-account-immunology-timisoara</loc>
  <lastmod>2022-10-03T14:02:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353867br/registration-manager-rcc-europe</loc>
  <lastmod>2022-09-29T12:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354043br/specialist-quality-operations</loc>
  <lastmod>2022-09-29T12:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354048br/production-supervisor-oncology-osd</loc>
  <lastmod>2022-09-29T12:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354034br/senior-patient-safety-specialist-mwd</loc>
  <lastmod>2022-09-29T14:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354046br/specialist-network-services-wan</loc>
  <lastmod>2022-09-29T14:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354054br/risk-resilience-lead</loc>
  <lastmod>2022-09-29T14:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354055br/r2r-specialist-gl-reporting</loc>
  <lastmod>2022-10-03T06:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354056br/drawing-documentation-executive</loc>
  <lastmod>2022-09-29T14:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354059br/customer-services-coordinator</loc>
  <lastmod>2022-09-29T14:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354060br/quality-operations-coordinator</loc>
  <lastmod>2022-09-29T14:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354062br/drawing-documentation-executive</loc>
  <lastmod>2022-09-29T14:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351963br/communications-engagement-head-chile</loc>
  <lastmod>2022-09-29T16:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354084br/transparency-manager</loc>
  <lastmod>2022-09-29T16:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354089br/qc-analyst-ii-mwd</loc>
  <lastmod>2022-09-29T16:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354093br/equipment-operator-i-mwd</loc>
  <lastmod>2022-09-29T16:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354094br/sr-brand-manager-breast-cancer</loc>
  <lastmod>2022-09-29T16:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353894br/validation-expert</loc>
  <lastmod>2022-09-29T18:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354099br/customer-experience-manager</loc>
  <lastmod>2022-09-29T18:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354112br/trial-monitoring-system-process-manager-remote</loc>
  <lastmod>2022-09-29T18:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354121br/senior-po-hr-business-partner</loc>
  <lastmod>2022-09-29T18:01:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354126br/clinical-scientific-expert-1</loc>
  <lastmod>2022-09-29T20:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351970br/tfg-hs-cosentyx-brand-manager-im-sao-paulo</loc>
  <lastmod>2022-09-29T20:01:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352792br/head-search-evaluation-hematology-innovative-medicines</loc>
  <lastmod>2022-09-30T20:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351455br/director-patient-marketing-oncology</loc>
  <lastmod>2022-09-29T22:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351844br/equipment-operator-chemops</loc>
  <lastmod>2022-09-29T22:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354159br/project-manager</loc>
  <lastmod>2022-09-30T00:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354181br/legal-and-contract-associate</loc>
  <lastmod>2022-09-30T02:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351174br/virtual-patient-engagement-associate</loc>
  <lastmod>2022-09-30T02:01:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354186br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-30T04:01:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354187br/xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2022-09-30T04:01:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354188br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-30T04:01:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/341890br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-30T04:01:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354190br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-30T06:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354191br/yiyuanzhunrujingli</loc>
  <lastmod>2022-09-30T06:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354193br/sfe-manager</loc>
  <lastmod>2022-09-30T06:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354199br/seniorarea-marketing-manager</loc>
  <lastmod>2022-09-30T06:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353724br/head-bpa-aaa-project</loc>
  <lastmod>2022-09-30T08:01:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354200br/specialist-representative-las-pinaslaguna</loc>
  <lastmod>2022-09-30T08:01:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354201br/specialist-representative-pasaymakati</loc>
  <lastmod>2022-09-30T08:01:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354202br/gaojiyiyaodaibiaozishenchanpinzhuguan</loc>
  <lastmod>2022-09-30T08:01:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354203br/specialist-representative-bulacanqc</loc>
  <lastmod>2022-09-30T08:01:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354204br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-30T08:01:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354205br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-30T08:01:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354206br/specialist-representative-manila</loc>
  <lastmod>2022-09-30T08:01:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351423br/analyst-life-cycle-management</loc>
  <lastmod>2022-09-30T10:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354222br/specialist-po-logistike</loc>
  <lastmod>2022-09-30T10:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354223br/gaojiyiyaodaibiao-zishenchanpinzhuguan</loc>
  <lastmod>2022-09-30T10:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352077br/medical-excellence-manager-dwm-befristet-bis-ende-112023</loc>
  <lastmod>2022-09-30T12:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353214br/specialist-upravljanja-kakovosti-i-skladnost-mzd</loc>
  <lastmod>2022-09-30T12:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354224br/gaojidequjingli</loc>
  <lastmod>2022-09-30T12:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354225br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-30T12:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354233br/legal-trainee-novartis-group-legal</loc>
  <lastmod>2022-09-30T12:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354235br/business-insights-and-forecasting-manager-region-europe-dfm</loc>
  <lastmod>2022-09-30T12:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354239br/medical-representative-caraga</loc>
  <lastmod>2022-09-30T12:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354242br/gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2022-09-30T12:01:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354243br/legal-counsel</loc>
  <lastmod>2022-09-30T14:01:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352948br/vodja-vzdrzevanja-mzd</loc>
  <lastmod>2022-09-30T16:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353666br/key-account-representative-craiova-diabetes-and-endocrinology</loc>
  <lastmod>2022-09-30T16:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353762br/msc-student-usp-cell-culture-development-fmd</loc>
  <lastmod>2022-09-30T16:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/353958br/edms-business-administrator</loc>
  <lastmod>2022-09-30T16:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354120br/value-and-access-policy-partner</loc>
  <lastmod>2022-09-30T16:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354250br/process-automation-engineer</loc>
  <lastmod>2022-09-30T16:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354252br/supply-operations-specialist-north-america-head-office</loc>
  <lastmod>2022-09-30T16:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352717br/productbrand-lead-primary-care</loc>
  <lastmod>2022-09-30T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354254br/vp-medical-team-head-cardiovascular-and-metabolism-cvm</loc>
  <lastmod>2022-09-30T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354261br/senior-scientist-ii</loc>
  <lastmod>2022-09-30T18:01:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/340526br/product-steward-fmd</loc>
  <lastmod>2022-09-30T20:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/351682br/director-external-engagement</loc>
  <lastmod>2022-09-30T20:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354169br/manager-data-science-and-analytics</loc>
  <lastmod>2022-09-30T22:01:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354280br/team-lead-drug-substance-pm</loc>
  <lastmod>2022-10-01T00:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352590br/senior-principal-biostatistician</loc>
  <lastmod>2022-10-01T00:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354177br/field-medical-technical-operations-manager</loc>
  <lastmod>2022-10-01T00:01:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354281br/research-scientist-aav-cell-gene-therapy</loc>
  <lastmod>2022-10-01T02:01:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354282br/senior-scientist-aav-cell-gene-therapy</loc>
  <lastmod>2022-10-01T02:01:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354285br/field-force-representative</loc>
  <lastmod>2022-10-01T04:00:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352957br/head-finance-gdpd-fmd-50-70</loc>
  <lastmod>2022-10-03T06:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354301br/sr-marketing-manager</loc>
  <lastmod>2022-10-03T06:01:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/343735br/senior-scientist-packaging-development</loc>
  <lastmod>2022-10-03T10:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354303br/senior-supply-chain-operation-specialist</loc>
  <lastmod>2022-10-03T10:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354304br/medical-science-liaison</loc>
  <lastmod>2022-10-03T10:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354306br/specialist-quality-operations</loc>
  <lastmod>2022-10-03T10:01:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354307br/associate-manager-life-cycle-management</loc>
  <lastmod>2022-10-03T10:26:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354313br/r2r-senior-specialist-gl-reporting-korean-speaker</loc>
  <lastmod>2022-10-03T12:03:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354316br/clinical-development-medical-director-car-t-80-100</loc>
  <lastmod>2022-10-03T12:03:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/352108br/manager</loc>
  <lastmod>2022-10-03T14:02:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354305br/internship-msd</loc>
  <lastmod>2022-10-03T14:02:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354322br/manager-digital-governance-enablement</loc>
  <lastmod>2022-10-03T14:02:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job-details/354326br/sales-officer-customer-service</loc>
  <lastmod>2022-10-03T14:02:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors</loc>
  <lastmod>2022-09-29T10:16:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/share-data-analysis</loc>
  <lastmod>2022-08-24T15:26:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about</loc>
  <lastmod>2022-09-08T07:15:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/patients-and-caregivers</loc>
  <lastmod>2022-09-16T07:35:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials</loc>
  <lastmod>2022-06-29T10:57:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals</loc>
  <lastmod>2022-07-11T14:19:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development</loc>
  <lastmod>2021-11-18T15:04:54+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/technology-platforms</loc>
  <lastmod>2021-10-08T14:50:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/coronavirus</loc>
  <lastmod>2022-05-12T11:05:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg</loc>
  <lastmod>2022-09-13T14:37:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news</loc>
  <lastmod>2022-08-25T07:25:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/company-overview</loc>
  <lastmod>2022-09-28T16:46:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/environmental-sustainability</loc>
  <lastmod>2022-09-13T14:31:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-and-european-union</loc>
  <lastmod>2022-06-02T09:03:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-teams</loc>
  <lastmod>2022-08-25T13:38:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/global-health</loc>
  <lastmod>2022-05-17T16:45:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering</loc>
  <lastmod>2022-03-21T17:19:27+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/reporting</loc>
  <lastmod>2022-07-06T16:04:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access</loc>
  <lastmod>2022-02-28T10:36:35+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/diversity-inclusion</loc>
  <lastmod>2022-09-08T07:12:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/novartis-institutes-biomedical-research</loc>
  <lastmod>2021-10-08T19:59:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/strategy/people-and-culture</loc>
  <lastmod>2022-02-28T10:41:04+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/strategy/data-and-digital</loc>
  <lastmod>2021-10-07T20:36:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/innovative-medicines/novartis-pharmaceuticals/novartis-gene-therapies</loc>
  <lastmod>2022-08-03T09:27:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond</loc>
  <lastmod>2021-10-07T18:49:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program</loc>
  <lastmod>2022-09-05T10:24:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/strategy/data-and-digital/artificial-intelligence</loc>
  <lastmod>2021-10-08T08:52:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/innovative-medicines</loc>
  <lastmod>2022-04-19T15:17:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/quality</loc>
  <lastmod>2021-10-08T17:36:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance</loc>
  <lastmod>2021-10-18T11:02:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases</loc>
  <lastmod>2022-09-29T17:37:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/technology-platforms/radioligand-therapy</loc>
  <lastmod>2021-10-05T14:49:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/technology-platforms/gene-therapy</loc>
  <lastmod>2021-10-05T18:17:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal</loc>
  <lastmod>2022-08-24T22:07:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-development/technology-platforms/cell-therapy</loc>
  <lastmod>2022-08-24T11:22:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations</loc>
  <lastmod>2022-07-25T14:41:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/what-we-do</loc>
  <lastmod>2022-07-25T14:42:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/what-we-do/mammalian-cell-culture</loc>
  <lastmod>2022-07-25T14:44:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/what-we-do/microbial-manufacturing</loc>
  <lastmod>2022-07-25T14:45:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/who-we-are</loc>
  <lastmod>2022-08-11T15:40:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/what-we-do/cell-gene</loc>
  <lastmod>2022-07-25T14:43:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/our-manufacturing-sites</loc>
  <lastmod>2022-07-25T14:42:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/what-we-do/plasmid-dna-rna</loc>
  <lastmod>2022-07-25T14:45:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/what-we-do/fill-finish</loc>
  <lastmod>2022-07-25T14:44:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/what-we-do/viral-vectors</loc>
  <lastmod>2022-07-25T14:46:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/what-we-do/cell-bank-manufacturing</loc>
  <lastmod>2022-07-25T14:43:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/contact-us</loc>
  <lastmod>2022-07-25T14:41:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/global-biotech-cooperations/what-we-do/quality-regulatory</loc>
  <lastmod>2022-07-25T14:45:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing</loc>
  <lastmod>2022-07-26T08:04:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/respiratory-allergy/foodallergy/NCT04984876-us-en</loc>
  <lastmod>2022-05-12T08:34:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/healthcare-professionals-researchers</loc>
  <lastmod>2022-06-29T11:05:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/patients</loc>
  <lastmod>2022-09-20T11:00:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/novartis-trials</loc>
  <lastmod>2022-09-02T13:17:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/NCT05089656</loc>
  <lastmod>2022-09-22T15:02:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-afinitor-significantly-improves-progression-free-survival-advanced-nonfunctional-gastrointestinal-and-lung-net</loc>
  <lastmod>2021-10-05T11:51:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-new-heart-failure-medicine-entrestotm-recommended-chmp-eu-approval</loc>
  <lastmod>2021-10-05T11:51:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-appoints-james-e-bradner-md-president-novartis-institutes-biomedical-research-mark-fishman-retires</loc>
  <lastmod>2022-04-08T11:39:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-nomme-le-dr-james-e-bradner-president-des-instituts-novartis-pour-la-recherche-biomedicale-suite-au-prochain-depart-la-retraite-de-mark-fishman</loc>
  <lastmod>2021-10-05T11:51:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ernennt-dr-james-e-bradner-zum-prasidenten-der-novartis-institutes-biomedical-research-da-mark-fishman-den-ruhestand-tritt</loc>
  <lastmod>2021-10-05T11:51:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-launches-novartis-access-portfolio-affordable-medicines-treat-chronic-diseases-lower-income-countries</loc>
  <lastmod>2021-10-05T11:51:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-lance-novartis-access-une-gamme-de-medicaments-prix-abordables-pour-lutter-contre-les-maladies-chroniques-dans-les-pays-faible-revenu</loc>
  <lastmod>2021-10-05T11:51:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-lanciert-novartis-access-ein-portfolio-von-erschwinglichen-medikamenten-zur-behandlung-von-chronischen-erkrankungen-landern-mit-niedrigen-einkommen</loc>
  <lastmod>2021-10-05T11:51:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/swissmedic-approves-novartis-new-heart-failure-medicine-entrestotm</loc>
  <lastmod>2021-10-05T11:51:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-foundation-healthcare-models-and-disease-elimination-programs-showcased-ectmih</loc>
  <lastmod>2021-10-05T11:51:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-eu-approval-farydak-first-its-class-anticancer-agents-approved-patients-multiple-myeloma</loc>
  <lastmod>2021-10-05T11:51:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-launches-zarxiotm-filgrastim-sndz-first-biosimilar-united-states</loc>
  <lastmod>2021-10-05T11:51:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-eu-approval-new-revolade-use-first-class-therapy-patients-severe-aplastic-anemia</loc>
  <lastmod>2021-10-05T11:51:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-global-partnership-amgen-develop-and-commercialize-pioneering-neuroscience-treatments</loc>
  <lastmod>2021-10-05T11:51:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-setzt-sich-weiter-fur-die-endgultige-ausrottung-von-lepra-ein</loc>
  <lastmod>2021-10-05T11:51:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-renouvelle-son-engagement-lapproche-de-la-derniere-ligne-droite-dans-la-lutte-visant-eradiquer-la-lepre</loc>
  <lastmod>2021-10-05T11:51:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-eu-approval-tafinlar-and-mekinist-first-combination-approved-patients-aggressive-form-melanoma</loc>
  <lastmod>2021-10-05T11:51:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-continues-commitment-go-last-mile-effort-eliminate-leprosy</loc>
  <lastmod>2021-10-05T11:51:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/das-novartis-international-biocamp-zeigt-wie-zusammenarbeit-und-vielfalt-innovationen-fordern-und-inspiriert-kunftige-wissenschaftliche-fuhrungskrafte</loc>
  <lastmod>2021-10-05T11:51:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/le-novartis-international-biocamp-souligne-le-role-de-la-collaboration-et-de-la-diversite-pour-stimuler-linnovation-et-inspirer-les-futurs-leaders-scientifiques</loc>
  <lastmod>2021-10-05T11:51:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-international-biocamp-highlights-how-collaboration-and-diversity-drive-innovation-and-inspires-future-science-leaders</loc>
  <lastmod>2021-10-05T11:51:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-expands-use-novartis-drug-promacta-include-treatment-children-ages-1-and-older-chronic-immune-thrombocytopenia</loc>
  <lastmod>2021-10-05T11:51:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-acquires-all-remaining-rights-gsks-ofatumumab-develop-treatments-ms-and-other-autoimmune-indications</loc>
  <lastmod>2021-10-05T11:51:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-odomzo-gains-eu-approval-locally-advanced-basal-cell-carcinoma-providing-new-non-invasive-therapy-patients</loc>
  <lastmod>2021-10-05T11:51:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-completes-divestiture-influenza-vaccines-business-csl-limited-usd-275-million</loc>
  <lastmod>2021-10-05T11:51:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-partners-phase-4-partners-and-institutional-investors-help-create-mereo-biopharma-group-ltd</loc>
  <lastmod>2021-10-05T11:51:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-foundation-confirms-new-members-its-board-trustees-including-new-chairman-dr-joerg-reinhardt</loc>
  <lastmod>2021-10-05T11:51:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-novartis-drug-odomzo-sonidegib-locally-advanced-basal-cell-carcinoma-labcc-form-skin-cancer</loc>
  <lastmod>2021-10-05T11:51:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-combination-therapy-tafinlar-and-mekinist-achieves-important-eu-and-us-regulatory-milestones</loc>
  <lastmod>2021-10-05T11:51:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-revolade-recommended-chmp-eu-approval-treat-patients-severe-aplastic-anemia-serious-blood-disorder</loc>
  <lastmod>2021-10-05T11:51:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-solid-performance-second-quarter-strong-innovation-and-progress-new-launches</loc>
  <lastmod>2021-10-05T11:51:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-solide-performance-au-deuxieme-trimestre-grace-la-force-de-linnovation-et-aux-progres-des-nouveaux-lancements</loc>
  <lastmod>2021-10-05T11:51:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-zweiten-quartal-eine-solide-performance-mit-starken-innovationen-und-fortschritten-bei-neueinfuhrungen</loc>
  <lastmod>2021-10-05T11:51:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-malaria-treatment-coartem-80480mg-receives-who-prequalification-enabling-greater-access-patients</loc>
  <lastmod>2021-10-05T11:51:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-new-heart-failure-medicine-lcz696-now-called-entrestotm-approved-fda-reduce-risk-cardiovascular-death-and-heart-failure-hospitalization</loc>
  <lastmod>2021-10-05T11:52:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-receives-european-approval-pre-loaded-intraocular-lens-delivery-system-treat-patients-undergoing-cataract-surgery</loc>
  <lastmod>2021-10-05T11:52:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pharmaceuticals-launches-first-app-visually-impaired-people-use-apple-watch-and-other-smart-watches</loc>
  <lastmod>2021-10-05T11:52:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-deepens-its-industry-leading-pipeline-acquisition-spinifex-pharmaceuticals-inc</loc>
  <lastmod>2021-10-05T11:52:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-publication-lancet-showing-sustained-efficacy-secukinumab-over-one-year-psoriatic-arthritis-patients</loc>
  <lastmod>2021-10-05T11:52:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-farydak-recommended-chmp-eu-approval-treat-multiple-myeloma-providing-patients-new-mechanism-action</loc>
  <lastmod>2021-10-05T11:52:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-us-launch-glatopatm-first-generic-competitor-copaxone-20mg</loc>
  <lastmod>2021-10-05T11:52:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-strong-innovation-momentum-its-second-meet-novartis-management-investor-day</loc>
  <lastmod>2021-10-05T11:52:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-receives-european-approval-new-trifocal-presbyopia-correcting-intraocular-lens-patients-undergoing-cataract-surgery</loc>
  <lastmod>2021-10-05T11:52:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-data-from-large-european-study-reinforcing-benefit-first-line-tasigna-newly-diagnosed-patients-cml</loc>
  <lastmod>2021-10-05T11:52:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-data-show-majority-patients-polycythemia-vera-treated-jakavi-achieved-long-term-disease-control</loc>
  <lastmod>2021-10-05T11:52:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-eha-show-increased-pfs-benefit-farydak-new-subgroup-patients-previously-treated-multiple-myeloma</loc>
  <lastmod>2021-10-05T11:52:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-arzerra-improved-median-progression-free-survival-54-patients-relapsed-chronic-lymphocytic-leukemia</loc>
  <lastmod>2021-10-05T11:52:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-new-analysis-showing-xolair-improving-quality-life-78-chronic-spontaneous-urticaria-patients</loc>
  <lastmod>2021-10-05T11:52:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-gains-fda-approval-promacta-providing-new-option-children-ages-6-and-older-chronic-itp-rare-blood-disorder</loc>
  <lastmod>2021-10-05T11:52:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-data-wcd-demonstrating-significant-efficacy-cosentyx-patients-psoriasis-nails-palms-and-soles</loc>
  <lastmod>2021-10-05T11:52:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-one-year-results-demonstrating-sustained-secukinumab-efficacy-ankylosing-spondylitis-patients</loc>
  <lastmod>2021-10-05T11:52:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-ctl019-data-showing-its-potential-treatment-specific-types-hard-treat-non-hodgkin-lymphoma</loc>
  <lastmod>2021-10-05T11:52:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-data-asco-zykadia-and-combination-tafinlar-and-mekinist-certain-nsclc-patients-unmet-needs</loc>
  <lastmod>2021-10-05T11:52:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/combination-novartis-drugs-tafinlar-and-mekinist-shows-significant-survival-benefit-patients-metastatic-melanoma</loc>
  <lastmod>2021-10-05T11:52:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-data-21-medicines-and-11-investigational-compounds-asco-and-eha</loc>
  <lastmod>2021-10-05T11:52:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-afinitor-extended-progression-free-survival-phase-iii-trial-advanced-gastrointestinal-or-lung-neuroendocrine-tumors</loc>
  <lastmod>2021-10-05T11:52:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-two-positive-us-phase-iii-programs-copd-qva149-and-nva237</loc>
  <lastmod>2021-10-05T11:52:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-lung-cancer-drug-zykadia-gains-eu-approval-providing-new-therapy-certain-patients-alk-nsclc</loc>
  <lastmod>2021-10-05T11:52:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-phase-iii-study-arzerra-met-primary-endpoint-improved-progression-free-survival-patients-relapsed-cll</loc>
  <lastmod>2021-10-05T11:52:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-sales-growth-cc-significant-margin-expansion-cc-and-strong-innovation-q11-now-more-focused-portfolio</loc>
  <lastmod>2021-10-05T11:52:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-affiche-au-t11-une-forte-progression-de-ses-ventes-tcc-une-hausse-importante-de-sa-marge-tcc-et-une-innovation-tres-dynamique-avec-un-portefeuille-desormais-mieux-cible</loc>
  <lastmod>2021-10-05T11:52:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-ersten-quartal1-umsatzsteigerungen-kwk-deutlich-hohere-margen-kwk-und-beachtliche-innovationen-jetzt-mit-einem-starker-fokussierten-portfolio</loc>
  <lastmod>2021-10-05T11:52:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-celebrates-19th-annual-community-partnership-day-more-27000-associates-volunteering-their-local-communities</loc>
  <lastmod>2021-10-05T11:52:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/data-aan-showed-gilenya-high-efficacy-achieving-no-evidence-disease-activity-previously-treated-highly-active-ms-patients</loc>
  <lastmod>2021-10-05T11:52:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-fda-approval-glatopatm-first-generic-competitor-ms-therapy-copaxone-20mg</loc>
  <lastmod>2021-10-05T11:52:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-receives-fda-approval-new-multifocal-intraocular-lens-treat-cataract-patients-united-states</loc>
  <lastmod>2021-10-05T11:52:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/data-lancet-show-novartis-drug-arzerra-plus-chlorambucil-improved-median-progression-free-survival-71-cll-patients</loc>
  <lastmod>2021-10-05T11:52:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/gilenya-data-aan-highlight-novartis-leadership-innovation-new-ms-assessment-methods-benefit-patients-and-physicians</loc>
  <lastmod>2021-10-05T11:52:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-fda-approval-jadenutm-simplify-treatment-administration-patients-chronic-iron-overload</loc>
  <lastmod>2021-10-05T11:52:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-accelerates-cancer-immunotherapy-efforts-aduro-biotech-alliance-and-launch-new-immuno-oncology-research-group</loc>
  <lastmod>2021-10-05T11:52:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyxtm-two-year-data-shows-sustained-effect-and-favorable-safety-profile-psoriasis-patients</loc>
  <lastmod>2021-10-05T11:52:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-data-shows-cosentyxtm-significantly-superior-stelara-and-clears-skin-pasi-90-nearly-80-psoriasis-patients</loc>
  <lastmod>2021-10-05T11:52:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-eu-approval-jakavi-polycythemia-vera-first-targeted-therapy-approved-patients-rare-blood-cancer</loc>
  <lastmod>2021-10-05T11:52:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-present-new-late-breaking-cosentyxtm-data-aad-2015-showing-significant-patient-benefit-achieving-clear-skin</loc>
  <lastmod>2021-10-05T11:52:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-first-biosimilar-zarxiotm-filgrastim-sndz-from-sandoz</loc>
  <lastmod>2021-10-05T11:52:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-completion-transactions-gsk</loc>
  <lastmod>2021-10-05T11:52:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-gibt-abschluss-von-transaktionen-mit-gsk-bekannt</loc>
  <lastmod>2021-10-05T11:52:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-annonce-la-conclusion-des-transactions-avec-gsk</loc>
  <lastmod>2021-10-05T11:52:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/positive-phase-ii-data-highlights-benefits-alcons-rth258-patients-neovascular-wet-age-related-macular-degeneration</loc>
  <lastmod>2021-10-05T11:52:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-novartis-board-directors</loc>
  <lastmod>2021-10-05T11:52:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration</loc>
  <lastmod>2021-10-05T11:52:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/aktionare-genehmigen-alle-antrage-des-verwaltungsrats-von-novartis</loc>
  <lastmod>2021-10-05T11:52:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-lung-cancer-drug-zykadia-recommended-eu-approval-patients-alk-nsclc-previously-treated-crizotinib</loc>
  <lastmod>2021-10-05T11:52:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-farydak-first-hdac-inhibitor-patients-multiple-myeloma</loc>
  <lastmod>2021-10-05T11:52:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-heart-failure-medicine-lcz696-granted-fda-priority-review</loc>
  <lastmod>2021-10-05T11:52:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-receives-fda-approval-pazeotm-solution-ocular-allergy-itch-relief</loc>
  <lastmod>2021-10-05T11:52:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-study-nejm-showing-jakavi-was-superior-standard-therapy-rare-blood-cancer-polycythemia-vera</loc>
  <lastmod>2021-10-05T11:52:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-solid-sales-growth-margin-expansion-and-pipeline-progress-2014-portfolio-transformation-will-focus-company-leading-businesses</loc>
  <lastmod>2021-10-05T11:52:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-enregistre-en-2014-une-forte-augmentation-de-ses-ventes-sa-marge-et-progres-de-son-pipeline-la-transformation-du-portefeuille-concentrera-lentreprise-sur-ses-principales-activites</loc>
  <lastmod>2021-10-05T11:53:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-2014-solide-umsatzsteigerungen-hohere-margen-und-fortschritte-der-pipeline-mit-der-umgestaltung-des-portfolios-fokussiert-sich-das-unternehmen-auf-fuhrende-geschaftsbereiche</loc>
  <lastmod>2021-10-05T11:53:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-bexsero-vaccine-approved-fda-prevention-meningitis-b-leading-cause-bacterial-meningitis-us</loc>
  <lastmod>2021-10-05T11:53:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-jakavi-recommended-chmp-eu-approval-treat-adults-rare-blood-cancer-polycythemia-vera</loc>
  <lastmod>2021-10-05T11:53:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-fda-approval-first-il-17a-antagonist-cosentyxtm-secukinumab-moderate-severe-plaque-psoriasis-patients</loc>
  <lastmod>2021-10-05T11:53:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyxtm-first-il-17-inhibitor-receive-eu-approval-first-line-treatment-moderate-severe-psoriasis-patients</loc>
  <lastmod>2021-10-05T11:53:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pharmaceuticals-announces-joint-investment-company-qualcomm-leading-innovation-digital-medicines-physicians-and-patients</loc>
  <lastmod>2021-10-05T11:53:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-robust-phase-iii-results-qva149-and-nva237-and-submits-regulatory-applications-us-fda</loc>
  <lastmod>2021-10-05T11:53:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-biosimilar-filgrastim-recommended-approval-fda-oncologic-drugs-advisory-committee</loc>
  <lastmod>2021-10-05T11:53:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-collaborates-intellia-therapeutics-and-caribou-biosciences-explore-making-medicines-and-drug-discovery-tools-crispr-genome-editing-technology</loc>
  <lastmod>2021-10-05T11:53:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-completes-divestment-animal-health-business-eli-lilly-usd-54-billion</loc>
  <lastmod>2022-05-18T12:22:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-sandoz-erelzitm-treat-multiple-inflammatory-diseases</loc>
  <lastmod>2021-10-05T12:04:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-convenes-experts-discuss-new-technologies-healthcare-novartis-international-biocamp</loc>
  <lastmod>2021-10-05T12:04:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/experten-diskutieren-am-novartis-international-biocamp-neue-technologien-im-gesundheitsbereich</loc>
  <lastmod>2021-10-05T12:04:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-convie-plusieurs-experts-au-novartis-international-biocamp-afin-de-discuter-des-nouvelles-technologies-en-matiere-de-sante</loc>
  <lastmod>2021-10-05T12:04:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-phase-iii-results-showing-efficacy-baf312-patients-secondary-progressive-ms</loc>
  <lastmod>2021-10-05T12:04:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/six-leading-scientists-receive-prestigious-novartis-prizes-immunology-16th-international-congress-immunology</loc>
  <lastmod>2021-10-05T12:04:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cdk46-inhibitor-lee011-ribociclib-receives-fda-breakthrough-therapy-designation-first-line-treatment-hrher2-advanced-breast-cancer</loc>
  <lastmod>2021-10-05T12:04:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-achieves-us-approval-cypass-micro-stent-micro-invasive-surgical-device-treat-glaucoma</loc>
  <lastmod>2021-10-05T12:04:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-solid-q2-despite-full-quarter-us-gleevec-generic-impact-significant-positive-innovation-news-strengthens-future-growth-prospects</loc>
  <lastmod>2021-10-05T12:04:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-realise-un-2eme-trimestre-solide-malgre-limpact-sur-le-trimestre-du-generique-de-gleevec-aux-us-nouvelles-positives-importantes-de-linnovation-renforcent-les-perspectives-de-croissance</loc>
  <lastmod>2021-10-05T12:04:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-2-quartal-solide-ergebnisse-trotz-us-generikakonkurrenz-fur-gleevec-im-gesamten-quartal-wichtige-positive-neuigkeiten-zu-innovationen-starken-zukunftige-wachstumsperspektiven</loc>
  <lastmod>2021-10-05T12:04:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-launches-dailies-total1-multifocal-contact-lenses-first-and-only-water-gradient-lenses-designed-people-presbyopia</loc>
  <lastmod>2021-10-05T12:04:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-biosimilar-etanercept-recommended-fda-advisory-committee-approval-treat-multiple-inflammatory-diseases</loc>
  <lastmod>2021-10-05T12:04:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-data-shows-sandoz-biosimilar-etanercept-candidate-has-equivalent-efficacy-originator-product</loc>
  <lastmod>2021-10-05T12:04:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pkc412-midostaurin-pivotal-data-published-nejm-show-60-response-rate-advanced-systemic-mastocytosis-sm</loc>
  <lastmod>2021-10-05T12:04:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/largest-global-psoriasis-survey-shows-84-people-face-discrimination-and-humiliation-because-their-skin</loc>
  <lastmod>2021-10-05T12:04:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-adds-bispecific-antibodies-its-growing-immuno-oncology-portfolio-through-collaboration-and-licensing-agreement-xencor</loc>
  <lastmod>2021-10-05T12:04:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/timely-use-novartis-entresto-could-prevent-or-postpone-over-28000-us-deaths-year-among-hfref-patients-according-expert-analysis-jama-cardiology</loc>
  <lastmod>2021-10-05T12:04:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expands-partnership-medicines-malaria-venture-develop-next-generation-antimalarial-treatment</loc>
  <lastmod>2021-10-05T12:04:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erweitert-partnerschaft-mit-medicines-malaria-venture-zur-entwicklung-von-malariamedikamenten-der-nachsten-generation</loc>
  <lastmod>2021-10-05T12:04:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-etend-son-partenariat-avec-medicines-malaria-venture-pour-developper-la-prochaine-generation-de-traitement-antipaludeen</loc>
  <lastmod>2021-10-05T12:04:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-long-term-safety-data-revolade-adults-chronic-immune-thrombocytopenia-rare-blood-disorder</loc>
  <lastmod>2021-10-05T12:04:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-data-showing-jakavi-superior-best-available-therapy-patients-less-advanced-polycythemia-vera-pv</loc>
  <lastmod>2021-10-05T12:04:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-data-demonstrates-sandoz-etanercept-and-rituximab-biosimilar-candidates-bioequivalent-originator-products</loc>
  <lastmod>2021-10-05T12:04:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-amg-334-significantly-reduces-patients-monthly-migraine-days-phase-ii-study-chronic-migraine-prevention</loc>
  <lastmod>2021-10-05T12:04:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-scientific-evidence-cosentyx-ankylosing-spondylitis-and-psoriatic-arthritis-patients-eular-2016</loc>
  <lastmod>2021-10-05T12:04:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-combination-therapy-tafinlar-mekinist-demonstrates-overall-survival-benefit-three-year-follow-patients-advanced-melanoma</loc>
  <lastmod>2021-10-05T12:04:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pivotal-data-tafinlar-mekinist-demonstrated-63-percent-overall-response-rate-treating-rare-form-lung-cancer</loc>
  <lastmod>2021-10-05T12:04:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-show-more-50-percent-eligible-ph-cml-patients-maintain-treatment-free-remission-tfr-after-stopping-tasigna</loc>
  <lastmod>2021-10-05T12:04:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-afinitor-receives-eu-approval-treat-certain-types-advanced-gastrointestinal-gi-and-lung-neuroendocrine-tumors-net</loc>
  <lastmod>2021-10-05T12:04:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-its-strong-foundation-long-term-sustainable-growth-third-meet-novartis-management-event</loc>
  <lastmod>2021-10-05T12:04:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-biosimilar-rituximab-regulatory-submission-accepted-european-medicines-agency</loc>
  <lastmod>2021-10-05T12:04:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-entresto-given-strong-class-i-recommendation-both-us-and-eu-heart-failure-guidelines-less-year-after-regulatory-approvals</loc>
  <lastmod>2021-10-05T12:04:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-investment-fortihfy-clinical-program-entresto-and-heart-failure</loc>
  <lastmod>2021-10-05T12:04:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-present-pivotal-data-hematologic-and-solid-tumor-cancers-2016-asco-annual-meeting</loc>
  <lastmod>2021-10-05T12:04:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/monaleesa-2-trial-novartis-lee011-ribociclib-stopped-due-positive-efficacy-results-interim-analysis-hrher2-advanced-breast-cancer</loc>
  <lastmod>2021-10-05T12:05:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-focuses-pharmaceuticals-division-creating-two-business-units-novartis-pharmaceuticals-and-novartis-oncology-appoints-leaders-executive-committee-novartis</loc>
  <lastmod>2021-10-05T12:05:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-renforce-la-division-pharmaceuticals-par-la-creation-de-deux-unites-daffaires-novartis-pharmaceuticals-et-novartis-oncology-et-nomme-de-nouveaux-dirigeants-son-comite-de-direction</loc>
  <lastmod>2021-10-05T12:05:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-fokussiert-ihre-division-pharmaceuticals-durch-schaffung-der-geschaftseinheiten-novartis-pharmaceuticals-und-novartis-oncology-und-beruft-deren-leiter-die-geschaftsleitung-von-novartis</loc>
  <lastmod>2021-10-05T12:05:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-foundation-and-partners-launch-innovative-hypertension-program-vietnam</loc>
  <lastmod>2021-10-05T12:05:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/major-study-published-nejm-confirms-novartis-ultibro-breezhaler-superiority-over-seretide-preventing-copd-exacerbations</loc>
  <lastmod>2021-10-05T12:05:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-afinitor-recommended-chmp-european-union-approval-treat-select-gi-and-lung-neuroendocrine-tumors</loc>
  <lastmod>2021-10-05T12:05:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-three-fda-breakthrough-therapy-designations-ilaris-treat-rare-types-periodic-fever-syndromes</loc>
  <lastmod>2021-10-05T12:05:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-solid-q1-despite-gleevec-loss-exclusivity-investing-behind-new-launches-long-term-growth</loc>
  <lastmod>2021-10-05T12:05:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-ersten-quartal-trotz-verlust-der-exklusivrechte-gleevec-solide-ergebnisse-und-investiert-neueinfuhrungen-zugunsten-langfristigen-wachstums</loc>
  <lastmod>2021-10-05T12:05:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-enregistre-un-premier-trimestre-solide-malgre-la-perte-dexclusivite-de-gleevec-et-investi-dans-de-nouveaux-lancements-pour-soutenir-la-croissance-long-terme</loc>
  <lastmod>2021-10-05T12:05:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-afinitor-significantly-reduces-seizures-phase-iii-study-patients-tuberous-sclerosis-complex</loc>
  <lastmod>2021-10-05T12:05:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-ec-approval-subcutaneous-route-administration-biosimilar-binocrits-nephrology-indication</loc>
  <lastmod>2021-10-05T12:05:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-eu-approval-revolade-first-class-therapy-children-aged-1-year-and-above-chronic-itp</loc>
  <lastmod>2021-10-05T12:05:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-analyses-show-novartis-entrestotm-reduced-cardiovascular-death-or-hospitalization-heart-failure-consistently-benefitting-patients-reduced-ejection-fraction-regardless</loc>
  <lastmod>2021-10-05T12:05:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-publishes-updated-2015-segment-financials-reflecting-new-division-structure</loc>
  <lastmod>2021-10-05T12:05:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-superior-stelara-delivering-long-lasting-skin-clearance-pasi-90-psoriasis-patients-52-weeks</loc>
  <lastmod>2021-10-05T12:05:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-new-indication-novartis-drug-afinitor-progressive-nonfunctional-gi-and-lung-neuroendocrine-tumors-net</loc>
  <lastmod>2021-10-05T12:05:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-board-directors</loc>
  <lastmod>2021-10-05T12:05:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration-0</loc>
  <lastmod>2021-10-05T12:05:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-aktionare-genehmigen-alle-antrage-des-verwaltungsrats</loc>
  <lastmod>2021-10-05T12:05:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-pkc412-midostaurin-receives-breakthrough-therapy-designation-from-fda-newly-diagnosed-flt3-mutated-acute-myeloid-leukemia-aml</loc>
  <lastmod>2021-10-05T12:05:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-expands-leadership-position-treating-glaucoma-through-acquisition-transcend-medical-inc</loc>
  <lastmod>2021-10-05T12:05:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-strengthens-its-biosimilars-portfolio-acquisition-pfizers-biosimilar-infliximab-eea</loc>
  <lastmod>2021-10-05T12:05:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-advances-its-biosimilars-program-ema-acceptance-regulatory-submission-biosimilar-pegfilgrastim</loc>
  <lastmod>2021-10-05T12:05:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-foundation-commemorates-world-leprosy-day-its-continued-efforts-go-last-mile-toward-elimination</loc>
  <lastmod>2021-10-05T12:05:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-strong-sales-growth-and-core-margin-expansion-cc1-2015-announces-plans-accelerate-growth-alcon-streamline-group-operations</loc>
  <lastmod>2021-10-05T12:05:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-enregistre-en-2015-une-forte-croissance-des-ventes-et-une-hausse-de-sa-marge-core-tcc1-et-annonce-des-plans-pour-accelerer-la-croissance-dalcon-et-rationaliser-les-operations-du-groupe</loc>
  <lastmod>2021-10-05T12:05:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-2015-eine-kraftige-steigerung-des-umsatzes-und-der-kern-gewinnmarge-kwk1-plane-zur-wachstumsbeschleunigung-bei-alcon-und-zur-straffung-der-konzernaktivitaten-bekannt-gegeben</loc>
  <lastmod>2021-10-05T12:05:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-two-new-fda-approvals-cosentyx-treat-patients-ankylosing-spondylitis-and-psoriatic-arthritis-us</loc>
  <lastmod>2021-10-05T12:05:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-continues-grow-immuno-oncology-pipeline-through-collaboration-and-licensing-agreement-surface-oncology</loc>
  <lastmod>2021-10-05T12:05:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pharmaceuticals-collaborates-qualcomm-digital-innovation-breezhalertm-inhaler-device-treat-copd</loc>
  <lastmod>2021-10-05T12:05:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-nejm-publication-two-major-trials-showing-significant-efficacy-cosentyx-ankylosing-spondylitis-patients</loc>
  <lastmod>2021-10-05T12:05:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/300-million-child-friendly-antimalarial-treatments-supplied-without-profit-novartis</loc>
  <lastmod>2021-10-05T12:05:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-advances-its-biosimilars-program-european-medicines-agency-ema-acceptance-regulatory-submission-biosimilar-etanercept</loc>
  <lastmod>2021-10-05T12:05:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-new-ctl019-phase-ii-data-demonstrating-93-complete-remission-pediatric-patients-rr-all</loc>
  <lastmod>2021-10-05T12:05:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/phase-iii-data-shows-sandoz-proposed-biosimilar-pegfilgrastim-has-similar-safety-and-efficacy-reference-product</loc>
  <lastmod>2021-10-05T12:05:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-pkc412-midostaurin-improves-overall-survival-23-global-phase-iii-study-aml-patients-flt3-mutations</loc>
  <lastmod>2021-10-05T12:05:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-ctl019-study-data-demonstrating-overall-response-adult-patients-certain-types-lymphoma</loc>
  <lastmod>2021-10-05T12:05:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-phase-iii-studies-jakavi-show-disease-improvement-patients-myelofibrosis-and-polycythemia-vera</loc>
  <lastmod>2021-10-05T12:05:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-data-targeted-combination-therapy-sabcs-reinforcing-commitment-breast-cancer-patients</loc>
  <lastmod>2021-10-05T12:05:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-clinical-advances-ash-2015-underscoring-leadership-hematology-research</loc>
  <lastmod>2021-10-05T12:05:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-heart-failure-medicine-entrestotm-receives-eu-approval</loc>
  <lastmod>2021-10-05T12:05:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-two-landmark-european-approvals-cosentyx-treat-patients-ankylosing-spondylitis-and-psoriatic-arthritis</loc>
  <lastmod>2021-10-05T12:05:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pharmaceuticals-corporation-finalizes-settlement-agreement-resolving-civil-suit-filed-us-attorneys-office-southern-district-new-york</loc>
  <lastmod>2021-10-05T12:05:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/regulatory-submission-sandoz-proposed-biosimilar-pegfilgrastim-accepted-fda</loc>
  <lastmod>2021-10-05T12:05:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/flame-study-shows-superiority-novartis-ultibro-breezhaler-over-seretide-reducing-copd-exacerbations</loc>
  <lastmod>2021-10-05T12:05:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-introduces-contoura-vision-first-personalized-lasik-procedure-american-academy-ophthalmology-annual-meeting</loc>
  <lastmod>2021-10-05T12:05:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-two-year-data-cosentyx-showing-no-progression-joint-damage-84-psoriatic-arthritis-patients</loc>
  <lastmod>2021-10-05T12:05:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-two-year-data-novartis-cosentyx-show-sustained-response-and-no-progression-spinal-damage-shown-x-ray-80-patients-ankylosing-spondylitis</loc>
  <lastmod>2021-10-05T12:05:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-nominating-elizabeth-doherty-and-ton-buechner-board-directors</loc>
  <lastmod>2021-10-05T12:05:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-foundation-and-partners-launch-new-hypertension-program-ghana</loc>
  <lastmod>2021-10-05T12:05:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-strong-core-margin-expansion-cc-and-continued-strengthen-pipeline-q3-track-full-year-guidance</loc>
  <lastmod>2021-10-05T12:06:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-realise-au-troisieme-trimestre-une-forte-hausse-de-sa-marge-core-tcc-et-continue-de-renforcer-son-pipeline-confirmant-ainsi-ses-previsions-pour-lexercice</loc>
  <lastmod>2021-10-05T12:06:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-steigert-die-kerngewinnmarge-kwk-im-dritten-quartal-kraftig-starkt-erneut-die-pipeline-und-ist-auf-kurs-fur-die-jahresprognose</loc>
  <lastmod>2021-10-05T12:06:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-first-il-17a-inhibitor-cosentyxtm-treat-ankylosing-spondylitis-and-psoriatic-arthritis</loc>
  <lastmod>2021-10-05T12:06:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-broadens-immuno-oncology-pipeline-acquisition-admune-therapeutics-and-licensing-agreements-xoma-and-palobiofarma</loc>
  <lastmod>2021-10-05T12:06:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/kenya-first-country-launch-novartis-access-expanding-affordable-treatment-options-against-chronic-diseases</loc>
  <lastmod>2021-10-05T12:06:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-data-showing-majority-patients-are-able-maintain-clear-or-almost-clear-skin-cosentyx-across-3-years</loc>
  <lastmod>2021-10-05T12:06:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/long-term-efficacy-gilenya-reinforced-new-no-evidence-disease-activity-neda-4-analysis-ms-patients-over-seven-years</loc>
  <lastmod>2021-10-05T12:06:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-receives-fda-approval-pre-loaded-intraocular-lens-delivery-system-treat-patients-undergoing-cataract-surgery</loc>
  <lastmod>2021-10-05T12:06:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-accepts-sandoz-regulatory-submission-proposed-biosimilar-etanercept</loc>
  <lastmod>2021-10-05T12:06:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-nejm-publication-secukinumab-phase-iii-data-confirming-significant-efficacy-patients-psoriatic-arthritis</loc>
  <lastmod>2021-10-05T12:06:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/patients-aggressive-form-melanoma-lived-more-two-years-average-when-taking-novartis-therapies-tafinlar-mekinist</loc>
  <lastmod>2021-10-05T12:06:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-next-generation-car-t-cell-therapy-ctl119-combined-ibrutinib-shows-high-rate-responses-cll-patients</loc>
  <lastmod>2021-10-05T12:08:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-expanded-use-zykadia-first-line-alk-positive-metastatic-non-small-cell-lung-cancer-nsclc</loc>
  <lastmod>2021-10-05T12:08:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-new-analyses-reinforce-potential-ultibro-breezhaler-copd-patients-historically-treated-steroids</loc>
  <lastmod>2021-10-05T12:08:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-first-line-use-zykadia-alk-positive-advanced-non-small-cell-lung-cancer-nsclc</loc>
  <lastmod>2021-10-05T12:08:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-asco-icml-and-eha-meetings-demonstrate-meaningful-advancements-cancer-care</loc>
  <lastmod>2021-10-05T12:08:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-foundation-and-partners-launch-initiative-tackle-hypertension-and-its-root-causes-low-income-urban-communities</loc>
  <lastmod>2021-10-05T12:08:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-celebrates-21st-annual-community-partnership-day-over-24500-associates-volunteering-their-local-communities</loc>
  <lastmod>2021-10-05T12:08:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-exercises-exclusive-option-agreement-conatus-treatment-nash</loc>
  <lastmod>2021-10-05T12:08:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-rydapt-newly-diagnosed-flt3-mutated-acute-myeloid-leukemia-aml-and-three-types-systemic-mastocytosis-sm</loc>
  <lastmod>2021-10-05T12:08:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-announces-eu-launch-cypass-micro-stent-micro-invasive-glaucoma-surgical-device-lower-intraocular-pressure-iop-patients-primary-open-angle-glaucoma</loc>
  <lastmod>2021-10-05T12:08:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-sales-growth-across-all-divisions-cc1-growth-drivers-including-cosentyx-and-entresto-more-offset-generic-erosion-innovation-momentum-continued</loc>
  <lastmod>2021-10-05T12:08:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ventes-en-progression-tcc1-dans-toutes-ses-divisions-les-moteurs-de-croissance-cosentyx-et-entresto-inclus-compensent-lerosion-due-aux-generiques-linnovation-toujours-en-plein-essor</loc>
  <lastmod>2021-10-05T12:08:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-umsatzsteigerungen-allen-divisionen-kwk1-wobei-wachstumstreiber-wie-cosentyx-und-entresto-die-einbussen-durch-generika-mehr-als-wettmachen-innovationsdynamik-setzt-sich-fort</loc>
  <lastmod>2021-10-05T12:08:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expands-global-collaboration-amgen-commercialize-first-class-amg-334-erenumab-program-migraine-prevention-us-and-canada</loc>
  <lastmod>2021-10-05T12:08:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-real-world-data-aan-confirms-benefit-gilenya-four-key-measures-disease-activity-relapsing-ms</loc>
  <lastmod>2021-10-05T12:08:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-proposed-biosimilars-rituximab-and-etanercept-recommended-approval-europe</loc>
  <lastmod>2021-10-05T12:08:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/nih-study-nejm-shows-novartis-drug-eltrombopag-first-line-therapy-standard-treatment-improves-responses-severe-aplastic-anemia</loc>
  <lastmod>2021-10-05T12:08:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expands-development-programs-nash-through-clinical-collaboration-allergan</loc>
  <lastmod>2021-10-05T12:08:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-car-t-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation-treatment-adult-patients-rr-dlbcl</loc>
  <lastmod>2021-10-05T12:08:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-strengthen-rd-pipeline-licensing-ecf843-ophthalmic-indications</loc>
  <lastmod>2021-10-05T12:08:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-combination-tafinlar-mekinist-receives-eu-approval-braf-v600-positive-advanced-non-small-cell-lung-cancer-nsclc</loc>
  <lastmod>2021-10-05T12:08:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-first-car-t-cell-therapy-bla-pediatric-and-young-adult-patients-rr-b-cell-all-granted-fda-priority-review</loc>
  <lastmod>2021-10-05T12:08:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-receives-us-fda-approval-new-acrysof-iq-restor-25-multifocal-toric-iol-activefocustm-design-uncompromised-distance-vision-and-presbyopia-correction</loc>
  <lastmod>2021-10-05T12:08:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-phase-iii-study-rlx030-serelaxin-patients-acute-heart-failure</loc>
  <lastmod>2021-10-05T12:08:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-first-and-only-il-17a-inhibitor-potentially-modify-course-psoriasis</loc>
  <lastmod>2021-10-05T12:08:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-analysis-shows-novartis-entresto-improves-glycemic-control-reduced-ejection-fraction-heart-failure-patients-diabetes</loc>
  <lastmod>2021-10-05T12:08:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-ribociclib-lee011-receives-fda-approval-first-line-treatment-hrher2-metastatic-breast-cancer-combination-any-aromatase-inhibitor</loc>
  <lastmod>2021-10-05T12:08:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-winners-inaugural-healthcare-access-challenge-sandoz-hack</loc>
  <lastmod>2021-10-05T12:08:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-shows-almost-all-psoriasis-patients-rapidly-regain-skin-clearance-following-treatment-pause</loc>
  <lastmod>2021-10-05T12:08:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-data-demonstrate-sandoz-proposed-biosimilar-adalimumab-has-equivalent-efficacy-reference-medicine</loc>
  <lastmod>2021-10-05T12:08:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-aktionare-genehmigen-der-ordentlichen-generalversammlung-alle-antrage-des-verwaltungsrats</loc>
  <lastmod>2021-10-05T12:08:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-board-directors-annual-general-meeting</loc>
  <lastmod>2021-10-05T12:08:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration-lors-de-lassemblee-generale-annuelle</loc>
  <lastmod>2021-10-05T12:08:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-tafinlar-mekinist-braf-positive-non-small-cell-lung-cancer-nsclc-patients</loc>
  <lastmod>2021-10-05T12:08:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-zykadia-receives-fda-priority-review-first-line-use-patients-alk-metastatic-nsclc</loc>
  <lastmod>2021-10-05T12:08:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-pharmaceuticals-ag-recu-la-certification-top-employer-suisse-2017</loc>
  <lastmod>2021-10-05T12:08:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-pharmaceuticals-ag-als-top-arbeitgeber-schweiz-2017-ausgezeichnet</loc>
  <lastmod>2021-10-05T12:08:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-votubia-receives-eu-approval-treat-refractory-partial-onset-seizures-patients-tsc</loc>
  <lastmod>2021-10-05T12:08:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-progress-towards-access-and-environmental-goals-2016-corporate-responsibility-performance-report</loc>
  <lastmod>2021-10-05T12:08:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-launches-new-trifocal-toric-intraocular-lens-patients-astigmatism-undergoing-cataract-surgery</loc>
  <lastmod>2021-10-05T12:08:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-solid-2016-performance-growth-products1-absorbing-gleevec-us-loe-innovation-momentum-continued-announces-share-buyback</loc>
  <lastmod>2021-10-05T12:08:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-solide-performance-en-2016-les-produits-de-croissance1-absorbant-la-perte-dexclusivite-de-gleevec-aux-usa-dynamique-continue-dinnovation-rachat-dactions-annonce</loc>
  <lastmod>2021-10-05T12:08:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-2016-solide-ergebnisse-wobei-die-wachstumsprodukte1-den-verlust-der-exklusivrechte-fur-gleevec-den-usa-wettmachen-innovationsdynamik-halt-aktienruckkauf-angekundigt</loc>
  <lastmod>2021-10-05T12:08:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-invests-next-generation-therapies-reduce-cardiovascular-risk-patients-underlying-lipid-disorders</loc>
  <lastmod>2021-10-05T12:08:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-bolsters-ophthalmology-pipeline-through-acquisition-encore-vision-inc</loc>
  <lastmod>2021-10-05T12:08:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-exclusive-option-collaboration-and-license-agreement-conatus-develop-new-oral-treatments-chronic-liver-diseases</loc>
  <lastmod>2021-10-05T12:08:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-recommendation-ilaris-treat-rare-diseases-adults-and-children-called-periodic-fever-syndromes</loc>
  <lastmod>2021-10-05T12:08:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-votubia-recommended-chmp-eu-approval-treat-refractory-partial-onset-seizures-patients-tsc</loc>
  <lastmod>2021-10-05T12:08:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-bolsters-innovative-dermatology-portfolio-through-acquisition-ziarco-group-limited</loc>
  <lastmod>2021-10-05T12:08:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-launches-sms-life-20-nigeria-help-improve-access-essential-medicines</loc>
  <lastmod>2021-10-05T12:08:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-lance-sms-life-20-au-nigeria-pour-aider-ameliorer-lacces-aux-medicaments-essentiels</loc>
  <lastmod>2021-10-05T12:08:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-fuhrt-sms-life-20-nigeria-ein-um-den-zugang-zu-unentbehrlichen-arzneimitteln-zu-verbessern</loc>
  <lastmod>2021-10-05T12:08:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-pegpleranib-phase-iii-clinical-trial-program-patients-neovascular-age-related-macular-degeneration-namd-or-wet-amd</loc>
  <lastmod>2021-10-05T12:08:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-lee011-ribociclib-plus-letrozole-analyses-show-superior-pfs-across-broad-spectrum-patients-first-line-hrher2-advanced-breast-cancer-versus-letrozole</loc>
  <lastmod>2021-10-05T12:08:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ultibro-breezhaler-improved-lung-function-and-copd-symptoms-after-direct-switch-from-previous-treatment</loc>
  <lastmod>2021-10-05T12:08:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-lucentis-received-eu-approval-new-indication-lucentis-only-treatment-available-wide-range-cnv-conditions</loc>
  <lastmod>2021-10-05T12:08:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-zykadia-first-line-study-results-showing-166-month-progression-free-survival-patients-alk-advanced-nsclc</loc>
  <lastmod>2021-10-05T12:08:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-shows-treatment-free-remission-rates-are-consistently-above-50-regardless-reason-switch-tasigna-from-glivec</loc>
  <lastmod>2021-10-05T12:09:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-survey-uncovers-real-world-burden-myeloproliferative-neoplasms-rare-blood-cancers-daily-activity-and-ability-work</loc>
  <lastmod>2021-10-05T12:09:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-interim-data-demonstrate-sandoz-proposed-biosimilar-rituximab-has-equivalent-efficacy-reference-product</loc>
  <lastmod>2021-10-05T12:09:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-results-from-first-global-registration-trial-ctl019-pediatric-and-young-adult-patients-rr-b-all</loc>
  <lastmod>2021-10-05T12:09:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-seg101-crizanlizumab-formerly-selg1-significantly-reduces-frequency-sickle-cell-pain-crises-phase-ii-study</loc>
  <lastmod>2021-10-05T12:09:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-access-communique-son-bilan-un-et-annonce-la-signature-dun-protocole-daccord-avec-le-rwanda</loc>
  <lastmod>2021-10-05T12:09:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-access-shares-one-year-learnings-and-announces-memorandum-understanding-rwanda</loc>
  <lastmod>2021-10-05T12:09:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-access-informiert-uber-erfahrungen-im-ersten-jahr-und-gibt-memorandum-understanding-mit-ruanda-bekannt</loc>
  <lastmod>2021-10-05T12:09:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-acquires-selexys-pharmaceuticals-corporation-and-selg1-antibody-reduction-pain-crises-sickle-cell-disease-scd</loc>
  <lastmod>2021-10-05T12:09:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-commends-publication-major-report-which-recommends-broad-use-dual-bronchodilators-treat-copd</loc>
  <lastmod>2021-10-05T12:09:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/innovative-study-three-treatment-switches-confirms-sandoz-biosimilar-etanercept-has-equivalent-efficacy-originator</loc>
  <lastmod>2021-10-05T12:09:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-amg-334-significantly-reduces-monthly-migraine-days-second-pivotal-phase-iii-episodic-migraine-study</loc>
  <lastmod>2021-10-05T12:09:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-ash-and-sabcs-showcase-latest-innovations-development-patients-blood-disorders-and-breast-cancer</loc>
  <lastmod>2021-10-05T12:09:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-analysis-novartis-entresto-data-shows-long-term-benefits-heart-failure-readmissions-and-total-cardiovascular-deaths</loc>
  <lastmod>2021-10-05T12:09:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-pkc412-midostaurin-granted-fda-priority-review-newly-diagnosed-flt3-mutated-aml-and-advanced-systemic-mastocytosis</loc>
  <lastmod>2021-10-05T12:09:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-cosentyx-data-showing-long-lasting-efficacy-psoriatic-arthritis-over-3-years-including-patient-reported-pain</loc>
  <lastmod>2021-10-05T12:09:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-improves-ranking-2016-access-medicine-index</loc>
  <lastmod>2021-10-05T12:09:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-lee011-ribociclib-granted-fda-priority-review-first-line-treatment-hrher2-advanced-breast-cancer</loc>
  <lastmod>2021-10-05T12:09:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-wins-two-prestigious-prix-galien-foundation-awards-gleevec-recognized-discovery-decade-best-pharmaceutical-product-cosentyx-best-biotechnology-product</loc>
  <lastmod>2021-10-05T12:09:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-solid-third-quarter-growth-products1-offsetting-gleevec-patent-expiration-several-positive-readouts-potential-blockbusters</loc>
  <lastmod>2021-10-05T12:09:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-dritten-quartal-solide-ergebnisse-wobei-die-wachstumsprodukte1-den-verlust-des-patents-fur-gleevec-wettmachen-mehrere-positive-daten-fur-potenzielle-blockbuster</loc>
  <lastmod>2021-10-05T12:09:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-realise-un-troisieme-trimestre-solide-les-produits-de-croissance1-ayant-compense-lexpiration-du-brevet-de-glivec-plusieurs-resultats-positifs-concernant-des-blockbusters-potentiels</loc>
  <lastmod>2021-10-05T12:09:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-launches-cypass-micro-stent-american-academy-ophthalmology-aao-2016-annual-meeting</loc>
  <lastmod>2021-10-05T12:09:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-alk-metastatic-nsclc-therapy-zykadia-extends-progression-free-survival-beyond-18-months-phase-ii-study</loc>
  <lastmod>2021-10-05T12:09:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-tafinlar-dabrafenib-mekinist-trametinib-demonstrate-superior-overall-survival-benefit-advanced-melanoma-patients-three-year-follow</loc>
  <lastmod>2021-10-05T12:09:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-breakthrough-therapy-lee011-plus-letrozole-demonstrates-superior-progression-free-survival-first-line-treatment-hrher2-advanced-breast-cancer-compared-standard-care</loc>
  <lastmod>2021-10-05T12:09:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-over-half-psoriasis-patients-do-not-reach-achievable-treatment-goal-clear-skin-largest-global-survey</loc>
  <lastmod>2021-10-05T12:09:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-late-breaking-data-show-cosentyx-delivers-high-and-long-lasting-skin-clearance-over-4-years-psoriasis-patients</loc>
  <lastmod>2021-10-05T12:09:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-phase-iii-study-shows-amg-334-significantly-reduces-monthly-migraine-days-people-episodic-migraine</loc>
  <lastmod>2021-10-05T12:09:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-invites-young-entrepreneurs-enter-sandoz-hack-global-competition-help-solve-healthcare-access-challenges</loc>
  <lastmod>2021-10-05T12:10:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-three-new-fda-approvals-expanded-use-ilaris-treating-rare-periodic-fever-syndrome-conditions</loc>
  <lastmod>2021-10-05T12:10:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-top-line-results-from-ascend-4-phase-iii-trial-zykadia-untreated-adult-alk-nsclc-patients</loc>
  <lastmod>2021-10-05T12:10:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novel-novartis-malaria-compound-shows-potential-be-effective-against-infections-resistant-all-currently-available-antimalarial-drugs</loc>
  <lastmod>2021-10-05T12:10:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/important-new-analysis-shows-novartis-entresto-associated-higher-relative-health-related-quality-life-scores-among-hfref-patients</loc>
  <lastmod>2021-10-05T12:10:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-baf312-reduces-risk-disability-progression-pivotal-phase-iii-study-secondary-progressive-ms-patients</loc>
  <lastmod>2021-10-05T12:10:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-data-presented-ectrims-show-benefit-gilenya-patient-disability-progression-10-years</loc>
  <lastmod>2021-10-05T12:10:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-positive-data-ehmtic-showing-amg-334-significantly-reduces-monthly-migraine-days-chronic-migraine</loc>
  <lastmod>2021-10-05T12:10:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-foundation-showcases-progress-leprosy-elimination-programs-19th-international-leprosy-congress</loc>
  <lastmod>2021-10-05T12:10:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-point-care-nijitm-system-may-provide-earlier-diagnosis-severe-allergic-asthma-and-faster-treatment-decisions</loc>
  <lastmod>2021-10-05T12:10:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-launches-ngenuity-3d-visualization-system-designed-further-enhance-retinal-surgeon-experience</loc>
  <lastmod>2021-10-05T12:10:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ultibro-breezhaler-consistently-more-effective-seretide-reducing-copd-flare-ups-across-different-patient-groups</loc>
  <lastmod>2021-10-05T12:10:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/airflusal-forspiro-showed-superiority-12-months-over-seretide-diskus1-persistence-treatment</loc>
  <lastmod>2021-10-05T12:10:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-new-data-reinforces-superiority-cosentyx-versus-stelara-achieving-skin-clearance-psoriasis-patients</loc>
  <lastmod>2021-10-05T12:36:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-regulatory-submission-proposed-biosimilar-adalimumab-accepted-fda</loc>
  <lastmod>2021-10-05T12:36:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-appoints-elizabeth-barrett-oncology-head</loc>
  <lastmod>2021-10-05T12:36:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ernennt-elizabeth-barrett-zur-chefin-onkologie</loc>
  <lastmod>2021-10-05T12:36:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-advances-head-head-superiority-trials-cosentyx-versus-humira-and-proposed-biosimilar-adalimumab</loc>
  <lastmod>2021-10-05T12:36:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-promacta-receives-fda-breakthrough-therapy-designation-first-line-use-severe-aplastic-anemia-saa</loc>
  <lastmod>2021-10-05T12:36:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-received-fda-breakthrough-therapy-designation-initial-endocrine-based-treatment-premenopausal-women-hrher2-advanced-breast-cancer</loc>
  <lastmod>2021-10-05T12:36:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-tasigna-approved-fda-first-and-only-cml-therapy-treatment-free-remission-data-its-label</loc>
  <lastmod>2021-10-05T12:36:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-combination-therapy-tafinlar-mekinist-granted-fda-priority-review-adjuvant-treatment-stage-iii-braf-v600-mutation-positive-melanoma</loc>
  <lastmod>2021-10-05T12:36:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-oncology-head-retire</loc>
  <lastmod>2021-10-05T12:36:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-gibt-rucktritt-des-onkologie-chefs-bekannt</loc>
  <lastmod>2021-10-05T12:36:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-crizanlizumab-shown-prolong-time-patients-first-sickle-cell-pain-crisis-subgroup-analysis-sustain-study</loc>
  <lastmod>2021-10-05T12:36:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/primary-analysis-results-from-novartis-pivotal-juliet-trial-show-kymriahtm-tisagenlecleucel-sustained-complete-responses-six-months-adults-rr-dlbcl-difficult-treat-cancer</loc>
  <lastmod>2021-10-05T12:36:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-new-phase-i-data-showing-proposed-biosimilar-pegfilgrastim-matches-reference-medicine</loc>
  <lastmod>2021-10-05T12:36:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-tender-offer-advanced-accelerator-applications-commences</loc>
  <lastmod>2021-10-05T12:36:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/kisqali-first-and-only-cdk46-inhibitor-show-superior-efficacy-vs-oral-endocrine-therapy-1l-treatment-randomized-phase-iii-trial-premenopausal-women-hrher2-advanced-breast-cancer</loc>
  <lastmod>2021-10-05T12:36:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-first-biologic-show-long-term-efficacy-nail-and-palmoplantar-psoriasis-which-can-impact-90-psoriasis-patients</loc>
  <lastmod>2021-10-05T12:36:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-phase-iii-strive-data-published-nejm-demonstrating-significant-and-sustained-efficacy-erenumab-amg334-migraine-prevention</loc>
  <lastmod>2021-10-05T12:36:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ultibro-breezhaler-significantly-improved-copd-patients-lung-function-after-direct-switch-from-seretide</loc>
  <lastmod>2021-10-05T12:36:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-tasigna-nilotinib-secures-eu-approval-first-and-second-line-treatment-ph-cml-cp-children</loc>
  <lastmod>2021-10-05T12:36:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ascp-and-acs-join-forces-fight-cancer-ethiopia-uganda-and-tanzania</loc>
  <lastmod>2021-10-05T12:36:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-data-sabcs-across-broad-range-breast-cancer-patient-populations-combination-treatments-and-lines-therapy</loc>
  <lastmod>2021-10-05T12:36:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-data-reinforces-clinical-basis-switching-sandoz-biosimilar-medicines</loc>
  <lastmod>2021-10-05T12:36:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-canakinumab-acz885-reduced-cardiovascular-risk-25-subgroup-cantos-phase-iii-trial-participants</loc>
  <lastmod>2021-10-05T12:36:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-its-differentiated-late-stage-pipeline-rd-update-and-investor-event</loc>
  <lastmod>2021-10-05T12:36:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-entresto-real-world-evidence-data-shows-beneficial-impact-quality-life-people-living-heart-failure</loc>
  <lastmod>2021-10-05T12:36:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/punjab-province-pakistan-signs-agreement-novartis-access-against-chronic-diseases</loc>
  <lastmod>2021-10-05T12:36:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-brolucizumab-rth258-demonstrates-superiority-versus-aflibercept-key-secondary-endpoint-measures-disease-activity-namd-leading-cause-blindness</loc>
  <lastmod>2021-10-05T12:36:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-positive-results-from-phase-iii-trial-kisqali-ribociclib-combination-therapy-premenopausal-women-hrher2-advanced-or-metastatic-breast-cancer</loc>
  <lastmod>2021-10-05T12:36:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-study-data-demonstrating-cosentyx-reduced-signs-and-symptoms-psoriatic-arthritis-while-inhibiting-progression-joint-structural-damage</loc>
  <lastmod>2021-10-05T12:36:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-seeks-leadership-cosentyx-showing-no-radiographic-progression-ankylosing-spondylitis-4-years</loc>
  <lastmod>2021-10-05T12:36:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reaches-another-regulatory-milestone-ctl019-tisagenlecleucel-submission-its-maa-ema-children-young-adults-rr-b-cell-all-and-adult-patients-rr-dlbcl</loc>
  <lastmod>2021-10-05T12:36:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-amgen-announce-expanded-collaboration-banner-alzheimers-institute-pioneering-prevention-program</loc>
  <lastmod>2021-10-05T12:36:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-data-ash-patients-serious-blood-disorders-lymphoma-leukemia-and-sickle-cell-disease</loc>
  <lastmod>2021-10-05T12:37:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-submits-application-fda-kymriahtm-tisagenlecleucel-adult-patients-rr-dlbcl-seeking-second-indication-first-ever-fda-approved-car-t-therapy</loc>
  <lastmod>2021-10-05T12:37:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-present-first-its-kind-evidence-cosentyx-potential-maintain-mobility-patients-and-psa</loc>
  <lastmod>2021-10-05T12:37:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-planned-acquisition-advanced-accelerator-applications-strengthen-oncology-portfolio</loc>
  <lastmod>2021-10-05T12:37:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-paradigms-data-show-children-and-adolescents-ms-had-82-lower-relapse-rate-gilenya-vs-interferon-beta-1a</loc>
  <lastmod>2021-10-05T12:37:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-proposed-biosimilar-pegfilgrastim-accepted-ema-regulatory-review</loc>
  <lastmod>2021-10-05T12:37:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-confirms-leadership-multiple-sclerosis-ms-scientific-advancements-and-new-data-presented-ectrims</loc>
  <lastmod>2021-10-05T12:37:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-growth-top-and-bottom-line-all-divisions-q3</loc>
  <lastmod>2021-10-05T12:37:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-au-troisieme-trimestre-croissance-du-chiffre-daffaires-et-du-resultat-dans-toutes-les-divisions</loc>
  <lastmod>2021-10-05T12:37:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-steigert-im-dritten-quartal-umsatz-und-gewinn-allen-divisionen</loc>
  <lastmod>2021-10-05T12:37:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-combination-adjuvant-therapy-tafinlar-mekinist-receives-fda-breakthrough-therapy-designation-stage-iii-braf-v600-mutation-positive-melanoma-patients</loc>
  <lastmod>2021-10-05T12:37:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-revolade-shows-long-term-disease-control-chronicpersistent-immune-thrombocytopenia-itp</loc>
  <lastmod>2021-10-05T12:37:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-receives-ce-mark-first-its-kind-autonometm-preloaded-intraocular-lens-iol-delivery-system-clareon-iol</loc>
  <lastmod>2021-10-05T12:37:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-introduces-new-innovations-cataract-surgery-european-society-cataract-refractive-surgeons-2017-annual-congress</loc>
  <lastmod>2021-10-05T12:37:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-uc-berkeley-collaborate-tackle-undruggable-disease-targets</loc>
  <lastmod>2021-10-05T12:37:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-max-foundation-transform-pioneering-cancer-access-program-people-lower-income-countries</loc>
  <lastmod>2021-10-05T12:37:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-rydapt-midostaurin-receives-eu-approval-newly-diagnosed-flt3-mutated-acute-myeloid-leukemia-aml-and-three-types-advanced-systemic-mastocytosis-sm</loc>
  <lastmod>2021-10-05T12:37:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-xolair-confirms-re-treatment-efficacy-chronic-spontaneous-urticaria-patients-after-treatment-interruption</loc>
  <lastmod>2021-10-05T12:37:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-proposed-biosimilar-adalimumab-matches-reference-biologic-terms-efficacy-and-safety-long-term-study</loc>
  <lastmod>2021-10-05T12:37:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-sets-new-benchmark-psoriasis-robust-5-year-sustained-phase-iii-efficacy-and-safety-data</loc>
  <lastmod>2021-10-05T12:37:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-proposed-biosimilar-rituximab-accepted-review-fda</loc>
  <lastmod>2021-10-05T12:37:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iii-study-demonstrates-adjuvant-tafinlar-mekinist-reduced-risk-disease-recurrence-53-patients-resected-braf-v600-mutation-positive-melanoma</loc>
  <lastmod>2021-10-05T12:37:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-analysis-demonstrating-amg-334-erenumab-significantly-reduced-monthly-migraine-days-patients-who-failed-previous-preventive-therapies</loc>
  <lastmod>2021-10-05T12:37:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-landmark-phase-iii-trial-shows-fingolimod-significantly-reduces-relapses-children-and-adolescents-ms</loc>
  <lastmod>2021-10-05T12:37:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-ceo-joseph-jimenez-retire-from-novartis-2018-vasant-narasimhan-appointed-ceo-effective-february-1-2018</loc>
  <lastmod>2021-10-05T12:37:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-ctl019-children-and-young-adults-b-cell-all-refractory-or-has-relapsed-least-twice</loc>
  <lastmod>2021-10-05T12:37:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-analysis-published-lancet-showing-acz885-reduced-lung-cancer-mortality-77-cantos-study-further-studies-planned</loc>
  <lastmod>2021-10-05T12:37:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iii-cantos-study-demonstrates-targeting-inflammation-acz885-reduces-cardiovascular-risk</loc>
  <lastmod>2021-10-05T12:37:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-appoints-bertrand-bodson-chief-digital-officer</loc>
  <lastmod>2021-10-05T12:37:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-ribociclib-receives-eu-approval-first-line-treatment-hrher2-locally-advanced-or-metastatic-breast-cancer-combination-any-aromatase-inhibitor</loc>
  <lastmod>2021-10-05T12:37:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-et-medicines-malaria-venture-lancent-une-etude-clinique-en-afrique-pour-kaf156-un-candidat-medicament-novateur-contre-le-paludisme-multiresistant</loc>
  <lastmod>2021-10-05T12:37:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-medicines-malaria-venture-launch-patient-trial-africa-kaf156-novel-compound-against-multidrug-resistant-malaria</loc>
  <lastmod>2021-10-05T12:37:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-und-medicines-malaria-venture-starten-afrika-eine-patientenstudie-mit-kaf156-einem-neuartigen-wirkstoff-gegen-multiresistente-malaria</loc>
  <lastmod>2021-10-05T12:37:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-expands-partnership-world-child-cancer-help-children-access-treatment-four-developing-countries</loc>
  <lastmod>2021-10-05T12:37:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-rydapt-midostaurin-newly-diagnosed-flt3-mutated-acute-myeloid-leukemia-aml-and-three-types-advanced-systemic-mastocytosis-sm</loc>
  <lastmod>2021-10-05T12:37:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/die-ergebnisse-im-zweiten-quartal-bestatigen-die-jahresprognosen-starke-forschungs-und-entwicklungsresultate-untermauern-das-potenzial-einiger-hoch-innovativer-produkte</loc>
  <lastmod>2021-10-05T12:37:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-resultats-du-t2-confirment-les-previsions-de-lexercice-2017-les-tres-bons-resultats-du-pipeline-etayent-le-potentiel-de-plusieurs-produits-hautement-novateurs</loc>
  <lastmod>2021-10-05T12:37:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/q2-results-confirm-full-year-guidance-strong-pipeline-results-underpin-potential-several-highly-innovative-products</loc>
  <lastmod>2021-10-05T12:37:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-confirms-5-year-data-first-and-only-fully-human-il-17a-inhibitor-cosentyx-reinforcing-sustained-efficacy-and-safety-profile-psoriasis</loc>
  <lastmod>2021-10-05T12:37:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-car-t-cell-therapy-ctl019-unanimously-10-0-recommended-approval-fda-advisory-committee-treat-pediatric-young-adult-rr-b-cell-all</loc>
  <lastmod>2021-10-05T12:38:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-approval-eu-cosentyx-label-update-includes-long-term-superiority-data-versus-stelara-psoriasis</loc>
  <lastmod>2021-10-05T12:38:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-eu-approval-first-line-use-zykadia-alk-positive-advanced-non-small-cell-lung-cancer-nsclc</loc>
  <lastmod>2021-10-05T12:38:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-approval-europe-erelzi-biosimilar-etanercept-treat-multiple-inflammatory-diseases</loc>
  <lastmod>2021-10-05T12:38:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/nejm-publishes-full-analysis-rydapt-midostaurin-phase-iii-ratify-trial-newly-diagnosed-flt3-mutated-acute-myeloid-leukemia-aml</loc>
  <lastmod>2021-10-05T12:38:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-ribociclib-receives-positive-chmp-opinion-first-line-treatment-hrher2-locally-advanced-or-metastatic-breast-cancer-combination-any-aromatase-inhibitor</loc>
  <lastmod>2021-10-05T12:38:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-shows-half-eligible-ph-cml-cp-patients-remain-treatment-free-remission-nearly-two-years-after-stopping-tasigna</loc>
  <lastmod>2021-10-05T12:38:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pivotal-ctl019-6-month-follow-data-show-durable-remission-rates-children-young-adults-rr-b-cell-all</loc>
  <lastmod>2021-10-05T12:38:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-combination-targeted-therapy-tafinlar-mekinist-receives-fda-approval-braf-v600e-mutant-metastatic-non-small-cell-lung-cancer-nsclc</loc>
  <lastmod>2021-10-05T12:38:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iii-study-shows-acz885-canakinumab-reduces-cardiovascular-risk-people-who-survived-heart-attack</loc>
  <lastmod>2021-10-05T12:38:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-achieves-important-regulatory-milestone-amg-334-erenumab-migraine-prevention-ema-filing-acceptance</loc>
  <lastmod>2021-10-05T12:38:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-rth258-brolucizumab-demonstrates-robust-visual-gains-namd-patients-majority-12-week-injection-interval</loc>
  <lastmod>2021-10-05T12:38:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-real-world-study-shows-almost-half-chronic-urticaria-patients-are-not-receiving-any-treatment-despite-significant-disease-burden</loc>
  <lastmod>2021-10-05T12:38:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-approval-europe-rixathon-biosimilar-rituximab-treat-blood-cancers-and-immunological-diseases</loc>
  <lastmod>2021-10-05T12:38:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-international-ag-new-patient-survey-highlights-need-more-action-help-severe-asthma-patients-gain-control-their-disease</loc>
  <lastmod>2021-10-05T12:38:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-accepts-sandoz-regulatory-submission-generic-version-advair-diskus</loc>
  <lastmod>2021-10-05T12:38:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-shows-sustained-improvements-signs-and-symptoms-both-and-psa-80-patients-3-years</loc>
  <lastmod>2021-10-05T12:38:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-data-demonstrating-efficacy-amg-334-erenumab-migraine-prevention-american-headache-society-annual-meeting</loc>
  <lastmod>2021-10-05T12:38:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-interim-results-from-global-pivotal-ctl019-trial-show-durable-complete-responses-adults-rr-dlbcl</loc>
  <lastmod>2021-10-05T12:38:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-tasigna-receives-eu-approval-inclusion-treatment-free-remission-tfr-data-product-label</loc>
  <lastmod>2021-10-05T12:38:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-clinical-collaboration-bristol-myers-squibb-evaluate-potential-treatments-metastatic-colorectal-cancer</loc>
  <lastmod>2021-10-05T12:38:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-ground-breaking-collaboration-ibm-watson-health-outcomes-based-care-advanced-breast-cancer</loc>
  <lastmod>2021-10-05T12:38:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-landmark-study-tafinlar-mekinist-demonstrates-durable-survival-benefit-five-years-patients-braf-mutation-positive-metastatic-melanoma</loc>
  <lastmod>2021-10-05T12:38:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-updated-data-reinforce-efficacy-and-safety-kisqali-ribociclib-plus-letrozole-first-line-option-hrher2-advanced-or-metastatic-breast-cancer</loc>
  <lastmod>2021-10-05T12:38:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/progress-reported-global-fight-against-diarrheal-disease-cryptosporidiosis</loc>
  <lastmod>2021-10-05T12:38:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-proposed-biosimilars-adalimumab-and-infliximab-accepted-regulatory-review-european-medicines-agency</loc>
  <lastmod>2021-10-05T12:38:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/meet-novartis-management-investor-event-novartis-highlights-focus-innovation-and-productivity-expects-next-growth-phase-begin-2018</loc>
  <lastmod>2021-10-05T12:38:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ernennt-dr-klaus-moosmayer-zum-chief-ethics-risk-and-compliance-officer</loc>
  <lastmod>2021-10-05T12:39:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-marks-new-era-migraine-patients-eu-approval-aimovig-first-its-kind-treatment-specifically-designed-migraine-prevention</loc>
  <lastmod>2021-10-05T12:39:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-european-commission-approval-biosimilar-hyrimoz-adalimumab</loc>
  <lastmod>2021-10-05T12:39:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-combination-tafinlar-mekinist-receives-positive-chmp-opinion-adjuvant-treatment-braf-v600-mutation-positive-melanoma</loc>
  <lastmod>2021-10-05T12:39:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-renews-drug-donation-egaten-triclabendazole-until-2022-reaffirming-its-commitment-fight-against-liver-fluke</loc>
  <lastmod>2021-10-05T12:39:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-demonstrates-commitment-lead-immuno-dermatology-licensing-il-17c-compound-atopic-dermatitis</loc>
  <lastmod>2021-10-05T12:39:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-now-first-and-only-cdk46-inhibitor-indicated-us-first-line-therapy-specifically-premenopausal-women-and-initial-therapy-fulvestrant-postmenopausal-women</loc>
  <lastmod>2021-10-05T12:39:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivers-solid-growth-second-quarter-and-continues-transformation-focused-medicines-company</loc>
  <lastmod>2021-10-05T12:39:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-realise-une-solide-croissance-au-deuxieme-trimestre-et-poursuit-sa-transformation-en-une-entreprise-axee-sur-les-medicaments</loc>
  <lastmod>2021-10-05T12:39:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-zweiten-quartal-ein-solides-wachstum-und-setzt-die-transformation-zu-einem-fokussierten-arzneimittelunternehmen-fort</loc>
  <lastmod>2021-10-05T12:39:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-kymriah-treating-two-aggressive-blood-cancers-marking-important-medical-advance-patients-europe</loc>
  <lastmod>2021-10-05T12:39:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erhalt-positive-chmp-stellungnahme-fur-kymriah-zur-behandlung-zweier-aggressiver-blutkrebsarten-ein-wichtiger-medizinischer-fortschritt-fur-patientinnen-und-patienten-europa</loc>
  <lastmod>2021-10-05T12:39:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-intention-seek-shareholder-approval-100-spinoff-alcon-eye-care-devices-business-initiates-share-buyback-usd-5-bn</loc>
  <lastmod>2021-10-05T12:39:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-gibt-absicht-bekannt-die-genehmigung-der-aktionare-fur-einen-100igen-spin-des-geschafts-mit-ophthalmologischen-produkten-von-alcon-einzuholen-und-leitet-gleichzeitig-einen-aktienruck</loc>
  <lastmod>2021-10-05T12:39:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-annonce-son-intention-de-solliciter-lapprobation-des-actionnaires-pour-la-scission-100-dalcon-sa-division-de-produits-ophtalmologiques-et-initie-un-rachat-dactions-hauteur-dusd</loc>
  <lastmod>2021-10-05T12:39:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-data-demonstrating-long-term-efficacy-safety-and-tolerability-aimovig-erenumab-patients-chronic-and-episodic-migraine</loc>
  <lastmod>2021-10-05T12:39:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-international-ag-global-study-novartis-and-european-migraine-and-headache-alliance-reveals-60-employed-people-severe-migraine-miss-average-week-work-month</loc>
  <lastmod>2021-10-05T12:39:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-clear-about-psoriasis-survey-data-highlights-challenges-psoriasis-patients-face-achieve-goal-clear-skin</loc>
  <lastmod>2021-10-05T12:39:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-international-ag-alcon-acrysof-iq-panoptix-trifocal-intraocular-lens-shows-superior-visual-performance-head-head-trial-post-cataract-surgery</loc>
  <lastmod>2021-10-05T12:39:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-juliet-trial-kymriah-demonstrates-more-one-year-durability-responses-adults-relapsed-or-refractory-dlbcl</loc>
  <lastmod>2021-10-05T12:39:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-survey-uncovers-real-world-impact-immune-thrombocytopenia-or-itp-rare-blood-disease-patients-quality-life</loc>
  <lastmod>2021-10-05T12:39:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-study-real-world-data-concludes-jakavi-associated-reduction-risk-death-and-dangerous-blood-clots-patients-rare-blood-cancer</loc>
  <lastmod>2021-10-05T12:39:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-presents-new-long-term-and-switching-data-biosimilars-zessly-infliximab-and-erelzi-etanercept-rheumatoid-arthritis</loc>
  <lastmod>2021-10-05T12:39:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-data-advance-understanding-role-il-17a-and-reinforce-cosentyx-leadership-spondyloarthritis</loc>
  <lastmod>2021-10-05T12:39:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-jco-publication-lutathera-netter-1-data-showing-significantly-longer-time-deterioration-key-quality-life-measures-patients-progressive-midgut-nets</loc>
  <lastmod>2021-10-05T12:39:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-schullabor-empfangt-hunderttausendsten-besucher</loc>
  <lastmod>2021-10-05T12:39:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/third-novartis-phase-iii-trial-shows-kisqali-combination-therapy-significantly-improves-pfs-hrher2-advanced-breast-cancer</loc>
  <lastmod>2021-10-05T12:39:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-data-presented-asco-find-nearly-half-cml-patients-treated-tasigna-remain-remission-almost-three-years-after-stopping-therapy</loc>
  <lastmod>2021-10-05T12:39:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-completes-sale-stake-consumer-healthcare-joint-venture-gsk-usd130-billion</loc>
  <lastmod>2021-10-05T12:40:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-positive-chmp-opinion-proposed-biosimilar-adalimumab</loc>
  <lastmod>2021-10-05T12:40:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-aimovig-erenumab-prevention-migraine</loc>
  <lastmod>2021-10-05T12:40:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-expedites-review-novartis-drug-promacta-first-line-severe-aplastic-anemia-saa</loc>
  <lastmod>2021-10-05T12:40:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-international-ag-patient-reported-outcomes-tool-revealed-significant-improvement-symptom-frequency-and-quality-life-domains-entresto</loc>
  <lastmod>2021-10-05T12:40:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-european-commission-approval-zessly-infliximab-gastroenterological-rheumatological-and-dermatological-diseases</loc>
  <lastmod>2021-10-05T12:40:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-amgen-announce-fda-approval-aimovigtm-erenumab-novel-treatment-developed-specifically-migraine-prevention</loc>
  <lastmod>2021-10-05T12:40:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-asco-and-eha-reinforce-companys-commitment-reimagining-cancer</loc>
  <lastmod>2021-10-05T12:40:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kundigt-veranderungen-der-geschaftsleitung</loc>
  <lastmod>2021-10-05T12:40:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/meet-novartis-management-investor-event-novartis-highlights-strategy-focus-company-and-drive-sustainable-growth</loc>
  <lastmod>2021-10-05T12:40:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-changes-executive-committee</loc>
  <lastmod>2021-10-05T12:40:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-successfully-completes-acquisition-avexis-inc</loc>
  <lastmod>2021-10-05T12:40:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-arrow-trial-assess-mechanistic-superiority-direct-il-17a-inhibition-cosentyx-over-il-23-inhibition-tremfya</loc>
  <lastmod>2021-10-05T12:40:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-completes-tender-offer-all-outstanding-shares-avexis-inc</loc>
  <lastmod>2021-10-05T12:40:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-fda-approval-gilenya-first-disease-modifying-therapy-pediatric-relapsing-multiple-sclerosis</loc>
  <lastmod>2021-10-05T12:40:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-cares-project-100-commits-reducing-cataract-blindness-globally</loc>
  <lastmod>2021-10-05T12:40:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-complete-response-letter-from-us-fda-proposed-biosimilar-rituximab</loc>
  <lastmod>2021-10-05T12:40:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/kymriah-tisagenlecleucel-first-class-car-t-therapy-from-novartis-receives-second-fda-approval-treat-appropriate-rr-patients-large-b-cell-lymphoma</loc>
  <lastmod>2021-10-05T12:40:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-proposed-acquisition-avexis</loc>
  <lastmod>2021-10-05T12:40:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-tafinlar-mekinist-adjuvant-treatment-braf-v600-mutant-melanoma</loc>
  <lastmod>2021-10-05T12:40:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-phase-iii-data-brolucizumab-demonstrate-reliability-12-week-treatment-interval</loc>
  <lastmod>2021-10-05T12:40:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-launches-focalview-app-providing-opportunity-patients-participate-ophthalmology-clinical-trials-from-home</loc>
  <lastmod>2021-10-05T12:40:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-analyses-aan-show-siponimods-efficacy-disability-and-cognition-secondary-progressive-ms-patients</loc>
  <lastmod>2021-10-05T12:40:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-appoints-john-tsai-head-global-drug-development-and-chief-medical-officer</loc>
  <lastmod>2021-10-05T12:40:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-strong-first-quarter-and-acted-become-more-focused-medicines-company</loc>
  <lastmod>2021-10-05T12:40:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-realise-une-bonne-performance-au-premier-trimestre-et-agi-pour-devenir-une-entreprise-plus-centree-sur-les-medicaments</loc>
  <lastmod>2021-10-05T12:40:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-verzeichnet-ein-starkes-erstes-quartal-und-ergreift-schritte-um-ein-starker-fokussiertes-arzneimittelunternehmen-zu-werden</loc>
  <lastmod>2021-10-05T12:40:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-signs-agreement-pear-therapeutics-develop-and-commercialize-prescription-digital-therapeutics-patients-substance-use-disorder-and-opioid-use-disorders</loc>
  <lastmod>2021-10-05T12:40:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-first-its-kind-evidence-aan-reinforcing-robust-and-consistent-efficacy-aimovigtm-erenumab-migraine-patients-multiple-treatment-failures</loc>
  <lastmod>2021-10-05T12:40:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-renews-commitment-malaria-elimination-investing-usd-100-million-research-and-develop-next-generation-antimalarials</loc>
  <lastmod>2021-10-05T12:40:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-bekraftigt-engagement-zur-eliminierung-von-malaria-und-investiert-usd-100-millionen-die-erforschung-und-entwicklung-der-nachsten-generation-von-malariamedikamenten</loc>
  <lastmod>2021-10-05T12:40:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-renouvelle-son-engagement-afin-deliminer-le-paludisme-en-investissant-100-millions-de-dollars-dans-la-recherche-et-le-developpement-dantipaludiques-de-nouvelle-generation</loc>
  <lastmod>2021-10-05T12:40:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-tender-offer-avexis-commences</loc>
  <lastmod>2021-10-05T12:40:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-analysis-demonstrating-entresto-helped-preserve-kidney-function-patients-chronic-heart-failure-especially-those-diabetes</loc>
  <lastmod>2021-10-05T12:40:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-enters-agreement-acquire-avexis-inc-usd-87-bn-transform-care-sma-and-expand-position-gene-therapy-and-neuroscience-leader</loc>
  <lastmod>2021-10-05T12:40:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-schliesst-vereinbarung-zum-erwerb-von-avexis-inc-fur-usd-87-mrd-ab-um-therapie-der-sma-zu-transformieren-und-position-als-fuhrendes-gentherapie-und-neuroscience-unternehmen-auszubauen</loc>
  <lastmod>2021-10-05T12:40:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-outlines-plans-next-healthcare-access-challenge-hack-support-local-digital-innovation</loc>
  <lastmod>2021-10-05T12:40:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-jama-cardiology-publication-data-showing-entresto-improves-physical-and-social-activity-hfref-patients-versus-enalapril</loc>
  <lastmod>2021-10-05T12:40:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-present-predictability-data-brolucizumab-namd-from-pivotal-hawk-and-harrier-trials-arvo</loc>
  <lastmod>2021-10-05T12:40:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-sell-stake-consumer-healthcare-joint-venture-gsk-usd130-billion-focus-strategic-priorities</loc>
  <lastmod>2021-10-05T12:40:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-verkauft-beteiligung-consumer-healthcare-joint-venture-fur-usd-13-milliarden-gsk-um-sich-auf-strategische-prioritaten-zu-konzentrieren</loc>
  <lastmod>2021-10-05T12:40:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-positive-chmp-opinion-proposed-biosimilar-infliximab</loc>
  <lastmod>2021-10-05T12:40:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/phase-iii-data-lancet-show-novartis-siponimod-significantly-improves-outcomes-patients-secondary-progressive-ms</loc>
  <lastmod>2021-10-05T12:40:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-tasigna-approved-fda-treat-children-rare-form-leukemia</loc>
  <lastmod>2021-10-05T12:40:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-teams-harvard-develop-next-generation-biomaterial-systems-deliver-immunotherapies</loc>
  <lastmod>2021-10-05T12:40:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-changes-executive-committee-support-strategic-priorities</loc>
  <lastmod>2021-10-05T12:40:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kundigt-veranderungen-der-geschaftsleitung-zur-unterstutzung-strategischer-prioritaten</loc>
  <lastmod>2021-10-05T12:40:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-annonce-des-changements-au-sein-de-son-comite-de-direction-afin-de-soutenir-ses-priorites-strategiques</loc>
  <lastmod>2021-10-05T12:41:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expands-alliance-science-37-advance-virtual-clinical-trials-program</loc>
  <lastmod>2021-10-05T12:41:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-xolair-recommended-new-global-chronic-urticaria-guideline</loc>
  <lastmod>2021-10-05T12:41:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-board-directors-annual-general-meeting-0</loc>
  <lastmod>2021-10-05T12:41:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration-lors-de-lassemblee-generale</loc>
  <lastmod>2021-10-05T12:41:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-aktionare-genehmigen-der-ordentlichen-generalversammlung-alle-antrage-des-verwaltungsrats-0</loc>
  <lastmod>2021-10-05T12:41:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-pear-therapeutics-develop-digital-therapeutics-patients-schizophrenia-and-multiple-sclerosis</loc>
  <lastmod>2021-10-05T12:41:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/treatment-novartis-ultibro-breezhaler-improved-cardiac-function-copd-patients-lung-hyperinflation</loc>
  <lastmod>2021-10-05T12:41:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-new-data-show-cosentyx-improved-quality-life-over-5-years-two-thirds-patients-moderate-severe-plaque-psoriasis</loc>
  <lastmod>2021-10-05T12:41:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-new-cosentyx-data-confirms-robust-efficacy-and-quality-life-improvements-scalp-psoriasis</loc>
  <lastmod>2021-10-05T12:41:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-forms-alliance-develop-medicines-treating-infectious-diarrheal-disease</loc>
  <lastmod>2021-10-05T12:41:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-us-fda-approval-and-launch-glatopa-40-mgml-three-times-week-generic-option-relapsing-forms-multiple-sclerosis</loc>
  <lastmod>2021-10-05T12:41:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-cosentyx-label-update-include-moderate-severe-scalp-psoriasis</loc>
  <lastmod>2021-10-05T12:41:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-completes-subsequent-offering-period-tender-offer-advanced-accelerator-applications-sa</loc>
  <lastmod>2021-10-05T12:41:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-nejm-publication-updated-analysis-from-eliana-trial-showing-longer-term-durable-remissions-kymriahtm-children-young-adults-rr-all</loc>
  <lastmod>2021-10-05T12:41:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/advanced-accelerator-applications-receives-fda-approval-lutathera-treatment-gastroenteropancreatic-neuroendocrine-tumors</loc>
  <lastmod>2021-10-05T12:41:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-exclusively-licenses-first-ophthalmology-gene-therapy-all-markets-outside-us-milestone-patients-rare-inherited-vision-loss</loc>
  <lastmod>2021-10-05T12:41:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-good-operational-performance-and-landmark-innovation-2017-entering-our-next-growth-phase</loc>
  <lastmod>2021-10-05T12:41:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-enregistre-en-2017-une-belle-performance-operationnelle-et-des-innovations-majeures-entrant-ainsi-dans-une-nouvelle-phase-de-croissance</loc>
  <lastmod>2021-10-05T12:41:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-2017-eine-gute-operative-performance-sowie-wegweisende-innovationen-und-ist-gut-gerustet-fur-die-nachste-wachstumsphase</loc>
  <lastmod>2021-10-05T12:41:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-erenumab-met-all-primary-and-secondary-endpoints-unique-phase-iiib-study-episodic-migraine-patients-who-have-failed-multiple-prior-preventive-treatments</loc>
  <lastmod>2021-10-05T12:41:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-completes-tender-offer-advanced-accelerator-applications-sa-and-announces-commencement-subsequent-offering-period</loc>
  <lastmod>2021-10-05T12:41:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-exclusive-global-collaboration-biocon-next-generation-biosimilars</loc>
  <lastmod>2021-10-05T12:41:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-granted-us-fda-priority-review-kymriahtm-tisagenlecleucel-formerly-ctl019-adults-rr-dlbcl</loc>
  <lastmod>2021-10-05T12:41:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/europe-africa-partnership-spearheads-development-next-generation-antimalarial-drug</loc>
  <lastmod>2021-10-05T12:42:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-drives-differentiated-portfolio-deal-commercialize-new-treatment-opioid-induced-constipation-key-european-countries</loc>
  <lastmod>2021-10-05T12:42:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-continues-transformation-leading-medicines-company-completion-alcon-spin</loc>
  <lastmod>2021-10-05T12:42:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-updates-migraine-collaboration-amgen</loc>
  <lastmod>2021-10-05T12:42:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-resubmits-biosimilar-pegfilgrastim-application-us-fda</loc>
  <lastmod>2021-10-05T12:42:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-first-class-cosentyx-approved-china-psoriasis-patients</loc>
  <lastmod>2021-10-05T12:42:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-expands-world-leading-gene-therapy-manufacturing-capacity-purchase-advanced-biologics-therapy-manufacturing-campus-longmont-colorado</loc>
  <lastmod>2021-10-05T12:42:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-adds-clinical-and-preclinical-anti-inflammatory-programs-portfolio-acquisition-ifm-tre</loc>
  <lastmod>2021-10-05T12:42:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-mayzent-siponimod-first-oral-drug-treat-secondary-progressive-ms-active-disease</loc>
  <lastmod>2021-10-05T12:42:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-plans-alcon-spin-april-9-2019</loc>
  <lastmod>2021-10-05T12:43:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-announces-acquisition-powervision-inc</loc>
  <lastmod>2021-10-05T12:43:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-joins-global-chagas-disease-coalition-and-also-announces-first-multinational-prospective-randomized-study-people-chronic-chagas-cardiomyopathy</loc>
  <lastmod>2021-10-05T12:43:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-change-sandoz-leadership</loc>
  <lastmod>2021-10-05T12:43:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/three-winners-2019-sandoz-healthcare-access-challenge-hack-are-announced-sxsw</loc>
  <lastmod>2021-10-05T12:43:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-shows-superior-improvements-psoriasis-patients-quality-life-versus-janssens-il-23-stelara</loc>
  <lastmod>2021-10-05T12:43:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-confirm-rapid-response-and-high-efficacy-cosentyx-psoriasis-patients-first-time-china</loc>
  <lastmod>2021-10-05T12:43:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-board-directors-annual-general-meeting-1</loc>
  <lastmod>2021-10-05T12:43:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/die-aktionare-von-novartis-heissen-der-generalversammlung-alle-antrage-des-verwaltungsrates-gut</loc>
  <lastmod>2021-10-05T12:43:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration-lors-de-lassemblee-generale-0</loc>
  <lastmod>2021-10-05T12:43:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-issues-summary-financial-information-alcon-eye-care-business-ahead-shareholder-vote-proposed-spin</loc>
  <lastmod>2021-10-05T12:43:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pursue-transformational-therapy-reduce-risk-cardiovascular-disease-people-living-elevated-levels-inherited-lipoproteina</loc>
  <lastmod>2021-10-05T12:43:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-egaten-treatment-fascioliasis-neglected-tropical-disease</loc>
  <lastmod>2021-10-05T12:43:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-strong-sales-growth-core-margin-expansion-built-leading-advanced-therapy-platforms-and-focused-company-2018</loc>
  <lastmod>2021-10-05T12:43:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/en-2018-novartis-enregistre-une-forte-croissance-de-ses-ventes-avec-une-expansion-de-sa-marge-core-developpe-des-plates-formes-leaders-de-traitements-de-pointe-et-recentre-lentreprise</loc>
  <lastmod>2021-10-05T12:43:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-2018-ein-kraftiges-umsatzwachstum-bei-gleichzeitiger-steigerung-der-kerngewinnmarge-baut-wegweisende-therapieplattformen-auf-und-fokussiert-das-unternehmen</loc>
  <lastmod>2021-10-05T12:43:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-therapy-crizanlizumab-seg101-receives-fda-breakthrough-therapy-designation-prevention-vaso-occlusive-crises-sickle-cell-disease</loc>
  <lastmod>2021-10-05T12:43:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-and-pear-therapeutics-announce-us-launch-reset-otm-help-treat-opioid-use-disorder</loc>
  <lastmod>2021-10-05T12:43:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-successfully-completes-acquisition-endocyte</loc>
  <lastmod>2021-10-05T12:43:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-european-commission-ec-approval-expanded-indication-kisqali-ribociclib</loc>
  <lastmod>2021-10-05T12:43:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-offer-acquire-cellforcure-expand-manufacturing-capacity-innovative-cell-and-gene-therapies</loc>
  <lastmod>2021-10-05T12:43:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-ceo-oncology-business-unit</loc>
  <lastmod>2021-10-05T12:43:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-enters-commercialization-and-supply-agreement-insulin-biosimilars-anticipating-growing-demand-diabetes-burden-rises</loc>
  <lastmod>2021-10-05T12:43:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-announces-acquisition-tear-film-innovations-inc</loc>
  <lastmod>2021-10-05T12:43:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-european-commission-approval-self-administration-xolair-across-all-indications</loc>
  <lastmod>2021-10-05T12:43:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-inc-and-pear-therapeutics-obtain-fda-clearance-reset-otm-treat-opioid-use-disorder</loc>
  <lastmod>2021-10-05T12:43:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-demonstrates-consistent-efficacy-and-tolerability-kisqali-combination-therapy-hrher2-advanced-breast-cancer-patients-difficult-treat-visceral-disease</loc>
  <lastmod>2021-10-05T12:43:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-byl719-alpelisib-plus-fulvestrant-consistently-improved-pfs-patients-pik3ca-mutated-hrher2-advanced-breast-cancer-new-solar-1-analyses</loc>
  <lastmod>2021-10-05T12:43:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-advances-ligelizumab-qge031-urticaria-phase-iii-basis-strong-phase-ii-head-head-data</loc>
  <lastmod>2021-10-05T12:43:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-fda-filing-acceptance-and-priority-review-avxs-101-one-time-treatment-designed-address-genetic-root-cause-sma-type-1</loc>
  <lastmod>2021-10-05T12:44:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/real-world-data-show-novartis-drug-revolade-improves-outcomes-itp-patients-compared-other-second-line-therapies</loc>
  <lastmod>2021-10-05T12:44:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-longer-term-analyses-from-pivotal-kymriah-trials-showed-durable-responses-are-maintained-patients-advanced-blood-cancers</loc>
  <lastmod>2021-10-05T12:44:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-crizanlizumab-seg101-data-analysis-sickle-cell-disease-and-investment-sentry-clinical-program</loc>
  <lastmod>2021-10-05T12:44:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-eu-approval-gilenya-children-and-adolescents-ms-making-it-first-and-only-oral-disease-modifying-treatment-these-patients-europe</loc>
  <lastmod>2021-10-05T12:44:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-eighth-european-commission-approval-biosimilar-ziextenzo-pegfilgrastim</loc>
  <lastmod>2021-10-05T12:44:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-highlight-its-vision-strategy-and-benefits-standalone-company-investors-and-analysts-new-york-and-london</loc>
  <lastmod>2021-10-05T12:44:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-landmark-eu-approval-one-time-gene-therapy-luxturna-restore-vision-people-rare-inherited-retinal-disease</loc>
  <lastmod>2021-10-05T12:44:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-rises-second-place-2018-access-medicine-index</loc>
  <lastmod>2021-10-05T12:44:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-and-pear-therapeutics-announce-launch-reset-treatment-patients-substance-use-disorder</loc>
  <lastmod>2021-10-05T12:44:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-novartis-drug-promacta-first-line-saa-and-grants-breakthrough-therapy-designation-additional-new-indication</loc>
  <lastmod>2021-10-05T12:44:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-expand-kisqali-combination-therapy-all-women-hrher2-locally-advanced-or-metastatic-breast-cancer</loc>
  <lastmod>2021-10-05T12:44:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-files-initial-form-20-f-registration-statement-sec-proposed-spinoff-plans-investor-days-new-york-and-london</loc>
  <lastmod>2021-10-05T12:44:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-study-supports-entresto-foundational-hfref-therapy-and-hospital-initiation-appropriate-stabilized-heart-failure-patients</loc>
  <lastmod>2021-10-05T12:44:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-rd-update-highlights-industry-leading-development-pipeline-including-potential-blockbusters-and-advanced-therapy-platforms</loc>
  <lastmod>2021-10-05T12:44:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-decides-not-pursue-us-biosimilar-rituximab-will-focus-robust-biosimilar-portfolio-unmet-access-and-sustainability-needs</loc>
  <lastmod>2021-10-05T12:44:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-ash-and-sabcs-show-strength-pipeline-and-portfolio-hematology-and-oncology</loc>
  <lastmod>2021-10-05T12:44:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-us-fda-approval-biosimilar-hyrimoztm-adalimumab-adaz</loc>
  <lastmod>2021-10-05T12:44:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-clinical-collaboration-pfizer-advance-treatment-nash</loc>
  <lastmod>2021-10-05T12:44:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/two-year-data-novartis-brolucizumab-reaffirm-superiority-versus-aflibercept-reducing-retinal-fluid-patients-namd</loc>
  <lastmod>2021-10-05T12:44:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-approval-cosentyx-label-update-europe-include-dosing-flexibility-psoriatic-arthritis</loc>
  <lastmod>2021-10-05T12:44:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-develop-smart-suite-digital-health-platform-cataract-surgery</loc>
  <lastmod>2021-10-05T12:44:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-lancet-publication-pioneering-study-migraine-prevention-showing-efficacy-aimovig-where-other-treatments-have-failed</loc>
  <lastmod>2021-10-05T12:44:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-combi-ad-study-tafinlar-mekinist-continues-demonstrate-relapse-free-survival-benefit-patients-braf-v600-mutant-stage-iii-melanoma</loc>
  <lastmod>2021-10-05T12:44:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-byl719-alpelisib-plus-fulvestrant-nearly-doubles-median-pfs-patients-pik3ca-mutated-hrher2-advanced-breast-cancer-compared-fulvestrant-alone</loc>
  <lastmod>2021-10-05T12:44:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-ii-geometry-mono-1-trial-investigational-medicine-capmatinib-inc280-shows-positive-results-patients-met-mutated-advanced-nsclc</loc>
  <lastmod>2021-10-05T12:44:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-presentation-new-lutathera-netter-1-data-esmo-demonstrating-significant-improvement-pfs-regardless-baseline-liver-tumor-burden</loc>
  <lastmod>2021-10-05T12:44:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-planned-acquisition-endocyte-expand-expertise-radiopharmaceuticals-and-build-commitment-transformational-therapeutic-platforms</loc>
  <lastmod>2021-10-05T12:44:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-strong-growth-and-innovation-during-third-quarter-including-progressing-advanced-therapy-platforms-drive-future-growth</loc>
  <lastmod>2021-10-05T12:44:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-enregistre-au-troisieme-trimestre-une-forte-croissance-et-fait-preuve-dune-innovation-dynamique-incluant-des-plateformes-therapeutiques-avancees-pour-soutenir-la-croissance-future</loc>
  <lastmod>2021-10-05T12:44:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-dritten-quartal-starkes-wachstum-und-treibt-innovationen-wie-fortschrittliche-therapieplattformen-voran-um-das-zukunftige-wachstum-zu-beschleunigen</loc>
  <lastmod>2021-10-05T12:44:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-5-year-data-psoriatic-arthritis-and-ankylosing-spondylitis-reinforces-cosentyx-leadership-spondyloarthritis</loc>
  <lastmod>2021-10-05T12:44:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-global-resolution-biosimilar-adalimumab-patent-disputes-securing-patient-access</loc>
  <lastmod>2021-10-05T12:44:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-data-from-first-direct-head-head-trial-demonstrate-superior-efficacy-gilenya-over-copaxone-patients-relapsing-remitting-multiple-sclerosis</loc>
  <lastmod>2021-10-05T12:44:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/breadth-data-ectrims-underpins-novartis-relentless-commitment-decoding-science-multiple-sclerosis-ms-and-decreasing-patient-burden</loc>
  <lastmod>2021-10-05T12:44:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-analysis-shows-crizanlizumab-seg101-increased-number-patients-free-sickle-cell-pain-crises-vs-placebo-during-sustain-study</loc>
  <lastmod>2021-10-05T12:44:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-fda-and-ema-filing-acceptance-siponimod-first-and-only-drug-shown-meaningfully-delay-disability-progression-typical-spms-patients</loc>
  <lastmod>2021-10-05T12:44:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-healthcare-access-challenge-hack-returns-seeking-digital-solutions-local-healthcare-access-challenges</loc>
  <lastmod>2021-10-05T12:44:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-licenses-three-novel-anti-infective-programs-boston-pharmaceuticals</loc>
  <lastmod>2021-10-05T12:44:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-five-grant-recipients-excellence-ophthalmology-vision-award-xova-nonprofit-sustainable-eye-health-initiatives</loc>
  <lastmod>2021-10-05T12:45:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-file-new-lucentis-ranibizumab-indication-retinopathy-prematurity-rop-rare-disease-premature-infants-often-leads-blindness</loc>
  <lastmod>2021-10-05T12:45:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-analysis-novartis-phase-iii-brolucizumab-rth258-data-reinforces-superior-reduction-retinal-fluid-key-marker-disease-activity-namd</loc>
  <lastmod>2021-10-05T12:45:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-positive-chmp-opinion-proposed-biosimilar-pegfilgrastim</loc>
  <lastmod>2021-10-05T12:45:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-gilenya-treatment-children-and-adolescents-ms-marking-major-medical-advance-young-ms-patients-europe</loc>
  <lastmod>2021-10-05T12:45:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-chmp-opinion-one-time-gene-therapy-luxturna-treat-children-and-adults-rare-inherited-retinal-disease</loc>
  <lastmod>2021-10-05T12:45:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/worlds-largest-alzheimers-survey-reveals-most-adults-believe-cure-will-be-developed-their-lifetime</loc>
  <lastmod>2021-10-05T12:45:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/launch-alcon-experience-academy-reinforces-commitment-training-and-education-eye-care-professionals</loc>
  <lastmod>2021-10-05T12:45:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-real-world-evidence-confirms-efficacy-and-safety-benefits-cosentyx-daily-life-psoriasis-patients</loc>
  <lastmod>2021-10-05T12:45:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-nejm-publication-landmark-paradigms-study-demonstrating-significant-benefit-gilenya-children-and-adolescents-ms</loc>
  <lastmod>2021-10-05T12:45:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-survey-shows-psoriasis-patients-want-treatment-effect-beyond-clear-skin</loc>
  <lastmod>2021-10-05T12:45:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-confirms-commitment-switzerland-ahead-proposed-spinoff-from-novartis</loc>
  <lastmod>2021-10-05T12:45:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-bestatigt-vor-dem-vorgeschlagenen-spin-von-novartis-das-engagement-der-schweiz</loc>
  <lastmod>2021-10-05T12:45:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-confirme-son-engagement-envers-la-suisse-en-perspective-de-la-scission-proposee-avec-novartis</loc>
  <lastmod>2021-10-05T12:45:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-divest-sandoz-us-dermatology-business-and-generic-us-oral-solids-portfolio-aurobindo</loc>
  <lastmod>2021-10-05T12:45:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/european-commission-approves-novartis-combination-therapy-tafinlar-mekinist-adjuvant-treatment-braf-v600-mutation-positive-melanoma</loc>
  <lastmod>2021-10-05T12:45:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-announces-voluntary-global-market-withdrawal-cypass-micro-stent-surgical-glaucoma</loc>
  <lastmod>2021-10-05T12:45:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-european-commission-approval-its-car-t-cell-therapy-kymriah-tisagenlecleucel</loc>
  <lastmod>2021-10-05T12:45:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erhalt-die-zulassung-fur-seine-car-t-zell-therapie-kymriah-tisagenlecleucel-von-der-europaischen-kommission</loc>
  <lastmod>2021-10-05T12:45:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-data-show-entresto-sacubitrilvalsartan-can-be-initiated-early-safely-hospitalized-patients-after-acute-heart-failure-episode</loc>
  <lastmod>2021-10-05T12:45:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/solar-1-trial-novartis-investigational-alpha-specific-pi3k-inhibitor-byl719-alpelisib-meets-primary-endpoint-hrher2-advanced-breast-cancer-pik3ca-mutation</loc>
  <lastmod>2021-10-05T12:45:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-appoints-dr-klaus-moosmayer-chief-ethics-risk-and-compliance-officer</loc>
  <lastmod>2021-10-05T12:45:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-breadth-data-2019-ash-demonstrates-commitment-reimagining-medicine-hematology-through-innovative-therapeutic-platforms</loc>
  <lastmod>2021-10-05T12:50:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-acquire-medicines-company-usd-97-bn-adding-inclisiran-potentially-transformational-investigational-cholesterol-lowering-therapy-address-leading-global-cause-death</loc>
  <lastmod>2021-10-05T12:50:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-launches-innovation-prize-assistive-tech-encourage-new-technologies-address-unmet-needs-multiple-sclerosis-community</loc>
  <lastmod>2021-10-05T12:50:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-paragon-hf-analyses-suggest-entresto-benefit-beyond-hfref</loc>
  <lastmod>2021-10-05T12:50:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-medicine-adakveo-crizanlizumab-approved-fda-reduce-frequency-pain-crises-individuals-living-sickle-cell-disease</loc>
  <lastmod>2021-10-05T12:50:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-mayzent-siponimod-treatment-adult-patients-active-secondary-progressive-multiple-sclerosis-spms</loc>
  <lastmod>2021-10-05T12:50:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-strategy-provide-innovative-medicines-more-patients-sub-saharan-africa</loc>
  <lastmod>2021-10-05T12:50:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-presents-real-world-data-showing-effectiveness-erelzi-etanercept-szzs-rheumatic-disease-treatment</loc>
  <lastmod>2021-10-05T12:50:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-prevent-data-show-cosentyx-delivers-early-relief-axial-spondyloarthritis</loc>
  <lastmod>2021-10-05T12:50:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-show-tropifexor-ljn452-significantly-improves-several-key-biomarkers-nash-patients-moderate-severe-fibrosis</loc>
  <lastmod>2021-10-05T12:50:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-agreement-acquire-aspens-japanese-operations-and-associated-assets-strengthening-position-worlds-third-largest-generics-market</loc>
  <lastmod>2021-10-05T12:50:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-us-fda-approval-long-acting-oncology-supportive-care-biosimilar-ziextenzotm-pegfilgrastim-bmez</loc>
  <lastmod>2021-10-05T12:50:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-shows-encouraging-results-versus-humira-from-first-its-kind-head-head-trial-psoriatic-arthritis</loc>
  <lastmod>2021-10-05T12:50:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-avxs-101-intrathecal-study-update</loc>
  <lastmod>2021-10-05T12:50:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-approval-cosentyx-label-update-europe-include-dosing-flexibility-ankylosing-spondylitis</loc>
  <lastmod>2021-10-05T12:50:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-another-strong-quarter-double-digit-sales-growth-and-core1-margin-expansion-2019-sales-and-profit-guidance-raised-beovu-launched-us</loc>
  <lastmod>2021-10-05T12:50:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-verzeichnet-ein-weiteres-starkes-quartal-mit-zweistelligem-umsatz-wachstum-und-hoherer-kerngewinnmarge1-umsatz-und-gewinnerwartung-fur-2019-angehoben-us-einfuhrung-von-beovu</loc>
  <lastmod>2021-10-05T12:50:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-encore-un-fort-trimestre-croissance-deux-chiffres-des-ventes-et-expansion-de-la-marge-core1-hausse-des-previsions-de-chiffre-daffaires-et-de-resultat-en-2019-beovu-lance-aux-usa</loc>
  <lastmod>2021-10-05T12:50:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-jakavi-ruxolitinib-meets-primary-endpoint-phase-iii-study-acute-graft-versus-host-disease</loc>
  <lastmod>2021-10-05T12:50:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-show-cosentyx-treatment-results-rapid-and-sustained-resolution-signs-and-symptoms-psoriatic-arthritis-patients-and-without-enthesitis</loc>
  <lastmod>2021-10-05T12:50:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-real-world-evidence-confirms-high-efficacy-long-term-response-and-favorable-safety-profile-cosentyx-clinical-practice</loc>
  <lastmod>2021-10-05T12:50:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-show-more-patients-are-completely-symptom-free-from-chronic-spontaneous-urticaria-ligelizumab-qge031-xolair-300-mg</loc>
  <lastmod>2021-10-05T12:50:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-beovu-offering-wet-amd-patients-vision-gains-and-greater-fluid-reductions-vs-aflibercept</loc>
  <lastmod>2021-10-05T12:50:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-presents-updated-strong-data-wms</loc>
  <lastmod>2021-10-05T12:50:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-positive-52-week-prevent-data-confirm-cosentyx-efficacy-addressing-entire-axspa-spectrum</loc>
  <lastmod>2021-10-05T12:50:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-microsoft-announce-collaboration-transform-medicine-artificial-intelligence</loc>
  <lastmod>2021-10-05T12:50:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-results-from-phase-iii-palladium-study-inhaled-combination-qmf149-patients-uncontrolled-asthma</loc>
  <lastmod>2021-10-05T12:50:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-results-from-phase-iii-iridium-study-inhaled-combination-qvm149-patients-uncontrolled-asthma</loc>
  <lastmod>2021-10-05T12:50:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-delivers-consistently-superior-overall-survival-monaleesa-3-trial-demonstrates-more-life-postmenopausal-hrher2-advanced-breast-cancer-patients</loc>
  <lastmod>2021-10-05T12:50:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-presents-new-data-epns-continuing-show-significant-therapeutic-benefit-zolgensma-prolonging-event-free-survival-now-5-years-age-patients-spinal-muscular-atrophy-sma-type-1</loc>
  <lastmod>2021-10-05T12:50:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/positive-results-from-novartis-five-year-verify-study-type-2-diabetes-demonstrate-long-term-clinical-benefits-early-combination-treatment-galvus-and-metformin</loc>
  <lastmod>2021-10-05T12:50:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-positive-16-week-prevent-results-advance-potential-new-indication-patients-axial-spondyloarthritis</loc>
  <lastmod>2021-10-05T12:50:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iii-asclepios-trials-demonstrate-robust-efficacy-ofatumumab-patients-relapsing-multiple-sclerosis</loc>
  <lastmod>2021-10-05T12:50:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-data-show-neuronal-and-glial-filaments-biomarkers-disease-activity-have-potential-support-decision-making-management-multiple-sclerosis-ms-patient</loc>
  <lastmod>2021-10-05T12:50:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-data-show-mayzent-can-help-preserve-mobility-longer-patients-secondary-progressive-multiple-sclerosis-spms</loc>
  <lastmod>2021-10-05T12:50:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-ectrims-highlight-innovative-approach-reimagining-care-people-living-multiple-sclerosis-ms</loc>
  <lastmod>2021-10-05T12:50:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-confirm-long-term-efficacy-and-safety-aimovig-majority-patients-episodic-migraine</loc>
  <lastmod>2021-10-05T12:50:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-lung-cancer-therapy-capmatinib-inc280-granted-fda-breakthrough-therapy-designation-patients-met-mutated-advanced-non-small-cell-lung-cancer</loc>
  <lastmod>2021-10-05T12:50:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-study-shows-migraine-support-workplace-can-improve-employee-quality-life</loc>
  <lastmod>2021-10-05T12:50:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-global-deal-commercialize-proposed-biosimilar-natalizumab-key-multiple-sclerosis-medicine</loc>
  <lastmod>2021-10-05T12:51:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/entresto-improved-measures-heart-structure-and-function-hfref-patients-new-novartis-study-additional-data-complement-findings</loc>
  <lastmod>2021-10-05T12:51:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-paragon-hf-trial-suggests-entresto-benefit-hfpef-patients-narrowly-misses-primary-endpoint</loc>
  <lastmod>2021-10-05T12:51:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ofatumumab-demonstrates-superiority-versus-aubagio-two-head-head-phase-iii-multiple-sclerosis-studies</loc>
  <lastmod>2021-10-05T12:51:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-present-new-entresto-hfpef-and-hfref-data-esc-congress-2019</loc>
  <lastmod>2021-10-05T12:51:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-will-appeal-district-court-new-jersey-ruling-biosimilar-erelzi-etanercept-szzs-us-patent-case</loc>
  <lastmod>2021-10-05T12:51:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-stands-behind-zolgensma-onasemnogene-abeparvovec-xioi-treatment-children-less-2-years-age-spinal-muscular-atrophy</loc>
  <lastmod>2021-10-05T12:51:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-significantly-prolongs-life-women-hrher2-advanced-breast-cancer-now-two-distinct-phase-iii-trials</loc>
  <lastmod>2021-10-05T12:51:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-phase-iii-paragon-hf-trial-heart-failure-patients-preserved-ejection-fraction-hfpef</loc>
  <lastmod>2021-10-05T12:51:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-lucentis-treatment-preterm-infants-retinopathy-prematurity-rop-disease-causing-visual-impairment-and-blindness</loc>
  <lastmod>2021-10-05T12:51:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-first-patient-enrolled-clinical-study-proposed-biosimilar-denosumab-osteoporosis</loc>
  <lastmod>2021-10-05T12:51:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-key-multiple-sclerosis-product-gilenya-approved-china</loc>
  <lastmod>2021-10-05T12:51:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivers-strong-sales-double-digit-core-operating-income-growth-and-launches-zolgensma-and-piqray-second-quarter-sales-and-profit-guidance-increased</loc>
  <lastmod>2021-10-05T12:51:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-au-2e-trimestre-fortes-ventes-croissance-deux-chiffres-du-resultat-operationnel-core-et-lancements-de-zolgensma-et-de-piqray-prevision-des-ventes-et-du-resultat-revue-la-hausse</loc>
  <lastmod>2021-10-05T12:51:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-zweiten-quartal-starke-umsatze-eine-zweistellige-steigerung-des-operativen-kernergebnisses-und-lanciert-zolgensma-und-piqray-anhebung-der-umsatz-und-gewinnerwartung</loc>
  <lastmod>2021-10-05T12:51:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-accepts-file-and-accelerates-review-novartis-sickle-cell-disease-medicine-crizanlizumab-seg101</loc>
  <lastmod>2021-10-05T12:51:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-amgen-and-banner-alzheimers-institute-discontinue-clinical-program-bace-inhibitor-cnp520-alzheimers-prevention</loc>
  <lastmod>2021-10-05T12:51:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-launches-oncology-generic-gefitinib-13-eu-countries-loss-market-exclusivity-expanding-access-essential-medicine</loc>
  <lastmod>2021-10-05T12:51:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-cognition-data-secondary-progressive-multiple-sclerosis-spms</loc>
  <lastmod>2021-10-05T12:51:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-successfully-completes-acquisition-xiidra-bolstering-ophthalmic-portfolio</loc>
  <lastmod>2021-10-05T12:51:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-show-aimovig-cuts-acute-migraine-medication-days-half-patients-who-failed-prior-preventive-therapies</loc>
  <lastmod>2021-10-05T12:51:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-underpin-long-term-efficacy-aimovig-where-other-treatments-have-failed</loc>
  <lastmod>2021-10-05T12:51:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-new-publication-showing-il-17a-antibody-cosentyx-improves-inflammation-and-rapidly-suppresses-il-23-plaque-psoriasis</loc>
  <lastmod>2021-10-05T12:51:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-phase-2b-encore-lf-trial-nash-cirrhosis</loc>
  <lastmod>2021-10-05T12:51:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-analysis-novartis-data-confirms-cosentyx-demonstrates-durable-comprehensive-treatment-across-psoriatic-disease</loc>
  <lastmod>2021-10-05T12:51:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-sandoz-biosimilar-adalimumab-data-confirms-switching-from-reference-biologic-has-no-impact-safety-or-efficacy</loc>
  <lastmod>2021-10-05T12:51:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-continues-innovate-cml-long-term-treatment-free-remission-results-following-tasigna-use-and-promising-combination-data-investigational-compound-asciminib-abl001</loc>
  <lastmod>2021-10-05T12:51:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/three-quarters-people-living-axial-spondyloarthritis-struggle-find-job-imas-survey-shows</loc>
  <lastmod>2021-10-05T12:51:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/cosentyx-provides-long-lasting-inhibition-radiographic-progression-psoriatic-arthritis-new-novartis-data-show</loc>
  <lastmod>2021-10-05T12:51:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-first-show-efficacy-all-key-manifestations-psoriatic-arthritis</loc>
  <lastmod>2021-10-05T12:51:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-leader-pharmaceuticals-business-unit</loc>
  <lastmod>2021-10-05T12:51:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-stellt-neue-leiterin-der-pharmaceuticals-business-unit-vor</loc>
  <lastmod>2021-10-05T12:51:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/advanced-accelerator-applications-receives-positive-chmp-opinion-lysakare</loc>
  <lastmod>2021-10-05T12:51:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-first-its-kind-histology-data-iscalimab-cfz533-suggesting-extended-survival-transplanted-organs-may-be-possible</loc>
  <lastmod>2021-10-05T12:51:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/long-term-survival-benefit-shown-metastatic-melanoma-patients-treated-novartis-tafinlar-mekinist</loc>
  <lastmod>2021-10-05T12:51:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shows-growing-strength-lung-cancer-innovation-new-capmatinib-investigational-data-and-novel-canakinumab-clinical-trials</loc>
  <lastmod>2021-10-05T12:51:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/xolair-omalizumab-significantly-reduced-nasal-polyps-and-congestion-symptoms-adults-chronic-rhinosinusitis-nasal-polyps-two-phase-iii-studies</loc>
  <lastmod>2021-10-05T12:51:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-significantly-extends-life-women-hrher2-advanced-breast-cancer-monaleesa-7-trial</loc>
  <lastmod>2021-10-05T12:51:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iii-quartz-study-new-investigational-inhaled-combination-treatment-qmf149-meets-primary-and-key-secondary-endpoints-patients-inadequately-controlled-asthma</loc>
  <lastmod>2021-10-05T12:51:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-novartis-piqray-first-and-only-treatment-specifically-patients-pik3ca-mutation-hrher2-advanced-breast-cancer</loc>
  <lastmod>2021-10-05T12:51:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-announces-innovative-zolgensma-gene-therapy-access-programs-us-payers-and-families</loc>
  <lastmod>2021-10-05T12:51:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-receives-fda-approval-zolgensma-first-and-only-gene-therapy-pediatric-patients-spinal-muscular-atrophy-sma</loc>
  <lastmod>2021-10-05T12:51:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-company-transformation-catalyst-rich-pipeline-and-strong-progress-strategy-meet-novartis-management-investor-event</loc>
  <lastmod>2021-10-05T12:51:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-ii-data-new-inhaled-combination-treatment-qvm149-demonstrates-significant-improvements-over-current-standard-care-inhaled-treatment</loc>
  <lastmod>2021-10-05T12:51:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-asco-and-eha-demonstrate-novel-approaches-reimagining-medicine-cancer-and-serious-blood-disorders</loc>
  <lastmod>2021-10-05T12:51:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-aan-show-gilenya-first-and-only-disease-modifying-therapy-proven-superiority-versus-glatiramer-acetate-relapsing-remitting-ms</loc>
  <lastmod>2021-10-05T12:51:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-demonstrates-strategic-focus-china-first-kind-generic-approval-under-quality-consistency-evaluation-system</loc>
  <lastmod>2021-10-05T12:51:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-acquire-xiidra-expanding-front-eye-portfolio-and-strengthening-leadership-eye-care</loc>
  <lastmod>2021-10-05T12:51:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-aan-show-mayzents-positive-impact-cognitive-processing-speed-core-element-cognitive-function-people-living-secondary-progressive-ms</loc>
  <lastmod>2021-10-05T12:52:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-avexis-data-aan-showed-long-term-durability-zolgensma-patients-spinal-muscular-atrophy-sma-type-1</loc>
  <lastmod>2021-10-05T12:52:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-first-its-kind-algorithm-based-tool-help-ms-patients-and-physicians-evaluate-and-discuss-early-signs-progression-secondary-progressive-ms</loc>
  <lastmod>2021-10-05T12:52:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-presented-robust-data-aan-demonstrating-efficacy-zolgensma-broad-spectrum-spinal-muscular-atrophy-sma-patients</loc>
  <lastmod>2021-10-05T12:52:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlight-extensive-long-term-safety-and-efficacy-data-aimovig-across-spectrum-migraine-aan</loc>
  <lastmod>2021-10-05T12:52:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-data-aan-reinforce-novartis-commitment-transforming-lives-people-all-ages-who-live-neurological-conditions</loc>
  <lastmod>2021-10-05T12:52:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-enters-agreement-proposed-trastuzumab-biosimilar-currently-phase-iii-development-treat-selected-her2-positive-cancer-tumors</loc>
  <lastmod>2021-10-05T12:52:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-starts-2019-strong-sales-and-double-digit-core1-operating-income-growth-mayzent-launch-and-alcon-spin-profit-guidance-upgraded</loc>
  <lastmod>2021-10-05T12:52:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-entame-2019-avec-une-forte-croissance-des-ventes-et-une-hausse-deux-chiffres-du-resultat-operationnel-core1-le-lancement-de-mayzent-et-le-spin-dalcon-profit-annuel-revu-la-hausse</loc>
  <lastmod>2021-10-05T12:52:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-startet-2019-mit-starken-umsatzen-und-einer-zweistelligen-steigerung-des-operativen-kernergebnisses1-einfuhrung-von-mayzent-sowie-abspaltung-von-alcon-gewinnprognose-angehoben</loc>
  <lastmod>2021-10-05T12:52:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-data-reinforce-effectiveness-zolgensma-treating-spinal-muscular-atrophy-sma-type-1</loc>
  <lastmod>2021-10-05T12:52:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-fda-filing-acceptance-and-priority-review-brolucizumab-rth258-patients-wet-amd</loc>
  <lastmod>2021-10-05T12:52:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-post-hoc-analysis-shows-high-dose-enerzair-breezhaler-reduces-asthma-exacerbations-versus-medium-dose-complementing-key-pivotal-iridium-study-findings</loc>
  <lastmod>2021-10-05T14:27:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-nejm-publication-pivotal-study-tabrectatm-patients-metex14-metastatic-non-small-cell-lung-cancer</loc>
  <lastmod>2021-10-05T14:27:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-collaboration-between-novartis-and-africa-medical-supplies-platform-facilitate-supply-covid-19-related-medicines</loc>
  <lastmod>2021-10-05T14:27:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-ambitious-esg-targets-increase-access-medicines-and-achieve-full-carbon-neutrality</loc>
  <lastmod>2021-10-05T14:27:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-new-analysis-shows-high-consistency-lowering-ldl-c-individual-response-investigational-inclisiran</loc>
  <lastmod>2021-10-05T14:27:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-results-from-phase-ii-study-lnp023-patients-paroxysmal-nocturnal-hemoglobinuria-pnh</loc>
  <lastmod>2021-10-05T14:27:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-novel-stamp-inhibitor-asciminib-abl001-meets-primary-endpoint-phase-iii-chronic-myeloid-leukemia-study</loc>
  <lastmod>2021-10-05T14:27:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-phase-iii-study-evaluating-investigational-spartalizumab-pdr001-combination-tafinlar-mekinist-advanced-melanoma</loc>
  <lastmod>2021-10-05T14:27:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-novartis-kesimpta-ofatumumab-first-and-only-self-administered-targeted-b-cell-therapy-patients-relapsing-multiple-sclerosis</loc>
  <lastmod>2021-10-05T14:27:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-us-district-court-district-delaware-upholds-validity-gilenya-fingolimod-dosage-regimen-patent</loc>
  <lastmod>2021-10-05T14:27:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-ec-approval-new-xolair-indication-treat-severe-chronic-rhinosinusitis-nasal-polyps</loc>
  <lastmod>2021-10-05T14:27:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-nejm-publication-phase-iii-asclepios-trials-demonstrating-superior-efficacy-ofatumumab-patients-relapsing-multiple-sclerosis</loc>
  <lastmod>2021-10-05T14:27:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-kymriah-meets-primary-endpoint-interim-analysis-pivotal-study-follicular-lymphoma</loc>
  <lastmod>2021-10-05T14:27:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-receives-eu-approval-first-line-systemic-treatment-pediatric-psoriasis</loc>
  <lastmod>2021-10-05T14:27:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-piqray-approval-europe-first-and-only-targeted-medicine-hrher2-advanced-breast-cancer-pik3ca-mutation</loc>
  <lastmod>2021-10-05T14:27:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-plans-joint-investment-help-strengthen-future-antibiotics-manufacturing-europe</loc>
  <lastmod>2021-10-05T14:27:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-analysis-shows-wet-amd-patients-achieved-sustained-fluid-control-faster-beovu-versus-aflibercept</loc>
  <lastmod>2021-10-05T14:27:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-adakveo-receives-positive-chmp-opinion-prevention-recurrent-vaso-occlusive-crises-patients-sickle-cell-disease</loc>
  <lastmod>2021-10-05T14:27:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-phase-iii-study-jakavi-chronic-graft-versus-host-disease-met-primary-and-key-secondary-endpoints</loc>
  <lastmod>2021-10-05T14:27:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-strong-h1-performance-fy-2020-guidance-confirmed-higher-end-core-operating-income-and-lower-end-sales</loc>
  <lastmod>2021-10-05T14:27:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielte-im-ersten-halbjahr-eine-starke-performance-die-jahresprognose-2020-fur-das-operative-kernergebnis-bzw-den-umsatz-wurde-am-oberen-bzw-unteren-ende-fruherer-voraussagen-bestatigt</loc>
  <lastmod>2021-10-05T14:27:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-realise-une-excellente-performance-au-s1-previsions-pour-2020-confirmees-dans-le-haut-de-la-fourchette-pour-le-resultat-operationnel-core-et-dans-le-bas-pour-le-chiffre-daffaires</loc>
  <lastmod>2021-10-05T14:27:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-launches-first-its-kind-not-profit-portfolio-medicines-symptomatic-treatment-covid-19</loc>
  <lastmod>2021-10-05T14:27:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iii-iridium-data-lancet-respiratory-medicine-show-benefit-enerzair-breezhaler-qvm149-first-class-inhaled-labalamaics-combination-uncontrolled-asthma</loc>
  <lastmod>2021-10-05T14:27:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-ec-approval-enerzair-breezhaler-including-first-digital-companion-sensor-and-app-can-be-prescribed-alongside-treatment-uncontrolled-asthma-eu</loc>
  <lastmod>2021-10-05T14:27:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-resolves-legacy-litigation-matters-finalizing-settlement-speaker-program-litigation-government-us-and-positioning-company-future-fully-scaling-its-next-generation-digital-engagement-technologies</loc>
  <lastmod>2021-10-05T14:27:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-reviewing-options-after-federal-circuit-upholds-lower-court-ruling-biosimilar-erelzi-case</loc>
  <lastmod>2021-10-05T14:27:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-met-inhibitor-tabrectatm-approved-japan-advanced-non-small-cell-lung-cancer-metex14</loc>
  <lastmod>2021-10-05T14:27:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-simultaneous-approval-five-new-products-from-japanese-ministry-health-labour-and-welfare-offering-japanese-patients-broad-range-novel-treatment-options</loc>
  <lastmod>2021-10-05T14:27:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-gains-positive-chmp-opinion-pediatric-psoriasis-reinforcing-established-efficacy-and-safety-profile</loc>
  <lastmod>2021-10-05T14:27:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-new-xolair-indication-treat-severe-chronic-rhinosinusitis-nasal-polyps</loc>
  <lastmod>2021-10-05T14:27:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-resolves-legacy-fcpa-investigations</loc>
  <lastmod>2021-10-05T14:28:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-winners-innovation-prize-assistive-tech-rewarding-new-technologies-could-improve-mobility-and-independence-people-living-multiple-sclerosis</loc>
  <lastmod>2021-10-05T14:28:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-research-shows-technology-talent-increasingly-drawn-pharma-industry-covid-19-solve-healthcare-challenges</loc>
  <lastmod>2021-10-05T14:28:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-discontinues-hydroxychloroquine-clinical-trial-based-slow-enrollment-remains-committed-pandemic-research-efforts</loc>
  <lastmod>2021-10-05T14:28:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expands-africa-sickle-cell-disease-program-uganda-and-tanzania</loc>
  <lastmod>2021-10-05T14:28:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-receives-fda-approval-new-indication-treat-active-non-radiographic-axial-spondyloarthritis</loc>
  <lastmod>2021-10-05T14:28:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/us-fda-approves-updated-novartis-beovu-label-include-additional-safety-information</loc>
  <lastmod>2021-10-05T14:28:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iiib-argon-study-meets-primary-endpoint-comparison-enerzair-breezhaler-qvm149-versus-free-combination-two-existing-inhaled-treatments-uncontrolled-asthma</loc>
  <lastmod>2021-10-05T14:28:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-prevent-data-show-cosentyx-helps-patients-realize-early-and-lasting-relief-axial-spondyloarthritis</loc>
  <lastmod>2021-10-05T14:28:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-fda-review-ofatumumab-self-administered-targeted-b-cell-therapy-patients-relapsing-multiple-sclerosis</loc>
  <lastmod>2021-10-05T14:28:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-long-term-relapse-free-survival-benefit-high-risk-stage-iii-melanoma-patients-treated-tafinlar-mekinist-following-surgery</loc>
  <lastmod>2021-10-05T14:28:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-piqray-receives-positive-chmp-opinion-treat-hrher2-advanced-breast-cancer-pik3ca-mutation</loc>
  <lastmod>2021-10-05T14:28:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-highlight-benefit-early-treatment-initiation-patients-secondary-progressive-multiple-sclerosis-spms</loc>
  <lastmod>2021-10-05T14:28:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-shows-overall-survival-benefit-hrher2-advanced-breast-cancer-consistent-findings-patients-more-aggressive-disease</loc>
  <lastmod>2021-10-05T14:28:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-late-breaking-ofatumumab-data-ean-demonstrating-robust-efficacy-and-safety-treatment-relapsing-forms-multiple-sclerosis-rms</loc>
  <lastmod>2021-10-05T14:28:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-study-reveals-migraine-support-workspace-can-significantly-decrease-impact-disease-affected-employees</loc>
  <lastmod>2021-10-05T14:28:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-receives-ec-approval-and-activates-day-one-access-program-zolgensma-only-gene-therapy-spinal-muscular-atrophy-sma</loc>
  <lastmod>2021-10-05T14:28:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-asco-and-eha-showcase-bold-approaches-reimagine-cancer-and-blood-disorders-through-multiple-therapeutic-platforms</loc>
  <lastmod>2021-10-05T14:28:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-fda-approval-met-inhibitor-tabrectatm-metastatic-non-small-cell-lung-cancer-metex14</loc>
  <lastmod>2021-10-05T14:28:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-chmp-positive-opinion-enerzair-breezhaler-qvm149-potential-first-class-inhaled-labalamaics-combination-uncontrolled-asthma</loc>
  <lastmod>2021-10-05T14:28:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-gains-fourth-indication-eu-first-class-approval-axial-spondyloarthritis-spectrum</loc>
  <lastmod>2021-10-05T14:28:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-maintains-strong-operational-performance-q1-confirms-fy-2020-guidance-time-and-advances-broad-range-efforts-support-global-response-covid-19</loc>
  <lastmod>2021-10-05T14:28:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-setzt-im-1-quartal-die-starke-operative-performance-fort-bestatigt-derzeit-die-prognose-2020-und-fordert-verschiedenste-aktivitaten-um-globale-massnahmen-gegen-covid-19-zu-unterstutzen</loc>
  <lastmod>2021-10-05T14:28:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-conserve-une-forte-performance-operationnelle-au-1er-trimestre-confirme-ce-stade-les-previsions-pour-2020-et-fournit-de-grands-efforts-pour-contribuer-la-reponse-mondiale-au-covid-19</loc>
  <lastmod>2021-10-05T14:28:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-data-showing-jakavi-ruxolitinib-more-effective-best-available-therapy-acute-graft-versus-host-disease</loc>
  <lastmod>2021-10-05T14:28:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kymriah-receives-fda-regenerative-medicine-advanced-therapy-designation-follicular-lymphoma</loc>
  <lastmod>2021-10-05T14:28:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-mayzent-siponimod-data-show-sustained-effect-delaying-disability-five-years-patients-secondary-progressive-multiple-sclerosis-spms</loc>
  <lastmod>2021-10-05T14:28:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-sponsor-large-clinical-trial-hydroxychloroquine-hospitalized-covid-19-patients</loc>
  <lastmod>2021-10-05T14:28:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-acquires-amblyotech-pursuing-novel-digital-therapy-children-and-adult-patients-lazy-eye</loc>
  <lastmod>2021-10-05T14:28:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-data-neurology-reinforcing-real-world-and-long-term-effectiveness-and-safety-aimovig-preventive-treatment-across-full-spectrum-migraine</loc>
  <lastmod>2021-10-05T14:28:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-plan-initiate-clinical-study-jakavi-severe-covid-19-patients-and-establish-international-compassionate-use-program</loc>
  <lastmod>2021-10-05T14:28:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-mutual-agreement-terminate-sale-sandoz-us-generic-oral-solids-dermatology-portfolio-aurobindo</loc>
  <lastmod>2021-10-05T14:28:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-new-analysis-further-shows-durable-and-potent-ldl-c-reduction-inclisiran-investigational-first-class-sirna-cholesterol-lowering-treatment</loc>
  <lastmod>2021-10-05T14:28:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-gains-positive-chmp-opinion-new-indication-axial-spondyloarthritis-spectrum</loc>
  <lastmod>2021-10-05T14:28:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-receives-positive-chmp-opinion-zolgensma-only-gene-therapy-spinal-muscular-atrophy-sma</loc>
  <lastmod>2021-10-05T14:28:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-life-sciences-companies-commit-expertise-and-assets-fight-against-covid-19-pandemic-alongside-bill-melinda-gates-foundation</loc>
  <lastmod>2021-10-05T14:28:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/zolgensma-data-shows-rapid-significant-clinically-meaningful-benefit-sma-including-prolonged-event-free-survival-motor-milestone-achievement-and-durability-now-5-years-post-dosing</loc>
  <lastmod>2021-10-05T14:28:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-presents-avxs-101-it-data-demonstrating-remarkable-increases-hfmse-scores-and-consistent-clinically-meaningful-response-older-patients-sma-type-2</loc>
  <lastmod>2021-10-05T14:28:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-commits-donate-130-million-doses-hydroxychloroquine-support-global-covid-19-pandemic-response</loc>
  <lastmod>2021-10-05T14:29:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-approval-from-japanese-ministry-health-labour-and-welfare-zolgensma-only-gene-therapy-patients-spinal-muscular-atrophy-sma</loc>
  <lastmod>2021-10-05T14:29:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-nejm-publication-three-pivotal-trials-showing-durable-and-potent-efficacy-inclisiran-investigational-first-class-sirna-cholesterol-lowering-therapy</loc>
  <lastmod>2021-10-05T14:29:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-broad-range-initiatives-respond-covid-19-pandemic-creates-usd-20-million-global-fund-support-impacted-communities</loc>
  <lastmod>2021-10-05T14:29:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/international-research-partnership-and-edctp-invest-eu44m-next-generation-antimalarials-combat-drug-resistant-malaria-africa</loc>
  <lastmod>2021-10-05T14:29:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-resolves-generic-drug-antitrust-investigation-us</loc>
  <lastmod>2021-10-05T14:29:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-board-directors-annual-general-meeting-2</loc>
  <lastmod>2021-10-05T14:29:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration-lassemblee-generale-annuelle</loc>
  <lastmod>2021-10-05T14:29:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-dndi-collaborate-development-new-oral-drug-treat-visceral-leishmaniasis</loc>
  <lastmod>2021-10-05T14:29:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-fda-and-ema-filing-acceptance-ofatumumab-novel-b-cell-therapy-patients-relapsing-forms-multiple-sclerosis-rms</loc>
  <lastmod>2021-10-05T14:29:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-ec-approval-beovu-next-generation-anti-vegf-treatment-wet-amd-leading-cause-blindness-worldwide</loc>
  <lastmod>2021-10-05T14:29:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-met-inhibitor-capmatinib-inc280-first-potential-treatment-metex14-mutated-advanced-non-small-cell-lung-cancer-granted-priority-fda-review</loc>
  <lastmod>2021-10-05T14:29:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-completes-acquisition-aspens-japanese-operations-strengthening-its-position-worlds-third-largest-market-generics-and-patent-medicines</loc>
  <lastmod>2021-10-05T14:29:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-builds-its-axspa-leadership-us-label-update-dosing-flexibility-ankylosing-spondylitis</loc>
  <lastmod>2021-10-05T14:29:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-strong-sales-growth-margin-expansion-and-breakthrough-innovation-launching-five-nmes-2019</loc>
  <lastmod>2021-10-05T14:29:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-2019-ein-starkes-umsatzwachstum-margen-steigerungen-und-bahnbrechende-innovationen-mit-der-markteinfuhrung-funf-neuer-wirkstoffe</loc>
  <lastmod>2021-10-05T14:29:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-realise-en-2019-une-forte-croissance-de-son-chiffre-daffaires-une-augmentation-de-sa-marge-et-une-percee-dans-linnovation-en-lancant-cinq-nouvelles-entites-moleculaires</loc>
  <lastmod>2021-10-05T14:29:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-eu-approval-mayzent-siponimod-adult-patients-secondary-progressive-multiple-sclerosis-spms-active-disease</loc>
  <lastmod>2021-10-05T14:29:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ligelizumab-qge031-more-effective-xolair-inhibiting-immunoglobulin-e-pathway-responsible-chronic-spontaneous-urticaria</loc>
  <lastmod>2021-10-05T14:29:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-successfully-completes-acquisition-medicines-company-adding-potentially-first-class-investigational-cholesterol-lowering-therapy-inclisiran</loc>
  <lastmod>2021-10-05T14:29:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-completes-tender-offer-all-outstanding-shares-medicines-company</loc>
  <lastmod>2021-10-05T14:29:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-luster-phase-iii-studies-patients-uncontrolled-gina-45-asthma</loc>
  <lastmod>2021-10-05T14:29:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-beovu-brolucizumab-treatment-wet-amd</loc>
  <lastmod>2021-10-05T14:29:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-data-show-superior-overall-survival-compared-fulvestrant-and-consistent-efficacy-across-advanced-breast-cancer-patient-subgroups-monaleesa-3</loc>
  <lastmod>2021-10-05T14:29:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kymriah-demonstrates-consistent-efficacy-and-safety-outcomes-us-patients-when-used-real-world-setting</loc>
  <lastmod>2021-10-05T14:29:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-global-survey-uncovers-profound-and-often-under-reported-effects-sickle-cell-disease-patients</loc>
  <lastmod>2021-10-05T14:29:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iii-data-new-inhaled-dual-combination-qmf149-show-significant-improvement-across-key-asthma-outcomes-versus-monotherapy</loc>
  <lastmod>2021-10-05T14:29:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-tender-offer-medicines-company-commences</loc>
  <lastmod>2021-10-05T14:29:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-oral-therapy-iptacopan-lnp023-shows-benefit-monotherapy-treatment-naive-patients-rare-and-life-threatening-blood-disorder-paroxysmal-nocturnal-hemoglobinuria</loc>
  <lastmod>2021-10-05T14:32:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-interim-analysis-phase-ii-data-iptacopan-rare-kidney-disease-c3-glomerulopathy-c3g</loc>
  <lastmod>2021-10-05T14:32:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-iptacopan-met-phase-ii-study-primary-endpoint-rare-kidney-disease-iga-nephropathy-igan</loc>
  <lastmod>2021-10-05T14:32:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-tabrecta-first-published-overall-survival-and-updated-overall-response-data-patients-metex14-metastatic-nsclc</loc>
  <lastmod>2021-10-05T14:32:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-checkpoint-inhibitor-tislelizumab-met-primary-endpoint-overall-survival-pivotal-phase-iii-trial-esophageal-cancer-after-systemic-therapy</loc>
  <lastmod>2021-10-05T14:32:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-clinically-relevant-improvement-median-overall-survival-data-final-analysis-pivotal-netter-1-study-targeted-radioligand-therapy-lutathera</loc>
  <lastmod>2021-10-05T14:32:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-177lu-psma-617-significantly-improves-overall-survival-and-radiographic-progression-free-survival-men-metastatic-castration-resistant-prostate-cancer-phase-iii-vision-study</loc>
  <lastmod>2021-10-05T14:32:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kymriah-pivotal-trial-demonstrates-strong-response-rates-and-remarkable-safety-profile-relapsed-or-refractory-follicular-lymphoma</loc>
  <lastmod>2021-10-05T14:32:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-reports-longest-median-overall-survival-postmenopausal-hrher2-metastatic-breast-cancer-patients</loc>
  <lastmod>2021-10-05T14:32:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-positive-phase-iii-results-from-junipera-study-supporting-cosentyx-potential-treatment-jia-population-eular-2021</loc>
  <lastmod>2021-10-05T14:32:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-moderate-severe-plaque-psoriasis</loc>
  <lastmod>2021-10-05T14:32:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-one-year-results-phase-iii-merlin-study-evaluating-beovu-every-four-week-dosing-and-provides-update-beovu-clinical-program</loc>
  <lastmod>2021-10-05T14:32:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-molecular-partners-announce-start-empathy-clinical-trial-ensovibep-treatment-covid-19</loc>
  <lastmod>2021-10-05T14:32:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-unveil-new-data-asco-and-eha-from-its-robust-portfolio-including-overall-survival-prostate-and-breast-cancer</loc>
  <lastmod>2021-10-05T14:32:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-plans-further-strengthen-its-antibiotics-manufacturing-setup-europe</loc>
  <lastmod>2021-10-05T14:32:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reaches-milestone-delivery-1-billion-courses-antimalarial-treatment</loc>
  <lastmod>2021-10-05T14:32:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/us-supreme-court-denies-sandoz-petition-review-biosimilar-erelzi-etanercept-szzs-case</loc>
  <lastmod>2021-10-05T14:32:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-confirms-late-stage-clinical-development-plans-proposed-biosimilar-aflibercept-key-ophthalmology-medicine</loc>
  <lastmod>2021-10-05T14:32:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iii-beovu-data-show-potential-fluid-resolution-more-diabetic-macular-edema-patients-fewer-injections-versus-aflibercept</loc>
  <lastmod>2021-10-05T14:32:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-key-growth-drivers-and-launches-continue-momentum-q1-maintaining-confidence-growth-group-guidance-fy-2021-confirmed</loc>
  <lastmod>2021-10-05T14:32:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-moteurs-cles-de-la-croissance-et-lancements-poursuivent-leur-essor-au-1er-trimestre-maintenant-la-confiance-dans-la-croissance-confirmation-des-previsions-pour-le-groupe-pour-2021</loc>
  <lastmod>2021-10-05T14:32:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/wichtige-wachstumstreiber-und-neueinfuhrungen-von-novartis-setzen-ihre-dynamik-im-ersten-quartal-fort-und-erhalten-das-vertrauen-das-wachstum-konzernprognose-fur-2021-bestatigt</loc>
  <lastmod>2021-10-05T14:32:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-initiate-smart-phase-3b-global-study-zolgensma-children-21-kg-building-real-world-experience</loc>
  <lastmod>2021-10-05T14:32:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/kesimpta-ofatumumab-data-aan-showed-reduction-disability-progression-independent-relapse-activity-newly-diagnosed-patients-rms</loc>
  <lastmod>2021-10-05T14:32:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-signs-initial-agreement-reserve-capacity-and-implement-technology-transfer-production-active-pharmaceutical-ingredient-roches-actemraroactemra</loc>
  <lastmod>2021-10-05T14:32:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-eu-approval-kesimpta-ofatumumab-first-and-only-self-administered-targeted-b-cell-therapy-adult-patients-relapsing-multiple-sclerosis</loc>
  <lastmod>2021-10-05T14:32:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expands-targeted-radioligand-therapy-pipeline-license-compounds-targeting-fibroblast-activation-protein-fap</loc>
  <lastmod>2021-10-05T14:32:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-result-phase-iii-study-radioligand-therapy-177lu-psma-617-patients-advanced-prostate-cancer</loc>
  <lastmod>2021-10-05T14:32:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-appoints-karen-hale-chief-legal-officer</loc>
  <lastmod>2021-10-05T14:32:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-zolgensma-data-demonstrate-age-appropriate-development-when-used-early-real-world-benefit-older-children-and-durability-5-years-post-treatment</loc>
  <lastmod>2021-10-05T14:32:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-phase-iii-study-evaluating-canakinumab-acz885-second-or-third-line-treatment-combination-chemotherapy-non-small-cell-lung-cancer</loc>
  <lastmod>2021-10-05T14:32:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-change-executive-committee</loc>
  <lastmod>2021-10-05T14:32:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-signs-initial-agreement-curevac-manufacture-covid-19-vaccine-candidate</loc>
  <lastmod>2021-10-05T14:32:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-board-directors-annual-general-meeting-3</loc>
  <lastmod>2021-10-05T14:32:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/die-aktionare-von-novartis-heissen-der-generalversammlung-alle-antrage-des-verwaltungsrats-gut</loc>
  <lastmod>2021-10-05T14:32:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration-lors-de-lassemblee-generale-annuelle-0</loc>
  <lastmod>2021-10-05T14:32:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-strengthens-oncology-pipeline-successful-closing-tislelizumab-licensing</loc>
  <lastmod>2021-10-05T14:32:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-gains-eu-label-update-first-its-kind-maximise-data-axial-manifestations-psoriatic-arthritis</loc>
  <lastmod>2021-10-05T14:32:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-bill-melinda-gates-foundation-collaborate-discover-and-develop-accessible-vivo-gene-therapy-sickle-cell-disease</loc>
  <lastmod>2021-10-05T14:32:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-entresto-granted-expanded-indication-chronic-heart-failure-fda</loc>
  <lastmod>2021-10-05T14:32:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-show-multiple-sclerosis-patients-and-nurses-prefer-kesimpta-ofatumumab-sensoready-autoinjector-pen</loc>
  <lastmod>2021-10-05T14:32:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-agreement-acquire-gsks-cephalosporin-antibiotics-business-reinforcing-its-leading-global-position-antibiotics</loc>
  <lastmod>2021-10-05T14:32:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-breakthrough-therapy-designations-investigational-stamp-inhibitor-asciminib-abl001-chronic-myeloid-leukemia</loc>
  <lastmod>2021-10-05T14:32:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-kesimpta-ofatumumab-self-administered-treatment-adult-patients-relapsing-multiple-sclerosis</loc>
  <lastmod>2021-10-05T14:32:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-signs-initial-agreement-provide-manufacturing-capacity-pfizer-biontech-covid-19-vaccine</loc>
  <lastmod>2021-10-05T14:32:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-renews-who-medicine-donation-pledge-aim-ending-leprosy</loc>
  <lastmod>2021-10-05T14:32:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-sales-growth-and-margin-expansion-continued-progress-its-next-wave-medicines-2020</loc>
  <lastmod>2021-10-05T14:32:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-hat-2020-umsatz-und-margen-gesteigert-und-die-nachste-welle-von-medikamenten-weiter-vorangetrieben</loc>
  <lastmod>2021-10-05T14:32:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/en-2020-novartis-enregistre-une-croissance-de-son-chiffre-daffaires-et-de-sa-marge-il-continue-de-faire-progresser-sa-prochaine-vague-de-medicaments</loc>
  <lastmod>2021-10-05T14:33:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-gsk-announce-collaboration-support-scientific-research-genetic-diversity-africa</loc>
  <lastmod>2021-10-05T14:33:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ligelizumab-qge031-receives-fda-breakthrough-therapy-designation-patients-chronic-spontaneous-urticaria-csu</loc>
  <lastmod>2021-10-05T14:33:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expands-oncology-pipeline-licensing-tislelizumab-from-beigene</loc>
  <lastmod>2021-10-05T14:33:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-complete-response-letter-from-us-fda-inclisiran</loc>
  <lastmod>2021-10-05T14:33:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-builds-commitment-addressing-need-neuropsychiatric-disorders-cadent-therapeutics-acquisition</loc>
  <lastmod>2021-10-05T14:33:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-oral-therapy-iptacopan-lnp023-receives-fda-breakthrough-therapy-designation-pnh-and-rare-pediatric-disease-designation-c3g</loc>
  <lastmod>2021-10-05T14:33:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-fda-advisory-committee-recommendation-use-entresto-treat-patients-hfpef</loc>
  <lastmod>2021-10-05T14:33:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-positive-topline-results-from-second-phase-iii-trial-beovu-patients-diabetic-macular-edema</loc>
  <lastmod>2021-10-05T14:33:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-ruxcovid-study-ruxolitinib-hospitalized-patients-covid-19</loc>
  <lastmod>2021-10-05T14:33:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-eu-approval-leqvio-inclisiran-first-class-sirna-lower-cholesterol-two-doses-year</loc>
  <lastmod>2021-10-05T14:33:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-data-demonstrate-superior-benefit-across-main-intrinsic-subtypes-metastatic-breast-cancer</loc>
  <lastmod>2021-10-05T14:33:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-demonstrates-nearly-five-years-median-overall-survival-metastatic-breast-cancer</loc>
  <lastmod>2021-10-05T14:33:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-stamp-inhibitor-asciminib-abl001-shows-superior-mmr-rate-bosulif-chronic-myeloid-leukemia-trial</loc>
  <lastmod>2021-10-05T14:33:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-analyses-confirm-benefit-kymriah-clinically-meaningful-rates-complete-response-seen-patients-certain-advanced-lymphomas</loc>
  <lastmod>2021-10-05T14:33:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-first-data-from-reach3-trial-showing-jakavi-ruxolitinib-significantly-improved-outcomes-patients-steroid-resistantdependent-chronic-gvhd</loc>
  <lastmod>2021-10-05T14:33:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-confidence-growing-sales-margin-expansion-fueled-market-brands-and-rich-pipeline-annual-meet-management-investor-event</loc>
  <lastmod>2021-10-05T14:33:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-secures-exclusive-rights-potential-acute-respiratory-distress-syndrome-cell-therapy</loc>
  <lastmod>2021-10-05T14:33:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-data-ash-reinforce-breadth-novartis-hematology-portfolio-across-multiple-blood-cancers-and-serious-hematologic-diseases</loc>
  <lastmod>2021-10-05T14:33:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-set-achieve-100-renewable-electricity-its-european-operations</loc>
  <lastmod>2021-10-05T14:33:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/results-from-real-world-data-and-post-hoc-analysis-novartis-beovu-pivotal-trials-presented-aao-2020</loc>
  <lastmod>2021-10-05T14:33:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-analyses-investigational-inclisiran-demonstrate-consistently-effective-and-sustained-ldl-c-reduction-month-17-regardless-age-and-gender</loc>
  <lastmod>2021-10-05T14:33:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-can-covid-trial-hospitalized-patients-covid-19-pneumonia-and-cytokine-release-syndrome-crs</loc>
  <lastmod>2021-10-05T14:33:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-shows-early-synovitis-reduction-patients-psoriatic-arthritis-first-its-kind-study</loc>
  <lastmod>2021-10-05T14:33:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-results-from-phase-iv-study-showing-superior-tolerability-and-efficacy-aimovig-erenumab-compared-topiramate-migraine-prevention</loc>
  <lastmod>2021-10-05T14:33:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-sickle-cell-medicine-adakveo-approved-europe-prevent-recurrent-vaso-occlusive-crises</loc>
  <lastmod>2021-10-05T14:33:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expands-kymriah-manufacturing-footprint-first-ever-approved-site-commercial-car-t-cell-therapy-manufacturing-asia</loc>
  <lastmod>2021-10-05T14:33:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-latest-phase-iii-data-reinforcing-cosentyx-first-line-systemic-treatment-pediatric-psoriasis</loc>
  <lastmod>2021-10-05T14:33:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-acquires-vedere-bio-adding-novel-optogenetic-gene-therapy-technology-treating-blindness</loc>
  <lastmod>2021-10-05T14:33:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-collaboration-molecular-partners-develop-two-darpin-therapies-designed-potential-use-against-covid-19</loc>
  <lastmod>2021-10-05T14:33:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivers-solid-q3-performance-11-core-operating-income-growth-net-sales-line-prior-year-strong-pipeline-progression-upgrades-full-year-core-operating-income-guidance</loc>
  <lastmod>2021-10-05T14:33:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-im-3-qu-mit-solider-performance-operatives-kernergebnis-steigt-um-11-nettoumsatz-auf-vorjahresniveau-starke-pipeline-fortschritte-jahresprognose-fur-operatives-kernergebnis-angehoben</loc>
  <lastmod>2021-10-05T14:33:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-au-t3-performance-solide-croissance-de-11-du-resultat-operationnel-core-chiffre-daffaires-net-proche-de-lan-dernier-pipeline-en-fort-progres-hausse-du-resultat-operationnel-core-prevu</loc>
  <lastmod>2021-10-05T14:33:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-promising-interim-phase-ii-data-potential-first-class-oral-therapy-iptacopan-lnp023-rare-renal-disease-c3-glomerulopathy-c3g</loc>
  <lastmod>2021-10-05T14:33:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-european-medicines-agency-ema-has-granted-orphan-drug-designation-iptacopan-lnp023-iga-nephropathy-igan</loc>
  <lastmod>2021-10-05T14:34:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-us-food-and-drug-administration-fda-orphan-drug-designation-branaplam-lmi070-huntingtons-disease-hd</loc>
  <lastmod>2021-10-05T14:34:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-leqvio-inclisiran-potential-first-class-sirna-treatment-high-cholesterol</loc>
  <lastmod>2021-10-05T14:34:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-received-european-medicines-agency-ema-prime-designation-iptacopan-lnp-c3-glomerulopathy-c3g</loc>
  <lastmod>2021-10-05T14:34:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-phase-iii-analysis-demonstrates-novartis-beovu-showed-improvement-best-corrected-visual-acuity-wet-amd-patients-early-persistent-fluid</loc>
  <lastmod>2021-10-05T14:34:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/zolgensma-data-including-patients-more-severe-sma-baseline-further-demonstrate-therapeutic-benefit-including-prolonged-event-free-survival-increased-motor-function-and-milestone-achievement</loc>
  <lastmod>2021-10-05T14:34:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-avxs-101-intrathecal-clinical-development-program</loc>
  <lastmod>2021-10-05T14:34:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-receives-highest-rating-any-cdk46-inhibitor-esmo-magnitude-clinical-benefit-scale</loc>
  <lastmod>2021-10-05T14:34:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-piqray-data-show-survival-benefit-patients-hrher2-advanced-breast-cancer-pik3ca-mutation</loc>
  <lastmod>2021-10-05T14:34:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-late-breaking-data-from-phase-iii-combi-i-trial-spartalizumab-pdr001-tafinlar-and-mekinist-advanced-melanoma</loc>
  <lastmod>2021-10-05T14:34:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-tafinlar-mekinist-demonstrates-long-term-relapse-free-survival-benefit-high-risk-stage-iii-melanoma-patients-study-published-nejm</loc>
  <lastmod>2021-10-05T14:34:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reinforces-commitment-patient-access-pricing-eur-185-billion-sustainability-linked-bond</loc>
  <lastmod>2021-10-05T14:34:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/european-medicines-agency-ema-approves-safety-label-update-novartis-beovu</loc>
  <lastmod>2021-10-05T14:34:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-positive-topline-results-from-first-phase-iii-trial-beovu-versus-aflibercept-patients-diabetic-macular-edema-dme</loc>
  <lastmod>2021-10-05T14:34:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-show-early-treatment-mayzent-siponimod-delays-disability-progression-and-show-benefits-cognitive-performance-patients-secondary-progressive-multiple-sclerosis-spms</loc>
  <lastmod>2021-10-05T14:34:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-data-actrims-ectrims-kesimpta-ofatumumab-newly-diagnosed-treatment-naive-adults-relapsing-multiple-sclerosis</loc>
  <lastmod>2021-10-05T14:34:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-actrims-ectrims-highlight-strength-leading-multiple-sclerosis-ms-portfolio-life-changing-therapies-people-across-ms-spectrum</loc>
  <lastmod>2021-10-05T14:34:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-community-statement-global-managed-access-program-avxs-101</loc>
  <lastmod>2021-10-06T12:17:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-community-statement-coronavirus-disease-covid-19</loc>
  <lastmod>2021-10-06T12:17:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-community-statement-global-managed-access-program-avxs-101-0</loc>
  <lastmod>2021-10-06T12:17:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-statement-changes-senior-leadership-team</loc>
  <lastmod>2021-10-06T12:17:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-statement-access-zolgensma-onasemnogene-abeparvovec-xioi</loc>
  <lastmod>2021-10-06T12:17:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-reports-first-quarter-2018-financial-and-operating-results</loc>
  <lastmod>2021-10-06T12:17:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-announces-first-patient-dosed-phase-3-trial-avxs-101-pre-symptomatic-sma-types-1-2-and-3</loc>
  <lastmod>2021-10-06T12:17:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-presents-initial-data-from-pivotal-us-trial-sma-type-1-and-24-month-follow-data-from-phase-1-trial-avxs-101-sma-type-1-annual-meeting-american-academy-neurology</loc>
  <lastmod>2021-10-06T12:18:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-present-avxs-101-data-annual-meeting-american-academy-neurology</loc>
  <lastmod>2021-10-06T12:18:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-gene-therapy-awarded-sakigake-designation-spinal-muscular-atrophy-type-1</loc>
  <lastmod>2021-10-06T12:18:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-enters-licensing-agreement-genethon</loc>
  <lastmod>2021-10-06T12:18:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-reports-fourth-quarter-and-full-year-2017-financial-and-operating-results</loc>
  <lastmod>2021-10-06T12:18:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-report-fourth-quarter-and-full-year-2017-financial-and-operating-results</loc>
  <lastmod>2021-10-06T12:18:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-initiate-screening-remaining-patients-pivotal-trial-avxs-101-sma-type-1-following-review-preliminary-data-from-first-three-patients</loc>
  <lastmod>2021-10-06T12:18:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-announces-closing-public-offering-common-stock-and-full-exercise-underwriters-option-purchase-additional-shares</loc>
  <lastmod>2021-10-06T12:18:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-announces-pricing-public-offering-common-stock</loc>
  <lastmod>2021-10-06T12:18:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-announces-proposed-public-offering-common-stock</loc>
  <lastmod>2021-10-06T12:18:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-announces-expanded-clinical-development-program-avxs-101-spinal-muscular-atrophy</loc>
  <lastmod>2021-10-06T12:18:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/regenxbio-and-avexis-announce-expansion-relationship-through-amended-license-agreement-development-and-commercialization-treatments-spinal-muscular-atrophy</loc>
  <lastmod>2021-10-06T12:18:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-announces-alignment-fda-next-steps-toward-bla-submission-avxs-101-sma-type-1</loc>
  <lastmod>2021-10-06T12:18:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expects-sustain-long-term-growth-robust-pipeline-25-potential-blockbusters-highlighted-rd-day</loc>
  <lastmod>2021-10-06T17:07:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-present-broad-range-portfolio-data-ectrims-reinforcing-long-standing-commitment-people-living-multiple-sclerosis</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-resolves-legacy-federal-government-civil-investigation-us-regarding-generic-drugs</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-show-rapid-and-effective-disease-activity-control-remibrutinib-lou064-patients-chronic-spontaneous-urticaria</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-accelerates-efforts-toward-esg-targets-increase-access-medicines-improve-health-equity-and-achieve-net-zero-carbon-emissions</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-medicines-malaria-venture-report-positive-results-phase-2b-study-novel-ganaplacidelumefantrine-combination-children-malaria</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-data-reinforce-efficacy-and-convenience-novartis-cosentyx-secukinumab-300-mg-autoinjector-adults-psoriasis</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-show-achieving-complete-control-chronic-spontaneous-urticaria-csu-improves-overall-quality-life-reported-patients</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-acquires-arctos-medical-expanding-optogenetics-portfolio-bring-gene-therapies-patients-severe-vision-loss</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-acquiert-arctos-medical-elargissant-ainsi-son-portefeuille-doptogenetique-afin-de-proposer-des-therapies-geniques-aux-patients-souffrant-dune-severe-perte-de-la-vision</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ubernimmt-arctos-medical-und-erweitert-damit-ihr-optogenetik-portfolio-um-patientinnen-und-patienten-mit-einem-schwerem-verlust-des-sehvermogens-gentherapien-anbieten-zu-konnen</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-collaboration-harmonia-phase-iii-head-head-trial-evaluating-kisqali-vs-ibrance-patients-hrher2-advanced-breast-cancer</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-kisqali-data-showing-longest-median-overall-survival-ever-reported-hrher2-advanced-breast-cancer</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-findings-from-real-world-study-alpelisib-demonstrating-clinical-benefit-people-pik3ca-related-overgrowth-spectrum-pros</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-positive-health-related-quality-life-data-177lu-psma-617-radioligand-therapy-patients-advanced-prostate-cancer-esmo-2021</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-first-fda-filing-acceptance-anti-pd-1-antibody-tislelizumab-people-esophageal-cancer</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-strengthens-pipeline-entering-agreement-biosimilar-bevacizumab-key-oncology-medicine</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-findings-ers-reinforcing-efficacy-enerzair-breezhaler-highlighting-its-digital-companion-well-showcasing-commitment-low-carbon-footprint-asthma-solutions</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/world-first-agreement-between-novartis-and-nhs-enables-broad-and-rapid-access-first-class-cholesterol-lowering-medicine-leqvio-vinclisiran</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-leqvio-inclisiran-analyses-show-effective-and-sustained-ldl-c-reduction-two-sub-populations-patients-ascvd</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-important-overall-survival-and-quality-life-results-across-solid-tumor-portfolio-among-other-key-data-esmo</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-belinda-study-investigating-kymriah-second-line-treatment-aggressive-b-cell-non-hodgkin-lymphoma</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-secures-new-approval-china-cosentyx-secukinumab-pediatric-psoriasis</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-results-from-phase-iii-trials-beovu-diabetic-macular-edema-including-dosing-intervals-16-weeks</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-lift-partial-clinical-trial-hold-and-plans-initiate-new-pivotal-phase-3-study-intrathecal-oav-101-older-patients-sma</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-strong-q2-performance-driven-momentum-key-growth-brands-fy-2021-guidance-unchanged</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-forte-performance-au-deuxieme-trimestre-soutenue-par-la-dynamique-des-marques-cles-de-croissance-previsions-pour-lexercice-2021-inchangees</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-hat-im-zweiten-quartal-dank-der-dynamik-wichtiger-wachstums-marken-eine-starke-performance-erzielt-prognose-fur-2021-unverandert</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pledges-10-year-commitment-morehouse-school-medicine-26-historically-black-colleges-universities-medical-schools-and-other-leading-organizations-co-create-effective-measurable-solutions-health-equity</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-nejm-publication-positive-phase-iii-reach3-data-jakavi-chronic-gvhd</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-appoints-rob-kowalski-chief-people-organization-officer</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-eu-launch-ready-dilute-generic-pemetrexed-treat-most-prevalent-form-lung-cancer</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/positive-survival-data-novartis-investigational-radioligand-therapy-177lu-psma-617-published-new-england-journal-medicine</loc>
  <lastmod>2021-12-02T12:33:04+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-hewlett-packard-enterprise-join-forces-advance-novartis-global-health-efforts</loc>
  <lastmod>2021-12-02T18:33:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/kesimpta-ofatumumab-data-show-long-term-preservation-iggigm-levels-and-no-increased-risk-serious-infections-people-living-multiple-sclerosis</loc>
  <lastmod>2021-12-03T22:33:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-zolgensma-data-demonstrate-age-appropriate-development-when-used-presymptomatically-and-rapid-clinically-meaningful-efficacy-symptomatic-children-even-those-severe-sma-baseline</loc>
  <lastmod>2021-12-04T11:03:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-completes-acquisition-gsks-cephalosporin-business-reinforcing-leading-global-position-antibiotics</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-fda-and-ema-filing-acceptances-beovu-patients-diabetic-macular-edema</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/kesimpta-ofatumumab-data-ectrims-highlights-preservation-igg-levels-and-safety-experience-over-extended-exposure-35-years-people-living-relapsing-multiple-sclerosis</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/global-heart-hub-and-novartis-partner-tackle-ascvd-global-health-crisis-and-worlds-1-killer</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-signs-new-initial-agreement-biontech-support-fill-and-finish-mrna-pfizer-biontech-covid-19-vaccine</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-top-line-results-canopy-1-phase-iii-study-support-further-evaluation-canakinumab-lung-cancer</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivers-solid-q3-results-strong-growth-innovative-medicines-announces-strategic-review-sandoz</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-realise-de-solides-resultats-au-3e-trimestre-avec-une-forte-croissance-dinnovative-medicines-et-annonce-un-examen-strategique-de-sandoz</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-dritten-quartal-solide-ergebnisse-mit-starkem-wachstum-bei-innovative-medicines-das-unternehmen-kundigt-eine-strategische-uberprufung-von-sandoz</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-priority-review-us-fda-and-filing-acceptance-ema-kymriah-treat-patients-relapsed-or-refractory-follicular-lymphoma</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-novartis-scemblix-asciminib-novel-mechanism-action-treatment-chronic-myeloid-leukemia</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-sell-its-roche-stake-bilateral-transaction-roche</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-verkauft-ihre-roche-beteiligung-einer-bilateralen-transaktion-roche</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-data-ash-spotlight-novartis-recently-approved-scemblix-next-generation-car-t-platform-and-expanding-hematology-portfolio</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-iptacopan-meets-primary-endpoints-phase-ii-study-rare-kidney-disease-c3-glomerulopathy-c3g</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/leqvio-inclisiran-reduced-ldl-c-people-who-are-overweight-or-obese</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-publication-cephalalgia-data-showcasing-superior-tolerability-and-efficacy-aimovig-erenumab-compared-topiramate-migraine-prevention</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-positive-phase-iii-results-cosentyx-children-active-enthesitis-related-arthritis-era-and-juvenile-psoriatic-arthritis-jpsa-acr-2021</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-rd-day-spotlights-attractive-growth-profile-underpinned-strong-market-brands-20-potential-high-value-pipeline-assets-and-technology-platforms</loc>
  <lastmod>2021-12-06T17:48:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/bilateral-transaction-between-novartis-and-roche-successfully-closed</loc>
  <lastmod>2021-12-06T17:48:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-kisqali-data-shows-consistent-overall-survival-benefit-across-genomic-and-clinical-subtypes-interest-hrher2-metastatic-breast-cancer</loc>
  <lastmod>2021-12-08T15:33:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-results-from-year-two-phase-iii-trial-beovu-diabetic-macular-edema</loc>
  <lastmod>2021-12-09T16:48:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-highlight-efficacy-piqray-hrher2-metastatic-breast-cancer-pik3ca-driver-mutation-immediately-post-cdk46i</loc>
  <lastmod>2021-12-10T14:03:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kymriah-demonstrates-strong-responses-high-risk-patients-relapsed-or-refractory-follicular-lymphoma-extended-study-follow</loc>
  <lastmod>2021-12-11T18:03:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-scemblix-demonstrates-sustained-response-rate-48-week-follow-patients-chronic-myeloid-leukemia</loc>
  <lastmod>2021-12-11T22:03:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-t-chargetm-next-generation-car-t-platform-first-human-data-ash-2021</loc>
  <lastmod>2021-12-13T20:48:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-initiates-new-usd-15-billion-share-buyback-highlighting-confidence-growth-and-pipeline</loc>
  <lastmod>2021-12-16T07:03:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-phase-iii-ligelizumab-qge031-studies-chronic-spontaneous-urticaria-csu</loc>
  <lastmod>2021-12-20T07:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-strengthens-immunotherapy-pipeline-option-collaboration-and-license-agreement-beigene-tigit-inhibitor-ociperlimab</loc>
  <lastmod>2021-12-20T12:18:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-submits-biologics-license-application-proposed-biosimilar-trastuzumab-us-fda</loc>
  <lastmod>2021-12-20T22:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-submits-marketing-authorization-application-proposed-biosimilar-trastuzumab-ema</loc>
  <lastmod>2021-12-22T07:18:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-acquire-gyroscope-therapeutics-adding-one-time-gene-therapy-could-transform-care-geographic-atrophy-leading-cause-blindness</loc>
  <lastmod>2021-12-22T08:03:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-novartis-leqvio-inclisiran-first-class-sirna-lower-cholesterol-and-keep-it-low-two-doses-year</loc>
  <lastmod>2021-12-22T22:18:04+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-enthesitis-related-arthritis-and-psoriatic-arthritis</loc>
  <lastmod>2021-12-23T00:03:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-board-directors-annual-general-meeting-4</loc>
  <lastmod>2022-03-03T13:19:05+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration-lors-de-lassemblee-generale-annuelle-1</loc>
  <lastmod>2022-03-03T13:19:05+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-entresto-granted-expanded-indication-chronic-heart-failure-fda-0</loc>
  <lastmod>2022-03-03T13:19:05+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-peer-reviewed-research-shows-no-increased-risk-serious-covid-19-infections-kesimpta-ofatumumab-treated-adults-multiple-sclerosis</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-targets-growth-opportunities-respiratory-and-complex-generics-through-acquisition-respiratory-device-company-coalesce</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-again-demonstrate-age-appropriate-development-when-zolgensma-used-presymptomatically-and-post-hoc-data-reveal-sma-type-1-patients-could-speak-swallow-and-maintain-airway-protection</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-signs-initial-agreement-carisma-therapeutics-manufacturing-her-2-targeted-car-m-cell-therapy</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/nejm-publication-novartis-kisqali-data-shows-longest-median-overall-survival-ever-reported-hrher2-advanced-breast-cancer</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-voyager-therapeutics-reach-license-option-agreement-next-generation-gene-therapy-vectors-neurological-diseases</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-board-directors-annual-general-meeting-5</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration-lors-de-lassemblee-generale-ordinaire</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/aktionarinnen-und-aktionare-von-novartis-heissen-der-ordentlichen-generalversammlung-alle-antrage-des-verwaltungsrats-gut</loc>
  <lastmod>2022-06-29T02:04:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-peer-reviewed-safety-and-tolerability-data-further-strengthens-kesimptas-ofatumumab-favorable-benefit-risk-profile-patients-relapsing-multiple-sclerosis</loc>
  <lastmod>2022-06-30T00:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-launches-generic-lenalidomide-19-countries-across-europe-expanding-access-essential-oncology-medicine</loc>
  <lastmod>2022-06-30T00:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivers-mid-single-digit-sales-growth-margin-expansion-and-advancement-robust-pipeline-2021</loc>
  <lastmod>2022-06-30T00:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-enregistre-en-2021-une-croissance-du-chiffre-daffaires-net-un-chiffre-dans-le-milieu-de-la-fourchette-une-expansion-de-la-marge-et-une-avancee-du-robuste-pipeline</loc>
  <lastmod>2022-06-30T00:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-2021-ein-umsatzwachstum-im-mittleren-einstelligen-bereich-verbessert-die-margen-und-treibt-die-solide-pipeline-voran</loc>
  <lastmod>2022-06-30T00:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-molecular-partners-report-positive-topline-data-from-phase-2-study-ensovibep-mp0420-darpin-antiviral-therapeutic-covid-19</loc>
  <lastmod>2022-06-30T00:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-collaboration-alnylam-explore-targeted-therapy-restore-liver-function</loc>
  <lastmod>2022-06-30T00:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-us-court-appeals-federal-circuit-cafc-upholds-validity-gilenya-fingolimod-dosage-regimen-patent</loc>
  <lastmod>2022-06-30T00:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pluvictotm-approved-fda-first-targeted-radioligand-therapy-treatment-progressive-psma-positive-metastatic-castration-resistant-prostate-cancer</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-jakavi-treat-acute-and-chronic-graft-versus-host-disease</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-kymriah-car-t-cell-therapy-adult-patients-relapsed-or-refractory-follicular-lymphoma-europe</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-european-commission-approval-beovu-people-living-diabetic-macular-edema</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-organizational-structure-accelerate-growth-strengthen-pipeline-and-increase-productivity</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-gibt-neue-organisationsstruktur-bekannt-fur-schnelleres-wachstum-eine-starkere-pipeline-und-hohere-produktivitat</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-four-year-data-efficacy-and-safety-kesimpta-ofatumumab-people-living-relapsing-multiple-sclerosis</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expands-zolgensma-manufacturing-capacity-approval-multi-product-north-carolina-facility</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-novartis-vijoice-alpelisib-first-and-only-treatment-select-patients-pik3ca-related-overgrowth-spectrum-pros</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-extends-collaboration-agreement-drive-cutting-edge-digital-solutions-global-fight-against-antimicrobial-resistance-amr</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-anti-pd-1-tislelizumab-accepted-ema-regulatory-review-esophageal-and-lung-cancers</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-early-clinical-data-unique-krasg12c-inhibitor-american-association-cancer-research-annual-meeting</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-launches-generic-brimonidine-tartratetimolol-maleate-eyedrop-us-patients-ocular-hypertension-expanding-leading-ophthalmic-portfolio</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-tabrecta-patients-metex14-advanced-non-small-cell-lung-cancer</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivers-solid-sales-and-profit-growth-strong-performance-market-brands-supports-confidence-mid-term-growth-outlook</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-solide-croissance-du-chiffre-daffaires-et-du-benefice-la-forte-performance-des-marques-existantes-soutient-la-confiance-dans-les-previsions-de-croissance-moyen-terme</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-ein-solides-umsatz-und-gewinnwachstum-die-starke-performance-auf-dem-markt-befindlicher-marken-stutzt-das-vertrauen-die-mittelfristigen-wachstumsaussichten</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-tislelizumab-plus-chemotherapy-significantly-improved-overall-survival-first-line-treatment-advanced-esophageal-cancer-phase-iii-study</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kymriah-receives-ec-approval-first-car-t-cell-therapy-adults-relapsed-or-refractory-follicular-lymphoma</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-data-demonstrate-only-kisqali-offers-more-life-first-line-setting-postmenopausal-hrher2-advanced-breast-cancer-patients</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-european-commission-approval-jakavi-be-first-post-steroid-treatment-acute-and-chronic-graft-versus-host-disease</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-production-radioligand-therapy-medicines</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-asco-and-eha-showcase-latest-oncology-research-and-innovation-including-breast-and-prostate-cancer</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-secukinumab-receives-positive-chmp-opinion-expanded-use-childhood-arthritic-conditions</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-appoints-new-board-representative-global-amr-industry-alliance</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-novartis-kymriah-car-t-cell-therapy-adult-patients-relapsed-or-refractory-follicular-lymphoma</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-new-global-act4biosimilars-initiative-improve-patient-access-and-increase-adoption-least-30-30-countries-2030</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-partnership-american-society-hematology-fight-sickle-cell-disease-sub-saharan-africa</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-cdk46i-data-asco-reinforce-novartis-kisqali-only-drug-class-consistently-proven-overall-survival-benefit-hrher2-metastatic-breast-cancer</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-data-show-piqray-effectiveness-across-key-biomarkers-patients-hrher2-metastatic-breast-cancer</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-tafinlar-dabrafenib-mekinist-trametinib-demonstrates-unprecedented-efficacy-pediatric-patients-braf-v600-low-grade-gliomas-phase-iiiii-study</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-scemblix-novel-mechanism-action-shows-superior-long-term-efficacy-and-consistent-tolerability-96-week-follow-chronic-myeloid-leukemia-trial</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-five-year-kymriah-data-show-durable-remission-and-long-term-survival-maintained-children-and-young-adults-advanced-b-cell-all</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-research-reveals-critical-actions-needed-ensure-covid-19-driven-surge-virtual-health-and-care-drives-health-access-and-equity</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-application-proposed-biosimilar-adalimumabs-high-concentration-formulation-accepted-ema</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-nature-medicine-publication-zolgensma-data-demonstrating-age-appropriate-milestones-when-treating-children-sma-presymptomatically</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-plans-petition-us-court-appeals-federal-circuit-further-review-uphold-validity-gilenya-fingolimod-dosing-regimen-patent</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-european-commission-approval-tabrecta-treatment-metex14-skipping-advanced-non-small-cell-lung-cancer</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-tafinlar-mekinist-receives-fda-approval-first-tumor-agnostic-indication-braf-v600e-solid-tumors</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-renews-commitment-neglected-tropical-disease-and-malaria-elimination-investing-usd-250-million-over-five-years-research-and-develop-new-treatments</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-scemblix-novel-treatment-adult-patients-chronic-myeloid-leukemia</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-extension-phase-data-show-nearly-80-rms-patients-treated-kesimpta-ofatumumab-had-no-evidence-disease-activity-neda-3</loc>
  <lastmod>2022-06-30T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/cosentyx-secukinumab-receives-expanded-approvals-eu-use-childhood-arthritic-conditions</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-phase-iii-data-show-novartis-tislelizumab-significantly-extended-median-overall-survival-more-6-months-first-line-advanced-esophageal-cancer-combination-chemotherapy</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-resumes-production-and-delivery-radioligand-therapy-medicines-ahead-schedule</loc>
  <lastmod>2022-07-04T14:34:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivers-continued-strong-momentum-key-growth-brands-progress-strategic-initiatives-and-confirms-fy22-group-guidance</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-eine-anhaltend-starke-dynamik-der-wichtigsten-wachstumsmarken-sowie-fortschritte-bei-strategischen-initiativen-und-bestatigt-die-konzernprognose-fur-das-geschaftsjahr-2022</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-continue-le-fort-elan-des-principales-marques-de-croissance-progresse-dans-ses-initiatives-strategiques-et-confirme-les-previsions-de-lexercice-2022-pour-le-groupe</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-supplemental-biologics-license-application-accepted-us-fda-biosimilar-hyrimoz-adalimumab-adaz-high-concentration-formulation-hcf</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/applications-proposed-first-kind-multiple-sclerosis-biosimilar-natalizumab-accepted-us-fda-and-ema</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-phase-iii-canopy-study-evaluating-canakinumab-adjuvant-treatment-non-small-cell-lung-cancer</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-intention-separate-sandoz-business-create-standalone-company-way-100-spin</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-will-das-sandoz-geschaft-durch-eine-hundertprozentige-ausgliederung-als-eigenstandiges-unternehmen-abspalten</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-scemblix-novel-mechanism-action-approved-european-commission-adult-patients-chronic-myeloid-leukemia</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-data-breast-and-prostate-cancer-esmo</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-appoints-fiona-marshall-phd-president-novartis-institutes-biomedical-research-jay-bradner-md-steps-down-from-executive-committee-novartis</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-depth-immunology-pipeline-novel-data-key-upcoming-international-congresses</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-adds-one-more-year-survival-benefit-broadest-set-patients-including-those-aggressive-hrher2-advanced-breast-cancer</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-tislelizumab-demonstrated-efficacy-and-tolerability-first-line-advanced-liver-cancer-phase-iii-trial</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-shows-clinically-meaningful-symptom-improvements-patients-hidradenitis-suppurativa-pivotal-phase-iii-trials</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-invests-early-technical-development-capabilities-next-generation-biotherapeutics</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-statement-regarding-competition-authority-investigation-assertion-patent</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-further-progress-its-biosimilar-pipeline-release-positive-results-denosumab-integrated-phase-iiii-clinical-trial</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-plans-petition-us-supreme-court-uphold-validity-gilenya-fingolimod-dosing-regimen-patent</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-unveils-new-focused-strategy-underpinned-eight-potential-multi-billion-dollar-peak-sales-brands-deep-pipeline-meet-management-event</loc>
  <lastmod>2022-09-22T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-financial-results-q1-2021</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-inaugurates-innovative-watershed-project-india-increase-water-availability</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-cancer-day-2021</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/global-health-corporate-responsibility</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-gene-therapies-recommits-global-managed-access-program-2021</loc>
  <lastmod>2021-10-13T10:59:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/achieving-100-renewable-electricity</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-appoints-marc-boutin-global-head-patient-engagement-advocacy</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-provides-update-use-and-safety-beovu-patients-wet-amd</loc>
  <lastmod>2021-09-14T13:02:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/avexis-data-integrity-updates</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/epis-explores-how-covid-19-shaping-future-digital-engagement-within-healthcare</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-ranks-second-2021-access-medicine-index</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/highlights-from-co-creating-impact-summit-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-chagas-disease-day-2021</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/bold-advocates-blood-cancers-and-blood-disorders</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/blood-cancer-awareness-month-cutting-edge-innovation-hematology</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/solar-1-nejm-publication</loc>
  <lastmod>2021-10-07T09:00:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/mission-transform-planetary-health</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-announces-flexible-return-office-and-site-field-activities-starting-may-11-2020</loc>
  <lastmod>2021-10-13T09:18:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-completes-safety-review-and-initiates-update-beovu-prescribing-information-worldwide</loc>
  <lastmod>2021-09-09T09:50:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-announces-first-european-donation-hydroxychloroquine-switzerland</loc>
  <lastmod>2021-09-09T09:51:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-coronavirus-update-supply-chain-response-measures-efpia-rd-call</loc>
  <lastmod>2021-10-14T08:01:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/expanding-car-t-manufacturing-australia</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-ash</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/why-healthcares-digital-moment-now</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/avexis-renamed-novartis-gene-therapies-signifying-growing-importance-gene-therapy-novartis-corporate-strategy</loc>
  <lastmod>2021-10-07T09:12:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/ruxcovid-clinical-trial</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/study-suggests-there-may-be-two-stages-fatal-lung-disease-covid-19</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/choice-responsibility-reimagining-how-we-work</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/international-womens-day-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-sight-day-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/standing-racial-equity-and-justice-one-novartis</loc>
  <lastmod>2021-09-09T09:49:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-update-following-who-solidarity-trial-announcement</loc>
  <lastmod>2021-09-09T09:49:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-announces-plan-initiate-clinical-trial-canakinumab-patients-covid-19-pneumonia</loc>
  <lastmod>2021-09-09T09:50:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/leading-performance-sustainability</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-heart-day-2020-from-our-heart-yours</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/50-climate-leaders</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/new-report-shows-how-ai-health-critical-covid-19-response-and-recovery</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-coronavirus-update-remote-working-business-travel-restrictions</loc>
  <lastmod>2021-09-14T13:02:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/expanding-car-t-manufacturing-europe-serve-more-patients</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/committed-increasing-access</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/pride-novartis-2020-inspired-make-difference</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-sickle-cell-day-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-asco</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/pride-novartis-2019</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-chagas-disease-day-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-covid-19-response-fund-provides-support-healthcare-workers-and-communities</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-esmo</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-launches-new-preferred-firm-program-legal-services</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/day-african-child-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-cancer-day-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-world-economic-forum-annual-meeting-davos-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/sustaining-momentum-toward-universal-health-coverage-africa</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/discussing-innovative-solutions-address-unmet-healthcare-needs-asia</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-joins-accelerating-covid-19-therapeutic-interventions-and-vaccines-activ-initiative</loc>
  <lastmod>2021-09-09T09:50:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-announces-further-steps-protect-and-support-its-associates-during-covid-19-pandemic</loc>
  <lastmod>2021-09-14T12:59:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-ranks-4-patientviews-2019-corporate-reputation-survey-patient-organizations</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/behind-research-driving-our-data-medical-conferences</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/uncovering-profound-and-under-reported-effects-people-living-sickle-cell-disease</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/amazon-web-services-aws-announces-strategic-collaboration-novartis-accelerate-digital-transformation-its-business-operations</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-opens-facility-innovative-cell-and-gene-therapies-switzerland</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-sight-day-2019</loc>
  <lastmod>2022-02-10T11:47:38+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-and-microsoft-announce-collaboration-transform-medicine-artificial-intelligence</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/health-experts-explore-response-chronic-illness-poor-countries</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-malaria-day-2019</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/global-equal-parental-leave-policy-all-novartis-parents</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-moves-address-superbug-threat</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/celebrating-community-partnership-day</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-recognized-global-leader-sustainable-water-and-climate-management</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/biosimilar-drugs-have-potential-save-more-usd-54-billion</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-foundation-joins-global-partnership-zero-leprosy</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-sickle-cell-day-2019</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/exploring-future-access-healthcare-lower-income-countries</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/alcon-survey-reveals-people-are-happier-and-more-satisfied-their-lives-after-cataract-surgery</loc>
  <lastmod>2021-08-23T10:08:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/car-t-therapies-are-manufactured-each-individual-patient</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/asthma-and-exercise-why-patients-can-and-should-stay-active</loc>
  <lastmod>2021-07-28T14:09:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/beyond-pill-precision-medicine-practice</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/improving-diabetes-awareness-and-treatment-adherence-india</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/how-digital-technologies-are-creating-new-normal-people-living-copd</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/when-innovation-draws-new-future-patient-treatments</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/taking-action-psoriasis-patients-who-psoriasis-resolution</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-medikidz-and-copd-foundation-partnership-superhero-proportions</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/innovation-practice-how-we-form-partnerships-pharma</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-evolving-business-practices-better-educate-medical-community</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/medical-researchers-using-new-tools-turn-science-fiction-science-fact</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/students-take-challenges-digital-medicine</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/fighting-high-blood-pressure-vietnam</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-asthma-day-2021</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/nurturing-next-generation-scientists</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-and-red-cross-partner-tackle-chronic-diseases-refugee-populations</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/essential-consultants-updates</loc>
  <lastmod>2021-10-14T09:40:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/avxs-101-managed-access-program</loc>
  <lastmod>2021-10-13T11:51:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-financial-results-q1-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-malaria-day-2021</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-financial-results-q2-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-dialogue-explore-solutions-rise-chronic-diseases-developing-world</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-financial-results-q3-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-financial-results-q1-2018</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-2020-financial-results</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-2017-financial-results</loc>
  <lastmod>2021-09-28T09:21:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-host-stakeholder-dialogue-ways-improve-access-healthcare-lower-income-countries</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-financial-results-q3-2018</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/european-patient-innovation-summit-recommends-increasing-impact-digital-technologies</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/alcon-becomes-separately-traded-standalone-company</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-rd-day</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-2018-financial-results</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-financial-results-q1-2019</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-jp-morgan-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-2015-financial-results</loc>
  <lastmod>2021-10-07T15:34:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-financial-results-q2-2019</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-2019-financial-results</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-financial-results-q3-2019</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-financial-results-q2-2018</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/co-creating-impact-summit-society-and-planet</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-2016-financial-results</loc>
  <lastmod>2022-02-02T08:45:07+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/life-science-companies-and-bill-melinda-gates-foundation-joint-communique</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/european-patient-innovation-summit-publishes-call-action-ensure-greater-patient-involvement-digital-health-solution-development</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-research-shows-technology-talent-increasingly-drawn-pharma-industry-covid-19</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-malaria-day-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/impact-measurement-and-valuation</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/ai-nurse-set-transform-standards-care-heart-failure-patients-china</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/meet-novartis-management-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-announces-discontinuation-cirrus-1-study-cfz533-iscalimab-kidney-transplant-patients</loc>
  <lastmod>2021-10-04T08:25:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-receives-fda-fast-track-designation-lna043-osteoarthritis-knee</loc>
  <lastmod>2021-10-04T08:28:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-sabatolimab-receives-orphan-drug-designation-from-european-commission-myelodysplastic-syndromes</loc>
  <lastmod>2021-10-14T13:31:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/fda-accelerates-review-novartis-stamp-inhibitor-asciminib-abl001-patients-chronic-myeloid-leukemia-cml</loc>
  <lastmod>2021-10-04T08:26:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-receives-fda-orphan-drug-designation-nis793-pancreatic-cancer</loc>
  <lastmod>2021-10-04T08:28:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-announces-complete-response-resubmission-inclisiran-new-drug-application</loc>
  <lastmod>2021-10-04T08:26:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-receives-fda-breakthrough-therapy-designation-investigational-177lu-psma-617-patients-metastatic-castration-resistant-prostate-cancer-mcrpc</loc>
  <lastmod>2021-10-04T08:28:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-entresto-indicated-treatment-hypertension-china</loc>
  <lastmod>2021-10-04T08:25:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-receives-fda-fast-track-designation-sabatolimab-mbg453-myelodysplastic-syndromes</loc>
  <lastmod>2021-10-04T08:28:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/industry-and-academia-collaborating-innovate-patients</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/fda-grants-priority-review-investigational-targeted-radioligand-therapy-177lu-psma-617-patients-metastatic-castration-resistant-prostate-cancer-mcrpc</loc>
  <lastmod>2021-10-14T10:02:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/one-billion-antimalarial-treatments-delivered-extraordinary-partnership-journey</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/asia-pacific-patient-innovation-summit-examines-capability-building-gaps-patient-organizations</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/enabling-our-associates-work-safely-our-sites</loc>
  <lastmod>2021-10-07T13:13:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/beacon-hope-addressing-health-disparities-through-holistic-community-based-collective-action</loc>
  <lastmod>2021-10-11T12:14:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-financial-results-q2-2021</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-hematology-relentless-pursuit-cure</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/two-decades-pioneering-innovation-cml-and-beyond</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/covid-19-news-feed</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-sight-day-2021</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-financial-results-q3-2021</loc>
  <lastmod>2021-10-26T13:22:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/sound-up</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/raising-awareness-prostate-cancer-during-movember</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-receives-fda-fast-track-designation-branaplam-lmi070-treatment-huntingtons-disease</loc>
  <lastmod>2021-12-16T10:00:12+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/2021-global-managed-access-program-community-update</loc>
  <lastmod>2022-01-31T14:36:51+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-2021-financial-results</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-co-creating-impact-summit-2021</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-announces-european-patent-office-orders-grant-european-gilenya-fingolimod-05mg-daily-dose-patent</loc>
  <lastmod>2022-02-15T10:02:38+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-condemns-war-ukraine-and-commits-supporting-humanitarian-efforts</loc>
  <lastmod>2022-03-15T08:49:19+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-expands-humanitarian-efforts-ukraine-through-donation-essential-medicines</loc>
  <lastmod>2022-03-08T16:49:12+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-condemns-war-ukraine-update-march-22</loc>
  <lastmod>2022-03-22T08:11:41+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-provides-more-usd-25-million-medical-aid-patients-ukraine-and-bordering-countries</loc>
  <lastmod>2022-04-19T14:32:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-financial-results-q1-2022</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-asco-and-eha-2022</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-resumes-business-ukraine</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-financial-results-q2-2022</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/from-the-heart</loc>
  <lastmod>2022-09-28T13:35:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/zolgensma-acute-liver-failure-update</loc>
  <lastmod>2022-08-16T17:30:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/branaplam-vibrant-hd-study-update</loc>
  <lastmod>2022-08-25T16:01:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-hematology-working-help-ensure-patients-are-getting-access-they-need</loc>
  <lastmod>2022-09-12T15:15:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/artificial-intelligence-decodes-cancer-pathology-images</loc>
  <lastmod>2022-02-10T13:40:05+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/african-experts-call-renewed-global-drive-beat-malaria</loc>
  <lastmod>2021-10-12T14:51:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/10-big-questions-dissect-science-papers</loc>
  <lastmod>2021-10-18T14:17:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/abcdes-melanoma-prevention-and-detection</loc>
  <lastmod>2021-10-18T07:50:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/challenging-young-scientist-focus-patients</loc>
  <lastmod>2021-10-14T07:38:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/biological-battle-bulge</loc>
  <lastmod>2021-10-07T10:20:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/building-boot-camps-immune-cells-near-tumors</loc>
  <lastmod>2021-10-08T14:58:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/bringing-gene-therapy-focus</loc>
  <lastmod>2022-02-11T14:53:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/can-we-unlock-bodys-ability-regenerate-lost-hearing</loc>
  <lastmod>2021-10-07T10:28:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/building-collaborations-fight-pandemic</loc>
  <lastmod>2021-10-07T12:27:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/breaking-vicious-cycle-inflammation</loc>
  <lastmod>2021-10-07T15:54:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/bringing-real-change-people</loc>
  <lastmod>2021-10-07T12:17:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/cancer-cocktails-abl001-hitting-one-target-twice</loc>
  <lastmod>2021-10-07T10:25:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/cancer-cocktails-come-age</loc>
  <lastmod>2021-10-07T10:25:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/bringing-science-and-medicine-together-help-patients-cancer</loc>
  <lastmod>2021-10-08T14:54:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/cancer-cocktails-lee011-popular-combination-partner</loc>
  <lastmod>2021-09-14T11:23:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/cancer-cocktails-ljm716-closing-common-release-valve</loc>
  <lastmod>2021-09-14T12:38:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/cancer-researchers-ready-aim-cures</loc>
  <lastmod>2021-10-07T07:10:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/chan-zuckerberg-initiative-friends-novartis-scientist-mission-conquer-disease</loc>
  <lastmod>2021-10-15T13:20:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/clinical-trial-comes-together-weeks-address-coronavirus</loc>
  <lastmod>2021-10-15T13:51:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/cellular-drama-heart-researchers-family</loc>
  <lastmod>2021-10-15T12:06:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/clinical-trials-make-move-toward-mice</loc>
  <lastmod>2021-10-15T13:48:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/close-look-cryo-electron-microscopy</loc>
  <lastmod>2021-10-15T14:00:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/collaborating-explore-new-gene-regulation-therapies</loc>
  <lastmod>2021-10-18T14:29:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/collaborating-unlock-secrets-microbiome</loc>
  <lastmod>2021-10-08T06:30:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/compound-designed-fight-alzheimers-disease-shows-promise-lab</loc>
  <lastmod>2021-10-07T14:27:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/compounds-spur-insulin-producing-cells-replicate-lab</loc>
  <lastmod>2021-10-15T15:20:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/combination-therapies-seeking-block-cancers-pathways-growth</loc>
  <lastmod>2021-10-15T14:43:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/counting-combos-complex-liver-diseases</loc>
  <lastmod>2022-06-08T10:16:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/confidence-led-researcher-swim-against-current</loc>
  <lastmod>2021-10-11T11:47:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/covid-19-answering-your-top-questions</loc>
  <lastmod>2021-10-01T06:28:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/data42-program-shows-novartis-intent-go-big-data-and-digital</loc>
  <lastmod>2021-10-11T14:30:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/could-umbilical-cords-yield-more-stem-cells-life-saving-transplants</loc>
  <lastmod>2021-10-15T15:31:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/digital-health-ecosystem-gets-boost-novartis-biome</loc>
  <lastmod>2022-01-07T09:15:56+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/embracing-big-data-understand-complex-diseases</loc>
  <lastmod>2021-10-18T14:31:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/decades-long-journey-blood-cancer-research</loc>
  <lastmod>2021-10-15T15:46:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/drug-development-gets-big-data-analytics-boost</loc>
  <lastmod>2021-10-07T10:45:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/evolution-scientist</loc>
  <lastmod>2021-10-07T10:43:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/experimental-gene-therapy-discovered-house-enters-clinical-testing</loc>
  <lastmod>2021-10-18T14:37:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/experimental-treatment-clears-malaria-infections-small-clinical-study</loc>
  <lastmod>2021-10-15T16:01:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/exploring-longstanding-questions-about-heart-disease</loc>
  <lastmod>2021-10-07T08:08:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/eye-fastest-muscle-human-body</loc>
  <lastmod>2021-07-21T14:12:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/dna-encoded-molecules-provide-new-edge-cancer-drug-hunts</loc>
  <lastmod>2021-10-01T06:43:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/factory-foreman-keeps-livers-line-workers-task</loc>
  <lastmod>2021-10-07T08:39:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/eyewitness-healer-pursues-new-treatments-patients</loc>
  <lastmod>2021-10-18T14:42:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/fresh-look-fighting-glaucoma</loc>
  <lastmod>2021-10-07T08:40:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/from-patient-patient-advocate-how-cancer-diagnosis-fueled-new-career-path</loc>
  <lastmod>2021-10-01T07:13:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/getting-down-roots-alzheimers-disease</loc>
  <lastmod>2021-10-07T14:25:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/going-global-meet-local-needs-china</loc>
  <lastmod>2021-10-15T16:50:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/how-love-sport-led-scientific-breakthrough</loc>
  <lastmod>2021-10-07T08:59:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/heart-failure-leading-cause-hospitalizations-it-doesnt-have-be</loc>
  <lastmod>2021-09-29T09:31:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/eye-patients-mind-innovation</loc>
  <lastmod>2021-10-01T07:09:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/helping-clinical-trial-patients-during-lockdown</loc>
  <lastmod>2021-10-18T09:37:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/how-scientists-aim-expand-immunotherapy-options-cancer-patients</loc>
  <lastmod>2022-06-07T17:03:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/immuno-oncology-researchers-seek-build-smart-drug-combos</loc>
  <lastmod>2021-10-18T14:45:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/innovating-trusted-class-antibiotics-attack-superbugs</loc>
  <lastmod>2021-10-18T09:55:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/investigating-myopia-mystery</loc>
  <lastmod>2022-06-21T15:35:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/it-takes-rd-village-fight-pandemic</loc>
  <lastmod>2021-10-18T14:47:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/intractable-tumor-cells-crippled</loc>
  <lastmod>2021-10-18T10:15:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/keeping-heart-patients-heart-everything-we-do</loc>
  <lastmod>2021-10-18T10:56:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/let-there-be-sight</loc>
  <lastmod>2021-10-07T09:08:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/loss-friend-liver-cancer-sharpens-focus-experimental-therapy</loc>
  <lastmod>2021-09-29T07:49:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/killing-three-diseases-one-stone-lab</loc>
  <lastmod>2021-09-29T08:11:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/leveraging-livers-ability-heal-scarred-tissue</loc>
  <lastmod>2021-10-18T12:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/making-possible-stepping-toward-future-cell-and-gene-therapy</loc>
  <lastmod>2022-01-14T16:58:56+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/meet-achim-leading-data42-program</loc>
  <lastmod>2021-10-07T09:14:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/mutant-protein-spreads-through-neural-circuit-huntingtons-disease</loc>
  <lastmod>2021-10-07T09:49:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/moving-from-speculation-science-during-pandemic</loc>
  <lastmod>2021-10-01T08:06:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/not-your-grandparents-nuclear-medicine</loc>
  <lastmod>2022-01-11T09:30:42+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/machine-learning-poised-accelerate-drug-discovery</loc>
  <lastmod>2022-06-21T17:07:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/neuroscientists-restore-cell-cell-signaling-and-sociability-autism-models</loc>
  <lastmod>2021-10-07T14:50:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/new-drug-manufacturing-tools-change-pharma-chemistry</loc>
  <lastmod>2021-10-07T09:54:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/new-recruit-has-big-dreams-cancer-immunotherapy</loc>
  <lastmod>2021-10-18T15:02:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/new-hope-treating-inflammatory-diseases-kidney</loc>
  <lastmod>2022-01-11T09:27:11+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-and-pfizer-join-forces-upend-oncology-dogma</loc>
  <lastmod>2021-10-18T15:13:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-cancer-researchers-advance-precision-medicine</loc>
  <lastmod>2021-10-18T15:59:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-researches-smas-genetic-roots</loc>
  <lastmod>2021-10-07T10:05:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/open-science-demystified</loc>
  <lastmod>2021-10-19T08:44:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-scientists-target-resistance-threat-malaria</loc>
  <lastmod>2021-10-07T10:09:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/organic-dealmaker-drug-discovery</loc>
  <lastmod>2021-10-11T11:55:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/open-resources-novartis-help-drive-innovation</loc>
  <lastmod>2022-01-14T15:56:41+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/physician-scientist-donald-ganem-takes-reins-infectious-disease</loc>
  <lastmod>2021-10-07T10:21:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/potential-weight-loss-treatment-takes-shape-help-from-patients</loc>
  <lastmod>2021-10-19T08:56:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/predictive-analytics-could-bring-medicines-patients-faster</loc>
  <lastmod>2021-10-19T09:01:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/reaping-cancer-clues-from-blood</loc>
  <lastmod>2021-09-28T11:25:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/rare-speed-rare-disease</loc>
  <lastmod>2021-10-19T09:23:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/researchers-overcome-hurdles-test-experimental-malaria-drug</loc>
  <lastmod>2021-10-07T14:36:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/researchers-aim-beat-trick-play-tumors-drug-combo</loc>
  <lastmod>2021-10-19T09:28:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/quest-new-measure-mental-health</loc>
  <lastmod>2021-10-19T09:04:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/researcher-races-find-new-treatment-his-progressive-disease</loc>
  <lastmod>2021-10-18T08:18:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/researchers-phd-leads-medical-breakthrough-rare-skin-disease</loc>
  <lastmod>2021-10-07T10:40:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/researcher-seeks-roots-plants-healing-power</loc>
  <lastmod>2021-10-19T09:32:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/respiratory-clinical-trials-putting-patients-heart-research</loc>
  <lastmod>2022-04-12T16:44:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/rewriting-playbook-clinical-testing-rare-disease</loc>
  <lastmod>2021-10-07T10:42:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/saving-tumor-suppressors-from-shredder</loc>
  <lastmod>2021-10-07T10:44:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/shaping-future-sickle-cell-disease</loc>
  <lastmod>2021-10-07T10:46:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/search-differences-make-difference</loc>
  <lastmod>2021-10-07T10:45:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/specter-malaria-resists-treatment</loc>
  <lastmod>2021-10-07T10:49:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/stepping-toward-regenerative-medicine-diabetes</loc>
  <lastmod>2021-10-18T08:21:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/small-viruses-could-accelerate-cell-and-gene-therapy-research</loc>
  <lastmod>2021-10-18T15:24:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/stopping-alzheimers-disease-it-starts</loc>
  <lastmod>2021-10-07T10:52:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/stifling-danger-signals-rheumatoid-arthritis</loc>
  <lastmod>2021-10-07T10:51:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/tackling-common-denominator-liver-disease</loc>
  <lastmod>2021-10-07T10:55:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/systematically-exposing-vulnerabilities-cancer-cells</loc>
  <lastmod>2022-01-11T09:33:46+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/taking-clinical-trials-next-level-through-technology</loc>
  <lastmod>2021-10-07T10:59:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/taking-obesity</loc>
  <lastmod>2021-10-18T15:26:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/tracking-patients-progress-radio-signals-and-machine-learning</loc>
  <lastmod>2021-10-07T11:30:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/talking-bruno-strigini-why-were-entering-transformative-time-cancer-care</loc>
  <lastmod>2021-10-07T11:26:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/teaming-academia-discover-medicines</loc>
  <lastmod>2021-10-07T11:28:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/turning-research-advances-innovative-medicines</loc>
  <lastmod>2021-11-23T16:15:54+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-cathryn-clary</loc>
  <lastmod>2021-10-19T06:42:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/visualizing-immuno-oncology-research</loc>
  <lastmod>2021-10-11T13:30:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-kristen-harrington-smith</loc>
  <lastmod>2021-10-07T11:42:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-annie-martin</loc>
  <lastmod>2021-10-07T11:39:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-mimi-huizinga</loc>
  <lastmod>2021-10-07T11:56:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-hannah-mosca</loc>
  <lastmod>2021-10-19T06:34:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-lauren-abrey</loc>
  <lastmod>2021-10-07T11:43:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-sandrine-piret-gerard</loc>
  <lastmod>2021-10-07T11:58:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-renee-rodgers</loc>
  <lastmod>2021-10-07T11:57:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-lilli-petruzzelli</loc>
  <lastmod>2021-10-07T11:45:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-shilpa-shah-mehta</loc>
  <lastmod>2021-09-28T12:36:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-shannon-campbell</loc>
  <lastmod>2021-10-07T11:59:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-susanne-schaffert</loc>
  <lastmod>2021-10-07T12:00:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-medy-attalla</loc>
  <lastmod>2021-10-07T11:51:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/word-street-what-cell-and-gene-therapy</loc>
  <lastmod>2021-10-07T12:03:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-tania-small</loc>
  <lastmod>2021-10-07T12:02:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/3-d-printing-scientists-reinvent-research-tools</loc>
  <lastmod>2021-10-07T12:05:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-virginia-lazala</loc>
  <lastmod>2021-10-18T14:39:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/bringing-virtual-reality-lab</loc>
  <lastmod>2022-01-11T09:54:21+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/brain-dish-researchers-take-neurological-disorders</loc>
  <lastmod>2021-10-07T12:08:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/5-tips-making-smart-decisions-research-projects</loc>
  <lastmod>2021-10-07T12:06:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/building-brain-organoids-shed-light-disease</loc>
  <lastmod>2021-10-07T12:09:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/cancer-spies-find-drug-beating-covert-cells</loc>
  <lastmod>2021-07-21T14:55:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/can-we-edit-our-genes-fight-disease</loc>
  <lastmod>2021-09-13T11:20:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/chemical-genetics-sleuthing-behind-modern-drug-discovery</loc>
  <lastmod>2021-10-07T12:14:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/could-digital-technology-drive-clinical-research-africa</loc>
  <lastmod>2021-10-07T12:15:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/disease-pathways-key-new-drug-discovery</loc>
  <lastmod>2021-10-07T12:18:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/electrical-brainstorms-traced-genetic-mutations</loc>
  <lastmod>2021-10-07T12:43:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/crispr-genome-editing-fuels-cancer-drug-discovery</loc>
  <lastmod>2021-10-18T09:44:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/countering-genome-reprogramming-cancer-cells</loc>
  <lastmod>2021-10-18T08:26:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/eye-disease-tracked-glitch-starburst-cells</loc>
  <lastmod>2021-10-07T12:45:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/five-things-look-scientific-mentor</loc>
  <lastmod>2021-10-07T12:48:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/hooked-science-jay-bradner-becomes-top-researcher-novartis</loc>
  <lastmod>2021-10-07T13:02:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/hardwiring-future</loc>
  <lastmod>2021-10-07T13:01:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/giraffes-have-high-blood-pressure-why-dont-they-drop-dead</loc>
  <lastmod>2021-10-07T13:00:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/fixing-whats-lost-translation</loc>
  <lastmod>2021-10-07T12:59:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/how-address-culture-gap-between-academia-and-industry-biomedicine</loc>
  <lastmod>2021-10-07T14:46:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/improving-science-communication-3-easy-steps</loc>
  <lastmod>2021-10-07T13:07:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/mhealth-revolution-healthcare</loc>
  <lastmod>2021-10-07T13:09:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/how-i-built-mini-gut-next-no-biology-training</loc>
  <lastmod>2021-10-07T13:05:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/how-zika-infects-growing-brain</loc>
  <lastmod>2021-10-07T13:06:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/minion-challenges-assumptions-about-genome</loc>
  <lastmod>2021-10-07T13:10:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/molecular-glue-kills-cancer-cells-mice</loc>
  <lastmod>2022-01-07T09:04:45+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/letters-my-younger-self-female-scientists-share-their-wisdom</loc>
  <lastmod>2021-10-07T13:08:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/neuroscientists-target-alzheimers-silent-stage</loc>
  <lastmod>2021-10-07T13:12:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/nurturing-life-science-ecosystem</loc>
  <lastmod>2021-10-07T13:14:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/opening-chemistry-education-world</loc>
  <lastmod>2021-10-07T13:15:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/rebuilding-blood</loc>
  <lastmod>2021-10-07T13:16:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/rediscovering-power-natures-exquisite-complexity</loc>
  <lastmod>2021-10-07T13:17:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/reigniting-passion-science</loc>
  <lastmod>2021-10-07T13:17:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/reimagining-protein-sequencing</loc>
  <lastmod>2021-10-07T13:16:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/robots-speed-pace-modern-drug-discovery</loc>
  <lastmod>2022-01-07T08:53:12+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/stopping-free-radicals-their-source</loc>
  <lastmod>2021-10-18T10:44:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-antibody-increases-muscle-growth-mice-and-human-cell-cultures</loc>
  <lastmod>2021-10-18T08:13:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/surfing-wave-big-data-analytics</loc>
  <lastmod>2021-10-18T15:31:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/three-lessons-ive-learned-industry-postdoc</loc>
  <lastmod>2021-10-07T11:12:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/turning-heat-tumors</loc>
  <lastmod>2021-10-07T11:21:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/visual-tour-scientific-strategies-combating-coronavirus</loc>
  <lastmod>2022-01-10T09:20:55+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/vision-hacker</loc>
  <lastmod>2021-10-07T11:28:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/tuning-drugs-succeed-cells-surface</loc>
  <lastmod>2021-10-18T10:16:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-alexandra-bach-weidmuller</loc>
  <lastmod>2021-10-07T11:46:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/what-goes-wrong-window-soul-glaucoma</loc>
  <lastmod>2021-10-18T10:23:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/when-tiny-brains-are-best-brain-research</loc>
  <lastmod>2021-10-07T11:33:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-jean-silveri</loc>
  <lastmod>2021-10-07T12:43:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-cyndy-grosskreutz</loc>
  <lastmod>2021-10-07T12:41:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/turning-power-nuclear-technology-medical-force</loc>
  <lastmod>2021-11-25T16:08:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-jennifer-allport-anderson</loc>
  <lastmod>2021-10-07T12:44:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/young-talent-emerging-technologies-come-together-biocamp</loc>
  <lastmod>2021-10-07T12:52:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/2-million-kids-receive-malaria-medicine</loc>
  <lastmod>2021-11-16T11:53:01+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-wendy-winckler</loc>
  <lastmod>2021-10-11T15:39:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-marjorie-eiref</loc>
  <lastmod>2021-10-18T08:19:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/ai-changing-face-healthcare</loc>
  <lastmod>2021-10-07T12:57:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/asian-health-experts-call-final-push-wipe-out-deadliest-form-malaria</loc>
  <lastmod>2021-10-12T15:17:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/bringing-chagas-disease-peoples-attention</loc>
  <lastmod>2021-10-13T08:24:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/bringing-modern-medicine-rural-vietnam</loc>
  <lastmod>2022-06-08T10:29:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/cancer-didnt-stop-covid-19</loc>
  <lastmod>2021-10-18T11:08:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/collaboration-strengthening-care-chronic-illness-ethiopia</loc>
  <lastmod>2021-10-07T13:11:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/chagas-disease-breaking-silence</loc>
  <lastmod>2021-10-07T13:12:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/confronting-global-spread-chronic-disease</loc>
  <lastmod>2021-10-07T13:06:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/tackling-rare-disease-working-toward-treatment-sma</loc>
  <lastmod>2021-10-07T10:56:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/sleuths-use-hi-tech-sensors-fight-pharmaceutical-crime</loc>
  <lastmod>2021-10-18T10:49:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/dealing-spread-chronic-disease-africa</loc>
  <lastmod>2021-10-07T13:02:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/fighting-malaria-africa</loc>
  <lastmod>2022-06-10T10:21:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/ensuring-medicine-supply-patients-during-covid-19</loc>
  <lastmod>2021-10-13T09:10:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/fighting-respiratory-disease-source</loc>
  <lastmod>2021-10-07T12:54:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/delivering-access-first-launch-kenya</loc>
  <lastmod>2021-10-18T11:28:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/health-collaboration-russia-helped-reduce-blood-pressure-deaths</loc>
  <lastmod>2021-10-18T11:32:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/fighting-pneumonia-biggest-killer-young-children</loc>
  <lastmod>2021-10-07T12:55:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/kenya-confronts-chronic-diseases-building-progress-against-aids</loc>
  <lastmod>2021-10-13T10:25:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/helping-people-sickle-cell-disease-painful-and-life-threatening-blood-disorder</loc>
  <lastmod>2021-10-07T11:53:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/helping-syrian-refugees-manage-chronic-diseases</loc>
  <lastmod>2021-10-07T11:52:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/improving-lives-through-community-based-care</loc>
  <lastmod>2021-10-13T10:18:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/sight-savers-jet-rescue</loc>
  <lastmod>2021-10-14T12:13:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/streamlining-systems-respond-covid-19</loc>
  <lastmod>2021-10-14T12:21:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/tailoring-tactics-tackle-chronic-disease-low-income-countries</loc>
  <lastmod>2021-10-14T12:39:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/talking-ann-aerts-head-novartis-foundation</loc>
  <lastmod>2021-10-14T13:10:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/life-dedicated-fighting-malaria</loc>
  <lastmod>2021-11-17T15:28:51+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/living-breast-cancer-uganda</loc>
  <lastmod>2021-10-13T11:00:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/living-hypertension-cameroon-few-dollars-day</loc>
  <lastmod>2021-09-28T14:41:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/malaria-fighter-rides-bicycle-battle-disease</loc>
  <lastmod>2021-10-13T12:26:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/malaria-still-disrupting-lives-despite-progress</loc>
  <lastmod>2021-10-13T13:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/talking-juergen-brokatzky-geiger-global-head-corporate-responsibility-novartis</loc>
  <lastmod>2021-10-11T13:40:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/talking-patrice-matchaba-global-head-corporate-responsibility-novartis</loc>
  <lastmod>2021-10-07T10:49:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/telemedicine-taking-health-care-worlds-far-corners</loc>
  <lastmod>2022-05-24T16:12:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/text-messages-africa-help-fight-malaria</loc>
  <lastmod>2021-11-18T16:25:22+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/treating-cataracts-leading-cause-preventable-blindness-worldwide</loc>
  <lastmod>2021-10-07T10:46:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-fionnuala-doyle</loc>
  <lastmod>2021-10-07T10:44:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/fighting-ms-through-innovation</loc>
  <lastmod>2021-10-11T13:33:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/from-melanoma-survivor-front-line-nurse</loc>
  <lastmod>2021-09-29T07:18:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/ai-nurse-evolving-heart-failure-patients-china</loc>
  <lastmod>2021-12-14T12:32:41+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/body-painter-captures-anguish-those-who-suffer-from-psoriasis</loc>
  <lastmod>2021-10-07T10:27:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/changing-landscape-cancer-treatment</loc>
  <lastmod>2021-10-07T10:24:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/caring-someone-heart-failure</loc>
  <lastmod>2021-10-07T10:25:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/choosing-right-care</loc>
  <lastmod>2021-10-07T10:22:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/conversations-patient-advocates-ron-hollander-president-inca</loc>
  <lastmod>2021-10-07T10:21:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/coping-eye-disease-and-fading-vision-late-life</loc>
  <lastmod>2021-10-07T10:07:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/meet-manuel-cobos-transplant-surgeon-and-researcher</loc>
  <lastmod>2021-10-13T14:51:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/creative-ways-help-kids-understand-rare-diseases</loc>
  <lastmod>2021-10-11T13:15:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/dealing-psoriasis</loc>
  <lastmod>2022-02-14T15:53:07+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/debunking-myths-about-multiple-sclerosis</loc>
  <lastmod>2021-10-07T10:03:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/digital-innovation-looks-set-dominate-2021-healthcare-agenda</loc>
  <lastmod>2021-10-11T12:01:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/digital-health-providing-opportunities-advocacy-groups-and-community-patients</loc>
  <lastmod>2021-10-07T10:02:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/meet-martin-grobusch-malaria-fighter</loc>
  <lastmod>2021-10-13T15:53:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/experts-call-new-approach-patient-and-physician-management-type-2-diabetes</loc>
  <lastmod>2021-10-07T09:59:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/giving-small-community-big-voice</loc>
  <lastmod>2021-10-15T15:57:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/fitness-trainer-strives-keep-his-mothers-mind-limber</loc>
  <lastmod>2021-10-11T11:48:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/from-nurse-patient-facing-aggressive-blood-cancer</loc>
  <lastmod>2021-10-18T06:19:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/glaucoma-silently-steals-sight</loc>
  <lastmod>2021-10-15T15:53:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/meet-visionary-who-beat-odds-realize-his-vision-inclusive-eye-care</loc>
  <lastmod>2021-11-24T16:14:46+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/groundskeeper-tackles-cancer-several-ways</loc>
  <lastmod>2021-10-15T15:50:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/heart-failure-coping-one-worlds-biggest-killers</loc>
  <lastmod>2021-10-15T15:45:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/importance-caregivers</loc>
  <lastmod>2021-10-15T15:39:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/inside-cancer-diagnosis</loc>
  <lastmod>2021-10-15T14:51:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/patients-perspective-biomarker-testing</loc>
  <lastmod>2021-10-15T11:46:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/led-steven-taylor-sjogrens-syndrome-foundation-raising-awareness-little-known-autoimmune-disease</loc>
  <lastmod>2021-10-08T10:39:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/lessons-from-blind-chef</loc>
  <lastmod>2022-01-07T09:19:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/living-heart-failure</loc>
  <lastmod>2021-10-15T11:45:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/living-hfpef-patients-story</loc>
  <lastmod>2021-11-17T17:37:31+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/longevity-vitality-japanese-elders-provide-examples-healthy-aging</loc>
  <lastmod>2021-10-15T12:09:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/lung-cancer-test-or-not-test</loc>
  <lastmod>2021-10-14T14:28:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/meet-tj-sharpe</loc>
  <lastmod>2021-10-14T14:13:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/most-europeans-have-limited-awareness-about-heart-failure</loc>
  <lastmod>2022-01-07T09:11:28+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/migraine-one-worlds-most-common-diseases</loc>
  <lastmod>2021-10-14T14:11:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/new-years-resolution-copd</loc>
  <lastmod>2021-10-14T13:51:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/no-longer-living-fear</loc>
  <lastmod>2021-10-15T12:22:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/one-boys-quest-battle-cancer</loc>
  <lastmod>2022-01-10T08:40:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/parenting-child-rare-disease</loc>
  <lastmod>2021-10-14T13:08:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/patient-advocacy-work-one-mans-contributions-copd-community</loc>
  <lastmod>2021-10-14T13:01:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/psoriasis-story-hidden-condition</loc>
  <lastmod>2021-10-11T11:09:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/putting-patients-first</loc>
  <lastmod>2022-02-14T11:58:04+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/rare-every-day-experiences-challenges-and-victories-rare-disease-community</loc>
  <lastmod>2021-09-30T09:08:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/protecting-our-tomorrows-portraits-meningococcal-disease</loc>
  <lastmod>2021-10-14T11:41:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/realities-living-premenopausal-metastatic-breast-cancer</loc>
  <lastmod>2021-11-17T11:46:58+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/reimagining-asthma-care-how-data-and-digital-could-bring-asthma-management-goals-within-reach</loc>
  <lastmod>2021-10-14T10:39:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/surviving-heart-failure</loc>
  <lastmod>2022-06-21T15:49:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/speaking-cml</loc>
  <lastmod>2021-09-29T10:00:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/targeting-roots-sjogrens-syndrome</loc>
  <lastmod>2021-09-29T10:18:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/tj-sharpe-why-clinical-trials-matter</loc>
  <lastmod>2021-09-29T10:20:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/visionary-silke-mader-has-vision-care-premature-infants-and-their-parents</loc>
  <lastmod>2021-10-11T10:30:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/why-research-rare-diseases-matters</loc>
  <lastmod>2021-08-25T13:31:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/turning-sound-patient-voices-lung-cancer-research-and-development</loc>
  <lastmod>2021-10-01T07:49:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/flexibility-novartis-ana-graf</loc>
  <lastmod>2021-09-29T11:17:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/enabling-130000-employees-grow-organization-committed-continuous-learning</loc>
  <lastmod>2021-09-29T10:38:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/your-genes-your-melanoma</loc>
  <lastmod>2021-09-29T10:27:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/flexibility-novartis-deepti-mittal</loc>
  <lastmod>2021-09-29T11:20:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/flexibility-novartis-christine-sturchler-and-aileen-wrynn</loc>
  <lastmod>2021-10-14T07:23:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/flexibility-novartis-janneke-van-der-kamp</loc>
  <lastmod>2021-09-29T11:22:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/flexibility-novartis-peter-canavan</loc>
  <lastmod>2021-10-14T06:37:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/flexibility-novartis-linda-karpiak</loc>
  <lastmod>2021-09-29T11:23:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/flexibility-novartis-robert-gschwentner-and-stefan-lackner</loc>
  <lastmod>2021-10-14T06:27:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/going-extra-mile-keep-clinical-trials-track-during-covid-19-pandemic</loc>
  <lastmod>2021-09-29T12:37:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/flexibility-novartis-shamsah-kazani</loc>
  <lastmod>2021-11-16T11:15:40+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-social-business-careers-improving-health-lower-income-countries</loc>
  <lastmod>2022-01-07T09:00:43+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/oncology-careers-life-changing-purpose</loc>
  <lastmod>2021-09-29T12:46:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/parental-leave-novartis-alfreds-story</loc>
  <lastmod>2022-05-24T16:23:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/parental-leave-novartis-michaels-story</loc>
  <lastmod>2021-11-23T16:50:24+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/nudging-bias-out-organization</loc>
  <lastmod>2021-09-23T11:39:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/qa-new-nibr-cio-dimitris-agrafiotis</loc>
  <lastmod>2021-09-30T14:50:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/reimagining-cancer-workplace</loc>
  <lastmod>2021-09-29T12:52:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/teaching-daughter-power-purpose</loc>
  <lastmod>2021-10-14T10:09:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/two-decades-volunteering-novartis</loc>
  <lastmod>2021-10-11T10:18:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/making-healthcare-sustainable-developing-world</loc>
  <lastmod>2021-10-06T07:37:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/positive-gains-are-needed-accelerate-change-women-lung-disease</loc>
  <lastmod>2021-10-01T10:03:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/new-drugs-could-offer-hope-malaria-patients</loc>
  <lastmod>2021-10-03T16:01:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/partnering-improved-cancer-care-around-globe</loc>
  <lastmod>2021-10-07T11:03:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/pioneering-business-approach-expands-healthcare-indian-villages</loc>
  <lastmod>2021-10-14T11:57:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-joins-pharma-wide-effort-meet-global-demand-covid-19-vaccines</loc>
  <lastmod>2022-05-20T15:35:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/new-orbis-flying-eye-hospital-helps-fight-blindness-china</loc>
  <lastmod>2021-10-14T08:54:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-access-impact-evaluation-progress-update-our-work-boston-university</loc>
  <lastmod>2021-10-01T10:07:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-invites-scrutiny-effort-improve-access-medicine</loc>
  <lastmod>2022-06-07T17:08:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/artificial-intelligence-decodes-cancer-pathology-images-without-image-gallery</loc>
  <lastmod>2021-08-24T11:51:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/can-data-from-heart-disease-trial-lead-potential-cancer-treatment</loc>
  <lastmod>2021-09-30T14:48:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/cancer-research-drives-breast-cancer-treatment-forward</loc>
  <lastmod>2021-09-30T09:47:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/discovery-gives-cystic-fibrosis-researchers-new-direction</loc>
  <lastmod>2021-10-11T10:39:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/guidance-system-lights-path-drug-discovery</loc>
  <lastmod>2021-10-18T09:03:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/need-new-heart-disease-medicines-drives-wave-potential-therapies</loc>
  <lastmod>2021-09-30T11:20:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/researchers-boost-understanding-t-cell-therapy-blood-cancer</loc>
  <lastmod>2021-09-30T11:41:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-and-uc-berkeley-take-undruggable-proteins-new-collaboration</loc>
  <lastmod>2022-05-24T16:17:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/striving-vanquish-leukemia</loc>
  <lastmod>2021-09-27T11:08:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/sourcing-innovation-strategically</loc>
  <lastmod>2021-09-30T12:12:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/take-visual-tour-medicines-target-rna</loc>
  <lastmod>2022-06-21T17:13:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/toward-improving-health-and-longevity-transplanted-organs</loc>
  <lastmod>2021-09-30T15:13:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/using-super-resolution-microscopy-see-neurodegeneration</loc>
  <lastmod>2021-09-30T15:30:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/visualizing-molecular-glues</loc>
  <lastmod>2021-09-30T15:43:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/advancing-medicine-through-collaboration</loc>
  <lastmod>2021-09-30T16:00:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/how-19th-century-technology-speeding-drug-discovery</loc>
  <lastmod>2021-09-30T16:13:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/seeing-through-knees-quest-alleviate-osteoarthritis</loc>
  <lastmod>2021-09-30T16:17:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/why-novartis-scouts-disruptive-technology</loc>
  <lastmod>2021-09-30T16:30:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/future-chronic-myeloid-leukemia-evolving</loc>
  <lastmod>2021-10-15T16:05:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/inspiring-daughter-make-her-own-path</loc>
  <lastmod>2021-10-15T12:05:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/being-and-becoming-data-science-company</loc>
  <lastmod>2021-09-30T14:30:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/doing-right-thing-good-business</loc>
  <lastmod>2021-10-11T08:41:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/discover-how-inflammation-could-fan-flames-cancer</loc>
  <lastmod>2021-10-11T10:42:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/your-neighborhood-community-based-approach-health-equity-us</loc>
  <lastmod>2021-10-26T16:09:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/search-new-options-patients-lung-cancer</loc>
  <lastmod>2021-10-01T12:27:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/toward-regrowing-cartilage</loc>
  <lastmod>2021-10-14T10:42:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/blood-cancer-patients-long-road-diagnosis</loc>
  <lastmod>2021-10-15T12:02:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/photographer-captures-patients-around-world-persevering-itp</loc>
  <lastmod>2021-10-08T08:09:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/expanding-new-digital-healthcare-solution-across-chronic-heart-disease-management</loc>
  <lastmod>2021-10-11T08:39:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/restoring-vision-and-hope-thousands-southeast-asia</loc>
  <lastmod>2021-10-15T13:41:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/demystifying-science-myelodysplastic-syndromes</loc>
  <lastmod>2021-10-25T17:10:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/breaking-down-barriers-patients-sickle-cell-disease</loc>
  <lastmod>2021-11-04T13:25:59+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/make-difference-start-patients</loc>
  <lastmod>2022-01-07T09:06:40+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/solving-puzzle-immunotherapy</loc>
  <lastmod>2021-11-08T18:14:27+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/stopping-coronavirus-and-next-one</loc>
  <lastmod>2021-11-25T15:35:49+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/art-drug-design-technological-age</loc>
  <lastmod>2021-11-18T17:06:23+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/when-it-comes-cancer-theres-power-good-partner</loc>
  <lastmod>2021-12-06T16:07:19+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/prioritizing-needs-patients</loc>
  <lastmod>2022-03-04T14:31:49+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/understanding-hidradenitis-suppurativa-through-jasmines-eyes</loc>
  <lastmod>2022-03-25T10:27:19+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/tackling-health-toll-climate-change</loc>
  <lastmod>2022-04-06T15:38:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/staying-one-step-ahead-malaria-parasite</loc>
  <lastmod>2022-04-19T18:16:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/boosting-access-cancer-care-where-its-needed-most</loc>
  <lastmod>2022-06-13T09:30:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/how-emilys-act-bravery-inspired-wave-continued-innovation</loc>
  <lastmod>2022-05-27T16:07:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/prostate-cancer-collective-commitment-serving-underserved-communities</loc>
  <lastmod>2022-06-13T09:12:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/shared-mission-take-impossible-cancer-research</loc>
  <lastmod>2022-06-15T08:37:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/sickle-cell-screening-urged-newborns-africa</loc>
  <lastmod>2022-06-29T08:28:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/renewing-our-commitment-neglected-tropical-disease-and-malaria-elimination</loc>
  <lastmod>2022-06-23T07:30:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
</urlset>
